New Strategies for Hydroxyl-Directed Organic Reactions by Blaisdell, Thomas Powers
Persistent link: http://hdl.handle.net/2345/bc-ir:104626
This work is posted on eScholarship@BC,
Boston College University Libraries.
Boston College Electronic Thesis or Dissertation, 2015
Copyright is held by the author, with all rights reserved, unless otherwise noted.
New Strategies for Hydroxyl-Directed
Organic Reactions
Author: Thomas Powers Blaisdell
Boston College 
The Graduate School of Arts and Sciences 
Department of Chemistry 
 
 
 
 
NEW STRATEGIES FOR HYDROXYL-DIRECTED ORGANIC REACTIONS 
 
 
 
A dissertation 
by 
THOMAS POWERS BLAISDELL 
 
 
 
submitted in partial fulfillment of the requirements 
for the degree of 
Doctor of Philosophy 
 
 
July 2015 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© copyright by THOMAS POWERS BLAISDELL 
2015  
NEW STRATEGIES FOR HYDROXYL-DIRECTED ORGANIC REACTIONS 
 
 
by 
THOMAS POWERS BLAISDELL 
 
Dissertation Advisors: 
Professors Kian L. Tan and James P. Morken 
 
ABSTRACT: Described herein are four different research projects spanning over two 
different research groups.  The first two projects describe the development and 
application of scaffolding catalysts for the (1) site-selective siliyation of ribonucleosides 
and (2) the distal and diastereoselective hydroformylation of homoallylic alcohols.  These 
projects emphasize the effectiveness of scaffolding catalysts to bind a hydroxyl-
containing substrate and control the site- or regioselectivity of a reaction using said 
substrate.  The third project describes a hydroxyl-directed diboration of homoallylic and 
bis-homoallylic alcohols.  The hydroxyl-containing 1,2-bis(boronates) are valuable 
intermediates for further synthetic manipulations.  One such manipulation, a hydroxyl-
directed Suzuki cross-coupling reaction, is the focus of the final project.  This directed 
cross-coupling reaction forges carbon-carbon bonds in a stereoselective manner, 
highlighted in the total synthesis of the naturally occurring compound, 
debromohamigeran E. 
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Chapter 1: Site-Selective Silylation of Ribonucleosides 
 
1.1 Introduction 
Ribonucleosides are composed of a ribose sugar and a nucleobase segment.  
When linked together by a phosphodiester bond, ribonucleosides make up the general 
structure of RNA.  Unlike DNA, the ribose moiety found in RNA contains hydroxyl 
groups at both the 2` and 3` carbons of the pentose ring (Scheme 1.1).  The presence of a 
hydroxyl group at the 2` carbon allows RNA to adopt an A-form double helix rather than 
the B-form geometry typically associated with DNA.1  Furthermore, the additional 
hydroxyl group makes RNA more susceptible to hydrolysis than DNA.  Of course, this 
susceptibility is what allows RNA to fulfill the role of a temporary transmitter of genetic 
information. 
 
Scheme 1.1 General Structures of RNA and DNA Nucleosides 
 
 
1.1.1 Automated RNA Synthesis 
In addition to the biological differences brought on by the 2`-hydroxyl group, its 
presence also introduces added complexity to the chemical synthesis of RNA.  The 
production of synthetic DNA benefited greatly from the development of solid-phase !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Salazar, M.; Fedoroff, O.; Miller, J.; Ribeiro, N.; Reid, B. Biochemistry 1993, 32, 4207 
– 4215. 
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HO OH
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3' 2'
O Base
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HO
ribonucleoside deoxyribonucleoside
3'
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automated synthesizers. Solid-support methods for the synthesis of RNA have also been 
developed, though to a lesser degree of efficiency (Scheme 1.2).2  Typically, a 4,4’-
dimethoxytrityl (DMTr)-protected ribonucleoside 1.1 is subjected to deprotection 
conditions (Scheme 1.2, A), followed by coupling to a nucleotide phosphoramidite 1.2 
using a tetrazole activator, such as 5-ethylthio-1H-tetrazole (ETT) (Scheme 1.2, B).  
Unreacted solid-supported ribonucleosides are “capped” by reaction with acetic 
anhydride, which prevents additional ribonucleosides adding to this group.  The 
phosphite 1.3 is oxidized to form the phosphate-linked ribonucleotides 1.4 (Scheme 1.2, 
C) and the whole process can then be repeated in order to lengthen the RNA strand.  
Once the appropriate length is reached, the 2-cyanoethyl group and the solid-support can 
be cleaved with mild base. 
 
 
 
 
 
 
 
 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 Somoza, A. Chem. Soc. Rev., 2008, 37, 2668 – 2675 
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Scheme 1.2 The Synthetic Strategy of an Automated RNA Synthesizer 
 
 
1.1.2 Importance of Ribonucleoside Functionalization 
The efficiency of this method of RNA synthesis depends heavily on the 
accessibility of the required nucleoside monomer units.  Generally, in the synthesis of 
deoxyribonucleoside monomers, the 3`- and the 5`-hydroxyl groups are readily 
differentiated.  However, in the case of ribonucleosides, the presence of two adjacent 
secondary hydroxyl groups greatly complicates matters due to their similar reactivities, 
especially during the installation of the phosphoramidite group. 
In addition to artificial RNA synthesis, the ribonucleoside scaffold has become an 
increasingly popular template for pharmaceuticals (Scheme 1.3).3  These nucleoside !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 Jordheim, L. P.; Durantel, D.; Zoulim, F.; Dumontet, C. Nat. Rev. Drug Discov. 2013, 
12, 447 – 464. 
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analogs target a wide variety of diseases including cancer (ribonucleotide reductase 
inhibitors)4 and viral infections.5  Notably, the 2`-hydroxyl group in many of these 
therapeutics has been manipulated in some manner, while the 3`-hydroxyl group remains 
unfunctionalized. 
 
Scheme 1.3 Examples of Therapeutics Containing a Modified Ribonucleoside Motif 
 
 
1.2 Examples of Selective Silylation of Ribonucleosides 
The tert-butyldimethylsilyl (TBS) protecting group, is one of the most popular 
means of protecting the secondary hydroxyl groups found in ribonucleosides. Its value 
lies in its tolerance for DMTr deprotection conditions, while still being readily removable 
by a fluoride anion source, such as TBAF.  The classical means of accessing 
monosilylated (either 2`- or 3`-) ribonucleosides is to subject the free nucleoside to an 
unselective silylation reaction and resolve the mixture of the two products by 
chromatographic separation.6  This method is extremely time inefficient, and unwanted 
byproduct formation is unavoidable.  For this reason, some have worked to develop 
methods for the selective silylation of ribonucleosides.   !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
4 Shao, J.; Zhou, B.; Chu, B.; Yen, Y. Curr. Cancer Drug Targets 2006, 6, 409 – 431. 
5 Dapp, M. J.; Bonnac, C.; Patterson, S. E.; Mansky, L. M. J. Virol. 2014, 88, 354 – 363. 
6 MatulicAdamic, J.; Beigelman, L.; Portmann, S.; Egli, R.; Usman, N. J. Org. Chem. 
1996, 61, 3909 – 3911. 
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Jones and coworkers7 found that selective silylation of the 2`-hydroxyl could be 
achieved by using tert-butyldimethylsilyl chloride (TBSCl) and ammonium phenyl-H-
phosphonate (Scheme 1.4).  It is believed that the phosphonate first forms a diester with 
the silyl chloride.  This species undergoes transesterification with the ribonucleoside to 
form a mixture of phosphitylated products 1.5 and 1.6.  Transfer of the silyl group occurs 
mostly at the more acidic 2`-hydroxyl group8; the authors report observing 10-15% 
3`-protected product.  Unfortunately, this methodology has been demonstrated only with 
phenoxyacetyl-protected adenosine (APac) and guanidine (GPac). 
 
Scheme 1.4 Phosphonate-Mediated 2`-Hydroxyl Silylation of APac and GPac 
 
Ogilvie and coworkers9 have developed two procedures for the selective silylation 
of either the 2`- or 3`-hydroxyl groups (Scheme 1.5).  When using TBSCl as the silyl 
chloride and AgNO3 as a stoichiometric additive, selective silylation of the 2`-hydroxyl 
was observed (Scheme 1.5, A).  While uridine (U), adenosine (A) and benzoyl-protected 
cytosine (CBz) gave useful yields of the 2`-protected product, benzoyl-protected 
guanidine (GBz) and an unnatural phenyl-substituted ribonucleoside (Ph) gave poor !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
7 Song, Q.; Wang, W.; Fischer, A.; Zhang, X.; Gaffney, B.; Jones, R. Tetrahedron 
Lett. 1999, 40, 4153 – 4156. 
8 For studies focused on the determination of the pKas of the 2` and 3` hydroxyls of 
adenosine, see: Åström, H.; Limén, E.; Strömberg, R. J. Am. Chem. Soc. 2004, 126, 
14710 – 14711. 
9 Hakimelahi, G.; Proba, Z.; Ogilvie, K. Can. J. Chem., 1982, 60, 1106 – 1113. 
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selectivity.  It should be noted that, in general, the separation of the two isomers by 
column chromatography is not trivial.  While the specific role of AgNO3 is unknown, 
when TBSNO3 was used in place of TBSCl/AgNO3, similar selectivities were observed.  
Interestingly, when silver perchlorate (AgClO4) was used instead of AgNO3, silylation 
became selective for the 3`-protection with good yields observed for most of the 
ribonucleosides (Scheme 1.5, B).  Although no explanation was given for the switch in 
selectivity, the authors asserted that 3`-silylation resulted from a direct reaction with the 
3`-hydroxyl group, and was not a consequence of silyl transfer from the 2`-silylated 
product. 
 
Scheme 1.5 AgNO3 and AgClO4-Mediated 2`- and 3`-Hydroxyl Silylation 
 
Another method to selectively functionalize the 2`-hydroxyl group involves the 
use of a disiloxane protecting group to simultaneously mask both the 3`- and 5`-hydroxyl 
groups.  Kwiatkowski and coworkers10 utilized this strategy for selective installation of a 
tert-butyldithiomethyl (DTM) group at the 2`-hydroxyl (Scheme 1.6).  Using 1,3-
dichloro-1,1,3,3-tetraisopropyldisiloxane (TIPDSiCl2), the 3`- and 5`-hydroxyl groups 
were smoothly protected, thereby allowing further functionalization of the 2`-hydroxyl 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
10 Semenyuk, A.; Földesi, A.; Johansson, T.; Estmer-Nilsson, C.; Blomgren, P.; 
Brännvall, M.; Kirsebom, L.; Kwiatkowski, M. J. Am. Chem. Soc., 2006, 128, 12356 – 
12357. 
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group.  The disiloxane protecting group could later be removed using a fluoride anion 
source, affording the 2`-protected product.   
 
Scheme 1.6 3`- and 5`-Hydroxyl Silyl Protection 
 
 
1.3 Selected Examples of Site-Selective Functionalization of Complex Molecules 
The development of techniques to perform a wide variety of site-selective 
functionalizations on complex molecules has been an ongoing goal for synthetic 
chemists.  Site-selective control can be accomplished by using inherent chemical 
selectivity within the molecule or through the use of a catalyst.  The ability to perform 
such late stage functionalizations on complex molecules provides an efficient and rapid 
means of synthesizing related analogs. 
Miller and coworkers have developed a class of small peptides that catalyze the 
selective functionalization of various complex molecules.  The site-selective 
functionalization of erythromycin A was achieved using different imidazole-based 
catalysts (Scheme 1.7).11  The two most reactive hydroxyl groups (C2’ and C4’) could be 
selectively protected using 1.7 and N-methylimidazole, yielding 1.8 in a greater than 10:1 
ratio relative to 1.10.  Alternatively, the hydroxyl groups at C2’ and C11 could be 
functionalized with 1.7 using chiral catalyst 1.9, furnishing 1.10 in 58% yield. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
11 Lewis, C. A.; Miller, S. J. Angew. Chem., Int. Ed. 2006, 45, 5616 – 5619. 
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Scheme 1.7 Site-Selective Functionalization of Erythromycin A 
 
In addition to selective protection of polyols, Miller and coworkers have 
investigated the site-selective bromination of vancomycin.12 Using peptide 1.11 and 
N-bromopthalimide as a brominating agent, arene 5 of vancomycin was selectively 
brominated (Scheme 1.8).  Without a catalyst, the reaction proceeds in a completely 
unselective manner, furnishing a complex mixture of aryl bromination products.  
Furthermore, Miller and coworkers 13  have also developed a site-selective 
dehydroxylation reaction of a protected analog of vancomycin.  Peptide 1.12 proved to 
efficiently transfer phenyl thionoformate to the Z6 hydroxyl group.  The resulting 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
12 Pathak, T.; Miller, S. J. Am. Chem. Soc. 2012, 134, 6120 – 6123. 
13 Fowler, B.; Laemmerhold, K.; Miller, S. J. Am. Chem. Soc. 2012, 134, 9755 – 9761. 
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thiocarbonyl ester can then be subjected to deoxygenation conditions, yielding 
Z6-dehydroxylated vancomycin after a deprotection step (Scheme 1.8).  
 
Scheme 1.8 Site-Selective Functionalization of Vancomycin 
 
In 2007, White and coworkers14 disclosed a site-selective C−H oxidation reaction 
using an iron catalyst and hydrogen perioxide.  The methodology proved to be effective 
for the late stage oxidation of a variety of complex molecules.  More specifically, 
(+)-artemisinin, a natural product effective in the treatment of malaria, was subjected to 
the mild oxidation conditions. Fascinatingly, only one of the five tertiary C−H bonds 
present was oxidized to the alcohol, furnishing 1.13 in 54% isolated yield (Scheme 1.9).  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
14 Chen, M. S.; White, M. C. Science 2007, 318, 783 – 787. 
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The high selectivity observed was attributed solely to the electronic and steric properties 
of the activated C–H bond. 
 
Scheme 1.9 Site-Selective C–H Oxidation of (+)-Artemisinin 
 
Kawabata and coworkers 15  developed a C2-symmetric chiral 4-pyrrolidino-
pyridine catalyst system that successfully catalyzed the site-selective acylation of 
monosaccardies (Scheme 1.10).  When subjecting octyl β-D-glucopyranoside to 
isobutyric anhydride and the 4-pyrrolidinopyridine catalyst 1.14, the secondary hydroxyl 
group at C4 was preferentially acylated, yielding 1.15 in excellent yield.  It should be 
noted that acylation at C4 is favored over acylation at the less hindered primary alcohol at 
C6, which is presumed to participate in hydrogen bonding with the amide carbonyl of the 
DMAP catalyst. 
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15 Kawabata, T; Muramatsu, W; Nishio, T.; Shibata, N.; Schedel, H. J. Am. Chem. Soc., 
2007, 129, 12890 – 12895 
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Scheme 1.10 Catalytic, Site-Selective Acylation of Monosaccarides 
 
 
1.4 Notable Catalysts for the Recognition of 1,2-Diols 
As already noted, 1,2-diols are a common motif in many naturally occurring 
molecules.  Additionally, symmetric syn-1,2-diols are a common substrate for 
desymmetrization methodologies.  Further extension of these methods, by the 
development of catalysts that can recognize and selectively functionalize such diols, 
would be a powerful tool for site selective catalysis.  Moreover, a catalyst that selectively 
binds to a 1,2-diol motif can be particularly useful for the site-selective functionalization 
of polyhydroxylated molecules (monosaccarides, ribonucleosides, etc.). 
 
1.4.1 Peptide-Based Catalyst 
In 2006, Hoveyda and Snapper 16  disclosed peptide catalyst 1.16 for the 
desymmetrization of 1,2- and 1,3-diols via silyl transfer (Scheme 1.11).  The reaction 
proceeds with excellent yields and enantioselectivities for the majority of the substrates 
investigated.  It is proposed that 1.16 binds the diol (through hydrogen-bonding with the !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
16 Zhao, Y.; Rodrigo, J.; Hoveyda, A. H.; Snapper, M. L. Nature 2006, 443, 67 – 70 
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amide and imidazole functionalities) and activates one of the hydroxyl groups for 
silylation.  The efficiency of the reaction was later greatly improved by the use of 
5-ethylthiotetrazole as a co-catalyst, which is proposed to further activate the silyl 
chloride.17  In addition to the desymmetrization of 1,2- and 1,3-diols, these peptide 
catalysts have shown to be effective for the resolution of racemic 1,2-diols18 and the 
desymmetrization of meso-1,2,3-triols.19 
 
Scheme 1.11 Peptide-Catalyzed Desymmetrization of 1,2- and 1,3-Diols 
 
 
1.4.2 Borinic Acid Catalyst 
Taylor and coworkers20 have developed a borinic acid catalyst system for the 
selective functionalization of 1,2-diols.  The diaryl borinic catalyst 1.18 binds to the diol, 
forming a tetracoordinate borinate complex, which will react with an electrophile.  In !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
17 Manville, N.; Alite, H.; Haeffner, F.; Hoveyda, A. H.; Snapper, M. L. Nat. Chem. 
2013, 5, 768 – 774 
18 (a) Zhao, Y.; Mitra, A. W.; Hoveyda, A. H.; Snapper, M. L. Angew. Chem., Int. Ed. 
2007, 46, 8471 – 8474. (b) Rodrigo, J. M.; Zhao, Y.; Hoveyda, A. H.; Snapper, M. L. 
Org. Lett. 2011, 13, 3778 – 3781. 
19 You, Z.; Hoveyda, A. H.; Snapper, M. L. Angew. Chem. Int. Ed. 2009, 48, 547 – 550. 
20 (a) Lee, D.; Taylor, M. S. J. Am. Chem. Soc. 2011, 133, 3724 – 3727. (b) Lee, D.; 
Williamson, C. L.; Chan, L.; Taylor, M. S. J. Am. Chem. Soc. 2012, 134, 8260 – 8267. 
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addition to simple 1,2-diols, the method can be used for the site selective 
functionalization of carbohydrates as well.  The tosylation of 1.17 yields 1.19 in 99% 
yield (Scheme 1.12).  In addition to sulfonyl chlorides, the scope of electrophiles used 
includes acyl chlorides and benzyl bromide. 
 
Scheme 1.12 Site-Selective Functionalization of Monosaccharides with a Borinic 
Catalyst 
 
 
1.4.3 Copper Ion Catalyst 
Another effective mode of activating 1,2-diols is through the use of copper ion 
catalysis. This approach is inspired by lectin proteins, which are known to bind sugars 
through a coordination of their metal centers to the sugars’ 1,2-diol units.  In 2003, 
Matsumura and coworkers21 disclosed the asymmetric benzoylation of 1,2-diols using 
copper ion-induced activation.  Dong and coworkers 22  have expanded on this 
methodology through the site-selective acylation and tosylation of a variety of different 
carbohydrates.  The efficiency of this method was displayed through the selective !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
21 Matsumura, Y.; Maki, T.; Murakami, S.; Onomura, O. J. Am. Chem. Soc. 2003, 125, 
2052 – 2053 
22 Chen, I.; Kou, K. G.; Le, D. N.; Rathbun, C. M.; Dong, V. M. Chem. Eur. J. 2014, 20, 
5013 – 5018 
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acylation of ribofuranoside 1.20 (Scheme 1.13). Both structural isomers were accessed 
through variation of the catalyst’s ligand structure.  (S,S)-1.21 proved to favor the 
3`-benzoylated product while the 2`-benzoylated product was the major isomer observed 
when (R,R)-1.22 was used as the ligand. 
 
Scheme 1.13 Copper-Catalyzed Acylation of Ribofuranosides 
 
 
1.4.4 Scaffolding Catalyst 
Scaffolding catalysis has been successfully used for the recognition and 
functionalization of 1,2-diols.  In its simplest form, scaffolding catalysis is the use of a 
catalyst (1.23) that will reversibly bind a molecule of substrate (1.24) and undergo an 
induced intramolecular reaction (1.25).  The release of product will turn over the catalyst.  
The key to an effective scaffolding catalyst is the rapid and reversible binding interaction 
between substrate and catalyst (Scheme 1.14). 
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Scheme 1.14 Catalytic Cycle of a Scaffolding Catalyst 
 
 
In 2011, Tan and coworkers 23  reported scaffolding catalyst 1.27 for the 
desymmetrization of 1,2-diols via silyl transfer (Scheme 1.15).  The catalyst contains 
both a N,O-acetal substrate binding site and a catalytic imidazole portion.  As mentioned 
previously, this class of catalysts benefits from an ability to form a reversible covalent 
bond with the diol substrate, forming a reactive diol-catalyst intermediate. This 
intermediate rapidly undergoes silylation and the monosilylated product is liberated from 
the catalyst. For the desymmetrization of syn-1,2-cyclopentane diol, the monoprotected 
product 1.26 was isolated in 84% yield and 97% enantioselectivity using catalyst 
(−)-1.27. 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
23 (a) Sun, X.; Worthy, A. D.; Tan, K. L Angew. Chem., Int. Ed. 2011, 50, 8167 – 8171. 
(b) Giustra, Z. X.; Tan, K. L. Chem. Commun., 2013, 49, 4370 – 4372. 
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Scheme 1.15 Desymmetrization of 1,2-Diols Using a Scaffolding Catalyst 
 
In addition to the desymmetrization of 1,2-diols, these scaffolding catalysts have 
been shown to be efficient for the regiodivergent resolution of racemic 1,2-diols24 and the 
site-selective functionalization of different polyhydroxylated complex molecules.25  For 
the latter case, both the 2`- and the 3`-silylated isomers (1.29 and 1.30) of mannose 
derivative 1.28 were isolated as the major product depending on which pseudoenantiomer 
of catalyst ((−)-1.31 and (+)-1.27) was used (Scheme 1.16, A).  In addition to 
monosaccharides, the site-selective acylation of the natural product digoxin was 
examined.  Both hydroxyl groups of the 1,2-diol motif were selectively acylated, yielding 
1.32 and 1.33 in 82% and 57% yield, respectively (Scheme 1.16, B). 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
24 (a) Worthy, A.; Sun, X.; Tan, K. J. Am. Chem. Soc. 2012, 134, 7321 – 7324. (b) Sun, 
X.; Worthy, A.; Tan, K. J. Org. Chem. 2013, 78, 10494 – 10499. 
25 Sun, X.; Lee, H.; Lee, S.; Tan, K. L. Nat. Chem. 2013, 5, 790 – 795. 
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Scheme 1.16 Site-Selective Functionalization of Polyhydroxylated Complex Molecules 
with a Scaffolding Catalyst 
 
 
1.5 Site-Selective Silylation of Ribonucleosides Using Scaffolding Catalysis26 
Given the success of scaffolding catalysts in the selective functionalization of 
carbohydrates, we sought to expand their use for the site-selective silylation of 
ribonucleosides.  A selective, one-step procedure to isolate a single structural isomer 
would be a substantial improvement over the current technology (Section 1.2).  Being 
able to obtain either one of the valuable monomers in a good ratio (>10:1) would !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
26 (a) Blaisdell, T. P.; Lee, S.; Kasaplar, P.; Sun, X.; Tan, K. L. Org. Lett. 2013, 15, 4710 
– 4713. (b) Lee, S., Blaisdell, T. P., Kasaplar, P., Sun, X. and Tan, K. L. Curr. Protoc. 
Nucleic Acid Chem. 2014, 57, 2.17.1 – 2.17.11. 
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eliminate the need for a lengthy purification step.  The overall usefulness of such a 
procedure would also depend, however, on the availability of the catalyst required.  
Fortunately, all the organocatalysts used in this work could be derived from inexpensive 
and commercially available starting materials in two or three steps.16a, 17a, 18 
 
1.5.1 Reaction Optimization 
 Initial studies were focused on 2`-protection of uridine using TBSCl.  A common 
catalyst for the silylation of alcohols is N-methylimidazole (NMI), which was used as a 
control catalyst.  As shown (entry 1, Table 1.1), reaction with NMI was only moderately 
selective.  However, when employing either scaffolding catalyst (−)-1.27 or (−)-1.31, 
there was a significant increase in the selectivity for 2`-TBS-U and moderate conversion 
(entries 2-3, Table 1.1).  When using catalyst (−)-1.34, which lacks a diol substrate-
binding site, the reaction became sluggish and essentially unselective (entry 4, Table 1.1).  
As the concentration of the reaction and the amount of TBSCl used were increased, full 
conversion was achieved with no loss of selectivity using catalyst (−)-1.31 (entry 5, Table 
1.1).  Reducing the catalyst loading to 10 mol% had no effect on conversion or selectivity 
and 2`-TBS-U was isolated in 93% yield (entry 6, Table 1.1).  Selectivity was maintained 
with 5 mol% of (−)-1.31, although the conversion decreased to 88% (entry 7, Table 1.1). 
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Table 1.1 TBS-Protection of D-Uridine: Reaction Optimization 
 
 
1.5.2 Selective Silylation of Natural Ribonucleosides with tert-Butyldimethylsilyl 
Chloride 
With optimization studies complete, the remaining ribonucleoside substrates were 
studied.  The TBS-protection of ABz using catalyst (−)-1.31 gave excellent selectivity for 
2`-TBS-ABz and good yield (entry 1, Table 1.2).  Likewise, the silylation of CBz gave 
both excellent selectivity and yield (entry 2, Table 1.2).  The silylation of GIb required 20 
mol% (−)-1.31 and an extended reaction time to furnish 2`-TBS-GIb in 97:3 selectivity 
and a 75% yield (entry 3, Table 1.2). 
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Table 1.2 TBS-Protection of the Other Natural Ribonucleosides 
 
 
1.5.3 Selective Silylation of Natural Ribonucleosides with Triethylsilyl Chloride 
With conditions developed for the selective silylation of the 2`-hydroxyl group, 
we turned our attention to accessing the 3`-protected ribonucleosides.  A common way of 
overturning the site-selectivity in similar reactions is to use the opposite enantiomer of 
catalyst.24  Unfortunately, when using TBSCl as the electrophile, both low conversions 
and selectivies were observed with catalyst (+)-1.27.  As demonstrated in the NMI control 
reaction, the 3`-hydroxyl group is less reactive then its 2`-counterpart.  Therefore, its 
functionalization requires a correspondingly more reactive electrophile.  Reaction with 
triethylsilyl chloride (TESCl) was thus attempted in place of TBSCl.  For 3`-TES 
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protection, (+)-1.27 and (+)-1.31 were used as catalysts, providing great selectivities 
(>10:1) and good isolated yields for U, ABz and CBz (entries 1, 3 and 5, Table 1.3).  
Moreover, only 5 mol% loading of catalyst was necessary for reaction completion within 
four hours.  The guanosine substrate required 20 mol% (+)-1.27 to obtain moderate 
selectivity and yield (entry 7, Table 1.3).  The 2`-hydroxyl can also be selectively TES-
protected using similar reaction conditions with (−)-1.31 as the catalyst.  Excellent 
selectivies and good yields were observed for all ribonucleosides substrates, with GIb 
requiring 10 mol% (−)-1.31 (entries 2, 4, 6 and 8, Table 1.3). 
 
Table 1.3 TES-Protection of the Natural Ribonucleosides 
 
 
1.5.4 Selective Silylation of Ribavirin 
 With the development of a procedure to selectively protect both the 2`- and 
3`-hydroxyl groups of the natural ribonucleosides, we extended this methodology to the 
antiviral agent, ribavirin.  Ribavirin is one of the most renowned antiviral drugs and is 
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currently on the World Health Organization’s list of “essential medicines.”  Since its 
discovery in 1972, a multitude of derivatives have been synthesized.27  When using 
(−)-1.31, unprotected ribavirin undergoes silylation at both the 5`- and 2`-hydroxyl 
groups with high selectivity (Scheme 1.17).  Similar selectivity for silylation at the 5`- 
and 3`-positions was observed when using (+)-1.27 as the catalyst.  Both 1.35 and 1.36 
can be considered important intermediates for the synthesis of analogs of ribavirin.   
 
Scheme 1.17 Selective Silylation of Ribavirin. 
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27 (a) Smee, D. F.; Alaghamandan, H. A.; Kini, G. D.; Robins, R. K. Antiviral Res. 1988, 
10, 253 – 262. (b) Tam, R.C.; Ramasamy, K.; Bard, J.; Pai, B. Antimicrobial 
Agents 2000, 1276 – 1283. (c) Liu, W. Y.; Li, H. Y.; Zhao, B. X.; Shin, D. S.; Lian, S.; 
Miao, J. Y. Carbohydrate Res. 2009, 344, 1270 – 1275. 
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1.6 Conclusion 
Through the use of scaffolding catalysis, the site-selective silylation of 
ribonucleosides was accomplished.  Both the 2`- and the 3`-protected products of all four 
ribonucleosides were obtained in useful yields and selectivities.  This methodology was 
extended to functionalization of unnatural ribonucleosides, highlighted through the 
selective silylation of ribavirin.  The work outlined is an excellent illustration of the 
power of scaffolding catalysis for the site-selective functionalization of complex 
molecules. 
 
1.7 Experimental Section 
1.7.1 General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers 
and used without further purification. N,N-Diisopropylethylamine and 
chlorotriethylsilane were purchased from Sigma Aldrich and distilled over CaH2 before 
use. Flash column chromatography was performed using EMD Silica Gel 60 (230-400 
mesh) and ACS grade solvents as received from Fisher Scientific. All experiments were 
performed in oven or flame dried glassware under an atmosphere of nitrogen or argon 
using standard syringe techniques, except where otherwise noted. All reactions were run 
with dry, degassed solvents dispensed from a Glass Contour Solvent Purification System 
(SG Water, USA LLC). 1H, 13C, and gCOSY NMR were performed on a Varian Gemini 
400 MHz, Varian Gemini 500 MHz or a Varian Unity Inova 500 MHz spectrometer. 
Deuterated solvents were purchased from Cambridge Isotope Labs and stored over 3Å 
molecular sieves. All NMR chemical shifts are reported in ppm relative to residual 
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solvent for 1H and 13C NMR. Signals are quoted as singlet (s), doublet (d), triplet (t), 
quartet (q), multiplet (m), and broad singlet (br s). Coupling constants are reported in Hz. 
All IR spectra were gathered on a Bruker Alpha FT-IR equipped with a single crystal 
diamond ATR module and values are reported in cm-1. HRMS data were generated in 
Boston College facilities.  
All protected ribonucleosides28 and catalysts16a,17a,18 were prepared following the 
previously reported procedures.  
The catalysts are commercially available through Strem: 1.27: 07-1222 and 
07-1223 1.31: 07-1226 and 07-1227. 
 
1.7.2 Silyl-Protection of Ribonucleosides, Representative Procedures 
General procedure for optimization of uridine silylation (Table 1.1) 
In a dry box, a suspension of the protected ribonucleoside (0.20 mmol), catalyst 
(0.04 mmol, 20 mol %), and N,N-diisopropylethylamine hydrochloride (1.1 mg, 0.006 
mmol, 3 mol %) in anhydrous THF (0.5 mL) was prepared in an oven-dried round-
bottom flask. The suspension was brought out of the dry box, and 
N,N-diisopropylethylamine (52 µL, 0.3 mmol, 1.5 eq) was added to the stirring reaction 
mixture at room temperature, followed by dropwise addition of tert-butyldimethylsilyl 
chloride (60 mg, 0.40 mmol, 2.0 eq) in THF (0.5 mL). The reaction was stirred at room 
temperature for 24 hours. DIPEA (30 µL) and methanol (50 µL) was added to quench the 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
28 Preparation of protected ribonucleoside: (a) DMTr-AdBz : Urata, H.; Hara, H.; Hirata, 
Y.; Ohmoto, N.; Akagi, M. Tetrahedron: Asymmetry 2005, 16, 2908 – 2917. (b) DMTr-
CyBz : Cui, Z.; Zhang, B. Helv. Chim. Acta 2007, 90, 297 – 310. Hakimelahi, G. H.; 
Proba, Z. A.; Ogilvie, K. K. Can. J. Chem. 1982, 60, 1106 – 1113. (c) DMTr-GuIb: 
Mourani, R.; Damha, M. Nucleosides, Nucleotides Nucleic Acids 2006, 25, 203 – 229. 
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reaction. The reaction mixture was put through a plug of silica gel (2 cm) and washed 
with EtOAc (15 mL). The solvent was removed under reduced pressure. Proton NMR 
was taken to determine conversion and product ratio using 1,3,5-trimethoxybenzene as 
internal standard.  
 
General procedure A for Site-Selective Silylation of Ribonucleosides (Table 1.2) 
 
In a dry box, a suspension of the protected ribonucleoside (0.30 mmol), catalyst 
(0.03 mmol, 10 mol %), and N,N-diisopropylethylamine hydrochloride (1.5 mg, 0.009 
mmol, 3 mol %) in anhydrous THF (0.2 mL) was prepared in an oven-dried round-
bottom flask. The suspension was brought out of the dry box, and 
N,N-diisopropylethylamine (78 µL, 0.45 mmol, 1.5 eq) was added to the stirring reaction 
mixture at room temperature, followed by dropwise addition of tert-butyldimethylsilyl 
chloride (90 mg, 0.60 mmol, 2.0 eq) in THF (0.1 mL). The reaction was stirred at room 
temperature for 24 hours. DIPEA (30 µL) and methanol (50 µL) was added to quench the 
reaction. The reaction mixture was put through a plug of silica gel (2 cm) and washed 
with EtOAc (15 mL). The solvent was removed under reduced pressure. Column 
chromatography on silica gel afforded the pure TBS-protected product. 
 
General procedure B for Site-Selective Silylation of Ribonucleosides (Table 1.3) 
base
O
OHOH
HH
DMTrO
10% (−)-1.23
TBSCl
DIPEA
3% DIPEA•HCl
THF, rt
base
O
OTBSOH
HH
DMTrO
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In a dry box, a mixture of the protected ribonucleoside (0.20 mmol), catalyst (0.01 
mmol, 5 mol %), and N,N-diisopropylethylamine hydrochloride (1.5 mg, 0.006 mmol, 3 
mol %) in anhydrous THF (1 mL) was prepared in an oven-dried round-bottom flask.  
The mixture was brought out of the dry box, and N,N-diisopropylethylamine (42 µL, 0.24 
mmol, 1.2 eq) was added to the stirring reaction at room temperature, followed by 
dropwise addition of triethylsilyl chloride (40 µL, 0.24 mmol, 1.2 eq). The reaction was 
stirred at room temperature for 4 hours. MeOH (50 µL) was added to quench the reaction. 
The reaction mixture was put through a plug of silica gel (2 cm) and washed with EtOAc 
(15 mL).  The solvent was removed under reduced pressure. Column chromatography on 
silica gel afforded the pure TES-protected product. 
 
General procedure C for Site-Selective Silylation of Ribavirin (Scheme 1.16) 
In a dry box, a suspension of the ribavirin (0.20 mmol), catalyst (0.02 mmol, 10 
mol %), and N,N-diisopropylethylamine hydrochloride (1.5 mg, 0.006 mmol, 3 mol %) in 
anhydrous THF (1 mL) was prepared in an oven-dried round-bottom flask.  The 
suspension was brought out of the dry box, and N,N-diisopropylethylamine (84 µL, 0.48 
mmol, 2.4 eq) was added to the stirring reaction at room temperature, followed by 
dropwise addition of triethylsilyl chloride (80 µL, 0.48 mmol, 2.4 eq). The reaction was 
stirred at room temperature for 24 hrs. MeOH (100 µL) was added to quench the reaction. 
The reaction mixture was put through a plug of silica gel (2 cm) and washed with EtOAc 
base
O
OHOH
HH
DMTrO
catalyst
TESCl
DIPEA
3% DIPEA•HCl
THF, 4 h
base
O
OHTESO
HH
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(15 mL).  The solvent was removed under reduced pressure. Column chromatography on 
silica gel afforded the pure TES-protected product. 
 
1.7.3 Full Characterization 
 2’-O-TBS-5’-O-DMTr-uridine (2`-TBS-U). The general procedure 
A was followed for the TBS-protection of 5’-O-DMTr-Uridine (168 
mg, 0.30 mmol) using catalyst (˗)-1.23 (8.4 mg, 0.03 mmol, 10 mol 
%).  Column chromatography (Ethyl acetate/Hexanes = 1:2 to 1:1) afforded the pure 
product 2’-O-TBS-5’-O-DMTr-uridine as a white solid (184 mg, 93%, 2’:3’ = >98:<2 ).  
 
1H NMR (CDCl3, 500 MHz) δ 9.28 (br s, 1H), 7.94 (d, 1H, J = 8.5 Hz), 7.38 (d, 1H, J = 
7.0 Hz), 7.32-7.23 (m, 7H), 6.85 (d, 1H, J = 9.0 Hz), 5.96 (d, 1H, J = 3.0 Hz), 5.30 (d, 
1H, J = 8.5 Hz), 4.37-4.34 (m, 2H), 4.11-4.10 (m, 1H), 3.80 (s, 6H), 3.54-3.48 (m, 2H), 
2.59 (d, 1H, J = 6.0 Hz), 0.93 (s, 9H), 0.19 (s, 3H), 0.16 (s, 3H). 13C NMR (CDCl3, 125 
MHz) δ 163.5, 159.0, 158.9, 150.5, 144.5, 140.4, 135.4, 135.2, 130.4, 130.3, 128.3 128.2, 
127.4, 113.5, 113.5, 102.5, 88.9, 87.4, 83.7, 76.5, 70.6, 62.5, 55.4, 25.9, 18.2, -4.4, -5.0 
IR: 3534, 2951, 2929, 1680, 1508, 1460, 1250, 1175, 1115, 1034, 908, 829, 728 cm–1. 
HRMS (DART-ESI+) calcd. for C36H44N2O8Si: [M+H]+: 661.2945, found: 661.2926. 
 
 N6-benzoyl-2’-O-TBS-5’-O-DMTr-adenosine (2`-TBS-ABz). 
The general procedure A was followed for the TBS-protection 
of N6-benzoyl-5’-O-DMTr-adenosine (164 mg, 0.20 mmol) 
using catalyst (˗)-1.23 (5.6 mg, 0.02 mmol, 10 mol %) in 0.5 M 
NH
O
ON
O
OTBSOH
HH
DMTrO
O
OTBSOH
HH
DMTrO N
N
N
N
HN Ph
O
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concentration in THF for 48 h. Column chromatography (Dichloromethane/methanol = 
100:0 to 95:5) afforded the pure product N6-benzoyl-2’-O-TBS-5’-O-DMTr-adenosine as 
a white solid (130 mg, 82%, 2’:3’ = 95:5).  
 
1H NMR (500 MHz, CDCl3-d) δ 9.10 (s, 1H), 8.73 (s, 1H), 8.23 (s, 1H), 8.03 (d, 2H, J = 
7.8 Hz), 7.60 (m, 1H), 7.52 (m, 2H), 7.45 (d, 2H, J = 7.8 Hz), 7.33 (d, 4H, J = 8.8 Hz), 
7.24 - 7.31 (m, 2H), 7.22 (m, 1H), 6.81 (d, 4H, J = 8.8 Hz), 6.11 (d, 1H, 5.4 Hz), 5.02 (t, 
1H, J = 5.4 Hz), 4.36 (m, 1H), 4.29 (m, 1H), 3.78 (s, 6H), 3.54 (dd, 1H, J = 10.8, 2.9 Hz), 
3.40 (dd, 1H, J = 10.8, 3.9 Hz), 2.72 (d, 1H, J = 3.9 Hz), 0.84 (s, 9H), -0.01 (s, 3H), -0.14 
(s, 3H) 13C NMR (CDCl3, 125 MHz) 164.7, 158.8, 153.1, 151.9, 149.8, 144.7, 141.9, 
135.8, 133.9, 133.0, 130.3, 129.1, 128.3, 128.1, 128.0, 127.2, 123.4, 113.4, 88.6, 86.9, 
84.5, 75.9, 71.7, 63.5, 55.4, 25.8, 18.1, -4.7, -5.0. IR: 2929, 1703, 1608, 1580, 1508, 1489, 
1454, 1258, 1135, 1002, 908, 728 cm–1. HRMS (DART-ESI+) calcd. for C44H50N5O7Si: 
[M+H]+: 788.3474, found: 788.3478. 
 
 N4-benzoyl-2’-O-TBS-5’-O-DMTr-cytidine (2`-TBS-CBz). The 
general procedure A was followed for the TBS-protection of 
N4-benzoyl-5’-O-DMTr-cytidine (195 mg, 0.30 mmol) using catalyst 
(˗)-1.23 (8.4 mg, 0.03 mmol, 10 mol %). Column chromatography 
(Ethyl acetate/hexanes = 1:2 to 1:1) afforded the pure product N4-benzoyl-2’-O-TBS-5’-
O-DMTr-cytidine as a white solid (208 mg, 91%, 2’:3’ = 98:2).  
 
O
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1H NMR (500 MHz, CDCl3-d) δ 8.52 (d, 1H, J = 6.8), 7.89 (d, 2H, J = 7.3), 7.60 (t, 1H, J 
= 7.8 Hz), 7.46 - 7.54 (m, 2H), 7.43 (d, 2H, J = 7.3 Hz), 7.24 - 7.37 (m, 7H), 6.88 (d, 4H, 
J = 8.8 Hz), 5.93 (s, 1H), 4.33 - 4.44 (m, 1H), 4.31 (d, 1H, J = 3.9 Hz), 4.11 (d, 1H, J = 
7.8 Hz), 3.82 (s, 6H), 3.59 (dd, 1H, J = 12.1, 2.0 Hz), 3.52 (dd, 1H, J = 11.6, 2.7 Hz), 
2.42 (d, 1H, J = 9.3 Hz), 0.93 (s, 9H), 0.31 (s, 3H), 0.20 (s, 3H) 13C NMR (CDCl3, 125 
MHz) δ 158.9, 144.3, 135.8, 135.5, 133.3, 130.3, 130.3, 129.2, 128.5, 128.3, 127.7, 127.4, 
113.5, 90.9, 87.4, 83.4, 69.3, 61.6, 55.4, 26.0, 18.3, -4.2, -5.2 IR: 2929, 2855, 1699, 1656, 
1484, 1445, 1252, 1176, 1116, 831, 788,726 cm–1. HRMS (DART-ESI+) calcd. for 
C43H50N3O8Si: [M+H]+: 764.3362, found: 764.3364. 
 
 N2-isobutyl-2’-O-TBS-5’-O-DMTr-guanosine (2`-TBS-
GIb). The general procedure A was followed for the TBS-
protection of N2-isobutyl-5’-O-DMTr-guanosine (131 mg, 
0.20 mmol) using catalyst (˗)-1.23 (11.2 mg, 0.04 mmol, 20 mol %) in 0.5 M 
concentration in THF for 48 h. Column chromatography (Dichloromethane/methanol = 
100:0 to 95:5) afforded the pure product N2-isobutyl-2’-O-TBS-5’-O-DMTr-guanosine as 
a white solid (114 mg, 74%, 2’:3’ = 97:3).  
 
1H NMR (500 MHz, CDCl3-d) δ 11.92 (s, 1H), 7.78 (s, 1H), 7.45 (d, 2H, J = 9.3 Hz), 
7.43 (d, 2H, J = 8.8), 7.10 - 7.30 (m, 5H), 6.81 (d, 2H, J = 9.3 Hz), 6.78 (d, 2H, J = 8.8 
Hz), 5.71 (d, 1H, J = 7.3 Hz), 5.32 (dd, 1H, J = 13.5, 8.1 Hz), 4.34 (d, 1H, J = 4.9 Hz), 
4.23 (s, 1H), 3.77 (s, 3H), 3.75 (s, 3H), 3.60 (dd, 1H, J = 10.8, 1.5 Hz), 3.02 (dd, 1H, J = 
11.0, 2.7 Hz), 2.78 (s, 1 H), 1.14 - 1.21 (m, 2H), 0.85 (s, 9H), 0.78 (d, 3H, J = 6.8 Hz), 
O
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0.49 (d, 3H, J = 6.8 Hz), 0.04 (s, 3H), -0.18 (s, 3H) 13C NMR (CDCl3, 125 MHz) δ 178.3, 
159.1, 159.1, 148.3, 147.2, 145.5, 139.6, 136.5, 135.9, 135.9, 130.2, 130.2, 128.3, 128.2, 
127.5, 123.1, 113.6, 113.6, 88.6, 86.3, 84.7, 74.0, 71.3, 63.9, 55.5, 36.2, 25.8, 18.5, 18.1, 
-4.8, -4.9IR: 2928, 2856, 1678, 1608, 1560, 1508, 1464, 1251, 1207, 1177, 1153, 1096, 
1036, 835, 783 cm–1. HRMS (DART-ESI+) calcd. for C41H52N5O8Si: [M+H]+: 770.3580, 
found: 770.3574. 
 
 2’-O-TES-5’-O-DMTr-uridine (2`-TES-U). The general 
procedure B was followed for the TES-protection of 5’-O-DMTr-
Uridine (112 mg, 0.20 mmol) using catalyst (˗)-1.23 (3.1 mg, 0.01 
mmol, 5 mol%).  Column chromatography 
(Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure product 2’-O-TES-5’-
O-DMTr-uridine as a white solid (114 mg, 86%, 2’:3’ = >98:<2).  
 
1H NMR (CDCl3, 500 MHz) δ 8.67 (br s, 1H), 7.94 (d, 1H, J = 8.0 Hz), 7.37 (m, 2H), 
7.27 (m, 7H), 6.84 (d, 4H, J = 9.0 Hz), 5.94 (d, 1H, J = 3.0 Hz), 5.29 (dd, 1H, J = 8.3, 
2.3 Hz), 4.37 – 4.33 (m, 2H), 4.13 – 4.10 (m, 1H), 3.80 (s, 6H), 3.53 – 3.46 (m, 2H), 2.66 
– 2.64 (m, 1H), 0.98 (t, 9H, J = 8.0 Hz), 0.70 (q, 6H, J = 8.0 Hz). 13C NMR (CDCl3, 500 
MHz) δ 163.5, 158.9, 158.9, 150.5, 144.5, 140.5, 135.4, 135.2, 130.4, 130.3, 128.3, 
128.2, 127.4, 113.5,113.5, 102.5, 88.9, 87.4, 83.7, 76.2, 70.6, 62.5, 55.4, 6.7, 4.7 IR: 
3197, 3058, 2955, 2912, 2876, 2836, 1680, 1607, 1582, 1508, 1458, 1413, 1381, 1332, 
1299, 1249, 1175, 1114, 1087, 1062, 1033, 1005, 912, 876, 827, 791, 729, 701, 583, 557, 
NH
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419 cm–1. HRMS (DART-ESI+) calcd. for C36H44N2O8NaSi: [M+Na]+: 683.2770, found: 
683.2759. 
 
 N6-benzoyl-2’-O-TES-5’-O-DMTr-adenosine (2`-TES-ABz). 
The general procedure B was followed for the TES-protection 
of N6-benzoyl-5’-O-DMTr-adenosine (135 mg, 0.20 mmol) 
using catalyst (˗)-1.23 (3.1 mg, 0.01 mmol, 5 mol %).  Column 
chromatography (Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure 
product N6-benzoyl-2’-O-TES-5’-O-DMTr-adenosine as a white solid (138 mg, 88%, 
2’:3’ = 98:2).   
 
1H NMR (CDCl3, 500 MHz) δ 9.04 (s, 1H), 8.72 (s, 1H), 8.22 (s, 1H), 8.03 (d, 2H, J = 
7.5), 7.62 – 7.59 (m, 1H), 7.54 – 7.51 (m, 2H), 7.44 (d, 2H, J = 7.5 Hz), 7.35 – 7.32 (m, 
4H), 7.28 – 7.25 (m, 2H), 7.23 – 7.20 (m, 1H), 6.82 – 6.79 (m, 4H), 6.09 (d, 1H, J = 6.0 
Hz), 5.08 (t, 1H, J = 5.5 Hz), 4.38 – 4.35 (m, 1 H), 4.29 – 4.27 (m, 1H), 3.78 (d, 6H, J = 
1.0 Hz), 3.53 (dd, 1H, J = 10.5, 3.5 Hz), 3.38 (dd, 1H, J = 10.5, 3.5 Hz), 2.79 (d, 1H, J = 
4), 0.82 (t, 9H, J = 8.0 Hz), 0.57 – 0.43 (m, 6H). 13C NMR (CDCl3, 500 MHz) δ 164.5, 
158.6, 152.8, 151.7, 149.6, 144.5, 141.9, 135.6, 133.7, 132.8, 130.1, 128.9, 128.1, 127.9, 
127.8, 127.0, 123.3, 113.2, 88.5, 86.7, 84.2, 75.1, 71.6, 63.3, 55.2, 6.4, 4.4 IR: 3296, 
3060, 2954, 2912, 2876, 2836, 1703, 1608, 1581, 1508, 1454, 1413, 1327, 1297, 1246, 
1175, 1134, 1088, 1070, 1031, 1003, 909, 857, 828, 793, 728, 704, 645, 584, 488, 404 
cm–1. HRMS (DART-ESI+) calcd. for C44H50N5O7Si: [M+H]+: 788.3520, found: 
788.3475. 
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 N4-benzoyl-2’-O-TES-5’-O-DMTr-cytidine (2`-TES-CBz). The 
general procedure B was followed for the TES-protection of 
N4-benzoyl-5’-O-DMTr-cytidine (130 mg, 0.20 mmol) using 
catalyst (˗)-1.23 (3.1 mg, 0.01 mmol, 5 mol %).  Column 
chromatography (Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure 
product N4-benzoyl-2’-O-TES-5’-O-DMTr-cytidine as a white solid (131 mg, 86%, 2’:3’ 
= 98:2).  
 
1H NMR (CDCl3, 500 MHz) δ 8.50 (d, 1H, J = 9.5 Hz), 7.87 (d, 1H, J = 9.5 Hz), 7.57 
(m, 1H), 7.48 (m, 2H), 7.42 (m, 2H), 7.32 (m, 9H), 7.25 (m, 2H), 6.86 (m, 4H), 5.89 (d, 
1H, J = 1.5 Hz), 4.37 (m, 1H), 4.29 (dd, 1H, J = 6.0, 1.5 Hz), 4.10 (m, 1H), 3.79 (d, 6H, 
J = 1.0 Hz), 3.55 (m, 2H), 2.49 (d, 1H, J = 12.0 Hz), 0.97 (t, 9H, J = 10.0 Hz), 0.78 (m, 
6H). 13C NMR (CDCl3, 500 MHz) δ 158.9, 144.3, 135.8, 135.5, 133.2, 130.3, 130.2, 
129.1, 128.4, 128.2, 127.7, 127.3, 113.5, 91.0, 87.3, 83.3, 77.6, 77.2, 76.9, 76.7, 69.1, 
61.6, 55.4, 6.8, 4.7 IR: 3062, 2953, 2911, 2875, 2836, 1698, 1663, 1609, 1554, 1508, 
1481, 1446, 1380, 1361, 1298, 1247, 1175, 1113, 1060, 1032, 1003, 966, 903, 828, 788, 
730, 701, 679, 584, 534, 494 cm–1. HRMS (DART-ESI+) calcd. for C43H50N3O8Si: 
[M+H]+: 764.3374, found: 764.3362. 
 
 N2-isobutyl-2’-O-TES-5’-O-DMTr-guanosine (2`-TES-
GIb). A modified general procedure B was followed for the 
TES-protection of N2-isobutyl-5’-O-DMTr-guanosine (131 
mg, 0.20 mmol) using 10 mol % of catalyst (˗)-1.23 (6.2 mg, 0.02 mmol).  Column 
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chromatography (Ethyl acetate/Hexanes = 1:2 to 1:1) afforded the pure product 
N2-isobutyl-2’-O-TES-5’-O-DMTr-guanosine as a white solid (109 mg, 71%, 2’:3’ = 
92:8). Note: This substrate undergoes silyl transfer within 8 hrs of isolation.  
 
1H NMR (CDCl3, 500 MHz) δ 11.89 (br s, 1H), 7.76 (s, 1H), 7.60 – 7.57 (m, 2H), 7.44 – 
7.40 (m, 4H), 7.27 – 7.21 (m, 2H), 7.15 (s, 1H), 6.80 – 6.75 (m, 4H), 6.70 (d, 1H, J = 7.2 
Hz), 5.34 – 5.31 (m, 1H), 4.32 (d, 1H, J = 4.8), 4.20 (s, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 
3.57 (dd, 1H, J = 10.8, 1.6 Hz), 3.00 (dd, 1H, J = 10.8, 2.8 Hz), 2.83 (s, 1H), 1.22 – 1.15 
(m, 1H), 0.83 (t, 9H, J = 8.0 Hz), 0.78 (d, 3H, J = 6.4 Hz), 0.58 – 0.43 (m, 6H), 0.48 (d, 
3H, J = 6.8 Hz). 13C NMR (CDCl3, 500 MHz) δ 178.2, 158.8, 158.8, 155.4, 148.1, 146.9, 
145.3, 139.5, 136.3, 135.7, 130.0, 130.0, 128.1, 128.0, 127.2, 113.3, 113.3, 88.3, 86.1, 
84.4, 73.5, 71.1, 63.7, 55.3, 35.9, 18.3, 18.3, 6.4, 4.4 IR: 3151, 2954, 2935, 2876, 1674, 
1606, 1558, 1508, 1463, 1445, 1405, 1377, 1301, 1249, 1176, 1143, 1093, 1034, 1018, 
948, 913, 868, 829, 790, 729, 702, 644, 617 596, 583, 549, 506, 417 cm–1. HRMS 
(DART-ESI+) calcd. for C41H52N5O8Si: [M+H]+: 770.3581, found: 770.3580. 
 
 3’-O-TES-5’-O-DMTr-uridine (3`-TES-U). The general 
procedure B was followed for the TES-protection of 5’-O-DMTr-
Uridine (112 mg, 0.20 mmol) using catalyst (+)-1.21 (2.8 mg, 0.01 
mmol, 5 mol %).  Column chromatography 
(Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure product 3’-O-TES-5’-
O-DMTr-uridine as a white solid (106 mg, 80%, 2’:3’ = 7:93).  
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1H NMR (CDCl3, 500 MHz) δ 8.36 (br s, 1H), 7.82 (d, 1H, J = 10.0 Hz), 7.35 – 7.22 (m, 
9H), 6.82 (dd, 4H, J = 2.0, 11.0 Hz), 5.96 (d, 1H, J = 5.5 Hz), 5.36 (dd, 1H, J = 10.0, 3.0 
Hz), 4.36 – 4.34 (m, 1H), 4.16 – 4.12 (m, 1H), 4.05 – 4.03 (m, 1H), 3.78 (s, 6H), 3.58 
(dd, 1H, J = 13.5, 3.0 Hz), 3.30 (dd, 1H, J = 13.5, 3.0), 2.89 (d, 1H, J = 8.0 Hz), 0.87 (t, 
9H, J = 10.0 Hz), 0.57 – 0.46 (m, 6H). 13C NMR (CDCl3, 500 MHz) δ 163.3, 159.0, 
150.6, 144.2, 140.4, 135.3, 135.2, 130.3, 128.4, 128.2, 127.4, 113.5, 113.4, 102.7, 89.5, 
87.3, 84.2, 75.4, 71.2, 62.4, 55.4, 6.8, 4.8 IR: 3441, 3170, 3058, 2954, 2911, 2875, 2836, 
1692, 1608 1581, 1508, 1459, 1415, 1389, 1300, 1250, 1176, 1150, 1112, 1066, 1035, 
1002, 910, 829, 729, 704, 676, 648, 633, 585, 427 cm–1. HRMS (DART-ESI+) calcd. for 
C36H44N2O8NaSi: [M+Na]+: 683.2771, found: 683.2759. 
 
 N6-benzoyl-3’-O-TES-5’-O-DMTr-adenosine (3`-TES-ABz). 
The general procedure B was followed for the TES-protection 
of N6-benzoyl-5’-O-DMTr-adenosine (135 mg, 0.20 mmol) 
using catalyst (+)-1.21 (2.8 mg, 0.01 mmol, 5 mol %).  Column 
chromatography (Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure 
product N6-benzoyl-3’-O-TES-5’-O-DMTr-adenosine as a white solid (134 mg, 85%, 
2’:3’ = 4:96).  
 
1H NMR (CDCl3, 500 MHz) δ 9.10 (br s, 1H), 8.75 (s, 1H), 8.24 (s, 1H), 8.01 (d, 2H, J = 
5.6 Hz), 7.60 – 7.57 (m, 1H), 7.51 – 7.48 (m, 2H), 7.40 – 7.38 (m, 2H), 7.30 – 7.23 (m, 
6H), 7.21 – 7.19 (m, 1H), 6.79 (d, 4H, J = 8.5 Hz), 6.07 (d, 1H, J = 4.5 Hz), 4.79 – 4.76 
(m, 1H), 4.60 – 4.58 (m, 1H), 4.19 (q, 1H, J = 4.0 Hz), 3.77 (s, 3H), 3.76 (s, 3H), 3.53 
O
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(dd, 1H, J = 10.5, 3.5 Hz), 3.30 (d, 1H, J = 6.5 Hz), 3.27 (dd, J = 11.0, 4.0 Hz, 1H), 0.92 
(t, 9H, J = 8.0), 0.64 – 0.54 (m, 6H). 13C NMR (CDCl3, 500 MHz) δ 164.5, 158.6, 152.7, 
151.7, 149.6, 144.4, 141.9, 135.6, 135.5, 133.7, 132.7, 130.0, 128.8, 128.1, 127.9, 127.8, 
126.9, 123.5, 113.2, 113.2, 89.2, 86.6, 84.7, 74.6, 71.9, 62.8, 55.2, 6.6, 4,7 IR: 3280, 
3058, 2953, 2912, 2875, 2836, 1702, 1608, 1580, 1508, 1454, 1412, 1327, 1298, 1245, 
1175, 1141, 1068, 1032, 1002, 909, 827, 791, 727, 703, 645, 583, 404 cm–1. HRMS 
(DART-ESI+) calcd. for C44H50N5O7Si: [M+H]+: 788.3520, found: 788.3480. 
 
 N4-benzoyl-3’-O-TES-5’-O-DMTr-cytidine (3`-TES-CBz). The 
general procedure B was followed for the TES-protection of 
N4-benzoyl-5’-O-DMTr-cytidine (130 mg, 0.20 mmol) using 
catalyst (+)-1.21 (2.8 mg, 0.01 mmol, 5 mol %).  Column 
chromatography (Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure 
product N4-benzoyl-3’-O-TES-5’-O-DMTr-cytidine as a white solid (131 mg, 86%, 2’:3’ 
= 2:98).  
 
1H NMR (CDCl3, 500 MHz) δ 8.41 (d, 1H, J = 10.0 Hz), 7.86 (d, 2H, J = 9.0 Hz), 7.59 
(m, 1H), 7.49 (m, 2H), 7.38 – 7.24 (m, 9H), 6.84 (m, 4H), 6.06 (d, 1H, J = 3.5 Hz), 4.34 
(m, 1H), 4.15 (m, 2H), 3.80 (d, 6H, J = 2 Hz), 3.68 (dd, 1H, J = 13.5, 3.5 Hz), 3.32 (dd, 
1H, J = 13.5, 3 Hz), 3.11 (bs, 1H), 0.84 (t, 9H, J =10 Hz), 0.55 – 0.43 (m, 6H). 13C NMR 
(CDCl3, 500 MHz) δ 162.5, 158.9, 144.9, 144.0, 135.3, 133.2, 130.3, 130.3, 129.1, 128.5, 
128.1, 127.8, 127.4, 113.4, 91.3, 87.2, 83.9, 70.7, 61.7, 55.4, 6.7, 4.7 IR: 3066, 2999, 
2953, 2912, 2876, 2837, 1698, 1660, 1609, 1557, 1509, 1484, 1447, 1416, 1372, 1301, 
O
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1252, 1176, 1152, 1112, 1066, 1034, 1002, 895, 830, 789, 728, 704, 585, 549, 512, 493, 
421 cm–1. HRMS (DART-ESI+) calcd. for C43H50N3O8Si: [M+H]+: 764.3379, found: 
764.3362. 
 
 N2-isobutyl-3’-O-TES-5’-O-DMTr-guanosine (3`-
TBS-GIb). A modified general procedure B was 
followed for the TES-protection of N2-isobutyl-5’-O-
DMTr-guanosine (131 mg, 0.20 mmol) using 20 mol % 
of catalyst (+)-1.21 (5.6 mg, 0.04 mmol).  Column chromatography (Ethyl 
acetate/Hexanes = 1:2 to 1:1) afforded the pure product N2-isobutyl-3’-O-TES-5’-O-
DMTr-guanosine as a white solid (120 mg, 78%, 2’:3’ = 14:86). Note: This substrate 
undergoes silyl transfer within 8 hrs of isolation.  
 
1H NMR (CDCl3, 400 MHz) δ 11.91 (br s, 1H), 7.81 (s, 1H), 7.73 (s, 1H), 7.51 (d, J = 
8.8, 2H), 7.38 (d, J = 8.8, 4H), 7.28 – 7.14 (m, 3H), 6.82 – 6.77 (m, 4H), 5.68 (d, J = 6.8, 
1H), 4.88 – 4.83 (m, 1H), 4.46 – 4.43 (m, 1H), 4.06 (s, 1H), 3.75 (dd, J = 4, 1.6, 6H), 
3.53 (d, J = 11.2, 1H), 3.24 (d, J = 8.4, 1H), 3.07 – 3.03 (m, 1H), 1.65 (m, 1H), 0.92 (d, J 
= 7.2, 3H), 0.85 (t, J = 8, 9H), 0.70 (d, J = 6.8, 3H), 0.55 – 0.45 (m, 6H). 13C NMR 
(CDCl3, 500 MHz) δ 178.2, 158.8, 155.4, 148.0, 147.0, 144.7, 138.6, 136.0, 135.6, 129.9, 
129.9, 128.1, 128.0, 127.1, 122.5, 113.3, 89.3, 86.2, 85.0, 73.3, 71.1, 62.8, 55.3, 36.1, 
18.5, 18.5, 6.6, 4.6. IR: 3140, 3061, 2954, 2911, 2876, 2837, 1677, 1607, 1560, 1509, 
1464, 1446, 1403, 1376, 1301, 1250, 1207, 1176, 1151, 1099, 1068, 1034, 1016, 948, 
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875, 828, 790, 728, 703, 642, 595, 583, 541, 416 cm–1. HRMS (DART-ESI+) calcd. for 
C41H51N5O8NaSi: [M+Na]+: 792.34010, found: 792.339911. 
 
2’,5’-O-TES-ribavirin (1.25). The general procedure C was 
followed for the TES-protection of ribavirin (49 mg, 0.20 mmol) 
using catalyst (-)-1.23 (6.2 mg, 0.02 mmol, 10 mol %).  Column 
chromatography (Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure 
product 2’,5’-O-TES-ribavirin as a white solid (80 mg, 84%, 2’,5’:3’,5’ = 94:6).  
 
1H NMR (500 MHz, CDCl3-d) δ 8.58 (s, 1H), 6.95 (br s, 1H), 5.96 (br s, 1H), 5.83 (d, 1H, 
J = 3.5 Hz), 4.57 (m, 1H), 4.26 (m, 1H), 4.16 (m, 1H), 3.96 (dd, 1H, J = 11.75, 2.75 Hz), 
3.80 (dd, 1H, J = 11.25, 2.75 Hz), 2.60 (d, 1H, J = 6.5 Hz), 0.94 (m, 18H), 0.63 (m, 12H). 
13C NMR (CDCl3, 500 MHz) δ 160.7, 156.7, 143.8, 93.3, 85.7, 76.8, 70.3, 61.9, 6.6, 6.4, 
4.5, 4.1IR: 3328, 2954, 2877, 1696, 1597, 1465, 1414, 1379, 1344, 1283, 1240, 1186, 
1128, 1074, 1002, 975, 910, 868, 841, 793, 729, 527 cm–1. HRMS (DART-ESI+) calcd. 
for C20H41N4O5Si2: [M+H]+: 473.26155, found: 473.26180. !
3’,5’-O-TES-ribavirin (1.26). The general procedure C was 
followed for the TES-protection of ribavirin (49 mg, 0.20 mmol) 
using catalyst (+)-1.21 (6.2 mg, 0.02 mmol, 10 mol %).  Column 
chromatography (Dichloromethane/Methanol = 99.5:0.5 to 99:1) afforded the pure 
product 3’,5’-O-TES-ribavirin as a white solid (69 mg, 73%, 2’,5’:3’,5’ = 8:92).  
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1H NMR (500 MHz, CDCl3) δ 8.53 (s, 1H), 6.98 (br s, 1H), 5.95 (br s, 1H), 5.91 (d, 1H, J 
= 2.5 Hz), 4.46 (t, 1H, J = 5.5 Hz), 4.40 (dd, 1H, J = 5, 2.5 Hz), 4.11 (m, 1H), 3.94 (dd, 
1H, J = 11, 3.5 Hz), 3.74 (dd, 1H, J = 11.5, 3 Hz), 2.95 (br s, 1H), 0.96 (m, 18H), 0.64 
(m, 12H). 13C NMR (CDCl3, 500 MHz) δ 160.8, 156.9, 143.7, 93.0, 85.2, 75.7, 70.1, 61.1, 
6.6, 6.6, 4.6, 4.1IR: 3326, 2954, 2911, 2876, 1686, 1599, 1466, 1414, 1378, 1286, 1239, 
1185, 1116, 1074, 1005, 973, 901, 839, 787, 725, 677, 547 cm–1. HRMS (DART-ESI+) 
calcd. for C20H41N4O5Si2: [M+H]+: 473.26155, found: 473.26016. 
 
1.7.4 Spectral Data 
For all published spectral data see the following link: 
http://pubs.acs.org/doi/suppl/10.1021/ol402023c 
See below for examples of 1H, 13C and NOESY spectra: 
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Chapter 2: Distal Selective Hydroformylation of Internal Olefins 
Using Scaffolding Ligands 
 
2.1 Introduction 
The functionalization of olefins has been a centerpiece for the development of 
novel organic reactions for many years.  One reason for this is the availability of olefin 
starting materials, in large part due to the use of simple alkenes as feedstocks for the 
petrochemical industry.  Additionally, the ability to control the olefin-geometry of multi-
substituted alkenes has become quite practical.  Hydroformylation is an olefin 
functionalization reaction that has been extensively studied, due to its practicality and 
usefulness on an industrial scale.  Also known as the “oxo process,” hydroformylation is 
the addition of hydrogen and carbon monoxide (CO) across an olefin to yield aldehyde-
containing products (Scheme 2.1).  It has become one of the largest homogenously 
catalyzed reactions in industry, producing over 10 million tons of aldehyde products 
annually.1  Like most olefin functionalization reactions, the control of regioselectivity is a 
major challenge in hydroformylation.  The two possible structural isomers formed from 
the hydroformylation of a terminal olefin are the linear and the branched products.  When 
considering the hydroformylation of internal olefins, two constitutional isomers are 
formed; for simplicity of this thesis we refer to the aldehyde forming near a functional 
group as the proximal isomer and far as the distal isomer.   
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Franke, R.; Selent, D.; Börner, A. Chem. Rev. 2012, 112, 5675 – 5732. 
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Scheme 2.1 Hydroformylation of Terminal Olefins 
 
 
2.1.1 Mechanism of Hydroformylation 
The mechanism of hydroformylation (Scheme 2.2) initiates by the dissociation of 
CO, followed by coordination of the olefin substrate. Hydrometallation affords both the 
branched and linear rhodium alkyl intermediates. Upon coordination of CO, migratory 
insertion yields isomeric metal acyl intermediates, which, upon oxidative addition of 
hydrogen gas, reductively eliminate to afford two aldehyde isomers. For most systems, 
the regiochemical outcome is determined during the hydrometallation step.  Due to steric 
considerations, the linear product is favored for simple terminal alkene substrates.  It 
should be noted that there are a number of electronically-biased substrates that do favor 
the branched hydroformylation products (styrenes, vinyl acetates, allyl cyanides)2. 
 
 
 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 (a) Whiteker, G. T., Babin, J. E. WO9393839, 1993. (b) Mazuela, J.; Coll, M.; Pámies, 
O.; Diéguez, M. J. Org. Chem. 2009, 74, 5440 – 5445. (c) Clark, T. P.; Landis, C. R.; 
Freed, S. L.; Klosin, J.; Abboud, K. A. J. Am. Chem. Soc. 2005, 127, 5040 – 5042. (d) 
Breeden, S.; Cole-Hamilton, D. J.; Foster, D. F.; Schwarz, G. J.; Wills, M. Angew. Chem. 
Int. Ed. 2000, 39, 4106 – 4108. 
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Scheme 2.2 Mechanism for the Hydroformylation of a Terminal Olefin 
 
 
2.2 Linear-Selective Hydroformylation 
Due to its industrial applications, many groups have developed active catalysts for 
the linear-selective hydroformylation of terminal alkenes.1,3  For instance, Casey and 
coworkers 4  have reported high selectivity for the linear aldehyde using bidentate 
phosphine ligands with large bite angles (Scheme 2.3, Eq. 1).  It has been demonstrated 
that 2,2'-bis[(diphenyl-phosphino)methyl]-l,l'-biphenyl (BISBI) produces the linear 
aldehyde of 2.1 in a 99:1 ratio to the branched aldehyde.  Similarly, van Leeuwen and !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 (a) Rhodium Catalyzed Hydroformylation; van Leeuwen, P. W. N. M., Claver, C., Eds.; 
Kluwer Academic Publishers: Dordrecht, Netherlands, 2000. (b)!van Leeuwen, P. W. N. 
M.; Kamer, P. C. J.; Reek, J. N. H.; Dierkes, P. Chem. Rev. 2000, 100, 2741 – 2769. (c) 
van Leeuwen, P. W. N. M.; Sandee, A. J.; Reek, J. N. H.; Kamer, P. C. J. J. Mol. Catal. 
A: Chem. 2002, 182-183, 107 – 123. 
4 Casey, C. P.; Whiteker, G. T.; Melville, M. G.; Petrovich, L. M.; Gavney, J. A.; Powell, 
D. R. J. Am. Chem. Soc. 1992, 114, 5535 – 5543. 
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coworkers5 disclosed the use of Xantphos and related derivatives for linear-selective 
hydroformylation.  Using Xantphos, the hydroformylation of 2.3 proceeded in a 98:2 
mixture of products favoring the linear isomer 2.4 (Scheme 2.3, Eq. 2).  Reek and 
coworkers 6  disclosed the linear-selective hydroformylation of 2.5 using the 
supramolecular bidentate ligand, SUPRAphos (Scheme 2.3, Eq. 3).  The two ligands 
used, a phosphoramidite and phosphine, are joined through a zinc(II)porphyrin–pyridine 
interaction.  This catalyst system favors the less favored linear aldehyde of 2.5 by a ratio 
of 2.5:1. 
 
Scheme 2.3 Linear-Selective Hydroformylation 
 
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
5 Kranenburg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van Leeuwen, P. W. N. M.; 
Goubitz, K.; Fraanje, J. Organometallics 1995, 14, 3081 – 3089. 
6 Goudriaan, P. E.; Kuil, M.; Jiang, X.-B.; van Leeuwen, P. W. N. M.; Reek, J. N. 
H. Dalton Trans. 2009, 1801 – 1805. 
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2.3 Branch-Selective Hydroformylation 
In addition to its industrial importance, hydroformylation is an atom economical 
transformation of high synthetic value.  Much of this utility hinges on the development of 
branch-selective hydroformylation, both from a regio- and stereochemical standpoint.  In 
the absence of a directing group, obtaining even modest regiocontrol (>5:1) for the 
branched product of an unactivated alkene is an extraordinary achievement.  The control 
of regiochemistry becomes especially crucial when a more elaborate olefin substrate is 
used. 
Takaya and coworkers7 reported a highly enantioselective hydroformylation of 
terminal olefins using the novel BINAPHOS ligand, a phosphine-phosphite bidentate 
ligand.  Using (S,R)-BINAPHOS, the branched product 2.7 from the hydroformylation of 
2.5 was achieved in a 88:12 ratio and 94% ee (Scheme 2.4, Eq. 1).  However, the 
hydroformylation of 2.1 provided the branched product 2.8 as the minor structural isomer 
and in diminished enantioselectivity (75% ee) (Scheme 2.4, Eq. 2).   
 
Scheme 2.4 Branch-Selective Hydroformylation with (S,R)-BINAPHOS 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
7 Sakai, N.; Mano, S.; Nozaki, K.; Takaya, H. J. Am. Chem. Soc.  1993, 115, 7033 – 
7034. 
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Clarke and coworkers8 have started to address some of the problems associated 
with the asymmetric hydroformylation of unactivated terminal olefins (Scheme 2.5).  
With the development of bobphos, a phosphine-phosphite bidentate ligand, the 
hydroformylation of 2.1 proceeds in a 3:1 regioselectivity favoring the branched product 
2.8 with a 93% enantioselectivity.  Although a tremendous step forward for the field of 
hydroformylation, this methodology has some drawbacks including sub-ambient reaction 
temperatures and long reaction times. 
 
Scheme 2.5 Branch-Selective Hydroformylation with (Sax,S,S)-Bobphos 
 
 
2.4 Stoichiometric Directing Groups in Hydroformylation 
The predictable control of regiochemistry is the paramount challenge in the 
context of hydroformylation.  In addition to developing traditional catalyst systems to 
control regioselectivity, many research groups have also found success in the use of 
directing groups.9  By appending a Lewis basic functionality to the substrate, the reaction 
could potentially proceed in an extremely selective fashion, through a reduction in 
activation entropy.  As shown below, this association of substrate and ligand can yield !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
8 Noonan, G. M.; Fuentes, J. A.; Cobley, C. J.; Clarke, M. L. Angew. Chem., Int. Ed. 
2012, 51, 2477 – 2480. 
9 For reviews related to directed reactions (a) Hoveyda, A. H.; Evans, D. A.; Fu, G. C. 
Chem. Rev. 1993, 93, 1307 – 1370. (b) Rousseau, G.; Breit, B. Angew. Chem., Int. Ed. 
2011, 50, 2450 – 2494. 
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hydroformylation products with almost complete control of both regio- and 
stereochemistry. 
In the context of the total synthesis of (+)-phyllanthocin, Burke and coworkers10 
utilized a cleavable phosphine-containing directing group for the selective installation of 
an aldehyde (Scheme 2.6).  In the absence of a phosphine directing group, the authors 
observed a unselective mixture of hydroformylation products.  The use of the meta-
(diphenylphosphanyl)benzoyl (m-DPPB) group proved vital for both a regio- and 
diastereoselective hydroformylation of 2.9, yielding 2.10 in 68% yield. 
 
Scheme 2.6 Directed Hydroformylation Towards the Total Synthesis of 
(+)-Phyllanthocin 
 
Leighton and coworkers 11  have described dibenzophosphole groups as an 
adequate directing moiety for the hydroformylation of allylic alcohols (Scheme 2.7).  
Synthesized from the subsequent methoxymethyl ether and dibenzophosphole lithium, 
2.11 undergoes branched-selective hydroformylation favoring the anti product 2.12.  This 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
10 Burke, S. D.; Cobb, J. E. Tetrahedron Lett. 1986, 27, 4237 – 4240. 
11 Krauss, I. J.; Wang, C. C.-Y.; Leighton, J. L. J. Am. Chem. Soc. 2001, 123, 11514 – 
11515. 
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methodology offers an alternative approach to the synthesis of aldol-like products, after 
the directing group is cleaved with reductive deprotection conditions.   
 
Scheme 2.7 Dibenzophosphole Directed Hydroformylation 
 
Breit and coworkers12 have found that when appending o-DPPB to primary allylic 
alcohols, the hydroformylation proceeds in an extremely selective manner (Scheme 2.8).  
When subjecting the nerol derived o-DPPB ester 2.13 to hydroformylation conditions, the 
proximal product 2.14 is observed in a 96:4 ratio and isolated in 86% yield.  This 
observation is in line with Keuleman’s rule,13 which states that hydroformylation will 
occur in an effort to not form a quaternary carbon atom. However, it should be noted that 
the reaction proceeds with complete site-selectivity for the proximal trisubstitued olefin. 
 
Scheme 2.8 o-DPPB Directed Hydroformylation 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
12 Breit, B.; Grünanger, C. U.; Abillard, O. Eur. J. Org. Chem. 2007, 2497 – 2503. 
13 Keulemans, A. I. M.; Kwantes, A.; van Bavel, T. Recl. Trav. Chim. Pays-Bas 1948, 67, 
298 – 308. 
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2.5 Catalytic Directing Groups in Hydroformylation 
Although an effective way to control selectivity, the use of phosphine-containing 
stoichiometric directing groups is hampered by clear drawbacks.  Those drawbacks 
include being wasteful in an atom economical sense as well as requiring a multistep 
sequence for the addition and removal of the group from the substrate and product, 
respectively.  An alternative approach is the development of catalytic directing groups.14  
Relying on the ability to reversibly covalently bond to the substrate, these catalysts 
induce the sought-after intramolecularity of a directed reaction while existing in catalytic 
quantities. 
Breit and coworkers have developed a catalytic directing group strategy for the 
branch-selective hydroformylation of homoallylic15 (Scheme 2.9) and bis-homoallylic16 
alcohols.  When using methyl phosphinite 2.16 as a ligand, 2.15 undergoes proximal 
hydroformylation, which produces the γ-lactone 2.17 upon PCC oxidation in an 85% 
yield.  Phosphinite 2.16 is presumed to undergo transesterification, forming a phosphine-
bound substrate adduct, which undergoes directed hydroformylation, favoring a six-
membered cyclic hydrometallation transition state 2.18.  The transesterification is 
assumed to be rapid enough to outcompete the linear-selective background reaction. 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
14  (a) Park, Y. J.; Park, J. W.; Jun, C. H. Acc. Chem. Res. 2008, 41, 222 – 234. (b) 
Rousseau, G.; Breit, B. Angew. Chem., Int. Ed. 2011, 50, 2450 – 2494. (c) Tan, K. L. 
ACS Catal. 2011, 1, 877 – 886. 
15 Grünanger, C. U.; Breit, B. Angew. Chem., Int. Ed. 2008, 120, 7456  – 7459. 
16 Grünanger, C. U.; Breit, B. Angew. Chem., Int. Ed. 2010, 49, 967 – 970. 
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Scheme 2.9 Breit’s Catalytic Directed Hydroformylation of Alkenyl Alcohols 
 
 
Tan and coworkers17 have developed a scaffolding catalyst for the proximal-
selective hydroformylation of homoallylic alcohols (Scheme 2.10).  The azaphosphole 
ligand 2.21 undergoes an exchange reaction with a molecule of substrate.  The covalently 
bound ligand-substrate complex undergoes directed hydroformylation upon Rh 
coordination to the phosphine (through transition state 2.22). The hydroformylation of 
2.19 proceeds with good regio- and diastereocontrol.  The observed anti diastereomer 
2.20 is attributed to the minimization of A1,3-strain during the hydrometallation step.  In 
addition to homoallylic alcohols, 2.21 and an enantiopure variant have been successful in 
the proximal-selective hydroformylation of both allylic alcohols18 and amines.19 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
17 Lightburn, T. E.; Dombrowski, M. T.; Tan, K. L. J. Am. Chem. Soc. 2008, 130, 9210 – 
9211. 
18 (a) Sun, X.; Frimpong, K.; Tan, K. L. J. Am. Chem. Soc. 2010, 132, 11841 – 11843. (b) 
Lightburn, T. E.; De Paolis, O. A.; Cheng, K. A.; Tan, K. L. Org. Lett. 2011, 13, 2686 – 
2689. 
19 (a) Worthy, A. D.; Gagnon, M. M.; Dombrowski, M. T.; Tan, K. L. Org. Lett. 2009, 
11, 2764 – 2767. (b) Worthy, A. D.; Joe, C. L.; Lightburn, T. E.; Tan, K. L. J. Am. Chem. 
Soc. 2010, 132, 14757 – 14759.  (c) Joe, C. L.; Tan, K. L. J. Org. Chem. 2011, 76, 7590 – 
7596. 
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Scheme 2.10 Scaffolding Catalysis for the Proximal Hydroformylation of Homoallylic 
Alcohols 
 
 
2.6 Distal Hydroformylation Using Supramolecular Catalysis 
The hydroformylation of unactivated 1,2-disubstitited olefins typically occurs 
slower then that of a terminal olefin and, in most cases, with no bias for one structural 
isomer over the other.  This observation is unsurprising when considering the similar 
electronic and steric environments of the olefinic carbons. As seen in Sections 2.4 and 
2.5, when using stoichiometric or catalytic directing groups, the regiochemical outcome 
typically favors the proximal over distal product (with the Burke example being the lone 
exception).  The use of supramolecular catalysts has been a successful means of 
accessing the distal hydroformylation product in excellent selectivity. 
In 2008, Breit and coworkers20 disclosed a supramolecular catalyst for the distal 
hydroformylation of unsaturated carboxylic acids (Scheme 2.11).  Catalyst 2.25A 
contains an acylguanidinium-based unit bound to a phosphine donor through a pyridine 
linker.  The hydroformylation of 2.23 undergoes formylation at the distal-most olefinic 
carbon with a high level of regiocontrol yielding 2.24.  It is presumed that the !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
20 Šmejkal, T.; Breit, B. Angew. Chem., Int. Ed. 2008, 47, 311 – 315. 
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1. 2% Rh(acac)(CO)2
    20% 2.21, 0.2% p-TsOH
    200 psi H2/CO
    benzene, 45 °C
2. PCC, NaOAc, 3A MS, DCM
70% yield
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92:8 dr (anti:syn)
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acylguanidinium functionality establishes a two-point hydrogen-bonding interaction with 
the carboxylic acid (2.25B), thus preorganizing the substrate for distal hydroformylation. 
 
Scheme 2.11 Supramolecular Distal-Selective Hydroformylation of Unsaturated 
Carboxylic Acids 
 
 Reek and coworkers 21  have reported an effective supramolecular 
hydroformylation catalyst using the bidentate DIMphos ligand.  Carboxylic acid 
substrates 2.26-2.28 undergo hydroformylation in a facile and selective manner to form 
the distal aldehydes (Scheme 2.12, Eq. 1).  Additionally, carboxylic acid-containing vinyl 
arenes, such as 2.29, are viable substrates under these reaction conditions, furnishing the 
distal hydroformylation products (Scheme 2.12, Eq. 2).  Due to π-benzyl stabilization, the 
proximal product (α-aldehyde) is typically the favored isomer.  The regiochemical 
control is attributed to the ability of the diamidodiindolylmethane pocket to bind strongly 
to the carboxylic acid functionality.   
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
21 (a) Dydio, P.; Detz, R. J.; Reek, J. N. H. J. Am. Chem Soc. 2013, 135, 10817 – 10828. 
(b) Dydio, P.; Reek, J. N. H. Angew. Chem. Int. Ed. 2013, 52, 3878 – 3882. 
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Scheme 2.12 Supramolecular Distal-Selective Hydroformylation of Unsaturated 
Carboxylic Acids and Vinyl Arenes Using DIMphos 
 
 
2.7 Distal Hydroformylation Using Scaffolding Catalysis 
 With the success of scaffolding catalysis in the proximal-selective 
hydroformylation of alkenyl alcohols and amines in our laboratory, we pursued a scaffold 
design that would favor the distal product.  In doing this, we sought to better understand 
what makes a directing group selective for one structural isomer over the other (Scheme 
2.13).  When considering some proximal-selective examples, the intermediates leading to 
the proximal aldehyde products are six- and seven-membered metallocycles.  Conversely, 
the distal-selective intermediates typically have macrocyclic rhodacycles, falling usually 
between 13 and 14 atoms.  Unlike the proximal-selective examples, these distal 
metallocycles always contain an extremely rigid array of sp2 hybridized carbon atoms.  
This rigid portion seems to be important in maintaining an energy difference between the 
proximal and distal rhodacycles. 
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Et3N (1.5 equiv.)
290 psi H2/CO, 40 °C, DCM
n = 1:  94% conv, 4:96 (p:d)
n = 2: >99% conv, 1:99 (p:d)
n = 3: 95% conv, 4:96 (p:d)
O OH
Me
1.0% Rh(acac)(CO)2
1.1% DIMPhos
Et3N (1.5 equiv.)
290 psi H2/CO, 40 °C, DCM
O OH
Me
CHO
98% yield
DIMPhos
( )n
( )n
2.26 (n = 1)
2.27 (n = 2)
2.28 (n = 3)
2.29
(1)
(2)
! 55 
Scheme 2.13 Metallocycle Size for Directed Hydroformylation Examples 
 
 
2.7.1 Scaffold Inspiration and Synthesis 
Due to the need for a large metallocycle, removing the phosphine from the 
exchange ring of proximal-selective ligand 2.21 seemed necessary.  As discussed in 
Chapter 1, the N,O-acetal portion of 1.27 is extremely efficient for the exchange of both 
primary and secondary alcohols. With this in mind, we developed ligand scaffold 2.30 as 
a possible distal-selective ligand (Scheme 2.14). 22   Closely resembling the Breit 
supramolecular catalyst 2.25, 2.30 would also form a 13-membered metallocycle when 
producing the distal product. 
 
Scheme 2.14 Development of a Distal-Selective Scaffolding Ligand 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
22 2.30 proved to be the most promising scaffolding for the hydroformylation of 
homoallylic alcohols.  The distal-selectivities observed with ortho-substituted or 
heteroaromatic-containing linkers were considerably lower then those observed with 
2.30. See page 87 for this data. 
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 Similar to 1.27, we envisioned that the synthesis of a library of 2.30-based ligands 
would be practical due to the modularity of the scaffold (Scheme 2.15).  The brominated 
triarylated phosphine 2.31 was attained from 2-bromoiodobenzene by either a cross-
coupling of the secondary phosphine oxide followed by a silane reduction or a Grignard 
exchange followed by addition of the chlorophosphine.  Next, 2.31 was subjected to 
lithium-halogen exchange conditions followed by the addition of 
N,N-dimethylformamide to furnish the benzaldehyde derivative 2.32.  Condensation of 
2.32 with an amino alcohol, followed by NaBH4 reduction of the imine yielded 2.33.  A 
simple cyclization of 2.33 using N,N-dimethylformamide dimethylacetal in methanol 
produced 2.34, which typically exist as a 1:1 mixture of diastereomers.   
 
Scheme 2.15 Synthetic Route for Distal-Selective Scaffolding Ligand 
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2.7.2 Probing the Equilibration Constant 
In order to probe whether this new ligand would be a suitable scaffolding catalyst, 
2.35 was synthesized and subjected to exchange conditions with homoallylic alcohol 
2.36.  The ligand-substrate complex 2.37 was observed and, after two hours at room 
temperature, the Keq of the exchange reaction was determined to be 0.51 (Scheme 2.16).  
This exchange reaction was deemed favorable, which is necessary in order to suppress 
the unselective background reaction. 
 
Scheme 2.16 NMR Exchange Experiments with Ligand 2.35 and Alcohol 2.36 
 
 
2.7.3 Initial Experiments on Simple Homoallylic Alcohols 
 To gauge the performance of 2.35 as a distal-selective scaffold ligand, it was used 
for the hydroformylation of 2.36, a simple cis-homoallylic alcohol.  At lower loadings of 
2.35, the hydroformylation of 2.36 produced an unselective mixture of regioisomers 
(Entries 1-2, Table 2.1).  It is of note that these regiochemical outcomes were similar to 
the control reaction when PPh3 was used as the ligand (54:46, proximal:distal).  However, 
with 5% loading of 2.35, the δ-lactone 2.39 was observed in a 79:21 ratio with the 
proximal regioisomer 2.38 (Entry 3, Table 2.1).  Interestingly, as the amount of 2.35 
added was increased, there is little effect on the regioselectivity of the reaction (Entries 4-
N O
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+ HO
Et
N O
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2.35
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5, Table 2.1).  However, with this increase, there appeared to be phosphine inhibition of 
the catalyst, as the conversion started to diminish. 
 
Table 2.1 Effect of 2.35 on the Distal Hydroformylation of 2.36 
 
 The reaction temperature and pressure of syn gas are two important variables 
when developing an efficient hydroformylation method.  Employing ligand 2.35 in the 
hydroformylation of 2.36, a direct correlation between the pressure of syn gas and 
conversion was observed (Entries 1-5, Table 2.2). This trend was accompanied with a 
minor decrease in regioselectivity.  From this data, a CO/H2 pressure of 400 psi proved to 
be the most efficient.  As expected, as the reaction temperature was increased, full 
conversion was obtained while the regioselectivity suffered, possibly due to an 
unselective background reaction (Entries 1 and 6-9, Table 2.2). 
 
 
 
 
1. xx% 2.35
    benzene, 45 °C
2. 1% Rh(acac)(CO)2
    
    400 psi H2/CO
    benzene, 45 °C
3. PCC, NaOAc, DCM
entry mol % of 2.35 regioselectivity
b
(prox:dist)
1
2
3
4
5
conversion (%)a
1%
2.5%
5%
10%
25%
>95
>95
90
73
78
49:51
42:58
21:79
22:78
22:78
a Conversion determined by 1H NMR using 1,3,5-trimethoxybenzene as an internal standard. b Ratio
was determined by gas chromatography after the oxidation.
2.38 2.39
HO
Et
O
O
n-Pr
O
O
Et
+
2.36
prox dist
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Table 2.2 Effect of Pressure and Temperature on the Distal Hydroformylation of 2.36 
 
 
2.8 Distal and Diastereoselective Hydroformylation Using Scaffolding Catalysis23 
 With promising regioselectivities observed for straight-chain homoallylic 
alcohols, we turned our attention to homoallylic alcohols with allylic stereocenters.  As 
shown previously for the proximal-selective hydroformylation,17 the diastereoselectivity 
of these substrates can be effectively controlled when using scaffolding catalysts.   
 
2.8.1 Ligand Optimization for the Distal-Selective Hydroformylation 
Using 2.19 as an optimization substrate, a small library of scaffolding ligands 
were screened.  The hydroformylation of 2.19 with PPh3 produced an unselective mixture 
of isomers in low conversion (Entry 1, Table 2.3).  Transitioning to 2.42 as the ligand 
afforded moderate regio- and diastereocontrol, favoring the anti diastereomer of the 
δ-lactone 2.41 (Entry 2, Table 2.3).  Importantly, when compared to PPh3, 2.42 gave !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
23 Joe, C. L.; Blaisdell, T. P.; Geoghan, A. F.; Tan, K. L. J. Am. Chem. Soc. 2014, 136, 
8556 – 8559. 
1. 5% 2.35
    benzene, 45 °C
2. 1% Rh(acac)(CO)2
    
    xx psi H2/CO
    benzene, xx °C
3. PCC, NaOAc, DCM
entry H2/CO (psi)
regioselectivityb
(prox:dist)
1
2
3
4
5
6
7
8
9
conversion (%)a
400
300
200
100
50
400
400
400
400
45
45
45
45
45
35
55
65
75
90
74
87
84
84
73
93
>95
>95
21:79
23:77
23:77
24:76
25:75
20:80
24:76
28:72
33:67
a Conversion determined by 1H NMR using 1,3,5-trimethoxybenzene as an internal standard. b Ratio was determined by
gas chromatography after the oxidation.
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2.36 2.38 2.39
prox dist
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significantly higher conversion, highlighting the rate accelerating affect when employing 
scaffolding ligands.  As ligands with stereogenic centers on the oxazolidine ring were 
screened, it was expected that a matched-mismatched effect would be observed between 
substrate and catalyst.  Therefore, both enantiomers of 2.19 were synthesized and 
subjected to hydroformylation using ligand 2.44.  The hydroformylation of (S)-2.19 
selectively yielded the distal product, albeit in diminished regio- and 
diastereoselectivities (Entry 3, Table 2.3).  In contrast, (R)-2.19 afforded the distal 
product 2.41 with an 88:12 dr and 91:9 regioselectivity  (Entry 4, Table 2.3).  Due to the 
presence of a matched-mismatched effect, we chose to use enantioenriched substrate for 
further ligand optimization and substrate scope analysis.  Manipulation of the group 
appended to the amino alcohol backbone proved to have a noticeable effect on activity of 
the ligand, with the alanine-derived ligand 2.43 affording poorer conversion, regio- and 
diastereoselectivity (Entry 5, Table 2.3).  On the contrary, the more sterically bulky 2.45 
ligand bolstered the conversion of (S)-2.19 to 92%, while maintaining regio- and 
diastereoselectivities similar to those of 2.44 (Entry 6, Table 2.3).  Modulating the 
electronics of the phosphine had a moderate effect on the ligand’s efficiency.  The more 
electron-rich 2.46 ligand displayed a severe decline in conversion and a minor regression 
in regio- and diastereoselectivity (Entry 7, Table 2.3).  Although similar, the electron-
deficient 2.47 ligand failed to outperform its electronically neutral counterpart, 2.45 
(Entry 8, Table 2.3).  Consequently, 2.45 was found to be the most effective distal-
selective scaffolding ligand.  In order to test whether 2.45 is truly preforming as a 
scaffolding catalyst, ligand 2.48, which lacks a substrate-binding site, was synthesized 
and used in the hydroformylation conditions (Entry 9, Table 2.3).  2.48 was shown to be 
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an ineffective ligand for hydroformylation, producing an unselective product mixture 
with a conversion of 44%.  Notably, the results using control catalyst 2.48 are similar to 
those obtained with PPh3 as the ligand, highlighting the importance of the substrate-
binding site to obtain high levels of activity and selectivity. Finally, in an effort to 
catalyze substrate exchange with 2.45, a catalytic amount of para-toluenesulfonic acid 
was added to the reaction (Entry 10, Table 2.3). This additive increased the conversion to 
95% without affecting the selectivity of the reaction.  Upon purification, 2.41 was 
isolated as a mixture of diastereomers in a 78% yield (Entry 1, Table 2.4). 
 
Table 2.3 Screening of Distal-Selective Scaffolding Ligands 
 
1. 10% ligand
    benzene, 45 °C
2. 3% Rh(acac)(CO)2
    
    400 psi H2/CO
    benzene, 55 °C
3. PCC, NaOAc, DCM
entry substrate ligand regioselectivity
b
(prox:dist)
1
2
3
4
5
6
7
8
9
10d
conversion (%)a
rac-2.19
rac 2.19
(S)-2.19
(R)-2.19
(R)-2.19
(R)-2.19
(R)-2.19
(R)-2.19
(R)-2.19
(R)-2.19
PPh3
2.42
2.44
2.44
2.43
2.45
2.46
2.47
2.48
2.45
30
60
65
87
55
92
63
88
44
95
46:54
19:81
28:72
9:91
24:76
9:91
14:86
10:90
44:56
9:91
53:47
76:24
67:33
88:12
74:26
87:13
84:16
85:15
58:42
87:13
a Conversion determined by 1H NMR using 1,3,5-trimethoxybenzene as an internal standard. b Ratio was determined by gas
chromatography after the oxidation. c Ratio was determined by 1H NMR (CD3OD) after oxidation. d Reaction run using
0.1% p-TsOH.
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Me n-Bu
O
O
Penyl
Me
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Me
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+
N O
Me
Me
OMe
PPh2
N O
OMe
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R
N O
OMe
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N O
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2.43: R = Me
2.44: R = i-Pr
2.45: R = t-Bu
2.46: Ar = Ph-p-OMe
2.47: Ar = Ph-p-CF3
2.42 2.48
diastereoselectivityc
(anti:syn)
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2.8.2 Investigation of the Substrate Scope 
An assortment of enantioenriched substrates were synthesized and subjected to 
hydroformylation conditions with 2.45 as the ligand.  The trans substrate 2.50 was 
modestly selective for distal product 2.51 (Entry 2, Table 2.4).  In agreement with the 
A1,3-strain model9,24, the major diastereomer observed was the syn product, albeit in only 
a 68:32 dr.  Due to their selective nature, a variety of cis-alkenyl alcohols were prepared.  
Most of the substrate modifications involve alterations to the group at the allylic position.  
2.52 underwent hydroformylation in an extremely regioselective manner (95:5 rr), 
furnishing lactone 2.53 in a 91:9 dr (Entry 3, Table 2.4).  In addition to alkyl groups, 
heteroatom-containing 2.54 produced the distal isomer 2.55 in 85:15 rr and 89:11 dr 
(Entry 4, Table 2.4).  Substrates containing aromatic substituents at the allylic position 
were also examined.  The hydroformylation of 2.56 furnished the distal product 2.57 with 
good regio- and diastereoselectivities (Entry 5, Table 2.4).  More electron rich substrates, 
2.58 and 2.66, generated the distal products in very good regioselectivies (Entries 6 and 
10, Table 2.4).  The mildly deactivated halogen-containing aryl substrates, 2.60 and 2.62, 
underwent hydroformylation providing synthetically useful regio- and 
diastereoselectivities for the distal products (Entry 7-8, Table 2.4).  The terminal olefin 
substrate 2.68 was only moderately selective for the distal product (Entry 11, Table 2.4).  
This result was surprising due to the likelihood that the distal (linear) product is the more 
favored isomer.  The low level of regioselection may be an indication that the pathways 
leading to both the proximal and distal products are both directed by the scaffolding 
catalyst.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
24 Hoffmann, R. W. Chem. Rev. 1989, 89, 1841 – 1860. 
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Table 2.4 Distal-Selective Hydroformylation of Various Homoallylic Alcohols  
 
 To further investigate the origin of regioselectivity observed with 2.45, we began 
to probe other alkenyl alcohol substrates.  Allylic alcohol 2.70 is fully consumed during 
hydroformylation, generating an unselective mixture of regioisomers (Entry 1, Table 2.5).  
It should be noted that when using PPh3 as the ligand, the reaction proceeded in a 
entry substrate majorproduct
regioselectivitya
(prox:dist)
1c
2c
3d
4e
5e
6e
7e
8e
9e
10e
11f
yield (%)b
9:91
20:80
5:95
15:85
12:88
7:93
13:87
12:88
9:91
9:91
16:84
diastereoselectivitya
(anti:syn)
HO
Me n-Bu
HO
i-Pr n-Bu
HO
Me
n-Bu
HO
Me
R
HO
Me
R
HO
TBSO Pentyl
HO
Ph
O
O
n-Bu
Me
O
O
n-Bu
i-Pr
O
O
n-Bu
Me
O
O
Penyl
OTBS
O
O
Me
Ph-(p-R)
O
O
Me
Ph-(o-R)
O
O
Ph
87:13
32:68
91:9
89:11
83:17
88:12
89:11
87:13
91:9
86:14
----
78%
52%
53%
50%
66%
72%
62%
68%
73%
77%
80%
aRegio- and diastereoselectivities were determined by GC or 1H NMR after oxidation. bIsolated yields of combined distal 
lactone products. c(i) 10 mol % 2.45, 0.10 mol % p-TsOH, 45 °C, benzene; (ii) 3 mol % Rh(acac)(CO)2, 55 °C, 400 psi H2/CO, 
benzene; (iii) PCC, NaOAc, 3 Å sieves, DCM. dStandard conditions except 20 mol % 2.45 and 6 mol % Rh(acac)(CO)2 were 
used. eStandard conditions except 12 mol % 2.45 and 4 mol % Rh(acac)(CO)2 were used. fStandard conditions except the 
hydroformylation was run at 35 °C using 5 mol % 2.45 and 2 mol % Rh(acac)(CO)2.
(S)-2.19
2.52
2.50
2.54
2.57: R = H
2.59: R = OMe
2.61: R = Br
2.63: R = Cl
2.65: R = CF3
2.67: R = OMe
2.68
2.49
2.53
2.51
2.55
2.69
2.56: R = H
2.58: R = OMe
2.60: R = Br
2.62: R = Cl
2.64: R = CF3
2.66: R = OMe
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marginally proximal-selective fashion.  As demonstrated above, the hydroformylation of 
homoallylic alcohols was noticeably distal-selective relative to the PPh3 control reaction 
(Entry 2, Table 2.5).  Furthermore, when considering conversion, the directed example 
proceeds at roughly double the rate compared to the PPh3 reaction.  Both the 2.45 and the 
PPh3-mediated reactions for the bis-homoallylic alcohol 2.72 proceeded in a generally 
unselective manner (Entry 3, Table 2.5).  Nevertheless, the conversion when using 2.45 
was more then double that of the control reaction.  This observation could possibly 
suggest that both regioisomers were accessed through directed pathways, both of which 
have similar energy barriers. 
 
Table 2.5 Hydroformylation of Different Alkenyl Alcohols Using 2.45 
 
 
1. 10% 2.45
    0.1% p-TsOH, C6D6
2. 3% Rh(acac)(CO)2
    
    400 psi H2/CO
    benzene, 55 °C
3. Derivatization
HO
Bn
( )n HydroformylationProducts
entry n proximalproduct
regioselectivityb
(prox:dist)
conversion (%)adistalproduct
1c
2d
3e
HO Bn
OHO
O
O
Bn
O
OH
Bn
O Bn
O
O
O
Bn
HO
( )3
O
Bn
n = 1
n = 2
n = 3
>99%
(>99%)f
84%
(40%)f
89%
(36%)f
58:42
(67:33)
21:79
(57:43)
46:54
(59:41)
aConversion based on remaining starting material after the hydroformylation reaction using mesitylene as an internal standard. 
bRegioselectivities (proximal:distal) were determined by 1H NMR. cCrude hydroformylation reaction was subjected to Pinnick 
oxidation. dCrude hydroformylation reaction was subjected to PCC oxidation. eNo derivatization of the crude hydroformylation
reaction was carried out. fResults in parentheses run under identical conditions, except PPh3 was used rather than ligand 2.45.
2.70
2.71
2.72
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2.9 Enantio- and Distal-Selective Hydroformylation 
 Due to the effectiveness of 2.45 as a distal-selective ligand, the use of 2.45 or an 
analog as a ligand for enantioselective hydroformylation was considered.  In addition to 
respectable conversion and regioselectivity, the hydroformylation of 2.73 yielded 2.75 in 
19% ee (Entry 1, Table 2.6).    Similar to a trend observed by Landis and coworkers25, as 
the pressure of syn gas was decreased, the enantioselectivity improved, reaching 37% ee 
at 100 psi. (Entries 2-3, Table 2.6).  Although quite low, this result suggests the 
possibility that a more effective scaffolding ligand can be synthesized to obtain 
synthetically useful enantioselectivites.  Unfortunately, such a ligand has yet to be 
discovered. 
 
Table 2.6 Enantioselective Hydroformylation Using 2.45 
 
 
2.10 Conclusion 
 Through the development of a novel class of scaffolding ligands, one of the few 
examples of distal-selective hydroformylation of 1,2-disubstituted olefins was achieved.  
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25 Watkins, A. L.; Landis, C. R. J. Am. Chem. Soc. 2010, 132, 14027 – 14029. 
1. 10% 2.45
    0.1% p-TsOH, C6D6
2. 3% Rh(acac)(CO)2
    
    xx psi H2/CO
    benzene, 45 °C
3. PCC, NaOAc
entry H2/CO (psi)
regioselectivitya
(prox:dist)
1
2
3
conversion (%)a
400
250
100
84
94
>95
21:79
29:71
23:77
19
20
37
a Conversion determined by 1H NMR using 1,3,5-trimethoxybenzene as an internal standard. 
b Determined by HPLC after the oxidation.
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This methodology separates itself from other distal examples by affording high levels of 
diastereoselectivity for the hydroformylation products. Together with proximal-selective 
methods, scaffolding catalysts have become a viable approach towards solving some of 
the major issues plaguing hydroformylation, as well as a promising solution for other 
olefin functionalization reactions. 
 
2.11 Experimental Section 
2.11.1 General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers 
and used without further purification.  Lithium reagents were titrated against 2-pentanol 
using 1,10-phenanthroline as the indicator.  Flash column chromatography was 
performed using Silicycle silica gel, SiliaFlash P60 (230-400 mesh) and ACS grade 
solvents as received from Fisher Scientific.  All experiments were performed in oven or 
flame dried glassware under an atmosphere of nitrogen or argon using standard syringe 
and cannula techniques, except where otherwise noted.  All reactions were run with dry, 
degassed solvents dispensed from a Glass Contour Solvent Purification System (SG 
Water, USA LLC).  1H, 13C, 31P, and 19F NMR were performed on either Varian Gemini 
400 MHz, Varian Unity Inova 500 MHz, Varian Gemini 500 MHz, or Varian 600 MHz 
spectrometers.  Deuterated solvents were purchased from Cambridge Isotope Labs and 
stored over 3Å molecular sieves.  C6D6 was degassed by three successive freeze-pump-
thaw cycles and stored over 3Å molecular sieves in a dry box under a nitrogen 
atmosphere.  All NMR chemical shifts are reported in ppm relative to residual solvent for 
1H and 13C and external standard (neat H3PO4) for 31P NMR.  Coupling constants are 
! 67 
reported in Hz.  All IR spectra were gathered on a Bru5ker Alpha FT-IR equipped with a 
single crystal diamond ATR module and values are reported in cm−1. HRMS and X-ray 
crystal structure data were generated in Boston College facilities. Optical rotations were 
measured on a Rudolph Analytical Research Autopol IV Polarimeter. An Agilent 
Technologies 7890A gas chromatography system equipped with a 7683B Series Injector 
was used to introduce samples into a J&W Scientific column (HP-5, 30 m x 0.320 mm ID 
x 0.25 µm film thickness) or Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film 
thickness).  Detection was by FID and data was worked up with Agilent Technologies 
GC ChemStation software.  Retention times are reported in minutes. Hydroformylation 
was performed in an Argonaut Technologies Endeavor® Catalyst Screening System 
using 1:1 H2/CO supplied by Airgas, Inc. 
 
2.11.2 Ligand Characterization 
The following compounds were synthesized according to literature procedures and 
matched all reported spectroscopic data: (3-bromophenyl)diphenylphosphane (10212-03-
0), 26  3-(diphenylphosphanyl)benzaldehyde (50777-69-0), 27  bis(4-
methoxyphenyl)phosphine oxide (15754-51-5), 28  bis(4-
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
26 Boezio, A. A.; Charette, A. B.; Poupon, J-C. Angew. Chem. Int. Ed. 2006, 45, 1415 – 
1420. 
27 Benet-Buchholz, J.; Escudero-Adan, E. C.; Freixa, Z.; Gulyas, H.; Rivillo, D.; Van 
Leeuwen, P. W. N. M. Angew. Chem. Int. Ed. 2007, 46, 7247 – 7250. 
28 Bayardon, J.; Maillard, D.; Sinou, D.; Cavazzini, M.; Pozzi, G.; Quici, S. Tetrahedron: 
Asymm. 2003, 14, 2215 – 2224.   
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(trifluoromethyl)phenyl)phosphine oxide (15929-43-8), 29  bis(3,5-
bis(trifluoromethyl)phenyl)phosphine oxide (15979-14-3).30 
 
General Procedure A (Reductive Amination): To a round-bottom flask containing 4 Å 
molecular sieves was added the 3-phosphinobenzaldehyde (1 equivalent) and amino 
alcohol (1.5 – 1.7 equivalents) in THF (0.3 M relative to benzaldehyde).  The solution 
was heated to 50 °C with vigorous stirring.  After 6 hours, the molecular sieves were 
filtered off and the resulting mixture was concentrated to a viscous residue, which was 
dissolved in anhydrous methanol (0.3 M).  The solution was cooled to 0 °C, sodium 
borohydride was added (3 equivalents), and the reaction was allowed to warm to room 
temperature over 2 hours.  The methanol was removed under reduced pressure, the 
residue was diluted with dichloromethane (20 mL), and the reaction was quenched by the 
addition of water (10 mL) at 0 °C.  The aqueous layer was extracted dichloromethane (2 
x 20 mL) and the combined organic layers were washed with brine (10 mL), dried over 
MgSO4, filtered, and concentrated in vacuo.  Purification by column chromatography 
afforded the title compound. 
 
General Procedure B (Ligand Closure): N,N-dimethylformamide dimethylacetal (5 
equivalents) was added to a solution of amino alcohol from the reductive amination (1 
equivalent) in freshly distilled methanol (0.1 M relative to amino alcohol) and the 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
29 McDougal, N. T; Streuff, J.; Mukherjee, H.; Virgil, S. C.; Stoltz, B. M. Tetrahedron 
Lett. 2010, 51, 5550 – 5554. 
30 Busaca, C. A.; Lorenz, J. C.; Grinberg, N.; Haddad, N.; Hrapchak, M.; Latli, B.; Lee, 
H.; Sabila, P.; Saha, A.; Sarvestani, M.; Shen, S.; Varsolona, R.; Wei, X.; Senanayake, C. 
H. Org. Lett. 2005, 7, 4277 – 4280. 
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reaction was stirred at room temperature for 3 hours.  The volatiles were removed on high 
vacuum and the residue was re-dissolved in dry methanol (0.1 M).  After stirring for 2 
hours at room temperature, the volatiles were removed under vacuum.  The crude residue 
was brought into the glovebox and extracted with dry, degassed pentane (2 x 15 mL).  
Removal of the pentane under vacuum afforded the title compound. 
 
2-((3-(diphenylphosphanyl)benzyl)amino)-2-methylpropan-1-
ol.  Synthesized according to the General Procedure A for 
reductive amination. Imine formation was carried out with 3-
(diphenylphosphanyl)benzaldehyde  (500 mg, 1.72 mmol) and 2-amino-2-methylpropan-
1-ol (250 mg, 2.97 mmol) in THF (9 mL).  Reduction of the imine occurred in methanol 
(9 mL) with sodium borohydride (195 mg, 5.15 mmol).  Purification by column 
chromatography (50% EtOAc/Hex containing 1% Et3N) afforded the title compound as a 
colorless solid (469 mg, 76%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.28 – 7.35 (m, 12H), 7.26 – 7.27 (m, 1H), 7.13 – 7.16 (m, 
1H), 3.63 (s, 2H), 3.30 (s, 2H), 1.10 (s, 6H); 13C NMR (CDCl3, 126 MHz) δ 141.2 (d, JC-P 
= 7.6 Hz), 137.6 (d, JC-P = 11.4 Hz), 137.4 (d, JC-P = 10.5 Hz), 133.9 (d JC-P = 20.0 Hz), 
133.7 (d, JC-P = 23.8 Hz), 132.5 (d, JC-P = 16.2 Hz), 128.9, 128.8 (d, JC-P = 5.7 Hz), 128.7, 
128.6 (d, JC-P = 6.7 Hz), 68.6, 54.2, 46.4, 24.4; 31P NMR (CDCl3, 202 MHz) δ – 5.4; IR: 
2967, 1476, 1433, 1051, 742, 694, 467 cm-1; HRMS (DART-TOF) calcd. for 
C23H27N1O1P1 [M+H]+: 364.1830, found: 364.1837. 
 
N
H
OH
Me Me
PPh2
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3-(3-(diphenylphosphanyl)benzyl)-2-methoxy-4,4-dimethyl-
oxazolidine (2.42). Synthesized according to the General Procedure B 
using N,N-dimethylformamide dimethylacetal (814 µL, 6.13 mmol) and 
2-((3-(diphenylphosphanyl)benzyl)amino)-2-methylpropan-1-ol (446 
mg, 1.23 mmol) in freshly distilled methanol (12 mL). The closure was cycled with 12 
mL anhydrous methanol.  Extraction with pentane (2 x 10 mL) and removal of pentane 
under vacuum afforded the title compound as a colorless solid (457 mg, 92%).   
 
1H NMR (C6D6, 500 MHz) δ 7.57 (d, 1H, J = 7.8 Hz), 7.43 (dt, 4H, J = 7.8, 1.5 Hz), 7.31 
– 7.34 (m, 1H), 7.28 (d, 1H, J = 7.3 Hz), 7.03 – 7.12 (m, 7H), 5.16 (s, 1H), 3.65 (d, 1H, J 
= 4.9 Hz), 3.63 (d, 1H, J = 11.7 Hz), 3.51 (d, 1H, J = 7.3 Hz), 3.43 (d, 1H, J = 14.1 Hz), 
3.01 (s, 3H), 0.90 (s, 3H), 0.82 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 140.2 (d, JC-P = 
6.9 Hz), 137.5 (d, JC-P = 9.2 Hz), 137.0 (d, JC-P = 10.7 Hz), 134.2 (d, JC-P = 19.8 Hz), 
133.9 (d, JC-P = 19.1 Hz), 133.3 (d, JC-P = 19.8 Hz), 129.4, 128.9, 128.7 (d, JC-P = 6.7 Hz), 
128.6 (d, JC-P = 6.7 Hz), 128.6 (d, JC-P = 6.9 Hz), 112.2, 78.5, 59.5, 51.0, 47.1, 24.4, 22.9; 
31P NMR (C6D6 , 202 MHz) δ – 5.4; IR: 2965, 2877, 1726, 1476, 1433, 1387, 1323, 
1245, 1092, 1076, 1039, 940, 743, 695, 495 cm-1; HRMS (DART-TOF) calcd. for 
C25H29N1O2P1 [M+H]+: 406.1936, found: 406.1918. 
 
(S)-2-((3-(diphenylphosphanyl)benzyl)amino)propan-1-ol.  
Carried out according to General Procedure A. The imine was 
synthesized from 3-(diphenylphosphanyl)benzaldehyde (600 mg, 
2.07 mmol) and (S)-2-aminopropan-1-ol (202 mg, 2.69 mmol) in tetrahydrofuran (7 mL). 
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Reduction occurred in anhydrous methanol (7 mL) with sodium borohydride (235 mg, 
6.21 mmol).  Purification using silica gel chromatography (1% Et3N/EtOAc) afforded the 
title compound as a colorless oil (456 mg, 64%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.28 – 7.35 (m, 12H), 7.27 – 7.26 (m, 1H), 7.15 – 7.18 (m, 
1H), 3.82 (d, 1H, J = 13.2 Hz), 3.70 (d, 1H, J = 13.2 Hz), 3.54 – 3.57 (m, 1H), 3.22 (dd, 
1H, J = 10.8, 6.9 Hz), 2.76 – 2.80 (m, 1H), 1.04 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 
140.8 (d, JC-P = 7.6 Hz), 137.6 (d, JC-P = 11.5 Hz), 137.4 (d, JC-P = 10.7 Hz), 133.9 (d, JC-
P = 19.8 Hz), 133.6 (d, JC-P = 22.9 Hz), 132.6 (d, JC-P = 16.8 Hz), 128.9, 128.8 (d, JC-P = 
6.1 Hz), 128.7, 128.6 (d, JC-P = 6.7 Hz), 65.7, 53.9, 51.1, 17.4; 31P NMR (CDCl3, 202 
MHz) δ – 5.4; IR: 3299, 2967, 2870, 1477, 1435, 1214, 1172, 1118m 1091, 1027, 998, 
745, 726, 696, 541 cm-1; HRMS (DART-TOF) calcd. for C22H25N1O1P1 [M+H]+: 
350.1674, found: 350.1685; [α]D20 = + 6.72 (c = 0.600, CHCl3, l = 50 mm). 
 
 (4S)-3-(3-(diphenylphosphanyl)benzyl)-2-methoxy-4-
methyloxazolidine (2.43).  Synthesized using General Procedure B with 
(S)-2-((3-(diphenylphosphanyl)benzyl)amino)propan-1-ol (355 mg, 1.03 
mmol), freshly distilled methanol (15 mL) and N,N-dimethylformamide 
dimethylacetal (684 µL, 5.15 mmol).  Extraction with pentane (2 x 10 mL) and removal 
of the volatiles under reduced pressure to afforded the title compound as a viscous oil as a 
1:1 mixture of diastereomers (325 mg, 81 %).   
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1H NMR (C6D6, 500 MHz) δ 7.64 (d, 0.5H, J = 8.3 Hz), 7.50 (d, 0.5H, J = 7.8 Hz), 7.41-
7.44 (m, 4H), 7.30 – 7.34 (m, 1.5H), 7.20 (d, 0.5H, J = 7.8 Hz), 7.03 – 7.16 (m, 7H), 5.22 
(s, 0.5H), 5.10 (s, 0.5H), 3.97 (t, 0.5H, J = 7.3 Hz), 3.75 (d, 0.5H, J = 13.2 Hz), 3.70 (dd, 
0.5H, J = 7.6, 6.6 Hz), 3.59 (t, 1H, J = 13.7 Hz), 3.36 – 3.43 (s, 1.5H), 3.12 (s, 1.5H), 
3.05 – 3.09 (m, 0.5H), 3.01 (s, 1.5H), 2.67 – 2.73 (m, 0.5H), 0.74 (d, 1.5H, J = 6.0 Hz), 
0.70 (d, 1.5H, J = 6.0 Hz); 13C NMR (CDCl3, 101 MHz) δ 139.3 (d, JC-P = 7.6 Hz), 138.7 
(d, JC-P = 6.9 Hz), 137.1 – 137.6 (11 signals), 133.8 – 134.5 (8 signals), 132.7 (d, JC-P = 
19.0 Hz), 132.5 (d, JC-P = 17.5 Hz), 128.9, 128.8 (d, JC-P = 1.5 Hz), 128.7 (d, JC-P = 6 .1 
Hz), 128.6 (d, JC-P = 6.9 Hz), 113.5, 110.3, 72.8, 72.1, 56.8, 54.0, 53.3, 52.6, 50.8, 49.4, 
17.3, 17.0; 31P NMR (C6D6, 202 MHz) δ – 5.4, – 5.5; IR: 2966, 2886, 1477, 1434, 1345, 
1289, 1156, 1064, 744, 697, 495 cm-1; HRMS (DART-TOF) calcd. for C24H27N1O2P1 
[M+H]+: 392.1779, found: 392.1782; [α]D20 = + 32.9 (c = 0.465, CHCl3, l = 50 mm). 
 
(S)-2-((3-(diphenylphosphanyl)benzyl)amino)-3-methylbutan-
1-ol.  A solution of (S)-2-amino-3-methylbutan-1-ol (1.97 g, 19.1 
mmol) and 3-(diphenylphosphanyl)benzaldehyde (3.69 g, 12.7 
mmol) in DCM (100 mL) was stirred at room temperature for 3 hours.  Triethylamine 
(2.7 mL, 19 mmol) and NaBH(OAc)3 (5.38 g, 25.4 mmol) were added to the flask and the 
reaction as allowed to stir at room temperature overnight.  The reaction was partitioned 
between water (70 mL) and DCM (150 mL).  The organic layer was washed with an 
additional portion of water (70 mL), dried over MgSO4, filtered, and concentrated under 
reduced pressure.  The crude residue was purified by silica gel chromatography (1% 
Et3N/EtOAc) to afford the title compound as a colorless oil (4.18 g, 88%).   
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1H NMR (CDCl3, 500 MHz) δ 7.27 – 7.35 (m, 13 H), 7.15 – 7.19 (m, 1H), 3.78 (d, 1H, J 
= 13.0 Hz), 3.71 (d, 1H, J = 13.5 Hz), 3.59 (dd, 1H, J = 10.5, 4.0 Hz), 3.33 (dd, 1H, J = 
11.0, 4.0 Hz), 2.38 – 2.42 (m, 1H), 1.80 – 1.85 (m, 1H), 0.92 (d, 3H, J = 7.0 Hz), 0.87 (d, 
3H, J = 7.0 Hz); 13C NMR (CDCl3, 126 MHz) δ 140.9 (d, JC-P = 7.9 Hz), 137.7 (d, JC-P = 
11.2 Hz), 137.4 (d, JC-P = 2.2 Hz), 137.3, 133.9 (d, JC-P = 19.1 Hz), 133.7 (d, JC-P = 21.3), 
132.6 (d, JC-P = 16.8 Hz), 128.9 (d, JC-P = 11.2 Hz), 128.9 (d, JC-P = 5.6 Hz), 128.7 (d, JC-
P = 6.7 Hz), 63.9, 60.6, 51.4, 29.0, 19.8, 18.6; 31P NMR (CDCl3, 202 MHz) δ – 5.4; IR: 
3367, 2957, 2872, 1586, 1476, 1434, 1180, 1092, 1042, 998, 788, 744, 696, 497 cm-1; 
HRMS (DART-TOF) calcd. for C24H29N1O1P1 [M+H]+: 378.1987, found: 378.1975; 
[α]D20 = + 3.86 (c = 0.680, CHCl3, l = 50 mm). 
 
 (4S)-3-(3-(diphenylphosphanyl)benzyl)-4-isopropyl-2-
methoxyoxazolidine (2.44). Followed General Procedure B with (S)-2-
((3-(diphenylphosphanyl)benzyl)amino)-3-methylbutan-1-ol (1.23 g, 3.28 
mmol), freshly distilled methanol (32 mL) and N,N-dimethylformamide 
dimethylacetal (2.2 mL 16 mmol).  Extraction with pentane (2 x 20 mL) and removal of 
the volatiles were removed under vacuum yielded the pure product as a colorless oil that 
exists as a 1:1 mixture of diastereomers (1.09 g, 80%).   
 
1H NMR (C6D6, 500 MHz) δ 7.58 (d, 0.5H, J = 7.8 Hz), 7.47 (d, 0.5H, J = 7.8 Hz), 7.40-
7.37 (m, 4H), 7.33-7.27 (m, 1.5H), 7.20 (d, 0.5H, J = 7.8 Hz), 7.09-6.99 (m, 7H), 5.15 (s, 
0.5H), 5.04 (s, 0.5H), 3.86 (dd, 0.5H, J = 8.3, 7.8 Hz), 3.83 (d, 0.5H, J = 13.2 Hz), 3.69 
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(dd, 0.5H, J = 7.3, 7.8 Hz), 3.64 (dd, 0.5H, J = 7.8, 5.9 Hz), 3.63 (d, 0.5H, J = 10.0 Hz), 
3.54 (dd, 1H, J = 14.7, 13.2 Hz), 3.40 (d, 0.5H, J = 14.2 Hz), 3.01 (s, 1.5H), 2.95 (s, 
1.5H), 2.94 – 2.90 (m, 0.5H), 2.44 (app q, 0.5H, J = 7.3 Hz), 1.56-1.49 (m, 1H), 0.74 (d, 
1.5H, J = 6.9 Hz), 0.65 (d, 1.5H, J = 3.4 Hz), 0.63 (d, 1.5H, J = 3.4 Hz), 0.57 (d, 1.5H, J 
= 6.9 Hz); 13C NMR (CDCl3, 126 MHz) δ 139.6 (d, JC-P = 6.7 Hz), 139.2 (d, JC-P =  6.7 
Hz), 137.2 – 137.5 (6 signals), 134.5 (d, JC-P = 9.5 Hz), 134.3 (d, JC-P =10.5 Hz), 133.9 
(d, JC-P = 20.0 Hz), 132.9 (d, JC-P = 20.0 Hz), 132.6 (d, JC-P = 19.1 Hz), 129.6 (d, JC-P = 
19.1 Hz), 128.9, 128.7 (d, JC-P = 6.7 Hz), 128.6 (d, JC-P = 13.4 Hz), 114.6, 110.6, 68.4, 
67.5, 66.0, 63.6, 57.0, 52.9, 51.4, 50.1, 31.1, 28.6, 20.4, 19.6, 17.7, 15,5; 31P NMR (C6D6, 
202 MHz) δ – 5.4, – 5.5; IR: 3069, 2929, 2279, 1884, 1817, 1585, 1364, 1155, 1057, 744, 
697, 494 cm-1; HRMS (DART-TOF) calcd. for C26H31N1O2P1 [M+H]+: 420.2092, found: 
420.2099; [α]D20 = + 34.7 (c = 0.480, CHCl3, l = 50 mm). 
 
(S)-2-((3-(diphenylphosphanyl)benzyl)amino)-3,3-
dimethylbutan-1-ol.  Followed General Procedure A using (S)-2-
amino-3,3-dimethylbutan-1-ol (884 mg, 7.54 mmol), 3-
(diphenylphosphanyl)benzaldehyde (1.46 g, 5.03 mmol) and THF 
(18 mL). The imine was reduced with NaBH4 (382 mg, 10.1 mmol) in anhydrous 
methanol (18 mL). Silica gel column chromatography (100 % EtOAc) to afford the title 
compound as a colorless oil (1.27 g, 64%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.28 – 7.34 (m, 13H), 7.17 – 7.18 (m, 1H), 3.83 (d, 1H, J 
= 13.2 Hz), 3.79 (d, 1H, J = 12.7 Hz), 3.60 (dd, 1H, J = 10.7, 4.9 Hz), 3.37 (dd, 1H, J = 
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10.7, 6.4 Hz), 2.30 – 2.32 (m, 1H), 0.90 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 140.9 (d, 
JC-P = 6.7 Hz), 137.8 (d, JC-P = 11.5 Hz), 137.3 (d, JC-P = 10.5 Hz), 133.9 (d, JC-P = 20.0 
Hz), 133.7 (d, JC-P = 21.9 Hz), 132.7 (d, 18.1 Hz), 129.0, 128.9 (d, JC-P = 6.7 Hz), 128.8, 
128.7 (d, JC-P = 7.6 Hz), 67.1, 60.2, 54.1, 34.6, 27.0; 31P NMR (CDCl3, 202 MHz) δ – 
5.4; IR: 3338, 2952, 2867, 1476, 1434, 1413, 1091, 1043, 1026, 997, 788, 743, 695, 495 
cm-1; HRMS (DART-TOF) calcd. for C25H31N1O1P1 [M+H]+: 392.2143, found: 
394.2148; [α]D20 = − 0.873 (c = 0.655, CHCl3, l = 50 mm). 
 
(4S)-4-(tert-butyl)-3-(3-(diphenylphosphanyl)benzyl)-2-
methoxyoxazolidine (2.45). Synthesized according to General 
Procedure B with N,N-dimethylformamide dimethylacetal (2.00 mL, 
14.9 mmol), (S)-2-((3-(diphenylphosphanyl)benzyl)amino)-3,3-
dimethylbutan-1-ol (1.17 g, 2.99 mmol) and methanol (30 mL). Extraction and removal 
of the volatiles under vacuum yielded a pale yellow oil that exists as a 1:1 mixture of 
diastereomers (1.10 g, 84%).  
 
1H NMR (C6D6, 500 MHz) δ 7.66 (d, 0.5H, J = 7.3 Hz), 7.59 (d, 0.5H, J = 7.3 Hz), 7.41 – 
7.45 (m, 4H), 7.31 – 7.37 (m, 1H), 7.03 – 7.14 (m, 8H), 5.05 (s, 0.5H), 5.03 (s, 0.5H), 
4.16 (d, 0.5H, J = 13.6 Hz), 3.90 – 3.93 (m, 0.5H), 3.82 (d, 0.5H, J = 13.7 Hz), 3.73 – 
3.78 (m, 1H), 3.69 (dd, 0.5H, J = 8.3, 2.4 Hz), 3.61 (d, 1H, J = 6.9 Hz), 2.92 (s, 1.5H), 
2.91 (s, 1.5H), 2.51 – 2.54 (m, 0.5H), 2.48 – 2.51 (m, 0.5H), 0.78 (s, 4.5H), 0.77 (s, 
4.5H); 13C NMR (CDCl3, 101 MHz) δ 140.2 (d, JC-P = 6.1 Hz), 140.0 (d, JC-P = 6.1 Hz), 
137.6 (d, JC-P =10.7 Hz), 137.4 (d, JC-P = 4.6 Hz), 137.3 (d, JC-P = 3.8 Hz), 137.1 (d, JC-P 
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= 17.7 Hz), 133.6 – 134.3 (7 signals), 132.9 (d, JC-P = 21.4 Hz), 132.5 (d, JC-P = 22.1 Hz), 
129.3, 128.9 (d, JC-P = 6.9 Hz), 128.8, 128.7 (d, JC-P =  6.9 Hz), 128.4 (d, JC-P = 7.0 Hz), 
115.6, 110.5, 73.1, 68.5, 66.5, 65.4, 60.1, 53.0, 52.4, 52.3, 35.3, 33.8, 26.9, 26.4; 31P 
NMR (C6D6, 202 MHz) δ – 5.6; IR: 2953, 2898, 1477, 1437, 1393, 1360, 1198, 1141, 
1085, 1065, 998, 946, 744, 696, 496 cm-1; HRMS (DART-TOF) calcd. for C27H33N1O2P1 
[M+H]+: 434.2249, found: 434.2232; [α]D20 = + 25.2 (c = 0.495, CHCl3, l = 50 mm). 
 
(3-bromophenyl)bis(4-methoxyphenyl)phosphine oxide.  
To a 100 mL, flame-dried, round-bottom flask in the 
glovebox was added bis(dibenzylideneacetone)palladium 
(317 mg, 0.552 mmol) and 1,3-
bis(diphenylphosphino)propane (228 mg, 0.552 mmol).  The flask was fitted with a dry 
reflux condenser, and the apparatus was brought out of the glovebox and placed under 
argon.  Toluene (22 mL), bis(4-methoxyphenyl)phosphine oxide (4.00 g, 15.3 mmol), 1-
bromo-3-iodobenzene (2.35 mL, 18.4 mmol), and Hunig’s base (3.37 mL, 19.3 mmol) 
were added to the flask successively.  The reaction was heated to reflux overnight.  After 
being cooled to room temperature, the crude mixture was partitioned between water (20 
mL) and ethyl acetate (70 mL).  The layers were separated and the aqueous layer was 
extracted with an additional portion of ethyl acetate (50 mL).  The combined organic 
layers were dried over MgSO4, filtered, and concentrated in vacuo.  The crude reaction 
mixture was purified by silica gel chromatography (2% Et3N/EtOAc) to afford an off 
white solid (3.31 g, 52%).   
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1H NMR ((CD3)2CO, 500 MHz) δ 7.81 (d, 1H, J = 11.7 Hz), 7.76 (d, 1H, J = 7.8 Hz), 
7.65 (s, 1H), 7.61 (app dd, 4H, J = 11.3 Hz, 8.8 Hz), 7.46 – 7.50 (app dt, 1H, J = 7.8 Hz, 
2.9 Hz), 7.09 (app dd, 4H, J = 8.8 Hz, 2.0 Hz), 3.87 (s, 6H); 13C NMR (CDCl3, 126 MHz) 
δ 162.8 (d, JC-P = 2.7 Hz), 136.5 (d, JC-P = 101 Hz), 134.8 (d, JC-P = 2.9 Hz), 134.4 (d, JC-
P = 10.5 Hz), 133.7 (d, JC-P = 11.4 Hz), 130.6 (d, JC-P = 8.6 Hz), 130.2 (d, JC-P = 13.4 Hz), 
123.4 (d, JC-P = 112 Hz), 123.2 (d, JC-P = 14.3 Hz), 114.3 (d, JC-P = 13.4 Hz), 55.5; 31P 
NMR (CDCl3, 202 MHz) δ + 27.5; IR: 1595, 1502, 1254, 1177, 1118, 802, 547 cm-1; 
HRMS (DART-TOF) calcd. for C20H19Br1O3P1 [M+H]+: 417.0255, found: 417.0249. 
 
(3-bromophenyl)bis(4-methoxyphenyl)phosphine.  To a 
solution of (3-bromophenyl)bis(4-methoxyphenyl)-
phosphine oxide (3.22 g, 7.72 mmol) in toluene (77 mL) 
was added triethylamine (5.90 mL, 42.5 mmol).  The 
solution was cooled to 0 °C and trichlorosilane (3.90 mL, 38.6 mmol) was added slowly 
to the stirring solution.  The flask was fitted with a reflux condenser and the solution was 
heated to reflux overnight.  The reaction was cooled to 0 °C and quenched by the addition 
of 30% NaOH (40 mL).  The aqueous layer was extracted with dichloromethane (2 x 50 
mL) and the combined organic layers were washed with an additional portion of water 
(30 mL).  The organic layer was dried over MgSO4, filtered, and concentrated to yield an 
opaque oil that was used in the next step without purification (3.00 g, 97%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.41 – 7.43 (m, 1H), 7.34 (d, 1H, J = 6.5 Hz), 7.24 – 7.27 
(m, 5H), 7.16 – 7.18 (m, 1H), 6.90 (d, 4H, J = 8.5 Hz), 3.81 (s, 6H); 13C NMR (CDCl3, 
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126 MHz) δ 160.6, 142.3 (d, JC-P = 15.3 Hz), 135.6 (d, JC-P = 21.9 Hz), 135.5 (d, JC-P = 
19.1 Hz), 131.7 (d, JC-P = 19.1 Hz), 131.4, 130.1 (d, JC-P = 5.7 Hz), 127.6 (d, JC-P = 7.6 
Hz), 123.2 (d, JC-P = 6.7 Hz), 114.6 (d, JC-P = 8.6 Hz), 55.4; 31P NMR (CDCl3, 202 MHz) 
δ – 7.8; IR: 1596, 1500, 1255, 1179, 1120, 829, 548 cm-1; HRMS (DART-TOF) calcd. 
for C20H19Br1O2P1 [M+H]+: 401.0306, found: 401.0291. 
 
3-(bis(4-methoxyphenyl)phosphino)benzaldehyde.  To a 
-78 °C solution of (3-bromophenyl)bis(4-
methoxyphenyl)phosphine (3.23 g, 8.05 mmol) in THF (81 
mL) was added n-BuLi (3.63 mL, 8.86 mmol, 2.44 M 
solution in hexanes).  After stirring at this temperature for 50 minutes, DMF (1.20 mL, 
16.1 mmol) was added and the resulting solution was warmed to room temperature over 4 
hours.  The reaction was quenched by the addition of saturated ammonium chloride (60 
mL) and extracted with ethyl acetate (150 mL).  The organic layer was extracted with an 
additional portion of water (40 mL), dried over MgSO4, filtered, and concentrated in 
vacuo.  Purification of the crude reaction mixture on silica gel (15% EtOAc/Hex) 
afforded the title compound as a colorless oil (1.53 g, 57%).   
 
1H NMR (CDCl3, 500 MHz) δ 9.93 (s, 1H), 7.81 (d, 1H, J = 6.8 Hz), 7.74 (d, 1H, J = 6.8 
Hz), 7.45 – 7.51 (m, 2H), 7.25 – 7.29 (m, 4H), 6.91 (d, 4H, J = 8.3 Hz), 3.82 (s, 6H); 13C 
NMR (CDCl3, 126 MHz) δ 192.4, 160.8, 141.1 (d, JC-P = 13.4 Hz), 138.9 (d, JC-P = 18.1 
Hz), 136.5 (d, JC-P = 4.8 Hz), 135.6 (d, JC-P = 21.0 Hz), 134.8 (d, JC-P = 19.1 Hz), 129.2 
(d, JC-P = 5.7 Hz), 129.0, 127.4 (d, JC-P = 7.6 Hz), 114.6 (d, JC-P = 8.6 Hz), 55.4; 31P 
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NMR (CDCl3, 202 MHz) δ – 8.8; IR: 1698, 1594, 1498, 1287, 1250, 1178, 828 cm-1; 
HRMS (DART-TOF) calcd. for C21H20O3P1 [M+H]+: 351.1150, found: 351.1146. 
 
(S)-2-((3-(bis(4-methoxyphenyl)phosphanyl)-
benzyl)amino)-3,3-dimethylbutan-1-ol.  Followed 
General Procedure A. Imine formation was carried out 
with (S)-2-amino-3,3-dimethylbutan-1-ol (216 mg, 
1.84 mmol) and 3-(bis(4-methoxyphenyl)-
phosphino)benzaldehyde (322 mg, 0.920 mmol). The imine was reduced with NaBH4 
(104 mg, 2.76 mmol) in anhydrous methanol. Work-up and silica gel chromatography of 
the resulting crude reside (1% Et3N/EtOAc) to gave the title compound as a colorless oil 
(172 mg, 41%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.20 – 7.28 (m, 7H), 7.11 – 7.14 (m, 1H), 6.88 (d, 4H, J = 
8.8 Hz), 3.83 (d, 1H, J = 13.1 Hz), 3.80 (s, 6H), 3.78 (d, 1H, J = 12.8 Hz), 3.60 (dd, 1H, J 
= 10.7, 4.9 Hz), 3.38 (dd, 1H, J = 10.7, 5.9 Hz), 2.30 – 2.32 (m, 1H), 0.91 (s, 9H); 13C 
NMR (CDCl3, 151 MHz) δ 160.5, 140.8 (d, JC-P = 6.9 Hz), 139.2 (3, JC-P = 11.6 Hz), 
135.5 (d, JC-P = 20.8 Hz), 133.0 (d, JC-P = 20.8 Hz), 132.1 (d, JC-P = 17.3 Hz), 128.7 (d, 
JC-P = 5.8 Hz), 128.4, 128.3, 114.4 (d, JC-P = 6.9 Hz), 67.1, 60.2, 55.4, 54.1, 34.6, 27.5; 
31P NMR (CDCl3, 202 MHz) δ – 8.6; IR: 3376, 2954, 2869, 1594, 1497, 1402, 1364, 
1285, 1177, 1095, 1030, 827, 796, 531 cm-1; HRMS (DART-TOF) calcd. for 
C27H35N1O3P1 [M+H]+: 452.2355, found: 452.2373; [α]D20 = − 2.89 (c = 0.485, CHCl3, l 
= 50 mm). 
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 (4S)-3-(3-(bis(4-methoxyphenyl)phosphanyl)benzyl)-4-(tert-
butyl)-2-methoxyoxazolidine (2.46).  Synthesized according to 
General Procedure B using N,N-dimethylformamide 
dimethylacetal (254 µL, 1.91 mmol), and (S)-2-((3-(bis(4-
methoxyphenyl)phosphanyl)benzyl)amino)-3,3-dimethylbutan-
1-ol (172 mg, 0.381 mmol) in methanol (5.5 mL).  Extraction in 
the glovebox with degassed pentane (2 x 10 mL) and removal of the volatiles under 
reduced pressure gave the title compound as a viscous oil (167 mg, 89 %).     
 
1H NMR (C6D6, 600 MHz) δ 7.70 (d, 0.6H, J = 7.3 Hz), 7.62 (d, 0.6H, J = 7.8 Hz), 7.37 – 
7.47 (m, 5H), 7.12 – 7.20 (m, 1.8H), 6.73 – 6.76 (m, 4H), 5.10 (s, 0.6H), 5.08 (s, 0.4H), 
4.22 (d, 0.4H, J = 13.7 Hz), 3.93 (t, 0.4H, J = 8.1 Hz), 3.87 (d, 0.4H, J = 13.7 Hz), 3.75 – 
3.81 (m, 1.2H), 3.70 (dd, 0.4H, J = 8.3, 2.4 Hz), 3.65 (d, 1.2H, J = 5.4 Hz), 3.24 (s, 
3.6H), 3.23 (s, 2.4H), 2.95 (s, 3H), 2.56 (dd, 0.4H, J = 7.8, 2.4 Hz), 2.52 (t, 0.6H, J = 8.3 
Hz), 0.81 (s, 5.4H), 0.79 (s, 3.6H); 13C NMR (CDCl3, 151 MHz) δ 160.5, 139.9 (d, JC-P = 
5.8 Hz), 139.8 (d, JC-P = 5.8 Hz), 138.8 (d, JC-P = 10.4 Hz), 138.5 (d, JC-P = 9.2 Hz), 135.5 
(d, JC-P = 20.8 Hz), 135.4 (d, JC-P = 20.8 Hz), 135.1 (d, JC-P = 8.4 Hz), 133.6 (d, JC-P = 
17.3 Hz), 133.1 (d, JC-P = 17.3 Hz), 132.2 (d, JC-P = 20.8 Hz), 131.8 (d, JC-P = 20.8 Hz), 
128.5 – 128.8 (7 signals), 128.3 (d, JC-P = 8.1 Hz), 115.6, 114.4 (d, JC-P = 8.1 Hz), 110.5, 
73.1, 68.5, 66.6, 65.4, 60.2, 55.4, 53.1, 52.4, 52.3, 35.3, 33.8, 26.8, 26.4; 31P NMR (C6D6, 
202 MHz) δ – 8.7; IR: 2952, 2900, 1593, 1496, 1461, 1304, 1283, 1244, 1094, 1063, 
1030, 826, 796, 530 cm-1; HRMS (DART-TOF) calcd. for C29H37N1O4P1 [M+H]+: 
494.2460, found: 494.2445; [α]D20 = + 20.8 (c = 0.570, CHCl3, l = 50 mm). 
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(3-bromophenyl)bis(4-(trifluoromethyl)phenyl)-
phosphine oxide.  To a flame-dried, 25-mL, round-bottom 
flask in a dry box was added bis(4-
(trifluoromethyl)phenyl)phosphine oxide (1.50 g, 4.44 
mmol), bis(dibenzylideneacetone)palladium (926 mg, 0.160 mmol), and 1,3-
bis(diphenylphosphino)propane (660 mg, 0.160 mmol).  The flask was brought out of the 
dry box and was placed under nitrogen.  The flask was charged, successively, with 
toluene (5 mL), 3-bromo-1-iodobenzene (0.682 mL, 5.35 mmol), and N,N-
diisopropylethylamine (1.01 mL, 5.62 mmol) and the reaction was heated to reflux 
overnight.  The reaction was cooled to room temperature and was partitioned between 
water (20 mL) and DCM (40 mL).  The aqueous layer was washed with an additional 
portion of DCM (40 mL).  The combined organic layers were dried over MgSO4, filtered, 
and concentrated in vacuo.  The crude reaction mixture was purified by silica gel 
chromatography (20% EtOAc/Hex containing 1% Et3N) to yield the title compound as 
colorless solid (1.91 g, 88%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.74 – 7.83 (m, 10H), 7.56 (dd, 1H, J = 12.0, 8.0 Hz), 7.39 
(dt, 1H, J = 8.0, 3.5 Hz); 13C NMR (CDCl3, 151 MHz) δ 136.1 (d, JC-P = 3.1 Hz), 135.7 
(d, JC-P = 103.0 Hz), 134.7 (d, JC-P = 10.7 Hz), 134.6 (dq, JC-P,F = 32.8, 3.1 Hz), 133.7 (d, 
JC-P = 103.0 Hz), 132.7 (d, JC-P = 10.7 Hz), 130.8 (d, JC-P = 13.0 Hz), 130.6 (d, JC-P = 9.9 
Hz), 126.0 – 126.1 (m), 123.9 (d, JC-P = 15.3 Hz), 123.6 (d, JC-F = 273 Hz); 19F NMR 
(CDCl3, 470 MHz) δ – 63.8; 31P NMR (CDCl3, 202 MHz) δ + 25.3; IR: 3057, 1611, 
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1504, 1321, 1128, 1062, 836, 766, 685, 572 cm-1; HRMS (DART-TOF) calcd. for 
C20H13Br1F6O1P1 [M+H]+: 492.9713, found: 492.9792. 
 
(3-bromophenyl)bis(4-(trifluoromethyl)phenyl)-
phosphane.  To a flame-dried flask was added (3-
bromophenyl)bis(4-(trifluoromethyl)phenyl)phosphine 
oxide (1.00 g, 2.03 mmol), Et3N (1.57, 11.2 mmol), and 
toluene (20 mL).  The solution was cooled to 0 °C and trichlorosilane was added 
dropwise.  The flask was fitted with a reflux condenser and the reaction was heated to 
reflux overnight.  The solution was cooled to room temperature, quenched by the addition 
of 30% NaOH (30 mL), and further diluted with water (10 mL).  The aqueous layer was 
extracted with DCM (3 x 40 mL).  The combined organic layers were dried over MgSO4, 
filtered, and concentrated under reduced pressure.  Silica gel chromatography (20% 
EtOAc/Hex) afforded the title compound as a colorless oil (932 mg, 95%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.63 (d, 4H, J = 8.0 Hz), 7.55 (d, 1H, J = 8.0 Hz), 7.45 (d, 
1H, J = 7.5 Hz), 7.40 (t, 4H, J = 8.0 Hz), 7.21 – 7.22 (m, 2H); 13C NMR (CDCl3, 151 
MHz) δ 140.6 (d, JC-P = 13.7 Hz), 137.9 (d, JC-P =14.4 Hz), 136.3 (d, JC-P = 22.0 Hz), 
133.8 (d, JC-P = 19.8 Hz), 133.0, 132.5 (d, JC-P = 19.5 Hz), 131.4 (q, JC-P = 33.0 Hz), 
130.5 (d, JC-P = 6.8 Hz), 128.8 (d, JC-P = 24.8 Hz), 125.6 – 125.6 (m), 125.2 (q, JC-F = 272 
Hz), 123.5 (d, JC-P = 8.4 Hz); 19F NMR (CDCl3, 470 MHz) δ – 62.9; 31P NMR (CDCl3, 
202 MHz) δ – 5.3; IR: 1606, 1396, 1166, 1106, 831, 781, 686 cm-1; HRMS (DART-TOF) 
calcd. for C20H13Br1F6P1 [M+H]+: 476.9842, found: 476.9842. 
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3-(bis(4-(trifluoromethyl)phenyl)phosphanyl)benz-
aldehyde.  To a flame-dried, round-bottom flask was added 
(3-bromophenyl)-bis((4-trifluoromethyl)phenyl)phosphine 
(789 mg, 1.84 mmol) and THF (10 mL).  The solution was 
cooled to – 78 °C, n-BuLi (0.884 mL, 2.21 mmol, 2.50 M solution in hexanes) was added 
dropwise, and the reaction was stirred for 30 minutes at this temperature.  N,N-
dimethylformamide (0.226 mL, 23.0 mL) was added to the solution and the cold bath was 
removed.  The reaction continued to stir at room temperature for 2 hours and was 
quenched by the addition of water (10 mL).  The aqueous layer was extracted with DCM 
(3 x 15 mL).  The combined organic layers were dried over MgSO4, filtered, a 
concentrated in vacuo.  The crude reaction was purified by silica gel chromatography 
(10% EtOAc/Hex) to afford the title compound as a colorless oil (371 mg, 47%).   
 
1H NMR (CDCl3, 500 MHz) δ 9.98 (s, 1H), 7.92 (d, 1H, J = 7.3 Hz), 7.86 (d, 1H, J = 7.8 
Hz), 7.64 (d, 4H, J  = 7.8 Hz), 7.53 – 7.58 (m, 2H), 7.41 (t, 4H, J = 7.6 Hz); 13C NMR 
(CDCl3, 126 MHz) δ 191.8, 140.7 (d, JC-P = 14.3 Hz), 139.6 (d, JC-P = 19.1 Hz), 137.2 (d, 
JC-P = 14.3 Hz), 137.0 (d, JC-P = 6.7 Hz), 135.3 (d, JC-P = 22.9 Hz), 134.1 (d, JC-P = 20.2 
Hz), 131.7 (q, JC-F = 32.4 Hz), 130.8, 129.9 (d, JC-P = 5.7 Hz), 125.7 – 125.9 (m), 124.0 
(q, JC-F = 273 Hz); 19F NMR (CDCl3, 470 MHz) δ – 62.9; 31P NMR (CDCl3, 202 MHz) δ 
– 6.1; IR: 3062, 2852, 2302, 1926, 1701, 1397, 1124, 1060, 1016, 794, 600 cm-1; HRMS 
(DART-TOF) calcd. for C21H14F6O1P1 [M+H]+: 427.0687, found: 427.0683. 
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(S)-2-((3-(bis(4-(trifluoromethyl)phenyl)-
phosphanyl)benzyl)amino)-3,3-dimethylbutan-1-ol. 
Synthesized according to General Procedure A using 
(S)-2-amino-3,3-dimethylbutan-1-ol (125 mg, 1.07 
mmol), THF (8 mL), and 3-(bis(4-
(trifluoromethyl)phenyl)phosphanyl). Reduction of the imine was carried out with NaBH4 
(94 mg, 2.5 mmol) in anhydrous methanol (6 mL). After workup, the crude residue as 
purified by column chromatography (1% Et3N/EtOAc) to afford the title compound as a 
colorless oil (218 mg, 50%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.72 (s, 1H), 7.60 (d, 4H, J = 7.8 Hz), 7.35 – 7.41 (m, 5H), 
7.31 (d 1H, J = 7.3 Hz), 7.19 (app t, 1H, J = 7.3 Hz), 3.88 (d, 1H, J = 13.2 Hz), 3.82 (d, 
1H, J = 13.2 Hz), 3.61 – 3.64 (m, 1H), 3.37 – 3.40 (m, 1H), 2.32 (dd, 1H, J = 5.9, 4.9 
Hz), 0.90 (s, 9H); 13C NMR (CDCl3, 151 MHz) δ 141.7 (d, JC-P = 9.3 Hz), 135.3 (d, JC-P 
= 10.4 Hz), 133.8 – 134.6 (6 signals), 133.0 (d, JC-P = 18.5 Hz), 131.3 (q, JC-F = 32.4 Hz), 
129.8, 129.4 (d, JC-P = 2.3 Hz), 124.2 (q, JC-F = 273 Hz), 67.4, 60.4, 54.1, 34.6, 27.5; 31P 
NMR (CDCl3, 202 MHz) δ – 5.6; 19F NMR (CDCl3, 470 MHz) δ – 62.9; IR: 3415, 2958, 
2870, 1477, 1396, 1323, 1127, 1107, 1060, 1016, 997, 832, 599 cm-1; HRMS (DART-
TOF) calcd. for C27H29F6N1O1P1 [M+H]+: 528.1891, found: 528.1874; [α]D20 = + 4.44 (c 
= 0.540, CHCl3, l = 50 mm). 
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 (4S)-3-(3-(bis(4-(trifluoromethyl)phenyl)phosphanyl)-
benzyl)-4-(tert-butyl)-2-methoxyoxazolidine (2.47). Followed 
General Procedure B using N,N-dimethylformamide 
dimethylacetal (256 µL, 1.90 mmol), (S)-2-((3-(bis(4-
(trifluoromethyl)phenyl)phosphanyl)benzyl)amino)-3,3-
dimethylbutan-1-ol (200 mg, 0.380 mmol), and methanol (6 
mL). Extraction pentane (2 x 10 mL) and concentration under reduced pressure afforded 
the title compound as a viscous oil (198 mg, 92%).  
 
1H NMR (C6D6, 500 MHz) δ 7.57 (d, 0.6H, J = 7.8 Hz), 7.53 (d, 0.4H, J = 7.8 Hz), 7.41 
(d, 0.4H, J = 7.8 Hz), 7.07 – 7.28 (m, 10.6H), 4.98 (s, 0.4H), 4.96 (s, 0.6H), 4.19 (d, 
0.4H, J = 13.7 Hz), 3.88 (t, 0.4H, J = 8.1 Hz), 3.85 (d, 0.4H, J = 13.7 Hz), 3.76 (t, 0.6H, J 
= 8.1 Hz), 3.64 – 3.70 (m, 1.6H), 3.58 (d, 0.6H, J = 15.2 Hz), 2.90 (s, 1.2H), 2.87 (s, 
1.8H), 2.52 (dd, 0.4H, J = 7.8, 2.4 Hz), 2.46 (dd, 0.6H, J = 8.8, 7.8 Hz), 0.74 (s, 3.6H), 
0.73 (s, 5.4H); 13C NMR (CDCl3, 151 MHz) δ 141.7 – 142.0 (5 signals), 141.9 (d, JC-P = 
5.8 Hz), 140.9 (d, JC-P = 5.8 Hz), 135.1 (d, JC-P = 10.4 Hz), 134.8 (d, JC-P = 9.4 Hz), 133.7 
– 134.2 (8 signals), 133.2 (d, JC-P = 24.3 Hz), 132.8 (d, JC-P = 24.3 Hz), 131.2 (q, JC-F = 
32.4 Hz), 129.9, 129.8, 129.1 (d, JC-P = 9.3 Hz), 128.9 (d, JC-P = 8.1 Hz), 125.6, 124.2 (q, 
JC-F = 273 Hz), 115.9, 110.3, 73.3, 68.5, 66.4, 65.4, 60.0, 53.0, 52.4, 52.2, 35.3, 33.8, 
26.8, 26.3; 31P NMR (C6D6, 202 MHz) δ – 5.8; 19F NMR (CDCl3, 564 MHz) δ – 62.9 IR: 
2956, 1606, 1477, 1396, 1320, 1164, 1124, 1106, 1059, 1016, 998, 831, 700, 599, 514 
cm-1; HRMS (DART-TOF) calcd. for C29H31F6N1O2P1 [M+H]+: 570.1997, found: 
570.1985; [α]D20 = + 16.4 (c = 0.475, CHCl3, l = 50 mm). 
N O
Me
Me
P
OMe
CF3
F3C
Me
! 86 
 
(S)-4-(tert-butyl)-3-(3-(diphenylphosphanyl)benzyl)oxazolidine (2.48).  
To a stirring suspension of (S)-2-((3-(diphenylphosphanyl)-
benzyl)amino)-3,3-dimethylbutan-1-ol (383 mg, 0.979 mmol) and 
paraformaldehyde (44 mg, 1.5 mmol) in anhydrous toluene (25 mL) was 
added p-toluenesulfonic acid monohydrate (39 mg, 0.20 mmol).  The solution was heated 
to reflux overnight with azeotropic removal of water.  The reaction was cooled to room 
temperature and the volatiles were removed under reduced pressure.  The remaining 
residue was diluted with chloroform (30 mL) and washed with saturated NaHCO3 (15 
mL).  The aqueous layer was extracted with an additional portion of chloroform (30 mL), 
the combined organics were dried over MgSO4, filtered, and concentrated in vacuo.  
Flash column chromatography (10% EtOAc/Hex) afforded the product as a colorless oil 
(203 mg, 51%).   
 
1H NMR (CDCl3, 500 MHz) δ 7.27 – 7.36 (m, 13H), 7.19 (t, 1H, J = 7.5 Hz), 4.18 (d, 
1H, J = 5.9 Hz), 4.00 (d, 1H, J = 6.4 Hz), 3.95 (t, 1H, J = 8.3 Hz), 3.79 (d, 1H, J = 13.7 
Hz), 3.72 (d, 1H, J = 13.2 Hz), 3.50 (dd, 1H, J = 8.8, 7.3 Hz), 2.71 (t, 1H, J = 7.3 Hz), 
0.82 (s, 9H); 13C NMR (CDCl3, 151 MHz) δ 140.8, 137.5 (d, JC-P = 10.4 Hz), 137.4 (d, 
JC-P = 9.3 Hz), 134.1 (d, JC-P = 25.4 Hz), 133.9 (d, JC-P = 18.5 Hz), 132.6 (d, JC-P = 19.7 
Hz), 129.2 128.9, 128.7 (d, JC-P = 6.9 Hz), 128.6 (d, JC-P = 6.9 Hz), 87.2, 73.6, 66.7, 62.2, 
34.6, 26.4; 31P NMR (CDCl3, 202 MHz) δ – 5.5; IR: 2953, 2867, 1477, 1434, 1392, 1157, 
1068, 1013, 913, 743, 696, 495 cm-1; HRMS (DART-TOF) calcd. for C26H31N1O1P1 
[M+H]+: 404.2143, found: 404.2131; [α]D20 = − 6.43 (c = 0.435, CHCl3, l = 50 mm). 
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Probing of Scaffolding Ligands with Other Linkers: 
 
 
2.11.3 Substrate Syntheses and Characterization 
The following compounds were synthesized according to literature procedures and 
matched all reported spectroscopic data: (S)-2-methyl-3-(trityloxy)propanal (111865-84-
0),31 2-(((R)-4,4-dibromo-2-methylbut-3-en-1-yl)oxy)tetrahydro-2H-pyran (1156545-93-
5), 32  methyl (S)-2-(hydroxymethyl)-3-methylbutanoate (189938-05-4), 33  (R)-2-
phenyloxirane (20780-53-4),34 (R)-2-(4-chlorophenyl)oxirane (21019-51-2),34 (R)-2-(4-
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
31 Gaunt, M. J.; Jessiman, A. S.; Orsini, P.; Tanner, H. R.; Hook, D. F.; Ley, S. V. Org. 
Lett. 2003, 5, 4819 – 4922. 
32 Ley, S. V.; Tackett, M. N.; Maddess, M. L.; Anderson, J. C.; Brennan, P. E.; Cappi, M. 
W.; Heer, J. P.; Helgen, C.; Masakuni, K.; Kouklovsky, C.; Marsden, S. P.; Norman, J.; 
Osborn, D. P.; Palomero, M. A.; Pavey, J. B. J.; Pinel, C.; Robinson, L. A.; Schnaubelt, 
J.; Scott, J. S.; Spilling, C. D; Watanabe, H.; Wesson, K. E.; Willis, M. C. Chem. Eur. J. 
2009, 15, 2874 – 2009. 
33 Imogai, H.; Larcheveque, M. Tetrahedron: Asymm. 1997, 8, 965 – 972. 
34 Shaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. 
E.; Furrow, M. E.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 1307 – 1315. 
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bromophenyl)oxirane (62566-68-1),35 (R)-2-(4-methoxyphenyl)oxirane (62600-73-1),36 
(R)-1-(3-(trifluoromethyl)phenyl)ethane-1,2-diol, 37  (R)-2-(3-(methoxy)phenyl)oxirane 
(62600-72-0),34 (R,Z)-non-3-ene-1,2-diol.38 
 
(R,Z)-(((2-methyloct-3-en-1-yl)oxy)methanetriyl)tribenzene.  
To a stirring suspension of (1-pentyl)triphenylphosphonium 
bromide (3.00 g, 7.26 mmol) in THF (30 mL) at – 78 °C was added n-butyllithium (2.2 
mL, 2.4 M solution in hexanes).  The reaction was stirred at – 78 °C for 10 minutes and 
was then allowed to warm to 0 °C over 25 minutes.  The bright orange solution was re-
cooled to – 78 °C and (S)-2-methyl-3-(trityloxy)propanal (1.60 g, 4.84 mmol) was added 
as a solution in THF (5 mL).  The reaction was quenched by the addition of water (20 
mL), extracted with Et2O (3 x 40 mL), and the combined organic phases were dried over 
MgSO4.  Filtration and removal of the solvent under reduced pressure afforded a yellow 
residue, which was subjected to silica gel chromatography (15% DCM/Hex) to afford the 
title compound as a colorless oil (1.58 g, 85%).  
 
1H NMR (600 MHz, CDCl3) δ 7.44 – 7.46 (m, 6H), 7.27 – 7.30 (m, 6H), 7.21 – 7.24 (m, 
3H), 5.34 – 5.38 (m, 1H), 5.14 – 5.18 (m, 1H), 2.94 – 2.97 (m, 1H), 2.86 – 2.89 (m, 1H), 
2.74 – 2.80 (m, 1H), 2.03 – 2.07 (m, 2H), 1.29 – 1.34 (m, 4H), 1.00 (d, 3H, J = 6.4 Hz), 
0.90 (t, 3H, J = 7.0 Hz); 13C NMR (126 MHz, CDCl3) δ 144.7, 133.1, 130.3, 129.0, !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
35 Barlow, T.; Dipple, A. Chem. Res. Toxicol. 1998, 11, 44 – 53. 
36 Kawasaki, K.; Katsuki, T. Tetrahedron 1997, 53, 6337 – 6350. 
37 Sasmal, P. K.; Vamseekrishna, C.; Potluri, V.; Tehim, A.; Gai, Y.; Zhang, H. 
Substituted Heterocyclic Acetamides as Kappa Opioid Receptor (KOR) Agonists. 
International Application No: PCT/CN2013/000230, May 5, 2013. 
38 Dussault, P. H.; Schultz, J. A. J. Am. Chem. Soc. 1999, 64, 8419 – 8422. 
Ph
Ph
Ph
O
Me Bu
! 89 
127.9, 127.0, 86.4, 68.5, 33.0, 32.3, 27.5, 22.6, 18.4, 14.2; IR 2957, 2927, 2870, 1491, 
1449, 1065, 1034, 774, 763, 705 cm-1; HRMS (ESI+) calcd. for C28H32O1Na1 [M+Na]+: 
407.2351, found: 407.2349; [α]D20 = − 39.4 (c = 0.420, CHCl3, l = 50 mm).  
 
(R,Z)-2-methyloct-3-en-1-ol ((R)-2.19).  In a round-bottom flask p-
toluenesulfonic acid monohydrate (635 mg, 3.34 mmol) and  (R,Z)-(((2-
methyloct-3-en-1-yl)oxy)methanetriyl)tribenzene (3.21 g, 8.35 mmol) were stirred in 
dichloromethane (14 mL) and anhydrous methanol (10 mL) overnight.  The volatiles 
were removed in vacuo and the residue was partitioned between saturated sodium 
bicarbonate (20 mL) and dichloromethane (40 mL).  The aqueous layer was washed with 
an additional portion of dichloromethane (40 mL).  The combined organic layers were 
dried over MgSO4, filtered, and concentrated in vacuo.  The crude residue was purified 
by silica gel chromatography (15% EtOAc/Hex), affording a colorless oil (743 mg, 62%).   
 
1H NMR (600 MHz, CDCl3) δ 5.50 – 5.54 (m, 1H), 5.11 (dt, 1H, J = 11.2, 1.2 Hz), 3.48 
(dd, 1H, J = 10.6, 5.9 Hz), 3.33 (dd, 1H, J = 10.6, 8.2 Hz), 2.68 – 2.73 (m, 1H), 2.02 – 
2.12 (m, 2H), 1.42 (br s, 1H), 1.30 – 1.36 (m, 4H), 0.94 (d, 3H, J = 7.0 Hz), 0.89 (t, 3H, J 
= 7.0 Hz); 13C NMR (151 MHz, CDCl3) δ 132.7, 132.1, 67.9, 35.0, 32.3, 27.6, 22.6, 17.2, 
14.2; IR 3330, 2956, 2927, 2972, 1456, 1378, 1068, 1002, 990, 713, 607 cm-1; HRMS 
(DART-TOF) calcd. for C9H19O1 [M+H]+: 143.1436, found: 143.1430; [α]D20 = + 11.8 (c 
= 0.805, CHCl3, l = 50 mm).  
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(S,Z)-2-methyloct-3-en-1-ol ((S)-2.19).  Same experimental procedure 
followed as (R,Z)-2-methyloct-3-en-1-ol and all spectral and analytical 
data are identical except for the optical rotation [α]D20 = − 9.51 (c = 0.745, CHCl3, l = 50 
mm). 
 
2-(((R)-2-methyloct-3-yn-1-yl)oxy)tetrahydro-2H-pyran.  To 
a solution of 2-(((R)-4,4-dibromo-2-methylbut-3-en-1-
yl)oxy)tetrahydro-2H-pyran (2.18 g, 6.64 mmol) in THF (50 mL) at – 78 °C was added 
n-BuLi (6.10 mL, 14.6 mmol, 2.40 M solution in hexanes).  The reaction was stirred at 
this temperature for 45 minutes and 1-iodobutane (3.80 mL, 33.3 mmol) was added.  
After warming the room temperature over 40 minutes, the reaction was heated to 55 °C 
for 3 hours.  The reaction was cooled to room temperature, quenched by the addition of 
saturated aqueous NH4Cl (30 mL), diluted further with water (5 mL), and extracted with 
dichloromethane (2 x 40 mL).  The combined organic layers were dried over MgSO4, 
filtered, and concentrated.  Silica gel chromatography (3% EtOAc/Hex) afforded the title 
compound as a colorless oil that exists as a 1:1 mixture of diastereomers (1.04 g, 70%).   
 
1H NMR (500 MHz, CDCl3) δ 4.65 (t, 0.5H, J = 3.4 Hz), 4.63 (t, 0.5H, J = 3.4 Hz), 3.84 
– 3.91 (m, 1H), 3.73 (dd, 0.5H, J = 9.5, 6.1 Hz), 3.55 (dd, 0.5H, J = 9.5, 8.1 Hz), 3.50 – 
3.51 (m, 1H), 3.45 (dd, 0.5H, J = 9.3, 6.4 Hz), 3.25 (dd, 0.5H, J = 9.5, 7.6 Hz), 2.66 – 
2.70 (m, 1H), 2.14 (t, 2H, J = 6.9 Hz), 1.82 – 1.85 (m, 1H), 1.68 – 1.73 (m, 1H), 1.36 – 
1.63 (m, 8H), 1.17 (d, 3H, J = 6.9 Hz), 0.89 (t, 3H, J = 7.3 Hz); 13C NMR (126 MHz, 
CDCl3) δ 99.1, 98.8, 82.3, 82.2, 81.3, 81.2, 72.1, 72.0, 62.4, 622, 31.4, 31.3, 30.8, 30.7, 
HO
Me Bu
O
Me
O
Bu
! 91 
27.0, 26.9, 25.7, 22.1, 19.6, 19.5, 18.6, 18.5, 18.4, 13.8; IR 2933, 2812, 1123, 1061, 
1034, 973 cm-1; HRMS (DART-TOF) calcd. for C14H25O2 [M+H]+: 225.1855, found: 
225.1855. 
 
(R)-2-methyloct-3-yn-1-ol.  To a round-bottom flask containing p-
TsOH monohydrate (130 mg, 0.674 mmol) was added 2-(((R)-2-
methyloct-3-yn-1-yl)oxy)tetrahydro-2H-pyran (1.51 g, 6.74 mmol) in anhydrous 
methanol (20 mL).  The reaction was allowed to stir at room temperature until all starting 
material was consumed (approx. 3 hours).  The solution was transferred to a separatory 
funnel, diluted with dichloromethane (40 mL) and washed with saturated aqueous 
NaHCO3 (15 mL).  The layers were separated and the aqueous layer was extracted with 
an additional portion of dichloromethane (30 mL).  The combined organic layers were 
dried over Na2SO4, filtered, and concentrated in vacuo.  Silica gel chromatography (15% 
EtOAc/Hex) afforded the title compound as a colorless oil (788 mg, 83%).   
 
1H NMR (600 MHz, CDCl3) δ 3.53 (dd, 1H, J = 10.3, 5.6 Hz), 3.44 (dd, 1H, J = 10.3, 7.1 
Hz), 2.62 – 2.65 (m, 1H), 2.16 (dt, 2H, J = 7.3, 2.2 Hz), 1.81 (br s, 1H), 1.45 – 1.49 (m, 
2H), 1.35 – 1.44 (m, 2H), 1.13 (d, 3H, J = 7.1 Hz), 0.90 (t, 3H, J = 7.3 Hz); 13C NMR 
(151 MHz, CDCl3) δ 82.9, 81.5, 67.3, 31.3, 29.8 22.1, 18.6, 17.5, 13.8; IR 3340, 2958, 
2932, 2874, 1457, 1379, 1329, 1039, 1015 cm-1; HRMS (DART-TOF) calcd. for C9H17O1 
[M+H]+: 141.1279, found: 141.1281; [α]D20 = + 15.2 (c = 1.13, CHCl3, l = 50 mm). 
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(R,E)-2-methyloct-3-en-1-ol (2.50).  A flame-dried, three-neck, 
round-bottom flask fitted with a dry ice condenser was charged with 
ammonia (7.2 mL) at – 78 ° C.  Sodium metal (328 mg, 14.3 mmol) was added piece-
wise at this temperature, upon which time the solution turned deep blue.  The solution 
was allowed to stir while warming to – 35 °C over 20 minutes and (R)-2-methyloct-3-yn-
1-ol (0.500 g, 3.57 mmol) was added drop-wise as a solution in THF (4 mL).  The 
reaction was allowed to stir for 3 hours at – 30 °C and was quenched by the careful 
addition of solid NH4Cl (approx. 10 eq).  The ammonia was allowed to evaporate and the 
reaction mixture was diluted with water (15 mL).  Extraction with dichloromethane (2 x 
30 mL), followed by drying over MgSO4 and concentration in vacuo showed that trace 
amounts of starting material remained.  The crude residue was re-subjected to the same 
reaction conditions and work-up procedure.  Purification on a short plug of silica afforded 
the title compound as a colorless oil (419 mg, 83%).   
 
1H NMR (600 MHz, CDCl3) δ 5.50 – 5.55 (m, 1H), 5.22 – 5.26 (m, 1H), 3.44 – 3.48 (m, 
1H), 3.32 – 3.36 (m, 1H), 2.27 – 2.32 (m, 1H), 2.00 – 2.02 (m, 2H), 1.44 (br s, 1H), 1.26 
– 1.37 (m, 4H), 0.97 (d, 3H, J = 7.0 Hz), 0.88 (d, 3H, J = 7.0 Hz); 13C NMR (151 MHz, 
CDCl3) δ 132.7, 132.4, 67.5, 40.0, 32.5, 31.9, 22.4, 16.8, 14.1; IR 3340, 2957, 2924, 
2972, 1457, 1378, 1034, 968 cm-1; HRMS (DART-TOF) calcd. for C9H19O1 [M+H]+: 
143.1436, found: 143.1433; [α]D20 = + 17.8 (c = 0.920, CHCl3, l = 50 mm).  
 
methyl-(S)-3-methyl-2-((trityloxy)methyl)butanoate.  Trityl 
chloride (3.00 g, 10.6 mmol), DMAP (74 mg, 0.59 mmol), O OMe
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methyl-(S)-2-(hydroxymethyl)-3-methylbutanoate (865 mg, 5.92 mmol), and 
dichloromethane (20 mL) were added to a round-bottom flask under nitrogen.  
Triethylamine (1.64 mL, 11.8 mmol) was added to the vigorously stirred solution slowly 
and the reaction was stirred at room temperature overnight.  The reaction was quenched 
by the addition of saturated NH4Cl (30 mL) and extracted with dichloromethane (2 x 60 
mL).  The combined organics were washed with water (20 mL), dried over MgSO4, 
filtered, and concentrated in vacuo.  The crude reside was purified by silica gel 
chromatography (10% EtOAc/Hex) to afford the title compound as a viscous oil (2.25 g, 
98%).   
 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.42 (m, 6H), 7.27 – 7.31 (m, 6H), 7.21 – 7.24 (m, 
3H), 3.73 (s, 3H), 3.33 (t, 1H, J = 8.8 Hz), 3.25 (dd, 1H, J = 8.8, 5.4 Hz), 2.39 – 2.44 (m, 
1H), 1.86 – 1.90 (m, 1H), 0.89 (t, 3H, J = 7.1 Hz), 0.83 (d, 3H, J = 6.5 Hz), 0.76 (d, 3H, J 
= 6.8 Hz); 13C NMR (126 MHz, CDCl3) δ 175.0, 144.2, 128.9, 127.9, 127.2, 86.8, 63.4, 
53.5, 51.5, 28.1, 20.8, 20.7; IR 1961, 1736, 1491, 1448, 1221, 1195, 1079, 1033, 773, 
763, 747, 633 cm-1; HRMS (ESI+) calcd. for C26H28O3Na1 [M+Na]+: 411.1936, found: 
411.1938; [α]D20 = + 14.3 (c = 0.355, CHCl3, l = 50 mm). 
 
(R)-3-methyl-2-((trityloxy)methyl)butan-1-ol.  To a suspension 
of lithium aluminum hydride (210 mg, 5.52 mmol) in THF (12 
mL) at 0 °C was added a solution of methyl-(S)-3-methyl-2-((trityloxy)methyl)butanoate 
(1.43 g, 3.58 mmol) in THF (6 mL).  The reaction was allowed to warm to room 
temperature overnight.  After cooling to 0 °C, the reaction was quenched by the slow, 
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drop-wise addition of water (2.5 mL).  Anhydrous MgSO4 was added to the flask, and the 
slurry was filtered and concentrated under reduced pressure to afford the title compound 
as a viscous colorless oil (1.30 g, 98%).   
 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.45 (m, 6H), 7.29 – 7.33 (m, 6H), 7.23 – 7.26 (m, 
3H), 3.72 – 3.76 (m, 1H), 3.65 – 3.70 (m, 1H), 3.38 (dd, 1H, J = 9.3, 3.9 Hz), 3.19 (dd, 
1H, J = 9.3, 7.3 Hz), 2.42 (dd, 1H, J= 6.9, 4.9 Hz), 1.72 – 1.77 (m, 1H), 1.59 – 1.62 (m, 
1H), 0.83 (d, 3H, J = 6.9 Hz), 0.76 (d, 3H, J = 6.8 Hz); 13C NMR (126 MHz, CDCl3) δ 
144.0, 128.8, 128.1, 127.3, 87.5, 65.3, 64.7, 47.2, 26.9, 20.5; IR 3428, 2957, 2974, 1490, 
1338, 1219, 1153, 1065, 1031 1002, 762, 745, 704, 648 cm-1; HRMS (ESI+) calcd. for 
C25H28O2Na1 [M+Na]+: 383,1987, found: 383.1990; [α]D20 = + 23.1 (c = 0.170, CHCl3, l 
= 50 mm). 
 
(S)-3-methyl-2-((trityloxy)methyl)butanal.  To a solution of 
oxalyl chloride (1.10 mL, 12.5 mmol) in DCM (31 mL) at – 78 °C 
was added DMSO (2.20 mL, 31.3 mmol).  After stirring at this temperature for 30 
minutes a solution of (R)-3-methyl-2-((trityloxy)methyl)butan-1-ol (2.26 g, 6.27 mmol) 
in DCM (6 mL) was added drop-wise.  The reaction mixture was stirred at – 78 °C for a 
further 45 minutes before Et3N (3.50 mL, 25.0 mmol) was added drop-wise to the 
solution.  After 15 minutes, the mixture was warmed to 0 °C and quenched by the 
addition of water (30 mL) then extracted with DCM (2 x 50 mL).  The combined organic 
layers were washed with saturated NaHCO3 (30 mL), brine (20 mL), dried over MgSO4, 
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filtered, and concentrated under reduced pressure to afford a yellow oil that was used in 
the next reaction immediately without further purification.   
 
1H NMR (500 MHz, CDCl3) δ 9.66 (d, 1H, J = 3.5 Hz), 7.36 – 7.39 (m, 6H), 7.24 – 7.26 
(m, 6H), 7.20 – 7.22 (m, 3H), 3.35 (d, 2H, J = 6.0 Hz), 2.26 – 2.30 (m, 1H), 2.05 – 2.08 
(m, 1H), 0.85 (d, 3H, J = 7.0 Hz), 0.77 (d, 3H, J = 6.5 Hz); 13C NMR (126 MHz, CDCl3) 
δ 205.0, 143.9, 128.8, 128.0, 127.3, 87.1, 61.2, 59.0, 26.2, 20.7, 20.2. 
 
(R,Z)-(((2-isopropyloct-3-en-1-yl)oxy)methanetriyl)tribenzene.  
To a suspension of (1-pentyl)triphenylphosphonium bromide 
(3.12 g, 7.56 mmol) in THF (40 mL) at –78 °C was added n-butyllithium (3.00 mL, 6.93 
mmol, 2.30 M in pentane).  The bright solution was stirred at -78 °C for 15 minutes, 
warmed to 0 °C over 30 minutes, and re-cooled to –78 °C.  (S)-3-methyl-2-
((trityloxy)methyl)butanal (2.26 g, 6.30 mmol) was added as a solution in THF (6 mL) 
and the reaction was allowed to warm to room temperature overnight.  The reaction was 
quenched by the addition of water (30 mL) and extracted with diethyl ether (2 x 60 mL).  
The combined organic layers were dried over MgSO4, filtered, and concentrated.  Silica 
gel chromatography (10% DCM/Hex) afforded the title compound as a colorless oil (1.98 
g, 76%).   
 
1H NMR (500 MHz, CDCl3) δ 7.44 – 7.46 (m, 6H), 7.27 – 7.30 (m, 6H), 7.20 – 7.23 (m, 
3H), 5.47 – 5.52 (m, 1H), 5.21 – 5.26 (m, 1H), 2.97 – 3.04 (m, 2H), 2.46 – 2.49 (m, 1H), 
2.05 – 2.08 (m, 2H), 1.84 – 1.89 (m, 1H), 1.31 – 1.35 (m, 4H), 0.90 (t, 3H, J = 6.9 Hz), 
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0.77 (d, 3H, J = 6.9 Hz), 0.74 (d, 3H, J = 6.8 Hz); 13C NMR (126 MHz, CDCl3) δ 144.7, 
131.9, 129.6, 129.0, 127.8, 127.0, 65.6, 44.1, 32.3, 29.0, 27.7, 22.7, 21.1, 18.8, 14.3; IR 
2955, 2925, 2870, 1490, 1448, 1068, 1032, 898, 762, 744, 632 cm-1; HRMS (ESI+) calcd. 
for C30H36O1Na1 [M+Na]+: 435.2664, found: 435.2659; [α]D20 = − 44.8 (c = 0.525, 
CHCl3, l = 50 mm). 
 
(R,Z)-2-isopropyloct-3-en-1-ol (2.52).  A solution of glacial acetic acid 
(32 mL), water (3.5 mL), and (R,Z)-(((2-isopropyloct-3-en-1-
yl)oxy)methanetriyl)tribenzene (1.98 g, 4.80 mmol) was heated to 50 °C for 5 hours.  The 
reaction was cooled to room temperature and the volatiles removed under reduced 
pressure.  Trityl alcohol was precipitated out by the addition of hexanes and filtered off.  
The organic layer was concentrated in vacuo and the crude reside was subjected to 
column chromatography (7% EtOAc/Hex) to afford the title compound as a colorless oil 
(531 mg, 65%).   
 
1H NMR (500 MHz, CDCl3) δ 5.65 – 5.70 (m, 1H), 5.12 – 5.16 (m, 1H), 3.66 – 3.68 (m, 
1H), 3.34 – 3.37 (m, 1H), 2.05 – 2.10 (m, 2H), 1.57 – 1.64 (m, 1H), 1.32 – 1.35 (m, 5H), 
0.91 (d, 3H, J = 6.8 Hz), 0.89 – 0.91 (m, 3H), 0.86 (d, 3H, J = 6.8 Hz); 13C NMR (101 
MHz, CDCl3) δ 134.9, 129.1, 64.9, 46.8, 32.2, 29.4, 27.8, 22.6, 21.0, 19.9, 14.2; IR 3331, 
2956, 2927, 1465, 1214, 1060, 1034, 1013, 750, 668 cm-1; HRMS (DART-TOF) calcd. 
for C11H23O1 [M+H]+: 171.1749, found: 171.1747; [α]D20 = − 3.26 (c = 0.470, CHCl3, l = 
50 mm). 
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(R,Z)-1-((4-methoxybenzyl)oxy)non-3-en-2-ol. A round-bottom 
flask was charged with (R,Z)-non-3-ene-1,2-diol (200 mg, 1.26 
mmol), dibutyltin oxide (430 mg, 1.71 mmol), and toluene (10 mL).  The reaction was 
heated to reflux with azeotropic removal of water overnight.  The reaction was cooled to 
room temperature and the Dean-Stark apparatus was removed.  To the flask was added 
tetrabutylammonium iodide (650 mg, 1.76 mmol) and 4-methoxybenzyl chloride (276 
mg, 1.76 mmol) and the reaction was heated to reflux for 4 hours.  After cooling to room 
temperature, the reaction was quenched with water (10 mL) and extracted with DCM (2 x 
30 mL).  The combined organic layers were dried over MgSO4, filtered, and concentrated 
in vacuo.  Purification by silica gel chromatography (12% EtOAc/Hex) afforded the title 
compound as a colorless oil (318 mg, 91%, contains 30% of an inseparable impurity).  
 
1H NMR (500 MHz, CDCl3) δ 7.27 (d, 2H, J = 9.3 Hz), 6.88 (d, 2H, J = 8.3 Hz), 5.54 – 
5.56 (m, 1H), 5.34 – 5.35 (m, 1H), 4.63 – 4.65 (m, 1H), 4.50 (m, 2H), 3.81 (s, 3H), 3.42 
(dd, 1H, J = 9.5, 3.8 Hz), 3.33 (dd, 1H, J = 9.8, 8.3 Hz), 2.37 (br s, 1H), 2.02 – 2.12 (m, 
2H), 1.24 – 1.38 (m, 6H), 0.88 (t, 3H, J = 7.1 Hz); 13C NMR (126 MHz, CDCl3) δ 158.7, 
134.6, 129.7, 129.6, 127.9, 114.1, 74.0, 73.2, 67.1, 55.5, 31.6, 29.5, 28.1, 22.7, 14.2; IR 
3448, 3007, 2955, 2927, 2856, 1612, 1586, 1513, 1464, 1247, 1174, 1100, 1074, 1036, 
821, 756 cm-1; HRMS (DART-TOF) calcd. for C17H30N1O3 [M+NH4]+: 296.2226, found: 
296.2235; [α]D20 =  − 36.8 (c = 0.445, CHCl3, l = 50 mm). 
 
(R,Z)-tert-butyl((1-((4-methoxybenzyl)oxy)non-3-en-2-
yl)oxy)dimethylsilane.  To a 50-mL round-bottom flask was 
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added (R,Z)-1-((4-methoxybenzyl)oxy)non-3-en-2-ol (318 mg, 1.14 mmol), 2,6-lutidine 
(0.33 mL, 2.9 mmol), and DCM (11 mL).  The solution was cooled to 0 °C and TBSOTf 
(0.52 mL, 2.3 mmol) was added slowly over 3 minutes.  The reaction was allowed to 
warm to room temperature over 90 minutes, quenched by the addition of saturated NH4Cl 
(15 mL), and extracted with DCM (2 x 30 mL).  The combined organics were dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude residue was 
purified by silica gel chromatography (1% EtOAc/Hex) to afford the product as a 
colorless oil (301 mg, 67%).  
 
1H NMR (500 MHz, CDCl3) δ 7.25 (app dd, 2H, J = 6.4, 2.0 Hz), 6.86 (app dd, 2H, J = 
6.4, 2.0 Hz), 5.40 – 5.45 (m, 1H), 5.30 – 5.34 (m, 1H), 4.62 – 4.65 (m, 1H), 4.57 (d, 1H, J 
= 11.7 Hz), 4.50 (d, 1H, J = 11.7 Hz), 3.81 (s, 3H), 3.41 (dd, 1H, J = 10.0, 7.1 Hz), 3.33 
(dd, 1H, J = 10.3, 4.9 Hz), 2.01 – 2.06 (m, 2H), 1.25 – 1.36 (m, 6H), 0.89 (s, 9H), 0.88 (t, 
3H, J = 8.3 Hz), 0.070 (s, 3H), 0.056 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 159.2, 
131.6, 131.0, 130.8, 129.3, 113.9, 75.0, 73.2, 68.9, 55.5, 31.8, 29.5, 28.2, 26.1, 22.7, 18.5, 
14.2, -4.3, -4.4; IR 2955, 2928, 2855, 1513, 1463, 1248, 1172, 1120, 1091, 1039, 1006, 
834, 776 cm-1; HRMS (DART-TOF) calcd. for C23H39O2Si1 [M+H-H2O]+: 375.2719, 
found: 375.2718; [α]D20 =  − 7.55 (c = 0.620, CHCl3, l = 50 mm). 
 
(R,Z)-2-((tert-butyldimethylsilyl)oxy)non-3-en-1-ol (2.54). To a 
vigorously stirred solution of (R,Z)-tert-butyl((1-((4-
methoxybenzyl)oxy)non-3-en-2-yl)oxy)dimethylsilane (150 mg, 0.38 mmol), DCM (6 
mL), and water (1.5 mL) at 0 °C was added DDQ (106 mg).  The reaction was allowed to 
HO
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warm to room temperature over 2 hours and was quenched by the addition of a 1:1:1 
mixture of saturated aqueous sodium thiosulfate:saturated aqueous sodium 
bicarbonate:water (10 mL).  The aqueous layer was extracted with DCM (2 x 30 mL) and 
the combined organic layers were dried over MgSO4.  Filtration, and removal of the 
solvent in vacuo afforded a crude residue, which was purified by silica gel 
chromatography (10% EtOAc/Hex) to afford the title compound as a colorless oil (87 mg, 
84%).  
 
1H NMR (500 MHz, CDCl3) δ 5.44 – 5.49 (m, 1H), 5.26 – 5.30 (m, 1H), 4.51 – 4.55 (m, 
1H), 3.40 (dd, 2H, J = 7.1, 5.6 Hz), 1.98 – 2.08 (m, 3H), 1.25 – 1.38 (m, 6H), 089 (s, 9H), 
0.88 (t, 3H, J = 8.3 Hz), 0.081 (s, 3H), 0.058 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
132.7, 129.9, 70.2, 66.9, 31.7, 29.5, 28.1, 26.0, 22.7, 18.3, 14.2, -4.0, -4.6; IR 3439, 2956, 
2928, 2857, 1463, 1235, 1095, 1062, 1036, 1005, 835, 812 cm-1; HRMS (DART-TOF) 
calcd. for C15H31O1Si1 [M+H-H2O]+: 255.2144, found: 255.2140; [α]D20 =  + 3.99 (c = 
0.315, CHCl3, l = 50 mm). 
 
General Procedure C (Preparation of Aryl Substrates): To a suspension enantiopure 
aryloxirane (1 equiv) and CuCl(COD) (0.10 equiv) in THF (0.40 M) at – 78 °C was 
added (Z)-prop-1-en-1-ylmagnesium bromide (1.5 equiv, 1.0 M solution in THF).  The 
reaction was allowed to warm to room temperature over 8 hours, quenched by the 
addition of water (15 mL), and extracted with EtOAc (2 x 40 mL).  The combined 
organic phases were dried over MgSO4, filtered, and concentrated under reduced 
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pressure.  The crude reside was subjected to silica gel chromatography (20% EtOAc/Hex) 
to afford the title compound.   
 
(S,Z)-2-phenylpent-3-en-1-ol (2.56).  Synthesized according to 
General Procedure C using (R)-2-phenyloxirane (1.64 mL, 19.3 mmol) 
to afford the title compound as a colorless oil (1.43 g, 46%).    
 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.34 (m, 2H), 7.22 – 7.27 (m, 3H), 5.71 – 5.74 (m, 
1H), 5.59 – 5.64 (m, 1H), 3.85 – 3.90 (m, 1H), 3.79 – 3.81 (m, 1H), 3.70 – 3.73 (m, 1H), 
1.70 (dd, 3H, J = 6.5, 1.5 Hz), 1.47 (br s, 1H); 13C NMR (126 MHz, CDCl3) δ 141.8, 
130.2, 129.0, 128.0, 127.6, 126.9, 67.2, 46.3, 13.5; IR 3560, 3026, 1493, 1452, 1050, 
757, 714, 699, 668 cm-1; HRMS (DART-TOF) calcd. for C11H13 [M+H-H2O]+: 145.1018, 
found: 145.1020; [α]D20 = + 164 (c = 0.440, CHCl3, l = 50 mm).  
 
(S,Z)-2-(4-methoxyphenyl)pent-3-en-1-ol (2.58). Synthesized 
according to General Procedure C using (R)-2-(4-
methoxyphenyl)oxirane (795 mg, 5.29 mmol) to afford the title 
compound as a yellow oil (674 mg, 85%).   
 
1H NMR (500 MHz, CDCl3) δ 7.17 (d, 2H, J = 8.3 Hz), 6.87 (d, 2H, J = 8.8 Hz), 5.68 – 
5.72 (m, 1H), 5.56 – 5.60 (m, 1H), 3.80 – 3.85 (m, 1H), 3.79 (s, 3H), 3.74 – 3.78 (m, 1H), 
3.66 – 3.70 (m, 1H), 1.69 (dd, 3H, J = 6.8, 2.0 Hz), 1.45 (br s, 1H); 13C NMR (126 MHz, 
CDCl3) δ 158.6, 133.7, 130.5, 128.9, 127.3, 114.4, 67.3, 55.5, 45.4, 13.5; IR 3394, 3011, 
HO
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2934, 2836, 1610, 1511, 1464, 1248, 1178, 1036, 828, 703 cm-1; HRMS (DART-TOF) 
calcd. for C12H15O1 [M+H-H2O]+: 175.1123, found: 175.1127; [α]D20 = + 157 (c = 0.450, 
CHCl3, l = 50 mm). 
 
(S,Z)-2-(4-bromophenyl)pent-3-en-1-ol (2.60). Synthesized according 
to General Procedure C using (R)-2-(4-bromophenyl)oxirane (1.00 g, 
5.02 mmol) to afford the title compound as a yellow oil (662 mg, 55%).   
 
1H NMR (500 MHz, CDCl3) δ 7.44 (d, 2H, J = 8.3 Hz), 7.13 (d, 2H, J = 8.3 Hz), 5.70 – 
5.75 (m, 1H), 5.54 – 5.58 (m, 1H), 3.81 – 3.84 (m, 1H), 3.76 – 3.79 (m, 1H), 3.70 (dd, 
1H, J = 10.8, 7.3 Hz), 1.68 (d, 3H, J = 6.9 Hz), 1.47 (br s, 1H); 13C NMR (126 MHz, 
CDCl3) δ 140.9, 132.0, 129.7, 129.6, 128.1, 120.7, 67.0, 45.7, 13.5; IR 3362, 3016, 2930, 
2874, 1487, 1377, 1214, 1072, 1052, 1010, 819, 785, 729, 668 cm-1; HRMS (DART-
TOF) calcd. for C11H12Br1 [M+H-H2O]+: 223.0122, found: 223.0115; [α]D20 = + 133 (c = 
0.710, CHCl3, l = 50 mm).  
 
(S,Z)-2-(4-chlorophenyl)pent-3-en-1-ol (2.62).  Synthesized according 
to General Procedure C using (R)-2-(4-chlorophenyl)oxirane (1.88 g, 
12.2 mmol) to afford the title compound as a yellow oil (700 mg, 30%).   
 
1H NMR (500 MHz, CDCl3) δ 7.29 (d, 2H, J = 8.3 Hz), 7.18 (d, 2H, J = 8.3 Hz), 5.71 – 
5.75 (m, 1H), 5.54 – 5.58 (m, 1H), 3.82 – 3.87 (m, 1H), 3.76 – 3.79 (m, 1H), 3.68 – 3.72 
(m, 1H), 1.68 (d, 3H, J = 6.8 Hz), 1.48 (br s, 1H); 13C NMR (126 MHz, CDCl3) δ 140.4, 
HO
Me
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132.6, 129.7, 129.3, 129.0, 128.0, 67.1, 45.6, 13.5; IR 3362, 2932, 2875, 1491, 1092, 
1048, 1014, 823, 735, 582 cm-1; HRMS (DART-TOF) calcd. for C11H23Cl1 [M+H-H2O]+: 
179.0628, found: 179.0634; [α]D20 = + 166 (c = 0.870, CHCl3, l = 50 mm). 
 
(R)-2-hydroxy-2-(3-(trifluoromethyl)phenyl)ethyl 4-
methylbenzenesulfonate.  To a solution of (R)-1-(3-
(trifluoromethyl)phenyl)ethane-1,2-diol (3.00 g, 13.8 mmol) in 
anhydrous pyridine (59 mL) at 0 °C was added p-toluenesulfonyl chloride (2.90 g, 15.2 
mmol).  The reaction was stirred under nitrogen overnight while warming to room 
temperature.  The reaction was quenched by the addition of water (20 mL) and the 
aqueous layer was extracted with DCM (3 x 50 mL).  The combined organic layers were 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude reside 
was purified by silica gel chromatography (20% EtOAc/Hex) to afford the title 
compound as a yellow oil (2.32 g, 44%).   
 
1H NMR (500 MHz, CDCl3) δ 7.74 (d, 2H, J = 8.3 Hz), 7.47 – 7.57 (m, 3H), 7.45 (d, 1H, 
J = 7.6 Hz), 7.32 (d, 2H, J = 8.3 Hz), 5.03 – 5.06 (m, 1H), 4.16 (dd, 1H, J = 10.8, 3.4 
Hz), 4.04 (dd, 1H, J = 10.5, 8.1 Hz), 2.87 (br s, 1H), 2.43 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 145.2, 139.6, 132.6, 131.5 (q, JC-F = 32.4 Hz), 130.2, 129.9, 129.4, 128.1, 
125.5, 124.1 (q, JC-F = 273 Hz), 123.3, 74.1, 71.6, 29.1; 19F NMR (470 MHz, CDCl3) δ – 
62.7; IR 3394, 3513, 1357, 1329, 1190, 1173, 1124, 1097, 1073, 974, 828, 811, 750, 703, 
670, 662, 554 cm-1; HRMS (DART-TOF) calcd. for C16H19F3N1O4S1 [M+NH4]+: 
378.0987, found: 378.0979; [α]D20 = − 33.6 (c = 0.780, CHCl3, l = 50 mm). 
OTs
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(R)-2-(3-(trifluoromethyl)phenyl)oxirane.  A solution of (R)-2-hydroxy-
2-(3-(trifluoromethyl)phenyl)ethyl 4-methylbenzenesulfonate (2.00 g, 5.39 
mmol) in THF (9 mL) and 6 M aqueous NaOH (9 mL) was stirred 
vigorously at room temperature for 4 hours.  The reaction was diluted with water (15 mL) 
and extracted with EtOAc (3 x 50 mL).  The combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo to afford the pure epoxide as a colorless oil 
(1.00 g, 93%).   
 
1H NMR (500 MHz, CDCl3) δ 7.55 – 7.57 (m, 1H), 7.54 (s, 1H), 7.46 – 8.47 (m, 2H), 
3.92 (dd, 1H, J = 3.9, 2.5 Hz), 3.18 (dd, 1H, J = 5.4, 4.4 Hz), 2.89 (dd, 1H, J = 5.6, 2.7 
Hz); 13C NMR (126 MHz, CDCl3) δ 139.0, 131.3 (q, JC-F = 32.4 Hz), 129.2, 129.0, 125.2, 
124.1 (q, JC-F = 273 Hz), 122.5, 52.0, 51.5; 19F NMR (470 MHz, CDCl3) δ – 62.8; IR 
2956, 2924, 2365, 2359, 1329, 1165, 1126, 1099, 1073, 1031, 803 cm-1; HRMS (DART-
TOF) calcd. for C9H8F3O1 [M+H]+: 189.0527, found: 189.0531; [α]D20 = − 3.39 (c = 
0.860, CHCl3, l = 50 mm). 
 
(S,Z)-2-(3-(trifluoromethyl)phenyl)pent-3-en-1-ol (2.64). 
Synthesized according to General Procedure C using (R)-2-(3-
(trifluoromethyl)phenyl)oxirane (700 mg g, 3.72 mmol) to afford the 
title compound as a yellow oil (376 mg, 44%).  
 
HO
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1H NMR (500 MHz, CDCl3) δ 7.44 – 7.50 (m, 4H), 5.75 – 5.79 (m, 1H), 5.58 – 5.63 (m, 
1H), 3.91 – 3.96 (m, 1H), 3.81 (dd, 1H, J = 10.9, 6.4 Hz), 3.75 (dd, 1H, J = 7.3, 3.4 Hz), 
1.70 (d, 3H, J = 6.9 Hz), 1.51 (br s, 1H); 13C NMR (126 MHz, CDCl3) δ 142.9, 131.4, 
131.2 (q, JC-F = 31 Hz), 129.3, 129.2, 128.5, 124.7, 124.3 (q, JC-F = 273 Hz), 123.8, 67.0, 
46.0, 13.5; 19F NMR (470 MHz, CDCl3) δ – 62.6; IR 3362, 1447, 1328, 1163, 1123, 
1095, 802, 718, 702 cm-1; HRMS (DART-TOF) calcd. for C12H12F3 [M+H-H2O]+: 
213.0891, found: 213.0892; [α]D20 = + 108 (c = 0.515, CHCl3, l = 50 mm). 
 
(S,Z)-2-(3-methoxyphenyl)pent-3-en-1-ol (2.66).  Synthesized 
according to General Procedure C using (R)-2-(3-
(methoxy)phenyl)oxirane (630 mg, 4.20 mmol) to afford the title 
compound as a yellow oil (270 mg, 34%).  
 
1H NMR (500 MHz, CDCl3) δ 7.25 (t, 1H, J = 7.8 Hz), 6.86 (d, 1H, J = 7.8 Hz), 6.77 – 
6.80 (m, 2H), 5.70 – 5.74 (m, 1H), 5.57 – 5.62 (m, 1H), 3.85 – 3.87 (m, 1H), 3.80 (s, 3H), 
3.78 – 3.82 (m, 1H), 3.71 – 3.73 (m, 1H), 1.70 (d, 3H, J = 6.9 Hz); 13C NMR (126 MHz, 
CDCl3) δ 160.1, 143.4, 130.1, 129.9, 127.7, 120.3, 114.0, 112.0, 67.1, 55.4, 46.3, 13.5; IR 
3389, 2933, 2875, 1600, 1584, 1488, 1465, 1453, 1433, 1288, 1152, 1047, 778, 697 cm-1; 
HRMS (DART-TOF) calcd. for C12H15O1 [M+H-H2O]+: 175.1123, found: 173.1130; 
[α]D20 = + 208 (c = 0.375, CHCl3, l = 50 mm). 
 
(S)-2-phenylbut-3-en-1-ol (2.68).  To a suspension of (R)-phenyloxirane 
(1.00 g, 8.32 mmol) and CuCl(COD) (172 mg, 0.84 mmol) in THF (12 
HO
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mL) at – 78 °C was added vinylmagnesium bromide (10.0 mL, 10.0 mmol, 1.0 M 
solution in THF).  The reaction as allowed to warm to room temperature over 8 hours.  
The reaction was quenched by the addition of saturated NH4Cl (30 mL) and extracted 
with ethyl acetate (3 x 40 mL).  The combined organics were dried over MgSO4, filtered, 
and concentrated in vacuo.  The crude residue was purified by silica gel chromatography 
(10% EtOAc/Hex) to afford the title compound as a colorless oil (872 mg, 71%).  
 
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.37 (m, 2H), 7.24 – 7.27 (m, 3H), 5.99 – 6.06 (m, 
1H), 5.18 – 5.24 (m, 2H), 3.83 – 3.85 (m, 2H), 3.54 (q, 1H, J = 7.3 Hz), 1.53 (br s); 13C 
NMR (126 MHz, CDCl3) δ 140.8, 138.4, 129.0, 128.2, 127.2, 117.3, 66.3, 52.7; IR 3355, 
3028, 2876, 1493, 1453, 1054, 1029, 994, 918, 756, 700, 680 cm-1; HRMS (DART-TOF) 
calcd. for C10H11 [M+H-H2O]+: 131.0861, found: 131.0867; [α]D20 =  + 67.5 (c = 0.545, 
CHCl3, l = 50 mm). 
 
2.11.4 Characterization of Hydroformylation 
General Hydroformylation Procedure. The Endeavor was charged with 500 µL of 
benzene per reaction well to fill the void volume between reactor wall and reaction tube, 
and oven dried glass reaction vials were placed into the wells. The Endeavor was sealed 
and purged with nitrogen (4×100 psi). The necessary injection(s) were made (see below). 
The Endeavor was purged with nitrogen (1×100 psi), stirring was started at 250 rpm, and 
the Endeavor was heated to and held at 55 ˚C for 10 minutes. Stirring was stopped, the 
Endeavor was charged with 400 psi H2/CO, stirring was re-initiated at 700 rpm, and the 
Endeavor was maintained at constant reaction temperature of 55 °C and pressure of 400 
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psi H2/CO for 15 h. The Endeavor was vented to ambient pressure and cooled to ambient 
temperature. The reaction vials were removed from the Endeavor, and the benzene was 
removed in vacuo.  A solution of mesitylene in chloroform-d (100 µL, 0.5408 M) was 
added.  The conversion of the reaction was determined by 1H NMR in chloroform-d with 
respect to remaining starting material.  The solvent was removed under reduced pressure.  
The crude hydroformylation mixture was added, as a solution in dichloromethane (3 mL), 
to a scintillation vial containing pyridinium chlorochromate (128.7 mg, 0.597 mmol), 
sodium acetate (16.0 mg, .195 mmol), and 4 Å molecular sieves. The reaction was stirred 
for 12 hours at room temperature and eluted through a short plug of silica gel (100% 
Et2O).  The regio- and diastereoselectivities were determined by either GC or 1H NMR.   
 
General Procedure D: In a dry box, (R,Z)-2-methyloct-3-en-1-ol (28.4 mg, 0.200 
mmol), (4S)-4-(tert-butyl)-3-(3-(diphenylphosphanyl)benzyl)-2-methoxyoxazolidine (8.7 
mg, 0.020 mmol), a p-toluenesulfonic acid in benzene (351 µL, 2.0 x 10-4 mmol, 5.7 x 10-
4 M solution) were mixed in C6D6 (0.8 mL) and allowed to equilibrate in a sealed NMR 
tube for 3 hours at 45 °C. (Note: the appearance of free MeOH can be monitored by 1H 
NMR.)  The solution was concentrated in the dry box to remove the generated MeOH, 
the residue was re-dissolved in C6D6, and was allowed to equilibrate for an additional 3 
hours at 45 °C before being concentrated again in the dry box. The resulting mixture was 
dissolved in benzene (3.5 mL), mixed with 3% Rh(acac)(CO)2 (1.5 mg, 0.006 mmol), and 
injected into the Endeavor, followed by 0.5 mL benzene to wash the injection port.   
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General Procedure E: Same as General Procedure D, except 20% (4S)-4-(tert-butyl)-3-
(3-(diphenylphosphanyl)benzyl)-2-methoxyoxazolidine (17.3 mg, 0.040 mmol) and 6% 
Rh(acac)(CO)2 (3.1 mg, 0.012 mmol) were used.  
 
General Procedure F: Same as General Procedure D, except 12% (4S)-4-(tert-butyl)-3-
(3-(diphenylphosphanyl)benzyl)-2-methoxyoxazolidine (10.4 mg, 0.024 mmol) and 4% 
Rh(acac)(CO)2 (2.1 mg, 0.008 mmol) were used.  
 
General Procedure G: Same as General Procedure D, except 5% (4S)-4-(tert-butyl)-3-
(3-(diphenylphosphanyl)benzyl)-2-methoxyoxazolidine (4.4 mg, 0.010 mmol) and 2% 
Rh(acac)(CO)2 (1.1 mg, 0.004 mmol) were used.  
 
Gas Chromatography Analysis Methods 
GC Method A: J&W Scientific column (HP-5, 30 m x 0.320 mm ID x 0.25 µm film 
thickness): 120 °C for 8 min, ramp 8 °C/min to 136 °C, 136 °C for 2 min, ramp 10 
°C/min to a final temperature of 220 °C, 220 °C for 3 min.  
 
GC Method B: J&W Scientific column (HP-5, 30 m x 0.320 mm ID x 0.25 µm film 
thickness): 120 °C for 8 min, ramp 8 °C/min to 136 °C, 136 °C for 1 min, ramp 10 
°C/min to a final temperature of 220 °C, 220 °C for 6 min.  
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GC Method C: Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness) 60 
°C for 5 min, ramp 1 °C/min to 150 °C, 150 °C for 10 min, ramp 8 °C/min to a final 
temperature of 220 °C. 
 
GC Method D: J&W Scientific column (HP-5, 30 m x 0.320 mm ID x 0.25 µm film 
thickness): 140 °C for 6 min, ramp 40 °C/min to 220 °C, 220 °C for 5 min.  
 
GC Method E: J&W Scientific column (HP-5, 30 m x 0.320 mm ID x 0.25 µm film 
thickness): 140 °C for 3 min, ramp 8 °C/min to 220 °C, 220 °C for 10 min.  
 
GC Method F: J&W Scientific column (HP-5, 30 m x 0.320 mm ID x 0.25 µm film 
thickness): 120 °C for 8 min, ramp 8 °C/min to 136 °C, 136 °C for 1 min, ramp 10 
°C/min to a final temperature of 220 °C, 220 °C for 10 min 
 
Table 2.4, Entry 1 
(R,Z)-2-methyloct-3-en-1-ol was subjected to hydroformylation using General Procedure 
D.  Achiral GC analysis using GC Method A afforded three peaks corresponding to each 
γ-lactone product (6.80 min and 7.93 min) and the combined δ-lactone products (8.47 
min).  The diastereoselectivity of the reaction was determined by 1H NMR in CD3OD.  
Silica gel chromatography (10% EtOAc/Hex) afforded the following compounds:   
 
(3R,5R)-3-butyl-5-methyltetrahydro-2H-pyran-2-one (2.49). Isolated as 
a colorless oil (27 mg, 78%). GC Method A: 8.47 min.; 1H NMR (500 O
O
Me
Bu
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MHz, CDCl3) δ 4.20 (dd, 1H, J = 10.8, 4.9 Hz), 3.89 (t, 1H, J = 10.8 Hz), 2.46 – 2.51 (m, 
1H), 2.12 – 2.17 (m, 1H), 1.84 – 1.88 (m, 1H), 1.69 – 1.72 (m, 2H), 1.42 – 1.45 (m, 1H), 
1.33 – 1.37 (m, 4H), 1.00 (d, 3H, J = 6.9 Hz), 0.91 (t, 3H, J = 7.1 Hz); 13C NMR (126 
MHz, CDCl3) δ 175.4, 73.2, 37.5, 32.7, 31.2, 29.3, 27.0, 22.8, 17.2, 14.2; IR 2957, 2931, 
2872, 1740, 1459, 1380, 1341, 1103, 1047, 1007, 725 cm-1; HRMS (DART-TOF) calcd. 
for C10H19O2 [M+H]+: 171.1380, found: 171.1384; [α]D20 = − 34.0 (c = 0.405, CHCl3, l = 
50 mm). 
 
Proof of Absolute Stereochemistry: 
The absolute stereochemistry was confirmed by 1D nOe experiements between the C(3) 
and C(5) hydrogen atoms.  No nOe via a 1,3-diaxial interaction is observed between these 
groups.  An nOe correlation is observed between the C(5)-H and the C(3)-butyl 
substituent; an nOe correlation is also observed between the C(3)-H and the C(5)-methyl 
substituent.  See spectroscopic data for further details. 
 
(3S,5R)-3-butyl-5-methyltetrahydro-2H-pyran-2-one. GC Method A: 
8.47 min.; 1H NMR (500 MHz, CDCl3) δ 4.28 (dd, 1H, J = 11.3, 3.9 Hz), 
3.83 – 3.90 (m, 1H), 2.39 – 2.43 (m, 1H), 2.03 – 2.12 (m, 1H), 1.86 – 1.92 
(m, 1H), 1.67 – 1.71 (m, 1H), 1.44 – 1.51 (m, 2H), 1.23 – 1.33 (m, 4H), 0.97 (d, 3H, J = 
6.4 Hz), 0.95 (t, 3H, J = 7.1 Hz); 13C NMR (126 MHz, CDCl3) δ 174.2, 74.8, 40.4, 34.4, 
31.5, 29.0, 28.8, 22.8, 17.6, 14.2; IR 2978, 2931, 2973, 1734, 1459, 1213, 1155, 1109, 
1045, 749, 750 cm-1; HRMS (DART-TOF) calcd. for C10H19O2 [M+H]+: 171.1380, 
found: 171.1384; [α]D20 = + 3.4 (c = 0.260, CHCl3, l = 50 mm). 
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anti-4-methyl-3-pentyldihydrofuran-2(3H)-one.  This compound has 
been synthesized previously in our laboratories and all spectroscopic data 
are in accord. GC Method A: 6.80 min. 
 
syn-4-methyl-3-pentyldihydrofuran-2(3H)-one. This compound has 
been synthesized previously in our laboratories and all spectroscopic data 
are in accord. GC Method A: 7.93 min. 
 
GC Trace for the Determination of Regioselectivity 
 
 
Table 2.4, Entry 2 
 (R,E)-2-methyloct-3-en-1-ol was subjected to hydroformylation using General Procedure 
D.  Achiral GC analysis using GC Method A afforded three peaks corresponding to each 
γ-lactone product (6.80 min and 7.93 min) and the combined δ-lactone products (8.47 
min). The diastereoselectivity of the reaction was determined by 1H NMR in CD3OD. 
Silica gel chromatography (10% EtOAc/Hex) afforded the following compounds:   
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(3S,5R)-3-butyl-5-methyltetrahydro-2H-pyran-2-one (2.51).  Isolated as 
a colorless oil (18 mg, 52%). GC Method A: 8.47 min.; 1H NMR (500 
MHz, CDCl3) δ 1H NMR (500 MHz, CDCl3) δ 4.28 (dd, 1H, J = 11.3, 3.9 
Hz), 3.83 – 3.90 (m, 1H), 2.39 – 2.43 (m, 1H), 2.03 – 2.12 (m, 1H), 1.86 – 1.92 (m, 1H), 
1.67 – 1.71 (m, 1H), 1.44 – 1.51 (m, 2H), 1.23 – 1.33 (m, 4H), 0.97 (d, 3H, J = 6.4 Hz), 
0.95 (t, 3H, J = 7.1 Hz); 13C NMR (126 MHz, CDCl3) δ 174.2, 74.8, 40.4, 34.4, 31.5, 
29.0, 28.8, 22.8, 17.6, 14.2;  IR 2978, 2931, 2973, 1734, 1459, 1213, 1155, 1109, 1045, 
749, 750 cm-1; HRMS (DART-TOF) calcd. for C10H19O2 [M+H]+: 171.1380, found: 
171.1384; [α]D20 = + 3.4 (c = 0.260, CHCl3, l = 50 mm). 
 
GC Trace for the Determination of Regioselectivity  
 
 
Table 2.4, Entry 3 
 (R,Z)-2-isopropyloct-3-en-1-ol was subjected to hydroformylation using General 
Procedure E.  Achiral GC analysis using GC Method B afforded three peaks 
corresponding to the γ-lactone product (12.19 min) and the combined δ-lactone products 
(13.68 min).  The diastereoselectivity of the reaction was determined by chiral GC 
O
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analysis using GC Method C to afford two signals, tminor = 107.6 min, tmajor = 107.9 min.  
Silica gel chromatography (10% EtOAc/Hex) afforded the following compounds:   
 
(3R,5S)-3-butyl-5-isopropyltetrahydro-2H-pyran-2-one (2.53).  
Isolated as a colorless oil (22 mg, 57%). GC Method B: 13.68 min, GC 
Method C: 107.9 min.; 1H NMR (500 MHz, CDCl3) δ 4.25 (dd, 1H, J = 
11.7, 4.9 Hz), 3.98 – 4.02 (m, 1H), 2.39 – 2.41 (m, 1H), 1.81 – 1.85 (m, 2H), 1.74 – 1.79 
(m, 1H), 1.56 – 1.61 (m, 2H), 1.30 – 1.40 (m, 4H), 0.94 (d, 3H, J = 6.9 Hz), 0.92 (d, 3H, 
J = 7.3 Hz), 0.90 (t, 3H, J = 6.9 Hz); 13C NMR (126 MHz, CDCl3) δ 175.8, 70.2, 38.7, 
37.6, 30.9, 29.9, 29.3, 28.5, 22.8, 20.2, 19.9, 14.1; IR 2957, 2932, 2873, 1746, 1467, 
1390, 1370, 1245, 1165, 1151, 1114, 1071, 1031 cm-1; HRMS (DART-TOF) calcd. for 
C12H23O2 [M+H]+: 199.1698, found: 199.1703; [α]D20 = − 58.6 (c = 0.480, CHCl3, l = 50 
mm). 
 
(3S,5S)-3-butyl-5-isopropyltetrahydro-2H-pyran-2-one. Isolated with 
(3R,5S)-3-butyl-5-isopropyltetrahydro-2H-pyran-2-one in an 88:12 ratio. 
GC Method B: 13.7 min, GC Method C: 107.6 min.; 1H NMR (500 
MHz, CDCl3) δ 4.32 (ddd, 1H, J = 10.3, 5.1, 1.7 Hz), 4.04 (dd, 1H, J = 11.3, 9.0 Hz), 
2.39 – 2.41 (m, 1H), 2.04 – 2.10 (m, 1H), 1.74 – 1.85 (m, 2H), 1.56 – 1.61 (m, 1H), 1.30 
– 1.40 (m, 6H), 0.94 (d, 3H, J = 6.9 Hz), 0.92 (d, 3H, J = 7.3 Hz), 0.90 (t, 3H, J = 6.9 
Hz). 
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(3R,4R)-4-isopropyl-3-pentyldihydrofuran-2(3H)-one.  GC 
Method B: 12.15 min.; 1H NMR (500 MHz, CDCl3) δ 4.29 – 
4.32 (m, 1H), 3.95 – 3.98 (m, 1H), 2.32 (q, 1H, J = 6.5 Hz), 2.09 
– 2.12 (m, 1H), 1.64 – 1.77 (m, 3H), 1.41 – 1.49 (m, 1H), 1.29 – 1.32 (m, 5H), 0.96 (d, 
3H, J = 7.0 Hz), 0.91 (d, 3H, J = 7.1 Hz), 0.89 (t, 3H, J = 6.8 Hz); 13C NMR (101 MHz, 
CDCl3) δ 180.1, 69.5, 46.4, 43.2, 32.0, 30.8, 30.6, 26.5, 22.6, 20.3, 19.2, 14.2. 
 
(3R,4R)-4-isopropyl-3-pentyldihydrofuran-2(3H)-one.  Not 
observed or isolated in any hydroformylation reaction (reactions 
carried out with ligand 3c and control reactions with PPh3). 
 
GC Trace for Determination of Regioselectivity 
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GC Trace for Determination of Diastereoselectivity 
 
 
Table 2.4, Entry 4 
(R,Z)-2-((tert-butyldimethylsilyl)oxy)non-3-en-1-ol was subjected to hydroformylation 
using General Procedure F. Achiral GC analysis using GC Method F afforded four peaks 
corresponding to each γ-lactone product (18.26 min and 18.61 min) and each δ-lactone 
product (18.97 min and 19.13 min).  Silica gel chromatography (10% EtOAc/Hex) 
afforded the following compounds:   
 
(R,Z)-2-((tert-butyldimethylsilyl)oxy)non-3-en-1-ol (2.55). Isolated as 
a colorless oil (30.9 mg, 51%). GC Method F: 18.97 min.; 1H NMR 
(500 MHz, CDCl3) δ 4.27 (dd, 1H, J = 13.0, 5.1 Hz), 4.10 – 4.15 (m, 
1H), 2.72 – 2.78 (m, 1H), 1.96 – 2.01 (m, 1H), 1.85 – 1.89 (m, 1H), 1.72 – 1.75 (m, 1H), 
1.45 – 1.50 (m, 1H), 1.27 – 1.34 (m, 7H), 0.88 (s, 9H), 0.87 (t, 3H, J = 8.3 Hz), 0.076 (s, 
3H), 0.072 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 174.2, 73.3, 64.1, 36.0, 33.9, 31.8, 
30.9, 26.4, 25.9, 23.0, 18.2, 14.2, -4.7; IR 2954, 2929, 2858, 1737, 1464, 1255, 1213, 
1102, 1059, 1026, 1007, 837, 807, 778 cm-1; HRMS (DART-TOF) calcd. for C16H33O3Si1 
[M+H]+: 301.2199, found: 301.2199; [α]D20 = − 9.7 (c = 775, CHCl3, l = 50 mm). 
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(3S,5R)-5-((tert-butyldimethylsilyl)oxy)-3-pentyltetrahydro-2H-
pyran-2-one. GC Method F: 19.13 min.; 1H NMR (500 MHz, CDCl3) δ 
4.21 (dd, 1H, J = 11.0, 2.7 Hz), 4.05 (dd, 1H, J = 11.0, 5.6 Hz), 2.34 – 
2.39 (m, 1H), 2.24 – 2.29 (m, 1H), 1.85 – 1.90 (m, 1H), 1.54 – 1.60 (m, 2H), 1.29 – 1.33 
(m, 7H), 0.88 (s, 9H), 0.87 (t, 3H, J = 8.3 Hz), 0.077 (s, 3H), 0.072 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 173.9, 72.9, 65.1, 38.2, 35.3, 31.9, 30.9, 26.6, 25.9, 22.7, 18.2, 14.2, 
-4.6. 
 
 (3R,4R)-4-((tert-butyldimethylsilyl)oxy)-3-hexyldihydrofuran-2(3H)-
one. GC Method F: 18.26 min.; 1H NMR (500 MHz, CDCl3) δ 4.32 – 
3.45 (m, 1H), 4.24 – 4.27 (m, 1H), 3.95 – 3.98 (m, 1H), 2.43 – 2.46 (m, 
1H), 1.69 – 1.73 (m, 1H), 1.47 – 1.56 (m, 1H), 1.42 – 1.48 (m, 2H), 1.25 – 1.32 (m, 6H), 
0.88 (s, 9H), 0.87 (t, 3H, J = 8.3 Hz), 0.082 (s, 3H), 0.066 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 177.8, 73.4, 73.3, 48.8, 31.8, 29.3, 28.4, 27.0, 25.8, 22.8, 18.0, 14.2, -4.4, -4.6. 
 
(3S,4R)-4-((tert-butyldimethylsilyl)oxy)-3-hexyldihydrofuran-2(3H)-
one.  GC Method F: 18.61 min.; 1H NMR (500 MHz, CDCl3) δ 4.51 – 
4.53 (m, 1H), 3.83 (dd, 1H, J = 11.3, 3.4 Hz), 3.67 (dd, 1H, J = 11.3, 2.9 
Hz), 2.69 – 2.71 (m, 1H), 2.31 – 2.36 (m, 1H), 1.94 – 1.98 (m, 1H), 1.85 – 1.87 (m, 1H), 
1.29 – 1.41 (m, 7H), 0.89 (s, 9H), 0.87 (t, 3H, J = 7.3 Hz), 0.077 (s, 3H), 0.062 (s, 3H). 
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GC Trace for the Determination of Regio- and Diastereoselectivity 
 
 
Table 2.4, Entry 5 
(S,Z)-2-phenylpent-3-en-1-ol was subjected to hydroformylation using General Procedure 
F.  Achiral GC analysis using GC Method D afforded three peaks corresponding to each 
γ-lactone product (7.67 min and 7.73 min) and the combined δ-lactone products (8.46 
min). The diastereoselectivity of the reaction was determined by 1H NMR in CDCl3. 
Silica gel chromatography (10% EtOAc/Hex) afforded the following compounds:   
 
(3R,5S)-3-methyl-5-phenyltetrahydro-2H-pyran-2-one (2.57).  Isolated 
as a colorless semi-solid (25 mg, 66%). GC Method D: 8.46 min.; 1H NMR 
(500 MHz, CDCl3) δ 7.35 – 7.38 (m, 2H), 7.25 – 7.30 (m, 3H), 4.33 – 4.41 
(m, 2H), 3.28 – 3.32 (m, 1H), 2.82 – 2.86 (m, 1H), 2.28 – 2.34 (m, 1H), 
1.95 – 2.02 (m, 1H), 1.31 (d, 3H, J = 6.8 Hz); 13C NMR (126 MHz, CDCl3) δ 175.4, 
140.6, 129.2, 127.6, 127.4, 72.3, 38.5, 34.6, 33.1, 16.8; IR 2973, 2935, 1742, 1380, 1214, 
1161, 1117, 1080, 1054, 1033, 755, 701, 668 cm-1; HRMS (DART-TOF) calcd. for 
C12H15O2 [M+H]+: 191.1072, found: 191.1067; [α]D20 = − 25.1(c = 0.255, CHCl3, l = 50 
mm). 
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Proof of Absolute Stereochemistry: 
The absolute stereochemistry was confirmed by 1D nOe experiements between the C(3) 
and C(5) hydrogen atoms.  No nOe via a 1,3-diaxial interaction is observed between these 
groups.  An nOe correlation is observed between the C(5)-H and the C(3)-methyl 
substituent; an nOe correlation is also observed between the C(3)-H and the C(5)-aryl 
substituent.  See spectroscopic data for further details. 
 
(3S,5S)-3-methyl-5-phenyltetrahydro-2H-pyran-2-one.  GC Method D: 
8.46 min.; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.36 (m, 2H), 7.27 – 7.30 
(m, 1H), 7.23 – 7.25 (m, 2H), 4.48 – 4.50 (m, 1H), 4.26 (dd, 1H, J = 11.3, 
10.3 Hz), 3.25 – 3.31 (m, 1H), 2.69 – 2.74 (m, 1H), 2.27 – 2.33 (m, 1H), 
1.99 (q, 1H, J = 12.7 Hz), 1.36 (d, 3H, J = 6.9 Hz); 13C NMR (126 MHz, CDCl3) δ 174.1, 
140.3, 129.1, 127.6, 127.3, 74.5, 40.4, 36.2, 35.8, 16.9. 
 
anti-3-ethyl-4-phenyldihydrofuran-2(3H)-one.  This compound has been 
synthesized previously in our laboratories and all spectroscopic data are in 
accord. GC Method D: 7.67 min. 
 
syn-3-ethyl-4-phenyldihydrofuran-2(3H)-one. This compound has been 
synthesized previously in our laboratories and all spectroscopic data are in 
accord. GC Method D: 7.73 min. 
 
 
O
O
Me
O
O
Et
O
O
Et
! 118 
GC Trace for the Determination of Regioselectivity 
 
 
Table 2.4, Entry 6 
(S,Z)-2-(4-methoxyphenyl)pent-3-en-1-ol was subjected to hydroformylation using 
General Procedure F.  Achiral GC analysis using GC Method B afforded two peaks 
corresponding to the combined γ-lactone products (18.16 min and 17.73 min) and the 
combined δ-lactone products (19.48 min).  The diastereoselectivity of the reaction was 
determined by 1H NMR in CDCl3.  Silica gel chromatography (15% EtOAc/Hex) 
afforded the following compounds:   
 
(3R,5S)-5-(4-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one 
(2.59).  Isolated as a colorless solid (32 mg, 72%).  GC Method B: 19.48 
min; 1H NMR (500 MHz, CDCl3) δ 7.17 (d, 2H, J = 8.8 Hz), 6.88 (d, 2H, J 
= 8.8 Hz), 4.30 – 4.36 (m, 2H), 3.80 (s, 3H), 3.21 – 3.28 (m, 1H), 2.78 – 
2.86 (m, 1H), 2.23 – 2.29 (m, 1H), 1.92 – 1.98 (m, 1H), 1.30 (d, 3H, J = 6.7 
Hz); 13C NMR (126 MHz, CDCl3) δ 175.4, 159.0, 132.5, 128.4, 114.5, 72.5, 55.5, 37.6, 
34.7, 33.0, 16.9; IR 2936, 1740, 1612, 130, 1278, 1248, 1214, 1161, 1084, 1055, 1033, 
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831, 750 cm-1; HRMS (DART-TOF) calcd. for C13H17O3 [M+H]+: 221.1178, found: 
221.1184; [α]D20 = − 16.2 (c = 0.420, CHCl3, l = 50 mm). 
 
Proof of Absolute Stereochemistry: 
The absolute stereochemistry was confirmed by 1D nOe experiements between the C(3) 
and C(5) hydrogen atoms.  No nOe via a 1,3-diaxial interaction is observed between these 
groups.  An nOe correlation is observed between the C(5)-H and the C(3)-methyl 
substituent; an nOe correlation is also observed between the C(3)-H and the C(5)-aryl 
substituent.  See spectroscopic data for further details. 
 
(3S,5S)-5-(4-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one. GC 
Method B: 19.48 min.; 1H NMR (500 MHz, CDCl3) δ 7.10 (d, 2H, J = 8.8 
Hz), 6.82 (d, 2H, J = 8.8 Hz), 4.45 (ddd, 1H, J = 13.2, 5.1, 2.2 Hz), 4.19 (t, 
1H, J = 10.8 Hz), 3.80 (s, 3H), 3.20 – 3.26 (m, 1H), 2.66 – 2.71 (m, 1H), 
2.23 – 2.29 (m, 1H), 1.84 (q, 1H, J = 12.7 Hz), 1.34 (d, 3H, J = 6.9 Hz); 13C 
NMR (126 MHz, CDCl3) δ 174.1, 159.1, 132.2, 128.3, 114.4, 74.7, 55.5, 39.6, 36.2, 35.9, 
17.3. 
 
(3R,4S)-3-ethyl-4-(4-methoxyphenyl)dihydrofuran-2(3H)-one. GC 
Method B: 17.73 min.; 1H NMR (500 MHz, CDCl3) δ 7.18 (d, 2H, J = 
8.8 Hz), 6.90 (d, 2H, J = 8.8 Hz), 4.49 – 4.52 (m, 1H), 4.06 – 4.09 (m, 
1H), 3.81 (s, 3H), 3.34 – 3.42 (m, 1H), 2.61 – 2.66 (m, 1H), 1.77 – 
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1.83 (m, 1H), 1.67 – 1.73 (m, 1H), 0.94 (t, 3H, J = 7.6 Hz); 13C NMR (101 MHz, CDCl3) 
δ 178.4, 159.3, 130.4, 128.5, 114.7, 72.4, 55.5, 47.9, 46.6, 22.1, 11.2. 
 
(3S,4S)-3-ethyl-4-(4-methoxyphenyl)dihydrofuran-2(3H)-one. GC 
Method B: 18.16 min.; 1H NMR (500 MHz, CDCl3) δ 7.08  (d, 2H, J = 
8.8 Hz), 6.85 (d, 2H, J = 8.3 Hz), 4.55 (dd, 1H, J = 9.3, 5.9 Hz), 4.43 
(dd, 1H, J = 9.3, 2.5 Hz), 3.80 (s, 3H), 3.65 – 3.69 (m, 1H), 2.67 – 2.72 
(m, 1H), 1.61 – 1.66 (m, 1H), 1.07 – 1.12 (m, 1H), 0.90 (t, 3H, J = 7.3 Hz); 13C NMR 
(126 MHz, CDCl3) δ 178.9, 130.8, 128.9, 128.1, 114.5, 73.0, 55.5, 46.5, 44.2, 19.4, 12.3. 
 
GC Trace for the Determination of Regioselectivity 
 
 
Table 2.4, Entry 7 
(S,Z)-2-(4-bromophenyl)pent-3-en-1-ol was subjected to hydroformylation using General 
Procedure F. The regioselectivity and diastereoselectivity of the hydroformylation 
reaction was determined by 1H NMR in CDCl3.  Silica gel chromatography (15% 
EtOAc/Hex) afforded the following compounds:   
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(3R,5S)-5-(4-bromophenyl)-3-methyltetrahydro-2H-pyran-2-one (2.61). 
Isolated as a colorless solid (33 mg, 62%). 1H NMR (500 MHz, CDCl3) δ 
7.47 (d, 2H, J = 8.3 Hz), 7.12 (d, 2H, J = 8.3 Hz), 4.29 – 4.37 (m, 2H), 3.23 
– 3.29 (m, 1H), 2.78 – 2.83 (m, 1H), 2.21 – 2.27 (m, 1H), 1.94 – 2.00 (m, 
1H), 1.29 (d, 3H, J = 6.9 Hz); 13C NMR (126 MHz, CDCl3) δ 175.0, 139.5, 
132.3, 129.1, 121.5, 71.9, 38.0, 34.6, 33.0, 16.9; IR 2973, 2936, 1743, 1490, 1361, 1160, 
1117, 1074, 1056, 1034, 1009, 821, 752 cm-1; HRMS (DART-TOF) calcd. for 
C12H14Br1O2 [M+H]+: 269.0177, found: 269.0187; [α]D20 = − 22.9 (c = 0.640, CHCl3, l = 
50 mm). 
 
(3S,5S)-5-(4-bromophenyl)-3-methyltetrahydro-2H-pyran-2-one.  1H 
NMR (500 MHz, CDCl3) δ 7.48 (d, 2H, J = 8.8 Hz), 7.11 (d, 2H, J = 8.8 
Hz), 4.46 – 4.49 (m, 1H), 4.22 (dd, 1H, J = 11.5, 9.5 Hz), 3.23 – 3.27 (m, 
1H), 2.68 – 2.73 (m, 1H), 2.27 – 2.33 (m, 1H), 1.83 (q, 1H, J = 12.4 Hz), 
1.35 (d, 3H, J = 6.9 Hz); 13C NMR (126 MHz, CDCl3) δ 173.9, 139.5, 
132.3, 129.0, 121.5, 73.9, 39.9, 36.0, 35.7, 17.1. 
 
(3R,4S)-4-(4-bromophenyl)-3-ethyldihydrofuran-2(3H)-one.  1H 
NMR (500 MHz, CDCl3) δ 7.50 (d, 2H, J = 8.3 Hz), 7.14 (d, 2H, J = 8.3 
Hz), 4.52 (t, 1H, J = 8.8 Hz), 4.07 (t, 1H, J = 9.5 Hz), 3.37 – 3.43 (m, 
1H), 2.62 – 2.66 (m, 1H), 1.78 – 1.84 (m, 1H), 1.67 – 1.72 (m, 1H), 0.93 
(t, 3H, J = 7.6 Hz); 13C NMR (126 MHz, CDCl3) δ 177.8, 137.8, 132.5, 129.1, 121.9, 
71.9, 47.9, 46.8, 22.2, 11.3. 
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(3S,4S)-4-(4-bromophenyl)-3-ethyldihydrofuran-2(3H)-one.  1H NMR 
(500 MHz, CDCl3) δ 7.45 (d, 2H, J = 8.8 Hz), 7.03 (d, 2H, J = 8.8 Hz), 
4.55 (dd, 1H, J = 9.3, 6.4 Hz), 4.40 (dd, 1H, J = 9.3, 2.0 Hz), 3.65 – 3.69 
(m, 1H), 2.73 (dt, 1H, J = 8.3, 5.4 Hz), 1.61 – 1.66 (m, 1H), 1.01 – 1.08 
(m, 1H), 0.90 (t, 3H, J = 7.3 Hz); 13C NMR (126 MHz, CDCl3) δ 178.3, 137.9, 132.3, 
129.5, 121.8, 72.5, 46.3, 44.5, 19.4, 12.3. 
 
Table 2.4, Entry 8 
(S,Z)-2-(4-chlorophenyl)pent-3-en-1-ol was subjected to hydroformylation using General 
Procedure F. The regioselectivity and diastereoselectivity of the hydroformylation 
reaction was determined by 1H NMR in CDCl3.  Silica gel chromatography (15% 
EtOAc/Hex) afforded the following compounds:   
 
(3R,5S)-5-(4-chlorophenyl)-3-methyltetrahydro-2H-pyran-2-one (2.63). 
Isolated as a colorless oil (30 mg, 68%). 1H NMR (500 MHz, CDCl3) δ 7.33 
(d, 2H, J = 8.3 Hz), 7.19 (d, 2H, J = 8.3 Hz), 4.29 – 4.37 (m, 2H), 3.25 – 
3.31 (m, 1H), 2.79 – 2.84 (m, 1H), 2.22 – 2.28 (m, 1H), 1.95 – 2.01 (m, 
1H), 1.31 (d, 3H, J = 6.8 Hz); 13C NMR (126 MHz, CDCl3) δ 175.0, 139.0, 
133.4, 129.3, 128.7, 71.9, 37.9, 34.5, 32.9, 16.8; IR 2973, 2936, 1743, 1493, 1413, 1236, 
1161, 1117, 1090, 1057, 1034, 827 cm-1; HRMS (DART-TOF) calcd. for C12H14Cl1O2 
[M+H]+: 225.0682, found: 221.0689; [α]D20 = − 22.4 (c = 0.500, CHCl3, l = 50 mm). 
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(3S,5S)-5-(4-chlorophenyl)-3-methyltetrahydro-2H-pyran-2-one.  1H 
NMR (500 MHz, CDCl3) δ 7.32 (dd, 2H, J = 6.4, 2.0 Hz), 7.16 (dd, 2H, J = 
6.4, 2.0 Hz), 4.46 – 4.49 (m, 1H), 4.22 (dd, 1H, J = 11.3, 9.8 Hz), 3.23 – 
3.29 (m, 1H), 2.67 – 2.73 (m, 1H), 2.27 – 2.32 (m, 1H), 1.82 (dd, 1H, J = 
24.9, 12.7 Hz), 1.35 (d, 3H, J = 7.3 Hz); 13C NMR (151 MHz, CDCl3) δ 
173.9, 138.9, 133.5, 129.3, 128.6, 74.0, 39.8, 36.0, 35.8, 17.2. 
 
Proof of Absolute Stereochemistry: 
The absolute stereochemistry was confirmed by 1D nOe experiements between the C(3) 
and C(5) hydrogen atoms.  An nOe correlation is observed between these two hydrogen 
substituents.  See spectroscopic data for further details. 
 
(3R,4S)-4-(4-chlorophenyl)-3-ethyldihydrofuran-2(3H)-one.  1H NMR 
(500 MHz, CDCl3) δ 7.34 (d, 2H, J = 8.3 Hz), 7.20 (d, 2H, J = 8.3 Hz), 
4.52 (t, 1H, J = 8.6 Hz), 4.08 (t, 1H, J = 9.3 Hz), 3.39 – 3.45 (m, 1H), 
2.62 – 2.66 (m, 1H), 1.78 – 1.84 (m, 1H), 1.67 – 1.73 (m, 1H), 0.94 (t, 
3H, J = 7.6 Hz); 13C NMR (126 MHz, CDCl3) δ 177.9, 137.24 133.9, 129.6, 128.8, 72.0, 
47.9, 46.8, 22.2, 11.3. 
 
(3S,4S)-4-(4-chlorophenyl)-3-ethyldihydrofuran-2(3H)-one.  1H NMR 
(500 MHz, CDCl3) δ 7.31 (dd, 2H, J = 6.4, 2.0 Hz), 7.10 – 7.11 (m, 2H), 
4.56 (dd, 1H, J = 9.3, 5.9 Hz), 4.42 (dd, 1H, J = 9.3, 2.0 Hz), 3.68 – 3.72 
(m, 1H), 2.71 – 2.78 (m, 1H), 1.62 – 1.68 (m, 1H), 1.03 = 1.09 (m, 1H), 
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0.91 (t, 3H, J = 7.3 Hz); 13C NMR (151 MHz, CDCl3) δ 178.3, 137.4, 133.7, 129.3, 
129.2, 72.6, 46.3, 44.4, 19.4, 12.3. 
 
Table 2.4, Entry 9 
(S,Z)-2-(3-trifluoromethylphenyl)pent-3-en-1-ol was subjected to hydroformylation using 
General Procedure F. The regioselectivity and diastereoselectivity of the 
hydroformylation reaction was determined by 1H NMR in CDCl3.  Silica gel 
chromatography (15% EtOAc/Hex) afforded the following compounds:   
 
(3R,5S)-3-methyl-5-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-
2-one (2.65). Isolated as a colorless oil (38 mg, 73%). 1H NMR (500 MHz, 
CDCl3) δ 7.55 (d, 1H, J = 7.8 Hz), 7.45 – 7.49 (m, 3H), 4.34 – 4.41 (m, 
2H), 3.33 – 3.40 (m, 1H), 2.82 – 2.87 (m, 1H), 2.27 – 2.33 (m, 1H), 1.99 – 
2.05 (m, 1H) 1.30 (d, 3H, J = 6.9 Hz); 13C NMR (126 MHz, CDCl3) δ 174.9, 141.6, 131.5 
(q, JC-F = 32 Hz), 130.9, 129.7, 124.5, 124.1, 124.0 (q, JC-F = 272 Hz), 71.7, 38.4, 34.5, 
32.9, 16.8; 19F NMR (470 MHz, CDCl3) δ − 62.7; IR 2977, 2939, 1745, 1382, 1162, 
1121, 1059, 917, 805, 704, 664 cm-1; HRMS (DART-TOF) calcd. for C13H14F3O2 
[M+H]+: 259.0946, found: 259.0946; [α]D20 = − 16.4 (c = 0.600, CHCl3, l = 50 mm). 
 
(3S,5S)-3-methyl-5-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-2-
one.  1H NMR (500 MHz, CDCl3) δ 7.55 (d, 1H, J = 7.3 Hz), 7.46 – 7.50 
(m, 3H), 4.51 (ddd, 1H, J = 13.7, 5.4, 2.2 Hz), 4.27 (dd, 1H, J = 11.3, 9.8 
Hz), 3.33 – 3.38 (m, 1H), 2.70 – 2.75 (m, 1H), 2.32 – 2.36 (m, 1H), 1.85 
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(m, 1H), 1.36 (d, 3H, J = 6.9 Hz); 13C NMR (126 MHz, CDCl3) δ 173.7, 141.5, 131.4, (q, 
JC-F = 32 Hz), 130.0, 129.7, 124.6, 124.2 (q JC-F = 273 Hz), 124.1, 73.3, 40.2, 36.0, 35.7, 
17.1; 19F NMR (470 MHz, CDCl3) δ − 62.7. 
 
(3R,4S)-3-ethyl-4-(3-(trifluoromethyl)phenyl)dihydrofuran-
2(3H)-one.  1H NMR (500 MHz, CDCl3) δ 7.58 (d, 1H, J = 7.8 Hz), 
7.46 – 7.57 (m, 3H), 4.58 (t, 1H, J = 8.6 Hz), 4.13 (t, 1H, J = 9.5 Hz), 
3.51 (app q, 1H, J = 9.6 Hz), 2.66 – 2.73 (m, 1H), 1.81 – 1.86 (m, 
1H), 1.70 – 1.76 (m, 1H), 0.95 (t, 3H, J = 7.3 Hz); 13C NMR (126 MHz, CDCl3) δ 177.6, 
129.9, 131.8 (q, JC-F = 32 Hz), 130.8, 130.0, 125.0, 124.4, 124.1 (q, JC-F = 272 Hz), 71.9, 
47.9, 47.1, 22.3, 11.2; 19F NMR (470 MHz, CDCl3) δ − 62.7. 
 
(3S,4S)-3-ethyl-4-(3-(trifluoromethyl)phenyl)dihydrofuran-
2(3H)-one.  1H NMR (500 MHz, CDCl3) δ 7.57 (d, 1H, J = 7.8 Hz), 
7.48 (t, 1H, J = 7.8 Hz), 7.40 (s, 1H), 7.38 (d, 1H, J = 7.8 Hz), 4.60 
(dd, 1H, J = 9.3, 6.4 Hz), 4.46 (dd, 1H, J = 9.5, 2.2 Hz), 3.78 – 3.81 
(m, 1H), 2.76 – 2.81 (m, 1H), 1.62 – 1.66 (m, 1H), 1.00 – 1.06 (m, 1H), 0.93 (t, 3H, J = 
7.3 Hz); 13C NMR (126 MHz, CDCl3) δ 178.1, 139.9, 131.4 (q, JC-F = 32 Hz), 130.8, 
129.8, 124.9, 124.8, 124.0 (q, JC-F = 273 Hz), 72.3, 46.3, 44.9, 19.5, 12.2; 19F NMR (470 
MHz, CDCl3) δ − 62.7. 
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Table 2.4, Entry 10 
(S,Z)-2-(3-methoxyphenyl)pent-3-en-1-ol was subjected to hydroformylation using 
General Procedure F. Achiral GC analysis using GC Method E afforded three peaks 
corresponding to each γ-lactone product (10.36 min and 10.51 min) and the combined δ-
lactone products (12.02 min).  The diastereoselectivity of the reaction was determined by 
1H NMR in CDCl3.  Silica gel chromatography (15% EtOAc/Hex) afforded the following 
compounds:   
 
(3R,5S)-5-(3-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one 
(2.67). Isolated as a colorless solid (34 mg, 77%). GC Method E: 12.02 
min.; 1H NMR (500 MHz, CDCl3) δ 7.24 – 7.28 (m, 1H), 6.77 – 6.83 (m, 
3H), 4.33 – 4.38 (m, 2H), 3.81 (s, 3H), 3.25 – 3.28 (m, 1H), 2.80 – 2.85 
(m, 1H), 2.26 – 2.32 (m, 1H), 1.96 – 2.00 (m, 1H), 1.30 (d, 3H, J = 6.9 Hz); 13C NMR 
(126 MHz, CDCl3) δ 175.4, 160.2, 142.2, 132.2, 119.6, 113.7, 112.4, 72.2, 55.5, 38.5, 
34.6, 33.0, 16.8; IR 2936, 1742, 1601, 1585, 1488, 1456, 1263, 1159, 1117, 1085, 1035, 
781, 670 cm-1; HRMS (DART-TOF) calcd. for C13H17O3 [M+H]+: 221.1178, found: 
221.1172; [α]D20 = − 13.1 (c = 1.01, CHCl3, l = 50 mm). 
 
(3S,5S)-5-(3-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one. 1H 
NMR (500 MHz, CDCl3) δ 7.27 – 7.30 (m, 1H), 6.77 – 6.83 (m, 3H), 4.49 
(ddd, 1H, J = 11.3, 5.4, 2.5 Hz), 4.25 (dd, 1H, J = 11.3, 10.3 Hz), 3.80 (s, 
3H), 3.22 – 3.27 (m, 1H), 2.67 – 2.73 (m, 1H), 2.27 – 2.32 (m, 1H), 1.83 – 
O
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1.91 (m, 1H), 1.35 (d, 3H, J = 7.3 Hz); 13C NMR (126 MHz, CDCl3) δ 174.0, 160.2, 
141.9, 130.2, 119.5, 113.5, 112.6, 74.4, 55.4, 40.4, 36.2, 35.8, 17.3. 
 
(3R,4S)-3-ethyl-4-(3-methoxyphenyl)dihydrofuran-2(3H)-one.  
1H NMR (500 MHz, CDCl3) δ 7.29 (t, 1H, J = 7.3 Hz), 6.83 – 6.87 
(m, 2H), 6.79 (s, 1H), 4.53 (t, 1H, J = 8.6 Hz), 4.12 (t, 1H, J = 9.3 
Hz), 3.82 (s, 3H), 3.38 – 3.44 (m, 1H), 2.67 – 2.71 (m, 1H), 1.77 – 1.85 (m, 1H), 1.69 – 
1.76 (m, 1H), 0.96 (t, 3H, J = 7.3 Hz); 13C NMR (126 MHz, CDCl3) δ 178.3, 160.3, 
140.4, 130.4, 119.7, 113.7, 112.8, 72.2, 55.5, 47.8, 47.3, 22.2, 11.2. 
 
(3S,4S)-3-ethyl-4-(3-methoxyphenyl)dihydrofuran-2(3H)-one.  
1H NMR (500 MHz, CDCl3) δ 7.23 (d, 1H, J = 7.8 Hz), 6.82 (dd, 
1H, J = 8.3, 2.4 Hz), 6.75 (d, 1H, J = 7.8 Hz), 6.69 (app t, 1H, J = 
2.0 Hz), 4.55 (dd, 1H, J = 9.3, 5.9 Hz), 4.46 (dd, 1H, J = 9.3 2.5 
Hz), 3.79 (s, 3H), 3.66 – 3.69 (m, 1H), 2.69 – 2.74 (m, 1H), 1.61 – 1.66 (m, 1H), 1.08 – 
1.14 (m, 1H), 0.92 (t, 3H, J = 7.3 Hz); 13C NMR (126 MHz, CDCl3) δ 178.7, 160.1, 
140.4, 130.2, 120.0, 113.9, 112.8, 72.7, 55.4, 46.4, 45.0, 22.8, 14.3. 
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GC Trace for the Determination of Regioselectivity 
 
 
Table 2.4, Entry 11 
(S)-2-phenylbut-3-en-1-ol was subjected to hydroformylation using General Procedure G. 
The regioselectivity of the hydroformylation reaction was determined by 1H NMR in 
CDCl3.  Silica gel chromatography (15% EtOAc/Hex) afforded the following 
compounds:   
 
(S)-5-phenyltetrahydro-2H-pyran-2-one (2.69).  Isolated as a colorless solid 
(28 mg, 80%).  This compound has been synthesized previously in our 
laboratories (in racemic form) and all spectroscopic data are in accord. [α]D20 = 
+ 25.1 (c = 0.520, CHCl3, l = 50 mm). 
 
Table 2.5 
The following compounds have been synthesized previously and are in accord with 
reported NMR spectra: (Z)-4-phenylbut-2-en-1-ol (2.70),39 5-phenylpent-3-yn-1-ol,40 (Z)-
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
39 Nicolaou, K. C.; Yue, E. W.; la Greca, S.; Nadin, A.; Yang, Z. Leresche, J. E.; Tsuri, 
T.; Naniwa, Y.; de Riccardis, F. Chem. Eur. J. 1995, 1, 467 – 494. 
O
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6-phenylhex-4-en-1-ol (2.72), 41  3-hydroxy-2-(2-phenylethyl)propionic acid, 42  3-
benzyldihydrofuran-2(3H)-one, 43  3-benzyltetrahydro-2H-pyran-2-ol, 44  3-
benzyltetrahydro-2H-pyran-2-one.45 
 
General Procedure H: In a dry box, the appropriate alcohol substrate (0.200 mmol), 
(4S)-4-(tert-butyl)-3-(3-(diphenylphosphanyl)benzyl)-2-methoxyoxazolidine (8.7 mg, 
0.020 mmol), a p-toluenesulfonic acid in benzene (351 µL, 2.0 x 10-4 mmol, 5.72 x 10-4 
M solution) were mixed in C6D6 (0.8 mL) and allowed to equilibrate in a sealed NMR 
tube at 45 °C for 3 hours.  (Note: the appearance of methanol can be monitored by 1H 
NMR). The solution was concentrated in the dry box to remove the generated MeOH, the 
residue was redissolved in C6D6, and was allowed to equilibrate for an additional 4 hours 
at 45 °C before being concentrated again in the dry box. The appearance of free MeOH 
can be monitored by 1H NMR.  The resulting mixture was dissolved in benzene (3.5 mL), 
mixed with 3% Rh(acac)(CO)2 (1.5 mg, 0.006 mmol), and injected into the Endeavor, 
followed by 0.5 mL benzene to wash the injection port.   
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
40 Qian, M.; Negishi, E. Tetrahedron 2005, 46, 2927 – 2930. 
41 Kwon, H.; Park, C.; Lee, S.; Youn, J.-H.; Kang, S. Chem. Eur. J. 2008, 14, 1023 – 
1028. 
42 Gersh, M.; Gut, F.; Korotkov, V. S.; Lehmann, J.; Bottcher, T.; Rusch, M.; Hedberg, 
C.; Waldmann, H.; Klebe, G.; Sieber, S. A. Angew Chem. Int. Ed. 2013, 52, 3009 – 3014.  
43 Miao, L.; Haque, I.; Manzoni, M. R.; Tham, W. S.; Chemler, S. R. Org. Lett. 2010, 12, 
4739 – 4741. 
44 Newsome, P. W.; Kuehn, C.; Takusagawa, F.; Takacs, J. M. Tetrahedron 1990, 46, 
5507 – 5522. 
45 Evans, D. A.; Kwan, E. E.; Scheerer, O. R. J. Org. Chem. 2013, 78, 175 – 203. !
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General Procedure I (Control reaction using PPh3 as ligand): In a dry box, the 
appropriate alcohol substrate (0.200 mmol), triphenylphosphine (5.2 mg, 0.020 mmol), 
and Rh(acac)(CO)2 (1.5 mg, 0.006 mmol) were mixed in benzene (3.5 mL).  The 
resulting yellow solution was injected into the Endeavor, followed by 0.5 mL benzene to 
wash the injection port.   
 
Table 2.5, Entry 1 
The reaction was carried out according to General Procedure H and I. Upon completion 
of the hydroformylation reaction, the benzene was removed in vacuo and internal 
standard (mesitylene in CDCl3) was added to determine conversion, based on remaining 
starting material, by 1H NMR.  The mixture was concentrated on a rotary evaporator in a 
glass scintillation vial.  To the vial was added a magnetic stir bar, acetonitrile (0.75 mL), 
water (0.75 mL), sodium phosphate (144 mg, 1.20 mmol), and 35% aqueous H2O2 (0.120 
mL, 1.23 mmol).  The reaction was cooled to 0 °C and a solution of sodium chlorite 
(tech. grade, 80%, 138 mg, 1.2 mmol) in water (0.75 mL), was added dropwise.  The 
reaction was stirred and warmed to room temperature over 3 hours.  The reaction as 
quenched by the addition of sodium sulfite (spatula tip) and 1M aqueous HCl (3 mL).  
The reaction was extracted with DCM (3 x 10 mL), dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude reaction was analyzed by 1H NMR in 
CDCl3 to determine the regioselectivity of the reaction. 
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Table 2.5, Entry 2 
(Z)-5-phenylpent-3-en-1-ol (2.71). A round-bottom flask was 
charged with Lindlar’s catalyst (330 mg) and purged with 
nitrogen. 5-phenylpent-3-yn-1-ol (660 mg, 4.11 mmol) in MeOH 
(12.5 mL) was added followed by quinoline (35 µL, 0.27 mmol). The flask was 
evacuated and refilled with H2 four times, fitted with a H2 balloon, and stirred at room 
temperature under H2 for 2.5 h. The reaction was filtered through a plug of silica and 
concentrated. Column chromatography (20% EtOAc/Hex) yielded a light yellow oil (495 
mg, 76%).  
 
1H NMR (500 MHz, CDCl3) δ 7.28 – 8.31 (m, 2H), 7.18 – 7.21 (m, 3H), 5.74 – 5.79 (m, 
1H), 5.51 – 5.56 (m, 1H), 3.71 (t, 2H, J = 6.6 Hz), 3.45 (d, 2H, J = 7.3 Hz), 2.44 – 2.48 
(m, 2H), 1.44 (br s, 1H); 13C NMR (126 MHz, CDCl3) δ 140.9, 131.6, 128.7, 128.5, 
126.4, 126.2, 62.5, 33.8, 31.0; IR 3337, 3025, 2939, 2883, 1602, 1495, 1453, 1400, 1047, 
738, 679, 621, 562 cm-1; HRMS (DART-TOF) calcd. for C11H15O1 [M+H-H2O]+: 
163.1123, found: 163.1128. 
 
The reaction was carried out according to General Procedure H and I. Upon completion 
of the hydroformylation reaction, the benzene was removed in vacuo and internal 
standard (mesitylene in CDCl3) was added to determine conversion, based on remaining 
starting material, by 1H NMR.  The regioselectivity of the reaction was determined at this 
point by comparison of the lactol peaks in the crude 1H NMR. The solvent was removed 
under reduced pressure.  The crude hydroformylation mixture was added, as a solution in 
HO
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dichloromethane (3 mL), to a scintillation vial containing pyridinium chlorochromate 
(129 mg, 0.597 mmol), sodium acetate (16.0 mg, 0.195 mmol), and 4 Å molecular sieves. 
The reaction was stirred for 12 hours at room temperature, eluted through a short plug of 
silica gel (100% Et2O), concentrated under reduced pressure, and subjected to silica gel 
chromatography (20% EtOAc/Hex). HPLC analysis of the δ-lactone was used to 
determine the enantioselectivity of the hydroformylation reaction.  
 
3-phenethyltetrahydrofuran-2-ol.  Exists as a 1:1 mixture of 
diastereomers.  1H NMR (500 MHz, CDCl3) δ 7.27 – 7.30 (m, 4H), 7.18 – 
7.21 (m, 6H), 5.34 (t, 1H, J = 3.7 Hz), 5.22 (t, 1H, J = 2.4 Hz), 4.09 – 4.13 (m, 1H), 4.03 
(dd, 1H, J = 15.7, 7.3 Hz), 3.93 – 3.97 (m, 1H), 3.82 (dd, 1H, J = 15.7, 7.3 Hz), 3.04 (d, 
1H, J = 2.9 Hz), 2.83 (d, 1H, J = 2.9 Hz), 2.66 – 2.70 (m, 4H), 2.17 – 2.22 (m, 1H), 2.11 
– 2.14 (m, 1H), 2.01 – 2.04 (m, 1H), 1.91 – 1.98 (m, 1H), 1.76 – 1.84 (m, 2H), 1.57 – 
1.65 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 142.4, 142.0, 128.6, 128.5, 126.1, 126.0, 
103.4, 98.4, 67.3, 67.1, 46.2, 44.0, 34.8, 34.4, 34.3, 30.7, 20.5, 29.1; IR 3394, 2930, 
2858, 1496, 1454, 1118, 1029, 1012, 986, 908, 749, 699, 497 cm-1; HRMS (DART-TOF) 
calcd. for C12H15O1 [M+H-H2O]+: 175.1123, found: 175.1118. 
 
3-benzyltetrahydro-2H-pyran-2-one. PCC oxidation and 
chromatography (15% EtOAc/Hex) afforded the title compound as a 
colorless oil). All spectroscopic data for this compound are in accord with previously 
published reports.45 HPLC (OD-H, 0.50 mL/min, 5% i-PrOH, 95% hexanes, 220 nm) 
tr(minor) = 23.2 min and tr(major) = 24.2 min, 19% ee. 
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Table 2.5, Entry 3 
The reaction was carried out according to General Procedure H and I. Upon completion 
of the hydroformylation reaction, the benzene was removed in vacuo and internal 
standard (mesitylene in CDCl3) was added to determine conversion, based on remaining 
starting material, by 1H NMR.  The regioselectivity of the reaction was determined at this 
point by comparison of the lactol and aldehyde peaks in the crude 1H NMR.   
 
3-phenethyltetrahydro-2H-pyran-2-ol.  Exists as a 1:1 mixture of 
diastereomers. 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.29 (m, 4H), 7.18 – 
7.21 (m, 6H), 5.11 (d, 1H, J = 2.5 Hz), 4.48 (d, 1H, J = 6.4 Hz), 3.97 – 4.02 (m, 2H), 3.55 
– 3.58 (m, 1H), 3.47 – 3.50 (m, 1H), 2.60 – 2.73 (m, 4H), 1.99 – 2.03 (m, 2H), 1.67 – 
1.76 (m, 2H), 1.45 – 1.61 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 142.6, 128.5, 125.9, 
99.7, 94.0, 65.4, 60.0, 41.5, 39.4, 33.5, 33.2, 27.4, 25.5, 24.9, 23.8; IR 3387, 2933, 2855, 
1496, 1454, 1273, 1130, 1072, 1027, 986, 903, 867, 577, 544 cm-1; HRMS (DART-TOF) 
calcd. for C13H17O1 [M+H-H2O]+: 189.1279, found: 189.1284. 
 
O
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2-benzyl-6-hydroxyhexanal.  1H NMR (500 MHz, CDCl3) δ 9.65 
(d, 1H, J = 5.0 Hz), 7.25 – 7.30 (m, 2H), 7.15 – 7.22 (m, 3H), 3.61 
(t, 2H, J = 6.4 Hz), 3.00 (dd, 1H, J = 14.1, 7.3 Hz), 2.74 (dd, 1H, J = 14.2, 6.8 Hz), 2.62 – 
2.64 (m, 1H), 1.35 – 1.67 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 204.7, 138.9, 129.1, 
128.7, 126.6, 62.7, 53.6, 35.2, 32.8, 28.4, 23.4; IR 3027, 2935, 2861, 1703, 1454, 1406, 
1210, 1170, 1072, 1053, 1030, 744, 699, 543 cm-1; HRMS (DART-TOF) calcd. for 
C13H17O2 [M-H]+: 205.1229, found: 205.1227. 
 
2.11.5 Spectral Data 
For all published spectral data see the following link: 
http://pubs.acs.org/doi/suppl/10.1021/ja504247g 
See below for examples of 1H, 13C and 31P spectra: 
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Chapter 3: The Stereoselective, Hydroxyl-Directed Diboration of 
Alkenyl Alcohols 
 
3.1 Introduction 
 The use of directing groups has been a long-standing approach for the 
stereoselective functionalization of olefins.1  Through a reversible preassociation between 
the substrate and either reagent or catalyst, an otherwise unselective reaction can attain 
high levels of regio- and stereoselectivity.  In many cases, the directing group involved 
does not need to be a highly specialized group (Section 2.4), but rather a common 
functional group.  For example, one of the most well-known classes of directed reactions 
is the hydroxyl-assisted epoxidation of alkenes (Scheme 3.1). These directed 
epoxidations can occur in two distinct ways: (1) hydrogen bonding to a peracid reagent 
(3.1)2 or (2) alkoxide coordination to a metal catalyst (such as Ti or V) (3.2).3  In either 
case, this mode of activation, by the hydroxyl group, can both control the selectivity of 
the reaction as well as improve the rate as compared to the undirected reaction. 
 
 
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 For reviews related to directed reactions (a) Hoveyda, A. H.; Evans, D. A.; Fu, G. C. 
Chem. Rev. 1993, 93, 1307 – 1370. (b) Rousseau, G.; Breit, B. Angew. Chem., Int. Ed. 
2011, 50, 2450 – 2494. 
2 Sabol, J. S.; Cregge, R. J. Tetrahedron Lett. 1989, 30, 3377 – 3380. 
3 Sato, T.; Gotoh, Y.; Watanabe, M.; Fujisawa, T. Chem. Lett. 1993, 1533 – 1536. 
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Scheme 3.1 Directed Epoxidation Methodologies 
 
 
3.2 Selected Examples of Directed and Intramolecular Hydrometallative and 
Bismetallative Reactions 
The use of hydrometallation and bismetallation reagents has been a popular 
method for the stereoselective functionalization of olefins.  In addition to catalyst-
controlled alkene functionalization, intramolecular and directed reactions have been two 
popular techniques for the control of regio-, chemo-, and stereoselectivity of these 
reactions.  With regard to intramolecular reactions, by covalently tethering the 
hydrometallic or bismetallic reagent to the alkene substrate, the functionalization occurs 
in a relatively active and predictable fashion. Conversely, directed reactions rely on the 
inherent electrophilicity of the metallic reagents to permit a transient association with a 
Lewis basic directing group, which facilitates the directed reaction pathway.  This section 
will highlight notable example of both directed and intramolecular functionalizations of 
alkenes using hydrometallic or bismetallic reagents. 
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3.2.1 Hydrosilylation 
Tamao and Ito 4  have developed the directed hydrosilylation of allylic and 
homoallylic alcohols.  Using extremely low quantities of a Pt catalyst, the hydrosilylation 
of 3.3 and 3.5 furnishes the 1,3-diols 3.4 and 3.6, respectively, in moderate yields and 
good to excellent stereocontrol (Scheme 3.2).  It is suggested that the selectivity arises 
from a covalent association between the alkoxide of the substrate and the hydrosilyl 
reagent.  Interestingly, the hydroxyl group directs the silicon atom to the β-olefinic 
carbon, whether that carbon is proximal or distal carbon, relative to the directing group.  
Similar to intermolecular examples, the hydrosilyl-substrate intermediate undergoes 
Pt-catalyzed hydrosilylation, starting with the oxidative addition into the Si-H bond. 
 
Scheme 3.2 Directed Hydrosilylation of Alkenyl Alcohols 
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3.2.2 Bis(silylation) 
Ito and coworkers5 have disclosed the intramolecular bis(silylation) of disilanyl 
alkenes, which are easily synthesized from the corresponding homoallylic alcohols.  With 
the olefin and disilane covalently bound, the intramolecular bis(silylation) of the alkene 
proceeds rapidly.  Using Pd(OAc)2 and a isocyanide ligand, 3.7 is transformed to the syn 
diastereomer 3.8 in 85% yield and >20:1 dr (Scheme 3.3).  It should be noted that when 
similar conditions were used for a similar intermolecular bis(silylation) of an alkene, no 
reaction was observed. Oxasilolane 3.8 can be oxidized and acylated to the protected 
1,3,4-triol 3.9 in good yield.   
 
Scheme 3.3 Intramolecular Bis(silylation) 
 
 
3.2.3 Silylformylation 
 Leighton and coworkers6 disclosed an intramolecular silylformylation of siloxy 
alkenes using a Rh catalyst and CO at elevated pressure.  Siloxy olefin 3.10 undergoes 
silylformylation, furnishing oxasilolane 3.11 in moderate yield and diastereoselectivity, 
after reduction of the aldehyde and protection of the subsequent alcohol (Scheme 3.4).  !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
5 (a) Murakami, M.; Andersson, P. G.; Suginome, M.; Ito, Y. J. Am. Chem. Soc. 1991, 
113, 3987 – 3988. (b) Murakami, M.; Suginome, M.; Fujimoto, K.; Nakamura, H.; 
Andersson, P. G.; Ito, Y. J. Am. Chem. Soc. 1993, 115, 6487 – 6498. 
6 Leighton, J. L.; Chapman, E. J. Am. Chem. Soc. 1997, 119, 12416 – 12417. 
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The high pressure of CO gas is necessary to out compete the competitive, undesirable 
hydrosilylation reaction. 
 
Scheme 3.4 Intramolecular Silylformylation 
 
 
3.2.4 Silaboration 
 In 2006, Suginome and coworkers7  reported the Pt-catalyzed intramolecular 
silylboration of alkenes.  Interestingly, a powerful ligand effect allowed for the selective 
synthesis of both diastereomers of the boronate-containing oxasilolane products.  When 
using diphenylcyclohexyl phosphine (PCyPh2) as the ligand, the silylboration of 3.12 
yields the anti product 3.13 in good yield and selectivity. This observed selectivity is 
overturned when phosphite 3.14 is used as the ligand, producing the syn product 3.15 in 
great yield and diastereoselectivity (Scheme 3.5).  The researchers concluded that bulkier 
ligands, especially phosphites, favored the formation of the syn diastereomer.  
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Scheme 3.5 Intramolecular Silaboration 
 
 
3.2.5 Hydroboration 
 The hydroboration of olefins is an excellent example of a reaction that has 
benefitted greatly from the use of directing groups.  Evans and coworkers8 reported one 
of the first examples of a directed hydroboration in 1991.  The presence of an amide 
functionality provided both a rate enhancement and a means of controlling selectivity of 
the hydroboration of both cyclic and acyclic alkenes using catecholborane.  For example, 
olefin 3.16 undergoes the Ir-catalyzed hydroboration and subsequent oxidation to yield 
3.17 in good yield and diastereoselectivity (Scheme 3.6).  It should be noted that none of 
the other regioisomer is observed.  Takacs and coworkers9 have expanded this concept to 
the amide-directed enantioselective hydroboration using pinacolborane and a chiral 
phosphoramidite-iridium catalyst. 
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Scheme 3.6 Amide-Directed Hydroboration 
 
 Vedejs and coworkers10 have examined the use of other functional groups as 
directing groups for hydroboration.  Homoallylic alcohol 3.18 associates with an 
activated borane (derived form Me2S!BH3 and TfOH), initiating a directed hydroboration 
and generating 3.19 as the favored regioisomer in moderate yield after an oxidative work-
up (Scheme 3.7, Eq. 1).  A similar outcome occurs when starting from the amine-borane 
complex 3.20, yielding 3.21 in good yield and excellent regioselectivity after oxidation 
(Scheme 3.7, Eq. 2).  The concept was extended to piperidine-containing olefin substrates 
such as 3.22, yielding the amino alcohol products with good diastereoselectivity (Scheme 
3.7, Eq. 3).  The proposed transition state 3.23 is used to account for the diastereomer 
observed. 
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Scheme 3.7 Vedejs’ Directed Hydroboration 
 
 
3.3 Stereoselective Methods for Installing 1,2-Bis(boronates) 
 The early development of the diboration of alkynes11 fueled the discovery of 
catalyst systems for the diboration of alkenes.  The discovery of Rh-12 and Pt-catalyst 
systems13 triggered an early example of a Pt-catalyzed, enantioselective diboration using 
a chiral diboron reagent.14  These initial catalyst systems have functioned as inspiration 
for the development of efficient asymmetric diboration reactions.  Over the past decade, 
the diboration reaction has become a proficient means of functionalizing olefins.  The 
development of asymmetric transition-metal catalyzed systems has allowed for the use of 
cheap, achiral diboron reagents, such as B2(pin)2 and B2(cat)2.  Like all hydrometallation 
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Organometallics, 1996, 15, 713 – 720.  
12 Baker, R. T; Nguyen, P.; Marder, T. B.; Westcott, S. A. Angew. Chem., Int. Ed., 1995, 
34, 1336 – 1338. 
13 Iverson, C. N.; Smith, III, M. R. Organometallics, 1997, 16, 2757 – 2759. 
14 Marder, T. B.; Norman, N. C.; Rice, C. R. Tetrahedron Lett. 1998, 39, 155 – 158. 
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and bismetallation reactions, the usefulness of diboration hinges on the utility of its 
products.  In addition to oxidation to the 1,2-diol or a homologation/oxidation sequence 
to the 1,4-diol, these 1,2-bis(boronates) can undergo a regioselective cross-coupling to 
furnish a readily functionalizable mono-organoboronate (Chapter 4).   
 
3.3.1 Generating Chiral 1,2-Bis(boronates) from Olefins 
In 2003, Morken and coworkers15 disclosed the first example of a catalytic, 
asymmetric diboration of alkenes.  Using a Rh/(S)-quinap catalyst, the diboration 
proceeds with excellent enantioselectivites for most of the di- and trisubstituted olefins 
screened.  The diboration of styrene 3.24 using the catalyst and B2(cat)2 yields the 
internal 1,2-diol 3.25 in 71% yield and 93% enantioselectivity, after oxidation (Scheme 
3.8).  Further studies demonstrated that some bulkier terminal olefins also undergo 
diboration in a selective fashion. 
 
Scheme 3.8 Rh-Catalyzed Asymmetric Diboration of Internal Olefins 
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 In 2009, and further improved in 2013, Morken and coworkers16 reported the first 
catalytic, asymmetric diboration of terminal alkenes.  Using a Pt/3.26 catalyst, the 
diboration of simple terminal olefins generally proceeds in high selectivities.   Using 
B2(pin)2 as the diboron reagent, 3.27 undergoes diboration to yield the diol 3.28 in 81% 
yield and 92% ee after oxidation (Scheme 3.9).  It is of note that the diboration of most 
di- and trisubstituted olefins does not occur under these conditions.  Additionally, the 
presence of hydroxyl groups, sterically unhindered ethers, and alkynes are believed to 
poison the Pt catalyst, leading to no reaction or diminished selectivity.  However, these 
conditions have been successfully adapted to the 1,2-diboration of 1,3-dienes17 and vinyl 
boronate esters.18  
 
Scheme 3.9 Pt-Catalyzed Asymmetric Diboration of Terminal Olefins 
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 Nishiyama and coworkers 19  have also developed an efficient diboration of 
terminal olefins.  Using 1% 3.29 and 5% NaOt-Bu, the diboration of alkyl and aryl 
α-olefins using B2(pin)2 occurs with excellent selectivities.  The diboration and NaBO3 
oxidation of 3.30 yields diol 3.31 in 96% yield and 99% ee (Scheme 3.10).  Similar to 
Pt-catalyzed systems, the diboration of more substituted olefins proceeds in lower yields 
and enantioselectivities. 
 
Scheme 3.10 Rh-Catalyzed Asymmetric Diboration of Terminal Olefins 
 
 
3.3.2 Generating Chiral 1,2-Bis(boronates) from Terminal Alkynes 
Morken and coworkers20 described an alternative approach to the synthesis of 
chiral 1,2-bis(boronates) through the Rh-catalyzed asymmetric hydrogenation of vinyl 
1,2-bis(boronates).  Interestingly, this reaction can be included in a one-pot sequence 
starting from the terminal alkyne.  Alkyne 3.32 is subjected to syn-selective diboration, 
followed by the enantioselective hydrogenation of the vinyl diboronate using a 
Rh/Walphos catalyst.   Oxidation of the vicinal diboronate yields the diol 3.33 in 66% 
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yield and 91% ee (Scheme 3.11).  Hoveyda and coworkers21 reported another method for 
the synthesis of chiral 1,2-bis(boronates) through sequential copper-catalyzed 
hydroborations of alkynes.  Using a Cu-3.34 catalyst, 3.35 undergoes an initial 
hydroboration to form the vinylboronate, which upon a second hydroboration furnishes 
3.36 in 84% yield and 91% ee (Scheme 3.11).  One reason for the success of the reaction 
is attributed to the ability of the catalyst to selectively form the terminal vinyl boronate 
during the first hydroboration. 
 
Scheme 3.11 Chiral 1,2-Bis(boronates) from Terminal Alkynes 
 
 
3.4 Hydroxyl-Directed Diboration22 
3.4.1 Inspiration 
Our research initially set out to investigate whether a hydroxyl group could serve 
as a suitable directing group for a diboration of olefins.  In part, this research was inspired !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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by the work of Fernández and coworkers, 23  who disclosed a transition metal-free 
diboration of terminal and internal olefins.  In that report, they propose that in situ 
formation of a methoxide anion, from a carbonate base and methanol, is an adequate 
activator of the diboron reagent for diboration.  For terminal olefin 3.37, the reaction 
furnishes 3.38 in good yield (Scheme 3.12, Eq. 1).  It should be noted that, in all cases, 
only very small amounts (<5%) of the hydroborated product is observed.  The diboration 
is shown to be syn-selective, yielding 3.40 in good yield and excellent diastereoselectivity 
from the diboration of 3.39 (Scheme 3.12, Eq. 2). 
 
Scheme 3.12 Transition Metal-Free Diboration of Alkenes 
 
 As mentioned above, the proposed mechanism suggests the formation and 
function of CsOMe is imperative to the success of the reaction (Scheme 3.13).  Although 
appearing to require catalytic amounts, the authors mentioned that excess methanol is 
required for an optimal reaction outcome.  Next, CsOMe reacts with B2(pin)2 creating the 
sp2-sp3 diboron species 3.42.  This activated diboron species reacts with the C1 carbon of 
olefin 3.43 to form 3.44, which rapidly forms borocycle 3.45 as a transition state.  
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Opening of 3.45, yields 3.46, which upon protonation, generates the 1,2-bis(boronate) 
product. 
 
Scheme 3.13 Mechanism for the Transition Metal-Free Diboration of Alkenes 
 
 
3.4.2 Directed Diboration of Alkynes 
As shown earlier, many hydrometallation and bismetallation reactions have been 
aided by the use of directing groups (Section 3.2).  Surprisingly, at the time of our 
research, there were no examples of a directed diboration.  However, since then, there 
have been two reports of the directed diboration of alkynes.   
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In 2014, Hirano and Uchiyama24 disclosed the hydroxyl-directed diboration of 
propargylic alcohols. Internal alkynes, such as 3.47, are subjected to deprotonation 
conditions followed by the addition of B2(pin)2 to furnish the trans cyclic vinyldiboronate 
3.48 in good yield (Scheme 3.14, Eq. 1).  Through a series of computational studies, the 
hydroxyl group was shown to play a major role in lowering the activation energy barrier 
of the boryl addition to the alkyne.  Interestingly, the lithium counterion is proposed to 
coordinate to the oxygen atoms of both boronates (as shown in 3.49) as well as stabilize 
the negative charge build up on the distal alkynyl carbon after the first borylation.   
In 2015, Ohmiya and Sawamura25 published the synthesis of similar products 
through the organocatalyzed diboration of 2-alkynoates.  Using B2(pin)2 and a catalytic 
amount of P(Bu)3, 3.50 was transformed to the trans vinyldiboronate 3.51 in moderate 
yield (Scheme 3.14, Eq. 2).  The observed reactivity and selectivity is justified through a 
proposed zwitterionic allenolate intermediate 3.52, which directs the first borylation.  In 
addition to diboration, the methodology was extended to a trans-selective silylboration.  
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Scheme 3.14 Directed Diboration of Alkynes 
 
 
3.4.3 Directed Dihydroxylation 
 As previously shown, a 1,2-bis(boronate) can be smoothly transformed to the 
1,2-diol using stereoretentive oxidation conditions. Therefore, a directed 
diboration/oxidation sequence would serve as an alternative to a directed dihydroxylation 
reaction of alkenes.  In a related process, Donohoe and coworkers26 have developed 
hydroxyl- and amine-directed dihydroxylations. Subjecting 3.53 or 3.54 to one equivalent 
of both OsO4 and TMEDA, yields syn products 3.55 and 3.56, respectively, in good to 
excellent diastereoselectivity (Scheme 3.15).  It is presumed that OsO4, once ligated by 
TMEDA, participates in hydrogen bonding with the proton of the directing group.  It is 
believed that the active osmium species is generated when TMEDA binds OsO4 in a 
bidentate fashion.  Due to steric considerations, reaction of 3.53 or 3.54 with traditional, 
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catalytic dihydroxylation conditions, favors the formation of the anti products 3.57 and 
3.58, respectively. 
 
Scheme 3.15 Amine and Hydroxyl-Directed Dihydroxylation 
 
 
3.5 Optimization of Reaction Conditions 
As we began our initial experiments, we subjected homoallylic alcohol 3.59 to 
similar reaction conditions used by Fernandez.  There was no observed reaction between 
3.59 and B2(pin)2 (Table 3.1, Entry 1).  Surprisingly, this was also the case when using a 
deprotonated form of 3.59 (Table 3.1, Entry 2).  Unexpectedly, when five equivalents of 
methanol were added to the mixture of B2(pin)2 and deprotonated 3.59, the olefin was 
mostly consumed and, after oxidation, the 1,3,4-syn-triol 3.60 was observed in good 
selectivity (Table 3.1, Entry 3).  Now, with methanol as an additive, only a catalytic 
amount of base is needed for the reaction.  As the base was varied, there was a clear 
effect on both the conversion and selectivity of the reaction (Table 3.1, Entries 4-8).  
Most notably, when screening carbonate bases, a counterion effect was observed; the 
reaction proceeded in a more selective fashion when using bases with larger cations.  The 
diboration of 3.59 using Na2CO3, K2CO3, and Cs2CO3 furnished 3.60 with 
DG
OH
OH
OH
OH
OH
OH
1 equiv OsO4
1 equiv TMEDA
DCM, -78 °C
1% OsO4
NMO
acetone/H2O, rt
98%
9:1 d.r.
94%
12:1 d.r.
NHCOCCl3
OH
OH
NHCOCCl3
OH
OH
1 equiv OsO4
1 equiv TMEDA
DCM, -78 °C
1% OsO4
NMO
acetone/H2O, rt
>25:1 d.r98%
3:1 d.r.
3.55
3.56
3.57
3.58
3.53: DG = OH
3.54: DG = NHCOCCl3
! 159 
diastereoselectivies of 7.9:1, 10.4:1, and 12.5:1, respectively (Table 3.1, Entries 6-8).  For 
this reason and due to its air stability, Cs2CO3 was decided to be the most suitable base 
for this transformation. 
Due to its apparent importance to the reaction, the alcohol additive was further 
studied.  Sterically encumbered alcohols, such as isopropanol and tert-butanol, furnished 
3.60 in diminished conversion and selectivity (Table 3.1, Entries 9-10).  The use of water 
as an additive yielded poor conversion and selectivity (Table 3.1, Entry 11).  The use of 
electron deficient alcohols, such as phenol and 2,2,2-trifluoroethanol, afforded lower 
conversion (Table 3.1, Entries 12-13).  In an effort to bolster the conversion of the 
reaction, the amount of Cs2CO3 and B2(pin)2 were increased and full conversion was 
observed (Table 3.1, Entry 14).  With these new conditions, the amount of methanol 
added was investigated.  Interestingly, with more methanol (17 equivalents) added, there 
was an enhancement in selectivity (Table 3.1, Entry 15).  Under these optimized 
conditions, 3.60 was isolated in 74% yield and a 12.9:1 d.r.  It should be noted that, with 
even higher amounts of methanol, the selectivity starts to diminish (Table 3.1, Entries 16-
18).  Fascinatingly, the reaction is still modestly selective when methanol is used as a 
solvent (Table 3.1, Entry 18).   
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Table 3.1 Reaction Optimization 
 
 
3.6 Exploration of the Substrate Scope 
 With 3.59 undergoing diboration in a selective manner, other alkenyl alcohols 
were synthesized and subjected to the optimized conditions.  Allylic alcohol 3.61 was 
only slightly selective for the anti 1,2,3-triol 3.62 (Table 3.2, Entry 1).  This modest 
selectivity could be attributed to the background reaction and not a directed pathway.  
Diboration of bis-homoallylic alcohol 3.63 yields the syn-1,4,5-triol 3.64 in good yield 
and selectivity (Table 3.2, Entry 2).  Although not the level of stereocontrol observed 
with 3.59, 3.63 is believed to proceed through a directed pathway.  The diboration of tris-
entry base(equiv)
B2(pin)2
(equiv) d.r.
bconversion (%)a
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
additive
(equiv)
none
NaH (1.0)
NaH (1.0)
NaOtBu (0.15)
KOtBu (0.15)
Na2CO3 (0.15)
K2CO3 (0.15)
Cs2CO3 (0.15)
Cs2CO3 (0.15)
Cs2CO3 (0.15)
Cs2CO3 (0.15)
Cs2CO3 (0.15)
Cs2CO3 (0.15)
Cs2CO3 (0.30)
Cs2CO3 (0.30)
Cs2CO3 (0.30)
Cs2CO3 (0.30)
Cs2CO3 (0.30)
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
2.0
2.0
2.0
2.0
2.0
-
-
MeOH (5)
MeOH (5)
MeOH (5)
MeOH (5)
MeOH (5)
MeOH (5)
i-PrOH (5)
t-BuOH (5)
H2O (5)
PhOH (5)
CF3CH2OH (5)
MeOH (5)
MeOH (17)
MeOH (25)
MeOH (50)
MeOH (solvent)
<5
<5
87
83
90
68
90
87
64
42
9
51
45
>95
>95 (74%)c
>95
>95
>95
na
na
12.5:1
7.7:1
12.3:1
7.9:1
10.4:1
12.5:1
7.4:1
9.5:1
3.8:1
13.2:1
5.6:1
9.9:1
12.9:1
12.1:1
9.5:1
5.7:1
a Conversion determined by 1H NMR using trimethoxybenzene as an internal standard. b Diasteroselectivity was
determined by SFC. c Number in parenthesis is the isolated yield.
Ph
OH
Ph
OH OH
OH
1. B2(pin)2, base,
    additive
    THF, 70 °C, 6 h
2. NaOH, H2O23.59 3.60
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homoallyic alcohol 3.65 yielded the triol 3.66 as an unselective mixture of diastereomers 
(Table 3.2, Entry 3).  
 
Table 3.2 Diboration of Other Alkenyl Alcohols 
 
Due to the high selectivity observed for 3.59, the diboration of various 
homoallylic alcohols was investigated.  Phenyl-substituted 3.67 proceeded in good yield 
and selectivity furnishing the syn product 3.68 (Table 3.3, Entry 1).  Surprisingly, 
increasing the steric bulk at the position α with respect to the hydroxyl group (3.69) led to 
only moderate diastereocontrol (Table 3.3, Entry 2).  This reaction extends to homoallylic 
alcohols with allylic substitution, as well.  The reaction of 3.71, 3.73, 3.75 and 3.77 
delivered the respective diboration products 3.72, 3.74, 3.76 and 3.78 in good to excellent 
selectivities (Table 3.3, Entries 3-6).  Due to low isolated yields of the triols, 3.74 and 
3.76 were isolated as the protected acetate and the silyl ether, respectively.  It is of note 
R
OH
n
n = 0, 2, 3
1. 2 equiv B2(pin)2
    30% Cs2CO3
    17 equiv MeOH
    THF, 70 °C
2. NaOH, H2O2 R
OH
n
OH
OH
entry substrate major product d.r.ayield (%)
Ph
OH
n-Bu
OH
n-pentyl
OH
Ph
OH
OH
OH
n-Bu
OH
OH
OH
n-pentyl
OH OH
OH
47
70
77
1.8:1
6:1
1:1
1
2
3
a Diastereoselectivity was determined by 1H NMR
3.61
3.63
3.62
3.64
3.65 3.66
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that most of the 1,2-bis(boronates) containing an unprotected alcohol are unstable to 
silica purification.  On silica gel, it is likely that the boronate esters are being slowly 
hydrolyzed to the boronic acid.  The methyl ether 3.79 reacted under the diboration 
conditions affords 3.80 as an unselective mixture of diastereomers (Table 3.3, Entry 7).   
This observation suggests, while not necessary for the reactivity of the olefin, a free 
hydroxyl group is an essential feature to control the diastereoselective outcome of the 
reaction. 
 
Table 3.3 Diboration of Various Terminal Homoallylic Alcohols 
 
entry substrate major product
Ph
OH
Cy
OH
OH
Ph
2
Me Me
OH
Ph
2
Me
OH
Ph
2
Me
OH
Ph
Ph
OH
Cy
OH
OH
Ph
2
Me Me
OH
Ph
2
Me
AcO
Ph
2
Me
TBSO
Ph
OH
OH
OH
B(pin)
B(pin)
OH
OH
OH
OH
B(pin)
B(pin)
OH
yield
1a
2a
3a
4b
5c
6a
d.r.
84% 14:1
51% 5:1
80% 7:1
66%
56%
69%
>20:1
11:1
>20:1
Ph
OMe
Ph
OMe OH
OH
Bis(boronates) are subjected to a H2O2/NaOH, b Ac2O, pyridine,c TBSCl, imidazole
78% 1:17a
3.67
3.69
3.73
3.71
3.75
3.77
3.79 3.80
3.78
3.76
3.74
3.72
3.70
3.68
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Internal olefin substrates 3.81, 3.83 and 3.85 participate in the reaction, yielding 
the 1,3,4-triol products 3.82, 3.84 and 3.86 in moderate to excellent diastereoselectivies 
(Table 3.4, Entries 1-3).  For these products, it can be elaborated that the reaction occurs 
with syn addition of the diboron reagent to the olefin.  Alcohols containing 1,1-
disubstituted olefins, 3.87 and 3.89, undergo the reaction, yielding 3.88 and 3.90, 
respectively with excellent diastereocontrol (Table 3.4, Entries 4-5).  The substrate scope 
was extended to trisubstituted olefin 3.91, which underwent diboration to yield the anti 
product 3.92 (Table 3.4, Entry 6).  It is believed that 3.91 underwent diboration in a 
directed fashion due to the inactivity of trisubstituted olefins to undirected Fernandez 
diboration conditions.  The more substituted 3.93 was unreactive toward the directed 
diboration reaction (Table 3.4, Entry 7).  Cyclic olefins 3.94 and 3.96 partook in the 
reaction yielding the corresponding cyclic boronates 3.95 and 3.97 in tremendous 
diastereocontrol (Table 3.4, Entries 8-9). 
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Table 3.4 Diboration of Various Internal Homoallylic Alcohols 
 
 In addition to studying different substrates, the diboron reagent used was varied 
for the diboration of 3.59.  The diboronate esters derived from 1,3-diols 3.98, 3.99 and 
3.100 furnished 3.60 in very similar selectivies (Table 3.5, Entries 1-3).  Notably, lower 
OH
Ph
2
Me
OH
Ph
2
n-hexyl
OH
Ph n-Bu
OH
Ph
n-Bu
OH
Me
Me
Ph
Ph
OH
H
OH
Me
Me
OHi-Pr
Ph
OH
H
OH
OH
HO
Ph
2
Me
HO
Ph
2
n-hexyl
OH
Ph n-Bu
OH
Ph n-Bu
OH
MeMe
Ph
OH
Me
Me
OHi-Pr
OH
OH
OH
HO
HO
OH
OH
B(pin)
B(pin)
B(pin)(pin)B
OH
OH
OH
1a
2a
3a
4a
5a
6a
7
8d
94% >20:1
64% 5:1
79% 9:1
64% 17:1
64% >20:1
55% 2:1
75% >20:1
60% >20:1
Bis(boronates) are subjected to a H2O2/NaOH, b Ac2O, pyridine,c TBSCl, imidazole or (d)
isolated as is.
entry substrate major product yield d.r.
OH
Ph
2
Me
Me
Me No product N/A N/A
9d
3.81
3.83
3.85
3.87
3.89
3.91
3.93
3.94
3.96 3.97
3.95
3.92
3.90
3.88
3.86
3.84
3.82
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conversions are observed in cases where a more sterically hindered diboron is used.  
Catechol-derived diboron 3.101 underwent diboration in an unselective manner (Table 
3.5, Entry 4).  The slight preference for the anti diastereomer could arise from the 
undirected background reaction.  Tetrahydroxyl diboron 3.102 participated in the 
diboration of 3.59, albeit with low selectivity (Table 3.5, Entry 5).  Unlike 3.102, 
tetradimethylamine diboron 3.103 undergoes diboration in an extremely selective manner 
(Table 3.5, Entry 6).  It is presumed that in excess methanol and elevated temperatures, 
the amine ligands bound to boron are exchanged for methoxy groups.  It is noteworthy 
that the use of these diboron reagents offers a more atom-economical diboration reaction, 
due to their low molecular weights.  Additionally, purification of the product after 
oxidation becomes trivial with no diol originating from the diboron reagent present.  In 
the case of 3.103, the amine generated, dimethylamine, is volatile and removed upon 
work up.  To our knowledge, this is the first example of a diboration using either 3.102 or 
3.103 as a diboron reagent.   
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Table 3.5 Diboration of 3.59 Using Various Diboron Reagents 
 
 
3.7 Probing Reactions 
 As demonstrated with the diboration of 3.79 (Table 3.3, Entry 7), the role that the 
hydroxyl group plays is vital to the selectivity of the reaction.  In an effort to investigate 
the effect of the hydroxyl group and its relative distance from the alkene, a series of 
competition experiments were pursued.  Equal amounts of 3.104, 3.105 and B2(pin)2 were 
subjected to the diboration conditions.  The conversion observed for homoallylic alcohol 
3.104 was greater then 4x the conversion of 3.105 (Scheme 3.16, A).  This observation 
suggests a lower limit of reaction rate ratio of ~4.  Unsurprisingly, the diboration of 3.104 
entry d.r. (syn:anti)bconversion (%)a
Ph
OH
Ph
OH OH
OH
1. 30% Cs2CO3
    17 equiv MeOH
    THF, 70 °C
2. NaOH, H2O2
R2B BR2+
(2 equiv)
R2B-BR2
B B
O
OO
O
B B
O
OO
O
Me
Me Me
Me
MeMe
B B
O
OO
O
Me
Me Me
Me
MeMe
Me
Me
B B
O
OO
O
Me
Me Me
Me
B B
OH
OHHO
HO
B B
NMe2
NMe2Me2N
Me2N
87% 2.6:1
>95% >20:1
67% 1:1.5
75% 7.8:1
51% 8.0:1
>95% 7.7:1
1
2
3
4
5
6
a Conversion determined by 1H NMR using trimethoxybenzene as an internal standard. 
b Diastereoselectivity was determined by SFC.
3.98
3.99
3.100
3.101
3.102
3.103
3.59 3.60
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and 3.63, which both underwent a selective diboration, proceeded with similar rates 
(Scheme 3.16, B).  The competition between 3.104 and 3.65 resembled that of the 
competition between 3.104 and 3.105 (Scheme 3.16, C).  This is likely due to the 
inability of 3.65 to undergo a directed diboration. 
 
Scheme 3.16 Competition Experiments 
 
 In addition to exploring the effect of the hydroxyl group within this reaction, we 
also wanted to study the interesting counterion effect observed in Table 3.1, Entries 4-8.  
The reactivity and selectivity seem to rely heavily on the base used.  We hypothesized 
that the counterion of the base is mechanistically relevant to the efficiency of the 
reaction. It was envisioned that, through the use of crown ethers, the importance of 
cations to the reaction could be explored. The diboration of 3.59 with K2CO3 proceeds 
with full conversion and good selectivity (Table 3.6, Entry 1).  However, upon addition 
of 18-crown-6 to the reaction, the conversion and, to a lesser degree, selectivity begin to 
X Y+ + B2(pin)2
30% Cs2CO3
17 equiv MeOH
THF, 70 °C, 6 h X Y
+
B(pin)
B(pin)
B(pin)
B(pin)
1.0 equiv 1.0 equiv 1.0 equiv
n-decyl
OH
n-dodecyl
49% conversion 12% conversion
+ n-decyl
OH
41% conversion
n-butyl
OH
30% conversion
n-decyl
OH
45% conversion
n-pentyl
OH
19% conversion
+
+
A. competition 1: B. competition 2:
C. competition 3:
3.104 3.105 3.104 3.63
3.104 3.65
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diminish (Table 3.6, Entries 2-5).27  Low conversion suggests that the sequestering of the 
cation inhibits both the directed and undirected pathways.   However, due to the slight 
decrease in selectivity, it is possible that the directed pathway is affected to a larger 
extent. Although similar inhibition is observed for 15-crown-5 (Table 3.6, Entry 6), 
reactivity and selectivity are restored with 12-crown-4 as an additive (Table 3.6, Entry 7).  
Furthermore, this phenomenon is witnessed with Cs2CO3 as the base and 18-crown-6 as 
an additive (Table 3.6, Entry 8). 
 Another observation of interest is the inability of amines to serve as bases during 
the diboration reaction.  Using DBU as a base, the diboration of 3.59 does not proceed, 
recovering only starting olefin after oxidation (Table 3.6, Entry 9).  Interestingly, when 
DBU and B2(pin)2 are heated in deuterated methanol (CD3OD), the formation of a 
tetracoordinate boron species can be determined by 11B NMR.  When using Cs2CO3 as 
the base, the same ate complex is observed in a comparable reaction time.  These 
experiments suggest that the ability of DBU to serve as a proper base for diboration is 
unrelated to its ability to form a tetracoordinate boron species.  One possible explanation 
is that amine bases lack a suitable counterion.  In order to test this hypothesis, a catalytic 
amount of sodium chloride (NaCl) was added to the diboration of 3.59 using DBU as a 
base.  The addition of NaCl introduces a sodium cation, which has been shown to 
produce a selective reaction (Table 3.1, Entries 3-4, 6).  In the presence of NaCl, the 
reaction proceeds, albeit with low conversion, yielding 3.60 with good selectivity (Table 
3.6, Entry 10).  Concerned with poor solubility of NaCl in tetrahydrofuran, the reaction 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
27 For binding affinity constants for different cations and crown ethers, see: Steed, J. W.; 
Atwood, J. L. Cation Binding by Crown Ethers. Supramolecular Chemistry, 2nd Ed. John 
Wiley & Sons, Ltd. United Kingdom 2009. 
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was run in methanol, furnishing 3.60 in full conversion and moderate selectivity (Table 
3.6, Entry 11).  In the absence of DBU, NaCl is unsuccessful in catalyzing the reaction 
(Table 3.6, Entry 12). 
 
Table 3.6 Effect of the Counterion During the Diboration of 3.59 
 
 
3.8 Stereochemical Model 
 The unselective diboration of 3.79 demonstrates that the presence of a hydroxyl 
group is essential for stereoinduction (Table 3.3, Entry 7).  Furthermore, the distance 
between the hydroxyl group and alkene is essential for stereoselective diboration (Table 
3.2).  Therefore, it is estimated that the hydroxyl group and the diboron reagent associate 
with one another.  We propose that this association can occur in one of two ways: (1) 
alkoxide coordination to the diboron reagent or (2) hydrogen-bonding of the hydroxyl 
entry base d.r.bconversion (%)a
1
2
3
4
5
6
7
8
9
10
11c
12
additive (equiv)
-
18-crown-6 (0.6)
18-crown-6 (1.2)
18-crown-6 (2.4)
18-crown-6 (4.8)
15-crown-5 (1.2)
12-crown-4 (1.2)
18-crown-6 (1.2)
-
NaCl (0.3)
NaCl (0.3)
NaCl (0.3)
>95
61
44
15
15
32
>95
31
<5
25
>95
<5
8.4:1
7.3:1
5.1:1
4.5:1
5.3:1
6.4:1
10.9:1
5.3:1
-
12.4:1
5.2:1
-
Ph
OH
Ph
OH OH
OH
1. 2 equiv B2(pin)2
    30% base, additive
    17 equiv MeOH
    THF, 70 °C, 6 h
2. NaOH, H2O2
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3
Cs2CO3
DBU
DBU
DBU
-
a Conversion determined by 1H NMR using trimethoxybenzene as an internal
standard. b Diastereoselectivity was determined by SFC. c Methanol used as
solvent
3.59 3.60
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group to one of the oxygen atoms of the diboron reagent.  However, the possibility of a 
hydrogen-bonding interaction between substrate and diboron reagent is unlikely due to 
the selective nature of the diboration of 3.59, where the solvent used is methanol (Table 
3.1, Entry 18). For this reason, it is believed that the directed pathway requires an 
substrate alkoxide/(B(OR)2)2 association (Scheme 3.17, 3.106).   
 Another variable that appears to be vital for the success of the reaction is the base 
used, and more specifically, the counterion of the base.  As described, large cations 
generate a more selective reaction (Table 3.1, Entries 6-8) and, upon the addition of 
crown ethers (potentially sequestering the cation), the reaction conversion starts to 
diminish (Table 3.6, Entries 1-8).  It is possible that during the first boryl addition to the 
proximal olefinic carbon, the cation stabilizes the negative charge build up at the distal 
carbon (Scheme 3.17, 3.107).  It is conceivable that the cation is crucial in the facilitation 
of this addition.  In line with the mechanism proposed by Fernandez, after the boryl 
addition, the boron shifts to the distal carbon, forming a 3-membered boracycle transition 
state 3.108. At this point, the proximal carbon binds to the sp3 boron atom, breaking the 
already weakened B-B bond and generating the 1,2-bis(boronate) 3.109.   
 
Scheme 3.17 Stereochemical Model for Hydroxyl-Directed Diboration 
 
Another curious feature of this reaction is the role of methanol.  As presented, a 
reaction without the addition of methanol fails to undergo diboration (Table 3.1, Entries 
1-2).  The most likely function of methanol is to solubilize the base during the course of 
R
O
B B
OR
ORRO
RO
M
R
R
H
H
H BR
R
O B
R
R OR
OR
(RO)2
M
H
H
H BR
R
O B
R
R O
R
R
O
R
HO
RR
R B(pin)B(pin)
(RO)2
M
3.106 3.107 3.108
3.109
R
δ+
δ-
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the reaction.  The amount of base, and therefore counterion, solubilized is crucial for the 
conversion and selectivity of the reaction (Table 3.6, 10-11).  This is plausible rationale 
for the need of excess methanol during Fernandez’s diboration, even though the reaction 
should only need a catalytic amount of alcohol additive (Scheme 3.13).  
 
3.9 Directed Diboration As a Synthetic Tool 
To study whether this methodology is an efficient means for the synthesis of 
1,3,4-triols, the scalability of the diboration of 3.59 was examined.  Using only 1.2 
equivalents of B2(pin)2, the reaction with 3.59 (31 mmol) furnished 5.1 grams of 3.60 in 
excellent yield and diastereoselectivity.  Notably, the reaction was carried out in an open 
flask without precautions taken to avoid moisture contamination. 
 
Scheme 3.18 Large-Scale Diboration of 3.59 
 
 In an effort to highlight the synthetic applicability of this method, the synthesis of 
the C6-C13 fragment of spongistatin was examined.  With six separate 1,3-diol motifs, 
spongistatin serves as an ideal synthetic target for directed diboration methodology 
(Scheme 3.19, A). Isolated in 1993, the spongistatin family of natural products exhibit 
subnanomolar efficacy for the inhibition of a variety of different human cancer cell 
Ph
OH
Ph
OH
OH
OH
1. 1.2 equiv B2(pin)2
    30% Cs2CO3
    17 equiv MeOH
    THF, 70 °C, 12 h
2. NaOH, H2O2
84%, 17:1 d.r.
5.1 grams
3.59 3.60
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lines.28  A multitude of syntheses of spongistatin 1 and 2 have been reported,29 including 
studies associated with the synthesis of the AB and CD spiroketals.30  In most cases, 
these spiroketals have been synthesized though an assortment of allylmetallations 
(Scheme 3.19, B).  With the utilization of diboration and cross coupling (Chapter 4) 
methodologies, we envisioned accessing similar structural patterns. 
 
Scheme 3.19  Spongistatin and a Common Approach to the AB Fragment 
 
 Starting from silyl ether 3.110, an asymmetric diboration/cross coupling/oxidation 
strategy was performed to yield homoallylic alcohol 3.111 in 90% yield and 88% ee 
(Scheme 3.20).  Directed diboration of 3.111 yielded the bis(boronate) 3.112, which after !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
28 Pettit, G. R.; Cichacz, Z. A.; Gao, F.; Herald, C. L.; Boyd, M. R.; Schmidt, J. M.; 
Hooper, J. N. A. J. Org. Chem. 1993, 58, 1302 – 1304.  
29 Reviews: (a) Yeung, K.-S.; Paterson, I. Chem. Rev. 2005, 105, 4237 – 4313. (b) 
Paterson, I.; Coster, M. J. Strategies and Tactics in Organic Synthesis; Elsevier: London, 
UK, 2004; Vol. 4, p 211. 
30 (a) Paterson, I.; Oballa, R. M.; Norcross; R. D. Tetrahedron Lett. 1996, 37, 8581 – 
8584. (b) Crimmins, M. T.; Washburn, D. G. Tetrahedron Lett. 1998, 39, 7487 – 7490. 
(c) Smith, A. B. III; Corbett, R. M.; Pettit, G. R.; Chapuis, J.-C.; Schmidt, J. M.; Hamel, 
E.; Jung, M. K. Bioorg. Med. Chem. Lett. 2002, 12, 2039 – 2042. (d) Crimmins, M. T.; 
Smith, A. C. Org. Lett. 2006, 8, 1003 – 1006. (e) Allais, F.; Cossy, J. Org. Lett. 2006, 8, 
3655 – 3657. 
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solvent removal, was subjected a palladium-catalyzed cross-coupling with chloroethene, 
formed in situ from 1,2-dichloroethane.  After oxidation, the 1,3-diol 3.113 was yielded 
in a 44% yield and excellent stereocontrol.   
 
Scheme 3.20 Synthesis of C6-C13 Fragment of Spongistatin 1 
 
 
3.10 Conclusion 
 The hydroxyl group has been proven to be a viable directing group for the 
transition-metal free diboration of olefins.  A variety of different homo- and bis-
homoallylic alcohols participate in the stereoselective diboration reaction.  The substrate 
is proposed to bind to the diboron reagent resulting in tetracoordinate boron alkoxide 
species.  The reaction has been shown to be an efficient synthetic tool for the synthesis of 
1,3,4-triols and, when combined with cross-coupling methodology, a surrogate for 
allylmetallation chemistry. 
 
TBDPSO TBDPSO OH Me
TBDPSO HO Me Bpin
Bpin
1. B2pin2 (1.05 equiv)
    1% Pt(dba)3, 1.2% 3.26
     THF, 60 °C, 3 h
2. Me
Cl
2.5% Pd(OAc)2
3% RuPhos
KOH (3 equiv)
THF/H2O, 70 °C, 12 h
then NaOH, H2O2(1.5 equiv.)
90%
88% ee
B2pin2 (1.5 equiv)
30% Cs2CO3
MeOH (17 equiv)
THF, 70 °C1,2-dichloroethane
(3 equiv)
KOt-Bu (6 equiv)
2.5% Pd(OAc)2/RuPhos
THF/H2O, 70°C, 12 h
then NaOH, H2O2
TBDPSO HO Me OH
44% (2 steps)
>20:1 dr
3.110 3.111
3.1123.113
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3.11 Experimental Section 
3.11.1 General Considerations 
1H NMR spectra were measured using a Varian Unity Inova 500 MHz and 
Varian Gemini 400 MHz spectrometers. Chemical shifts are reported in ppm with the 
solvent resonance as the internal standard (CDCl3: 7.24 ppm, CD3OD: 3.31 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants (Hz) 
and assignment. Proton-decoupled 13C NMR spectra were recorded on Varian Unity 
Inova 500 MHz (125 MHz) or Varian Gemini 400 MHz (100 MHz) spectrometers. 
Chemical shifts are reported in ppm with the solvent resonance as the internal standard 
(CDCl3: 77.0 ppm, CD3OD: 49.2 ppm). Infrared (IR) spectra were recorded on a Bruker 
α-P Spectrometer. Frequencies are reported in wavenumbers (cm-1) as follows: strong 
(s), broad (br), medium (m), and weak (w). High resolution mass spectrometry 
(HRMS) and X-ray diffraction were performed at Merkert Chemistry Center, Boston 
College, Chestnut Hill, MA. 
Liquid chromatography was performed using forced flow (flash 
chromatography) on silica gel (SiO2, 230 x 400 mesh) purchased from Silicycle. Thin 
layer chromatography (TLC) was conducted on 250 µm glass backed plates from 
Silicycle. Visualization was performed using ultraviolet light (254 nm), potassium 
permanganate (KMnO4), and Seebach's "magic" stain (phosphomolybic acid/cerium(IV) 
sulfate/sulfuric acid/water). Analytical supercritical fluid chromatography (SFC) was 
performed using a Thar Supercritical Chromatograph equipped with an auto sampler 
and a Waters photoiodide array detector with methanol as the modifier. Melting points 
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were obtained using a Laboratory Devices, Inc. Mel-Temp II apparatus. 
All reactions were conducted in oven- or flame-dried glassware under an 
inert atmosphere of nitrogen or argon unless specifically mentioned otherwise. 
Tetrahydrofuran, dichloromethane, and diethyl ether were purified using Pure Solv 
MD-4 solvent purification system (Innovative Technology, Inc.) by passing the 
solvent through two activated alumina columns after being purged with argon. Ethyl 
acetate, triethylamine, and diisopropylamine were distilled from calcium hydride. 
Bis(pinacolato)diboron was obtained from Allychem Co., Ltd. and recrystallized from 
pentane prior to use. All other chemicals were purchased from Aldrich, Fisher 
Scientific, or Alfa Aesar and used without further purification. 
 
3.11.2 Preparation of Homoallylic Alcohols 
Preparation of 1-phenylpent-4-en-2-ol (3.59): 
 
 The title compound was prepared as shown above using standard 
procedure. A flame dried round bottom flask was charged with 2-
phenylacetaldehyde (1.95 mL, 16.65 mmol) and diethyl ether (17 mL) and cooled to 0 
°C. Allylmagnesium bromide (20.8 mL, 20.8 mmol, 1.00 M solution in diethyl ether) was 
added dropwise over 30 minutes. The cooling bath was removed and the reaction mixture 
was allowed to warm to room temperature and stir for one hour. A saturated aqueous 
solution of NH4Cl was added to the flask until the white precipitate disappears. The 
layers were separated and the aqueous layer was washed with ethyl acetate (3 x 50 mL). 
Ph
OH
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The organic layers were combined and washed with a brine solution. The organic layer 
was dried over MgSO4, filtered, and concentrated in vacuo. The crude reaction mixture 
was purified by column chromatography on silica gel (2.5-10% ethyl acetate/hexanes, Rf 
= 0.50 in 20% ethyl acetate/hexanes, stain in KMnO4) to afford a clear, colorless oil (2.1 
g, 76%). 
 
1H NMR (400 MHz, CDCl3): δ 1.71 (1H, br s), 2.17 – 2.52 (1H, m), 2.29 – 2.36 (1H, m), 
2.71(1H, dd, J = 13.4 Hz, 8.2 Hz), 2.81 (1H, dd, J = 13.4 Hz, 5.0 Hz), 3.84 – 3.90 (1H, 
m), 5.12 – 5.18 (2H, m), 5.80 – 5.91 (1H, m), 7.20 – 7.24 (3H, m), 7.29 – 7.32 (2H, m); 
13C NMR (100 MHz, CDCl3): δ 41.2, 43.3, 71.7, 118.1, 126.5, 128.5, 129.4, 134.7, 
138.4; IR (neat): 3403.4 (w), 3064.4 (m), 3027.7 (m), 2978.1 (m), 2918.5 (w), 1640.5 
(m), 1603.7 (w), 1495.4 (m), 1454.1 (m), 1113.6 (m), 1078.4 (m), 915.3 (m), 744.5 (m), 
700.1 (s) cm-1; HRMS-(ESI+) for C11H13 [M+H-H2O]: calculated: 145.1017, found: 
145.1022. 
 
Preparation of 1-phenylbut-3-en-1-ol (3.67): 
 The title compound was prepared according to the same procedure as 
1-phenylpent-4-en-2-ol with minor modifications. The crude product 
was purified on silica gel (3% ethyl acetate in hexanes) to afford the title compound as a 
clear oil (1.9 g, 95% yield). Spectral data are in agreement with the literature.31 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
31 Ishiyama, T.; Ahiko, T.; Miyaura, N. J. Am. Chem. Soc. 2002, 124, 12414 – 12415. 
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Preparation of 1-cyclohexylbut-3-en-1-ol (3.69): 
 The title compound was prepared according to the same procedure as 
1-phenylpent-4-en-2-ol with minor modifications. The crude product 
was purified on silica gel (5-10% ethyl acetate in hexanes) to afford the title compound as 
a pale yellow oil (0.44 g, 18%). Spectral data are in agreement with literature.32 
 
Preparation of 5-methyl-1-phenylhex-5-en-1-ol (3.87): 
 
 
 The title compound was prepared according to the following 
procedure as reported in the literature.33 To a flame-dried round 
bottom flask equipped with a magnetic stirbar was added β-methallyl alcohol (7.4 mL, 88 
mmol) and acetic anhydride (8.3 mL, 88 mmol) under a nitrogen atmosphere. The flask 
was cooled to 0 °C and DMAP (0.11 g, 0.88 mmol) was quickly added and the flask was 
sealed. A mixture of triethylamine (7 mL) and DCM (7 mL) was prepared in a separate 
flame-dried flask, then added dropwise to the first flask. The reaction mixture was 
allowed to stir while warming to room temperature for 2 h. The reaction mixture was 
poured into a flask containing 2 M HCl and ice, and the aqueous and organic layers were 
separated. The aqueous layer was washed with DCM (2 x 10 mL) and the combined 
organic layers were washed with saturated aqueous sodium bicarbonate solution. The !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
32 Thadani, A. N.; Batey, R. A. Org. Lett. 2002, 4, 3827 – 3830. 
33 Zhang, P.; Roundtree, I. A.; Morken, J. P. Org. Lett. 2012, 14, 1416 – 1419. 
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organic layer was separated, dried over magnesium sulfate, filtered, and concentrated by 
rotary evaporation. The crude product was purified by silica gel (5-10% ethyl acetate in 
hexanes) to afford 2-methylallyl acetate as a clear liquid (7.4 g, 74% yield). The purified 
acetate was then used in the following procedure. An oven-dried 20 mL scintillation vial 
equipped with a magnetic stirbar was brought into the glovebox. To the vial was 
sequentially added Ni(cod)2 (60 mg, 0.22 mmol), PPh3 (58 mg, 0.22 mmol), ethyl acetate 
(8 mL), 2-methylallyl acetate (0.50 g, 4.4 mmol), and B2(pin)2 (1.11 g, 4.40 mmol).  The 
vial was tightly sealed and stirred at 65 °C for 12 h.  The reaction mixture was then 
cooled to room temperature and 3-phenylpropionaldehyde (0.61 mL, 4.6 mmol) was 
added. The reaction was stirred at room temperature for 24 h before being quenched with 
10 mL of a 1:1 mixture of water and diethyl ether. The organic and aqueous layers were 
separated, and the aqueous layer was extracted with diethyl ether (3 x 5 mL). The 
combined organic layers were dried over magnesium sulfate, filtered, and concentrated 
by rotary evaporation. The crude product was purified on silica gel (5-10% ethyl acetate 
in hexanes) to afford the title compound as a pale yellow oil (0.59 g, 71% yield).  
Spectral data are in agreement with the literature. 
 
Preparation of 4,4-dimethyl-1-phenylhex-5-en-3-ol (3.77): 
 The desired compound was prepared according to the same 
procedure as 5-methyl-1-phenylhex-5-en-1-ol with minor 
modifications. 3-methylbut-2-en-1-ol was used to prepare the necessary acetate substrate.  
The crude product was purified on silica gel (5-10% ethyl acetate in hexanes) to afford 
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Ph
2
Me Me
! 179 
the title compound as a pale yellow oil (0.70 g, 88% yield).  Spectral data are in 
agreement with the literature.34 
 
Preparation of 5-methylene-1-phenylundecan-3-ol (3.89): 
 
 
 The desired compound was prepared according to the sequence 
shown above. The α-methylenation step was followed from a 
literature procedure.35  Preparation of the necessary acetate and 
borylation/allylation follow the same procedure for the preparation of 5-methyl-1-
phenylhex-5-en-1-ol with minor modifications. The final product of the sequence was 
purified on silica gel (5% ethyl acetate in hexanes) and isolated as a colorless oil (0.85 g, 
60%). 
 
1H NMR (500 MHz, CDCl3): δ 0.88 (3H, t, J = 7.0 Hz), 1.32-1.21 (6H, m), 1.47-1.33 
(2H, m), 1.81-1.72 (3H, m), 1.98 (2H, t, J = 7.5 Hz), 2.12-2.05 (1H, m), 2.27-2.22 (1H, 
m), 2.85-2.65 (2H, m), 3.71 (1H, m), 4.81 (1H, s), 4.87 (1H, s), 7.21-7.14 (3H, m), 7.29-
7.25 (2H, m); 13C NMR (100 MHz, CDCl3): δ 14.1, 22.6, 27.7, 29.0, 31.7, 32.1, 35.8, !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
34 Kobayashi, S.; Nishio, K. J. Org. Chem. 1994, 59, 6620 – 6628. 
35 Ardolino, M. J.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 8770 – 8773. 
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38.8, 44.6, 68.1, 112.3, 125.8, 128.4, 128.4, 142.2, 146.8,; IR (neat): 2925.6 (m), 2856.0 
(m), 1642.7 (w), 1495.5 (w), 1454.2 (m), 1051.2 (m), 892.4 (m), 744.9 (m), 697.9 (m); 
HRMS-(ESI+) for C18H28O [M+H-H2O]: calculated: 243.2113, found: 243.2115. 
 
Preparation of (E)-1-phenylnon-4-en-2-ol (3.81): 
 
 
The title compound was prepared as shown above from 1-hexyne.   To a flame-dried, 
round-bottomed flask equipped with a stir bar was added 1-hexyne (2.66 mL, 23.1 mmol) 
and THF (43 mL) under N2. The reaction mixed was cooled to -78°C. To the flask, nBuLi 
(9.30 mL, 23.1 mmol, 2.50 M) was added dropwise and stirred for 30 mins at -78°C.  2-
(phenylmethyl)oxirane (2.07 g, 15.4 mmol) and BF3·OEt2 (2.02 mL, 12.7 mmol) were 
added dropwise to the flask at - 78°C. Allow the reaction to warm to rt and stir at rt for 
1.5 hours. Quench with saturated aqueous NH4Cl (40 mL), diluted with diethyl ether and 
allow the layers were separated. The aqueous layer was washed with diethyl ether (3 x 50 
mL) and the organic layers were combined, dried over MgSO4, filtered, and concentrated 
in vacuo. The crude product was purified by column chromatography on SiO2 (0-10% 
ethyl acetate/ hexanes, Rf = 0.35 in 9:1 hexanes:ethyl acetate, stain in KMnO4) to afford a 
clear, colorless oil (2.7 g, 54%). To a flame-dried, round- bottomed flask equipped with a 
reflux condenser and stir bar in the glove box was added LiAlH4 (0.394 g, 10.4 mmol). 
Outside the glove box, THF (1.5 mL) was added and the flask was cooled to 0°C in an 
n-Bu
1. nBuLi, THF
2.
     BF3•OEt2
O Ph
Ph
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ice/water bath.  Add diglyme (5.3 mL) and 1-phenylnon-4-yn-2-ol (0.75 g, 3.5 mmol) 
dropwise to the reaction flask. Heat the reaction to reflux for 6 days. Sequentially quench 
the reaction with water (0.40 mL), 2.5 M NaOH (aq) (0.40 mL) and water (1.3 mL). Pour 
solution into 2.5 M HCl (5.0 mL) and dilute with pentane. The aqueous layer was washed 
with pentane (3 x 25 mL). The combined organic layer was washed with water and brine. 
The organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The crude 
product was purified by column chromatography on SiO2 (0-10% ethyl acetate/ hexanes, 
Rf = 0.35 in 9:1 hexanes:ethyl acetate, stain in KMnO4) to afford a clear, colorless oil 
(0.49 g, 65%). 
 
1-phenylnon-4-yn-2-ol.  1H NMR (500 MHz, CDCl3): δ 0.92 
(3H, t, J = 7.5 Hz), 1.39-1.53 (4H, m), 1.98 (1H, br s), 2.18-
2.22 (2H, m), 2.36 (2H, qdt, J = 16.3 Hz, 5.8 Hz, 2.3 Hz), 2.82 (1H, dd, J = 13.8 Hz, 7.3 
Hz), 2.90 (1H, dd, J = 13.3 Hz, 5.8 Hz), 3.94 (1H, pentet, J = 6.0 Hz), 7.22-7.26 (3H, m), 
7.30-7.33 (2H, m); 13C NMR (100 MHz, CDCl3): δ 13.6, 18.4, 22.0, 26.8, 31.1, 42.5, 
71.2, 75.8, 83.6, 126.5, 128.5, 129.4, 138.0; IR (neat): 3400.7 (w), 3027.6 (w), 2956.2 
(m), 2929.3 (s), 2871.4 (m), 1496.1 (m), 1454.2 (m), 1069.0 (s), 1045.3 (s), 741.7 (s), 
699.1 (s) cm-1; HRMS- (ESI+) for C15H21O [M+H]: calculated: 217.1592, found: 
217.1599. 
 
 (E)-1-phenylnon-4-en-2-ol (3.81). 1H NMR (500 MHz, 
CDCl3): δ 0.90 (3H, t, J = 6.8 Hz), 1.29-1.39 (4H, m), 1.72 – 
1.73 (1H, m), 2.05 (1H, q, J = 7.0 Hz), 2.13-2.18 (1H, m), 2.25-2.30 (1H, m), 2.72 (1H, 
Ph
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dd, J = 13.5, 8.0), 2.81 (1H, dd, J = 13.3, 5.3 Hz), 3.80 – 3.86 (1H, m), 5.42 – 5.48 (1H, 
m), 5.54 – 5.60 (1H, m), 7.22 – 7.25 (3H, m), 7.30 – 7.33 (2H, m); 13C NMR (125 MHz, 
CDCl3): δ 13.9, 22.2, 31.6, 32.4, 40.0, 43.2, 72.0, 125.6, 126.4, 128.5, 129.4, 134.8, 
138.6; IR (neat): 3556.6 (w), 3418.3 (w), 3062.5 (w), 3027.0 (m), 2955.5 (m), 2923.8 (s), 
2871.0 (m), 2856.0 (m), 1602.0 (w), 1495.7 (m), 1454.1 (m), 969.5 (s), 740.9 (s), 698.7 
(s) cm-1; HRMS-(ESI+) for C15H26NO [M+NH4]: calculated: 236.2014, found: 236.2002. 
 
Preparation of (Z)-1-phenylnon-4-en-2-ol (3.83): 
 
 
The title compound was prepared as shown above from 1-phenylnon-4-yn-2-ol.   To a 
flame-dried, round-bottomed flask equipped with a stir bar was added Lindlar’s catalyst 
(15 mg). To the flask, ethyl acetate (3.6 mL) and quinoline (35 µL, 0.30 mmol) were 
added. 1-phenylnon-4-yn-2-ol (306 mg, 1.42 mmol) was then added to the flask. The 
flask was evacuated and refilled (3x) with H2 from a balloon. The reaction was allowed to 
stir at rt for 1 hr. After one hour, the reaction mixture was put through a plug of silica and 
washed with EtOAc (25 mL) and concentrated in vacuo. The crude product was purified 
by column chromatography on SiO2 (0-10% ethyl acetate/hexanes, Rf = 0.35 in 9:1 
hexanes:ethyl acetate, stain in KMnO4) to afford a clear, colorless oil (0.26 g, 85%). 
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 (Z)-1-phenylnon-4-en-2-ol (3.83). 1H NMR (400 MHz, 
CDCl3): δ 0.88 (3H, t, J = 7.0 Hz), 1.25-1.37 (4H, m), 1.63 (1H, 
br s), 2.02 – 2.07 (2H, m), 2.23-2.32 (2H, m), 2.70 (1H, dd, J = 
13.8 Hz, 8.2 Hz), 2.82 (1H, dd, J = 13.8 Hz, 4.6 Hz), 3.84 (1H, pentet, J = 6.2 Hz), 5.40 – 
5.46 (1H, m), 5.53 – 5.60 (1H, m), 7.20 – 7.24 (3H, m), 7.28 – 7.32 (2H, m); 13C NMR 
(100 MHz, CDCl3): δ 13.9, 22.3, 27.1, 31.8, 34.6, 43.3, 72.4, 124.8, 126.4, 128.5, 129.4, 
133.5, 138.6; IR (neat): 3395.7 (w), 3062.3 (w), 3025.9 (w), 2954.9 (m), 2857.4 (m), 
1602.5 (w), 1495.4 (m), 1453.9 (m), 1078.4 (m), 742.8 (m), 698.1 (s) cm-1; HRMS-
(ESI+) for C15H26NO [M+NH4]: calculated: 236.2014, found: 236.2013. 
 
Preparation of 5-methyl-1-phenylhex-4-en-2-ol (3.91): 
 
 
 5-methyl-1-phenylhex-4-en-2-ol (3.91). The title compound 
was prepared as shown above using standard procedure. A 
flamed dried round bottom flask was charged with 2-methyl-1-
propenylmagnesium bromide (16.4 mL, 8.20 mmol, 0.50 M solution in THF) and cooled 
to -35 °C. Copper(I) iodide (81 mg, 0.37 mmol) was added and stirred for 15 minutes 
at -35 °C. 2-(phenylmethyl)oxirane (1.00 g, 7.45 mmol) was added dropwise to the flask 
over 20 minutes. Allow the reaction to warm to room temperature and stir for 1.5 hours. 
The reaction mixture was poured into a separatory funnel containing 12 M HCl (4.0 mL) 
Ph O
BrMg
Me
Me
, CuI
THF, -35 °C
Ph
OH
Me
Me69%
OH
Ph
n-Bu
OH
Me
Me
Ph
! 184 
and brine (60 mL). The layers were separated and the aqueous layer was washed with 
ethyl acetate (3 x 25 mL). The organic layers were combined, dried over sodium sulfate, 
filtered, and concentrated in vacuo. The crude reaction mixture was purified by column 
chromatography on silica gel (5-10% ethyl acetate/hexanes, Rf = 0.25 in 10% ethyl 
acetate/hexanes, stain in KMnO4) to afford a clear, yellow oil (0.98 g, 69%). 
 
1H NMR (400 MHz, CDCl3): δ 1.63 (3H, s), 1.64 (1H, s), 1.74 (3H, s), 2.21 (2H, t, J = 
6.6 Hz), 2.70 (1H, dd, J = 13.6 Hz, 7.6 Hz), 2.81 (1H, dd, J = 13.4 Hz, 5.0 Hz), 3.82 (1H, 
pentet, J = 6.4 Hz), 5.20 (1H, t, J = 7.4 Hz), 7.19-7.24 (3H, m), 7.28-7.31 (2H, m); 13C 
NMR (100 MHz, CDCl3): δ18.0, 25.9, 35.5, 43.3, 72.6, 119.9, 126.3, 128.5, 129.4, 135.1, 
138.7; IR (neat): 3404.0 (w), 3062.0 (w), 3027.2 (w), 2967.1 (w), 2913.8 (s), 1601.8 (w), 
1495.2 (m), 1452.4 (m), 1048.1 (m), 740.5 (s), 698.1 (s) cm-1;  HRMS-(ESI+)  for 
C13H19O [M+H]:  calculated: 191.1436,  found: 191.1435. 
 
Preparation of (3R,4R)-4-methyl-1-phenylhex-5-en-3-ol (3.71): 
 
 
 The title compound was synthesized by following a literature 
procedure.36 To a stirred mixture of potassium tert-butoxide (2.8 g, 
25 mmol), THF (7 mL), and cis-2-butene (9.0 mL, 0.10 mol), n-!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
36 Herbert C. Brown , Krishna S. Bhat, J. Am. Chem. Soc. 1986, 108, 5919 – 5923. 
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butyllithium in hexanes (2.3 M, 25 mmol) was added  at -78 °C.  After complete addition 
of n-butyllithium, the mixture was stirred at -45 °C for 10 min.  The resulting solution 
was cooled to -78 °C, and to it was added dropwise methoxydiisopinocampheylborane in 
THF (1.0 M, 25 mmol). After the reaction mixture was stirred at -78 °C for 30 min, boron 
trifluoride etherate (4.00 mL, 33.5 mmol) was added dropwise. Then aldehyde (5.3 mL, 
40 mmol) was added dropwise at -78 °C. The mixture was now stirred at -78 °C for 3 h 
and then treated with 18.3 mL (55.0 mmol) of 3.00 M NaOH and 7.5 mL of 30% H2O2, 
and the contents were refluxed for 1 h. The organic layer was separated, washed with 
water (30 mL) and brine (30 mL), and dried over anhydrous Na2SO4. The residue, after 
removal of the solvent, was purified on silica gel chromatography (1-3% ethyl 
acetate/hexanes) to furnish the desired product (2.9 g, 61% yield) with spectral properties 
reported in literature.37 
 
Preparation of (3R,4S)-4-methyl-1-phenylhex-5-en-3-ol (3.73): 
 The title compound was prepared according to the same procedure 
as (3R,4R)-4-methyl-1-phenylhex-5-en-3-ol with minor 
modifications. The crude product was carefully purified by silica gel 
chromatography (1-3% ethyl acetate/hexanes) to furnish the desired product (1.7 g, 58%) 
with spectral properties reported in literature.38 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
37 Kobayashi, S.; Nishio, K. J. Org. Chem. 1994, 59, 6620 – 6628. 
38 Roush, W.R.; Ando, K.; Powers, D.B.; Palkowitz, A.D.; Halterman, R.L. J. Am. Chem, 
Soc. 1990, 112, 6339 – 6348. 
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Preparation of cyclohex-2-enyl(phenyl)methanol (3.85): 
 
 
 The title compound was synthesized by following literature procedure. 
To a mixture of benzaldehyde (1.0 mL, 10 mmol) and 3-
bromocyclohexene (1.73 mL, 15.0 mmol) in water (10 mL), SnCl2•H2O 
(4.5 g, 20 mmol) and copper powder (0.64 g, 10 mmol) were added. This mixture was 
vigorously stirred at room temperature for 24 h. Then the mixture was extracted with 
ether (3 x 30 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated by rotary evaporation. The crude material was purified on silica gel (3% 
ethyl acetate in hexanes) to afford the title compound as a clear, colorless oil (1.58 g, 
84%).  Spectral properties are in agreement with the literature.39 
 
Preparation of 1-isopropylcyclopent-3-en-1-ol (3.96): 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
39 Tan, X.-H.; Tao, C.-Z.; Hou, Y.-Q.; Luo, L.; Liu, L.; Guo Q.-X. Chinese Journal of 
Chemistry, 2005, 23, 237 – 241. 
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 The title compound was prepared according to the following two-step 
sequence. To a flame-dried round bottom flask equipped with a magnetic 
stirbar, added allylmagnesium bromide solution (1.0 M in diethyl ether, 41 
mmol) under a nitrogen atmosphere.  The flask was cooled to 0 °C, at which time a 
solution of ethyl isobutyrate (2.60 mL, 19.4 mmol) and diethyl ether (13 mL) was added 
dropwise to the Grignard reagent. The solution was allowed to stir while slowly warming 
to room temperature. After 6 h, the flask was cooled to 0 °C and quenched with saturated 
aqueous ammonium chloride. The layers were separated and the aqueous layer was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were washed with 
brine, dried over magnesium sulfate, filtered, and concentrated by rotary evaporation. 
The crude product was purified on silica gel (2.5-5% ethyl acetate in hexanes) to afford 
4-isopropylhepta-1,6-dien-4-ol as a pale yellow oil (1.88 g, 63%). 
A flame-dried round bottom flask equipped with a magnetic stirbar was brought 
into a glovebox and charged with 4-isopropylhepta-1,6-dien-4-ol (1.30 g, 8.43 mmol), 
Grubbs 2nd generation olefin metathesis catalyst (72 mg, 0.084 mmol), and 
dichloromethane (30 mL). The flask was sealed, removed from the glovebox, and stirred 
at 35 °C until TLC indicated the consumption of starting material. The reaction mixture 
was concentrated by rotary evaporation and the crude product purified on silica gel (10% 
ethyl acetate in hexanes) to afford the product as a colorless oil (0.48 g, 48%). 
 
1H NMR (500 MHz, CDCl3): δ 5.70 (2H, s), 2.49 (2H, dd, J = 16.0 Hz, 1.0 Hz), 2.27 (2H, 
dd, J = 15.5 Hz, 1.0 Hz), 1.78 (1H, pentet, J = 7.0 Hz), 0.96 (3H, s), 0.95 (3H, s); 13C 
NMR (100 MHz, CDCl3): δ 128.7, 84.0, 45.6, 36.8, 17.6; IR (neat): 3415.1 (w), 2961.8 
OHi-Pr
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(m), 2932.9 (m), 2879.9 (m), 900.3 (m), 860.1 (m), 671.5 (m) cm-1; HRMS-(ESI+) for 
C8H14O [M+H−H2O]: calculated: 109.1017, found: 109.1020. 
 
Preparation of 6,6-dimethylcyclohex-3-en-1-ol (3.94): 
 
 The title compound was prepared according to the following two-step 
sequence. To a flame-dried round bottom flask equipped with a magnetic 
stirbar was added allylmagnesium bromide solution (1 M in diethyl ether, 
14.3 mL). The flask was cooled to 0 °C, and a solution of 2,2-dimethylpent-4-enal (1.8 
mL, 13 mmol) in diethyl ether (20 mL) was slowly added to the Grignard reagent. The 
reaction mixture was stirred and allowed to slowly warm to room temperature. The 
reaction was quenched with 1 M HCl, and the aqueous and organic layers were separated. 
The aqueous layer was extracted with diethyl ether (3 x 15 mL). The combined organic 
layers were washed with saturated aqueous sodium bicarbonate, dried over sodium 
sulfate, filtered, and concentrated by rotary evaporation.  The crude material was purified 
on silica gel (5% ethyl acetate in hexanes) to afford 5,5-dimethylocta-1,7-dien-4-ol (1.60 
g, 80%). 
For the ring-closing metathesis, a flame-dried round bottom flask equipped with a 
magnetic stirbar was brought into a glovebox and charged with 5,5-dimethylocta-1,7-
dien-4-ol (1.30 g, 8.43 mmol), Grubbs 1st generation catalyst (69 mg, 0.040 mmol), and 
dichloromethane (30 mL). The flask was sealed, removed from the box, and stirred at 
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room temperature until TLC indicated consumption of the starting material. The reaction 
mixture was concentrated by rotary evaporation and purified on silica gel (10% ethyl 
acetate in hexanes) to afford the title compound as a colorless oil (0.52 g, 50%). 
 
1H NMR (500 MHz, CDCl3): δ 0.90 (3H, s), 0.92 (3H, s), 1.41 (1H, br s), 1.84-1.80 (1H, 
m), 2.02-1.91 (2H, m), 2.35-2.30 (1H, m), 3.50 (1H, t, J = 11 Hz), 5.59-5.50 (2H, m); 13C 
NMR (100 MHz, CDCl3): δ 22.0, 26.3, 31.7, 33.6, 37.4, 73.9, 123.2, 126.0; IR (neat): 
3383.2 (br, m), 3025.0 (m), 2954.6 (m), 2925.9 (m), 2897.1 (m), 1055.7 (s), 982.8 (m), 
897.5 (w), 771.1 (w), 658.8 (s) cm-1; HRMS-(ESI+) for C8H14O [M+H-H2O]: calculated: 
109.1017, found: 109.1020. 
 
Preparation of non-1-en-5-ol (3.63): 
 
 
 The title compound was prepared as shown above using standard 
procedure. A flamed dried round bottom flask was charged with 
copper(I) bromide (73 mg, 0.51 mmol) and allylmagnesium bromide (4.5 mL, 4.5 mmol, 
1.0 M solution in diethyl ether). The flask was cooled to -10 °C and 2-butyloxirane (0.36 
mL, 3.0 mmol) in tetrahydrofuran (19 mL) was added slowly. The reaction was allowed 
to warm to room temperature overnight. A saturated aqueous solution of ammonium 
chloride (10 mL) was added to the flask. The layers were separated and the aqueous layer 
was washed with diethyl ether (3 x 25 mL). The organic layers were combined and 
n-Bu
O BrMg
THF, -10 °C
CuBr
n-Bu
OH
80%
n-Bu
OH
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washed with a brine solution. The organic layer was dried over MgSO4, filtered, and 
concentrated by rotary evaporation. The crude reaction mixture was purified by column 
chromatography on silica gel (0-10% ethyl acetate in hexanes) to afford a clear, colorless 
oil (0.35 g, 80%). 
 
1H NMR (400 MHz, CDCl3): δ 0.89 (3H, t, J  = 7.0 Hz), 1.26 – 1.60 (9H, m), 2.07 – 2.24 
(2H, m), 3.60 (1H, pentet, J = 2.8 Hz), 4.93 – 5.06 (2H, m), 5.78 – 5.88 (1H, m); 13C 
NMR (100 MHz, CDCl3): δ 14.0, 22.7, 27.8, 30.1, 36.4, 37.2, 71.5, 114.7, 138.6; IR 
(neat): 3345.9 (m), 3077.9 (w), 2956.7 (m), 2928.9 (s), 2859.3 (m), 1640.9 (m), 1452.7 
(m), 1125.6 (m), 1038.0 (m), 994.4 (m), 908.0 (s), 640.8 (w) cm-1; HRMS-(ESI+) for 
C9H19O [M+H]: calculated: 143.1436, found: 143.1429. 
 
Preparation of undec-1-en-6-ol (3.65): 
 
 
 The title compound was prepared according to the 
following procedure. To a flame-dried round bottom flask 
equipped with a magnetic stirbar, added ground magnesium turnings (0.53 g, 22 mmol).  
The flask was flame dried and then backfilled with nitrogen.  The flask was then charged 
with THF (39 mL), cooled to 0 °C, and then 5-bromo-1-pentene (2.30 mL, 19.4 mmol) 
was added and allowed to slowly warm to room temperature. To a flame-dried narrow 
bottom flask, added hexanal (2.20 mL, 17.6 mmol) and THF (24 mL). The round bottom 
n-pentyl H
O
n-pentyl
OHBrMg
THF, 0 °C to RT
71%
n-pentyl
OH
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flask containing the prepared Grignard reagent was cooled to 0 °C, and the hexanal 
solution was transferred to this flask by syringe. The solution was allowed to slowly 
warm to room temperature. After 12 h, the reaction was cooled to 0 °C and quenched 
with 15 mL of saturated aqueous ammonium chloride. The layers were separated and the 
aqueous layer was extracted with diethyl ether (3 x 15 mL). The combined organic layers 
were washed with brine, dried over sodium sulfate, filtered, and concentrated by rotary 
evaporation. The crude product was purified on silica gel (5-10% ethyl acetate in 
hexanes) to afford the title compound as a colorless oil (2.14 g, 71%). 
 
1H NMR (500 MHz, CDCl3): δ 0.87 (3H, t, J = 7 Hz), 1.55-1.26 (12H, m), 2.08-2.04 (2H, 
m), 3.58 (1H, m), 5.01-4.92 (2H, m), 5.83-5.75 (1H, m); 13C NMR (100 MHz, CDCl3): δ 
14.0, 22.6, 24.9, 25.3, 31.9, 33.7, 36.9, 37.5, 71.8, 114.5, 138.8; IR (neat): 3336.6 (br, m), 
2927.6 (s), 2858.2 (m), 1641.1 (m), 1458.4 (m), 1126.0 (m), 993.1 (m), 908.1 (s), 635.6 
(m) cm-1; HRMS-(ESI+) for C11H22O [M+H]: calculated: 171.1749, found: 171.1743. 
 
Preparation of (2-methoxypent-4-en-1-yl)benzene (3.79): 
 
 
 The title compound was prepared as shown above using standard 
procedure. A flamed dried round bottom flask was charged with 1-
phenylpent-4-en-2-ol (200 mg, 1.23 mmol) and tetrahydrofuran (2 mL) and cooled to 0 
°C. Sodium hydride (59 mg, 2.5 mmol) was added in one shot and stirred at 0°C for 10 
Ph
OH 1. NaH, THF, 0 °C
2. MeI, 0 °C
Ph
OMe
85%
Ph
OMe
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minutes. Iodomethane (0.22 mL, 3.6 mmol) was added dropwise to the flask and the 
reaction was allowed to warm to room temperature overnight. A saturated aqueous 
solution of NH4Cl (2 mL) was added to the flask. The layers were separated and the 
aqueous layer was washed with ethyl acetate (3 x 10 mL). The organic layers were 
combined and washed with a brine solution. The organic layer was dried over sodium 
sulfate, filtered, and concentrated by rotary evaporation. The crude reaction mixture was 
purified by column chromatography on silica gel (0-5% ethyl acetate in hexanes) to 
afford a clear, colorless oil (0.18 g, 85%). 
 
1H NMR (400 MHz, CDCl3): δ 2.18 – 2.30 (2H, m), 2.73 (1H, dd, J = 13.8 Hz, 6.2 Hz), 
2.82 (1H, dd, J = 13.8 Hz, 6.6 Hz), 3.19 (3H, t, J = 0.8 Hz), 3.44 (1H, pentet, J = 6 Hz), 
5.05 – 5.06 (1H, m), 5.08 – 5.09 (1H, m), 5.79 – 5.90 (1H, m), 7.17 – 7.21 (3H, m), 7.24 
– 7.29 (2H, m); 13C NMR (100 MHz, CDCl3): δ 37.5, 39.8, 57.0, 81.7, 117.1, 126.1, 
128.2, 129.4, 134.7, 138.9; IR (neat): 3063.8 (w), 3027.7 (w), 2977.6 (w), 2927.9 (m), 
2822.6 (w), 1640.2 (w), 1604.3 (w), 1495.0 (m), 1454.0 (m), 1359.0 (m), 1094.2 (s), 
911.9 (s), 743.3 (s), 698.0 (s) cm-1; HRMS-(ESI+) for C11H13 [M+H-CH3OH]: calculated: 
145.1017, found: 145.1020. 
 
Preparation of 2-phenylbut-3-en-1-ol (3.75): 
 The title compound was synthesized by following literature procedure.40 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
40 Lightburn, T. E.; Dombrowski, M. T.; Tan, K. L. J. Am. Chem. Soc. 2008, 130, 9210 – 
9211. 
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Preparation of 1-phenylbut-3-en-2-ol (3.61): 
 The title compound was synthesized by following literature 
procedure.41 
 
Preparation of tetradec-1-en-4-ol (3.104): 
 
 
 The title compound was prepared as shown above using standard 
procedure.  See the synthesis of 3.59 for an identical procedure.  
The crude reaction mixture was purified by column chromatography on silica gel (2.5-5% 
ethyl acetate/hexanes, Rf = 0.60 in 20% ethyl acetate/hexanes, stain in KMnO4) to afford 
a clear, colorless oil (0.87 g, 41%). 
 
1H NMR (500 MHz, CDCl3): δ 0.88 (3H, t, J = 7.1 Hz), 1.22 – 1.34 (14H, m), 1.43 – 1.49 
(3H, m), 1.53 – 1.55 (1H, m), 2.14 (1H, dt, J = 14.2 Hz, 7.8 Hz), 2.28 – 2.33 (1H, m), 
3.61 – 3.67 (1H, m), 5.12 (1H, s), 5.14 – 5.16 (1H, m), 5.79 – 5.87 (1H, m); 13C NMR 
(125 MHz, CDCl3): δ 14.1, 22.7, 25.7, 29.3, 29.6, 29.6, 31.9, 36.8, 41.9, 70.7, 118.0, 
134.9; IR (neat): 3341.6 (w), 3076.9 (w), 2922.2 (s), 2853.0 (s), 1641.2 (w), 1465.2 (m), 
1021.2 (m), 993.7 (m), 911.6 (s), 721.2 (w) cm-1; HRMS- (ESI+) for C14H27 [M+H-
H2O]: calculated: 195.21128, found: 195.21197. !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
41 Lin, H.; Liu, Y.; Wu, Z-L. Chem. Comm. 2011, 47, 2610 – 2612 
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3.11.3 Diboration of Homoallylic Alcohols, Representative Procedure 
 
In a glovebox under an argon atmosphere, an oven-dried 2 dram vial equipped with a 
magnetic stirbar was charged with 1-phenylpent-4-en-2-ol (40 mg, 0.50 mmol), 
bis(pinacolato)diboron (254 mg, 1.00 mmol), THF (1.0 mL, 0.50 M), and cesium 
carbonate (49 mg, 0.15 mmol). The vial was sealed with a cap with a septum, and 
removed from the glovebox. Under a line of nitrogen, methanol (0.34 mL, 8.5 mmol) was 
added to the reaction mixture. The nitrogen line was removed and the septum was 
covered with electrical tape. The reaction vial was placed in an oil bath at 70 °C for 6 h. 
After 6 h, the vial was allowed to cool to room temperature and then transferred to a 20 
mL vial with about 1 mL of THF. The vial was cooled to 0 °C, followed by the dropwise 
addition of 3 M sodium hydroxide (1 mL) and 30% aqueous hydrogen peroxide (1 mL). 
The reaction was allowed to slowly warm to room temperature while stirring for at least 4 
h. After the necessary time period, the vial was again cooled to 0 °C and cautiously 
quenched with saturated aqueous sodium thiosulfate (2 mL), then diluted with water. The 
aqueous later was extracted with ethyl acetate (5 x 5 mL). The organic layers were 
combined, dried over sodium sulfate, filtered, and concentrated in vacuo. The crude 
material was purified on silica gel (25-100% ethyl acetate in hexanes) to afford a clear oil 
(72 mg, 64%). 
 
Ph
OH
Ph OH
OH OH
2 equiv B2(pin)2
30% Cs2CO3
17 equiv MeOH
THF, 70 °C, 6 h
then  NaOH, H2O23.59 3.60
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3.11.4 Full Characterization and Stereochemical Proofs 
 syn-5-phenylpentane-1,2,4-triol (3.60). The diboration 
was performed according to the representative procedure with 
1-phenylpent-4-en-2-ol (40 mg, 0.50 mmol), B2(pin)2  (254 mg, 1.00 mmol), Cs2CO3  (49 
mg, 0.15 mmol), methanol (0.34 mL, 8.5 mmol) and tetrahydrofuran (1 mL). The crude 
reaction mixture was purified on silica gel (50-100% ethyl acetate in hexanes) to afford a 
clear, colorless oil (73 mg, 74%). 
 
1H NMR (500 MHz, CD3OD): δ 1.54 (1H, dt, J = 14 Hz, 8.3 Hz), 1.69 (1H, dt, J = 14.0 
Hz, 4.5 Hz), 2.72 – 2.80 (2H, m), 3.30 (1H, pentet, J = 1.5 Hz), 3.42 (1H, dd, J = 11.5 Hz, 
6.5 Hz), 3.47 (1H, dd, J = 11.5 Hz, 4.8 Hz), 3.79 – 3.83 (1H, m), 3.99 – 4.04 (1H, m), 
7.15 – 7.19 (1H, m), 7.21 – 7.27 (4H, m); 13C NMR (100 MHz, CDCl3): δ 38.4, 44.6, 
66.6, 72.3, 73.0, 126.7, 128.7, 129.4 137.7; IR (neat): 3332.4 (m), 3027.5 (w), 2920.1 
(m), 1495.3 (m), 1453.4 (m), 1266.1 (m), 1079.7 (m), 1031.1 (m), 734.8 (s), 698.7 (s)  
cm-1;  HRMS-(ESI+)  for  C11H17O3 [M+H]: calculated: 197.1178, found: 197.1177. 
 
Proof of Stereochemistry: 
The diastereoselectivity was determined from SFC analysis, where the products of 
the reaction were compared to products from an OsO4/NMO dihydroxylation of the 
substrate. Diastereomer ratio was determined to be 13:1. To prove relative 
stereochemistry, the triol was silyl protected and cyclized to form the acetonide. The 13C 
NMR displayed characteristic carbon signals for a syn-1,3-diol.42 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
42 Rychnovsky, S. D.; Rodgers, B.; Yang, G. J. Org. Chem., 1993, 58, 3511 – 3515. 
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SFC (2EP 4.6x250, 35 °C, 3mL/min, 5% MeOH, 100 bar) 
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Preparation of ((6-benzyl-2,2-dimethyl-1,3-dioxan-4-yl)methoxy)(tert-butyl)diphenyl-
silane. 
 
 
 ((6-benzyl-2,2-dimethyl-1,3-dioxan-4-yl)methoxy)(tert- 
butyl)diphenylsilane. The title compound was prepared as 
shown above using standard procedure. 
 
1H NMR (400 MHz, CDCl3): δ 1.05 (9H, s), 1.20 (1H, q, J = 11.5 Hz), 1.42 (3H, s), 1.43 
(3H, s), 1.55 (1H, dt, J = 12.5 Hz, 2.3 Hz), 2.64 (1H, dd, J = 13.5 Hz, 7.0 Hz), 2.95 (1H, 
dd, J = 13.5 Hz, 5.8 Hz), 3.54 (1H, dd, J = 10.3 Hz, 5.8 Hz), 3.72 (1H, dd, J = 10.3 Hz, 
5.3), 3.91 – 3.96 (1H, m), 4.03 – 4.08 (1H, m), 7.22 – 7.25 (3H, m), 7.29 – 7.32 (2H, m), 
7.35 – 7.39 (4H, m), 7.41 – 7.45 (2H, m), 7.66 – 7.68 (4H, m); 13C NMR (125 MHz, 
CDCl3): δ 19.3, 19.8, 26.8, 30.0, 33.2, 43.1, 67.5, 69.8, 69.9, 98.5, 126.3, 127.6, 127.6, 
128.2, 129.5, 129.6, 129.6, 133.7, 133.8, 135.7, 135.7, 138.0; IR (neat): 2991.3 (m), 
2930.2 (m), 3857.6 (m), 1427.4 (m), 1378.3 (m), 1198.7 (m), 1106.5 (s), 937.8 (m), 697.9 
Ph OH
OH OH
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(s), 612.2 (m), 502.1 (s) cm-1; HRMS-(ESI+) for C30H38O3SiNa [M+Na]: calculated: 
497.2491, found: 497.2491. 
 
 4-phenylbutane-1,2,4-triol (3.68). The diboration was performed 
according to the representative procedure with 1-phenylbut-3-en-
1-ol (74 mg, 0.50 mmol), Cs2CO3  (49 mg, 0.15 mmol), B2(pin)2  (254 mg, 1.00 mmol), 
methanol (0.34 mL, 8.5 mmol), and tetrahydrofuran (1 mL).  The crude material was 
purified on silica gel (30%-100% EtOAc/Hexane) to afford the title compound was 
obtained as a white solid (74 mg, 85%).  Spectral data is in agreement with the 
literature.43 
 
Analysis/Proof of Stereochemistry: 
The relative stereochemistry was determined to be syn by comparison to the 1H 
NMR data within the literature.   Diastereomer ratio was determined to be 14.3:1. 
 
 4-cyclohexylbutane-1,2,4-triol (3.70). Prepared according to the 
general diboration/oxidation procedure using 1-cyclohexylbut-3-
en-1-ol (77 mg, 0.50 mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 (254 mg, 1.00 mmol), 
methanol (0.34 mL, 8.5 mmol), and THF (1 mL).   The crude product was purified on 
silica gel (25-100% ethyl acetate in hexanes) to afford the title compound as a clear, 
colorless oil (48 mg, 51%). 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
43 a) Asano, K.; Matsubara, S. Org. Lett. 2012, 14, 1620 – 1623; (b) Kang, J. Y.; Connell, 
B. T.  J. Am. Chem. Soc. 2011, 132, 7826 – 7827. 
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1H NMR (500 MHz, CDCl3): δ 1.05-0.92 (2H, m), 1.25-1.07 (3H, m), 1.35-1.27 (1H, m), 
1.59-1.47 (2H, m), 1.68-1.60 (2H, m), 1.80-1.69 (3H, m), 3.50-3.41 (2H, m), 3.64-3.56 
(2H, m), 3.86-3.79 (1H, m); 13C NMR (100 MHz, CDCl3): δ 26.1, 26.2, 27.9, 28.7, 35.7, 
44.3, 66.8, 72.9; IR (neat): 3329.9 (br, m), 2921.3 (m), 2850.8 (m), 1448.2 (m), 1318.3  
(m), 1042.4  (m), 976.1 (m), 891.5 (m), 845.9 (m), 732.3 (m); HRMS-(ESI+) for 
C10H20O3 [M+H-H2O]: calculated: 189.1491, found: 189.1490. 
 
Analysis of Stereochemistry: 
The starting material was subjected to dihydroxylation with osmium tetroxide and 
4-methylmorpholine N-oxide to give a mixture of diastereomers as determined by 13C 
NMR. Diastereomer ratio from the diboration/oxidation sequence was then determined 
by comparison of the 13C NMR and was found to be 5.3:1.  Relative stereochemistry was 
assigned by analogy. 
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 2-methyl-6-phenylhexane-1,2,4-triol (3.88).  The title 
compound was prepared according to the general diboration 
procedure using 5-methyl-1-phenylhex-5-en-1-ol (95 mg, 0.50 mmol), B2(pin)2 (254 mg, 
1.00 mmol), Cs2CO3 (49 mg, 0.15 mmol), MeOH (0.34 mL, 8.5 mmol), and THF (1 mL). 
 
1H NMR (500 MHz, CDCl3): δ 1.21 (3H, s), 1.49-1.46 (1H, d, J = 15.0 Hz), 1.86-1.70 
(3H, m), 2.79-2.64 (2H, m), 3.41 (2H, s), 4.11-4.04 (1H, m), 7.20-7.15 (3H, m), 7.30-
7.25 (2H, m); 13C NMR (100 MHz, CDCl3): δ 23.8, 31.8, 40.0, 40.7, 68.3, 70.8, 73.1, 
125.9, 128.4, 128.5, 141.7; IR (neat): 3331.2 (br, m), 2925.9 (m), 2862.4 (w), 1453.5 (m), 
1046.4 (s), 897.2 (m), 849.2 (m), 746.2 (s), 697.8 (s); HRMS-(ESI+) for C13H20O3 
[M+H]: calculated: 225.1491, found: 225.1485. 
 
Analysis of Diastereoselectivity:  
The starting material was subjected to dihydroxylation with osmium tetroxide and 
4-methylmorpholine N-oxide to give a mixture of diastereomers as determined by 1H 
NMR. Diastereomer ratio from the diboration/oxidation sequence was then determined 
by comparison of the 1H NMR spectra and was found to be 17:1. 
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Proof of Stereochemistry: 
The purified triol was protected as an acetonide by the sequence shown below, 
and stereochemistry was proven using 2D NMR (NOE). 
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tert-butyldiphenyl(((4R,6R)-2,2,4-trimethyl-6-phenethyl-
1,3- dioxan-4-yl)methoxy)silane. An oven-dried 20 mL 
vial equipped with a magnetic stirbar was charged with 2-
methyl-6-phenylhexane-1,2,4-triol (85 mg, 0.38 mmol) and dichloromethane (3.8 mL).   
The vial was cooled to 0 °C, and imidazole (31 mg, 0.46 mmol) was quickly added.  The 
vial was then charged with tert-butyldiphenylsilyl chloride (0.11 mL, 0.42 mmol) and 
allowed to stir to room temperature. The reaction was quenched with saturated aqueous 
sodium bicarbonate. The layers were separated and the organic layer was sequentially 
washed with water and then brine. The organic layer was separated, dried over sodium 
sulfate, filtered, and concentrated by rotary evaporation. The crude product was purified 
on silica gel (5-10% ethyl acetate in hexanes) to afford a white solid (0.11 g, 63%). 
To an oven-dried 20 mL vial equipped with a magnetic stirbar, added the silyl-
protected triol (0.11 g, 0.24 mmol), dichloromethane (3 mL), and 2,2-dimethoxypropane 
(0.44 mL, 3.60 mmol). The vial was cooled to 0 °C, then pyridinium p-toluenesulfonate 
(5 mg, 0.02 mmol) was quickly added. The reaction was stirred while warming to room 
temperature, then quenched with triethylamine and concentrated by rotary evaporation. 
The crude material was purified on silica gel (10% ethyl acetate in hexanes) to afford a 
clear, colorless film (0.10 mg, 84%). 
 
1H NMR (500 MHz, CDCl3): δ 1.06 (9H, s), 1.36-1.34 (6H, d, J = 10.5 Hz), 1.45 (3H, s), 
1.48-1.47 (2H, d, J = 5.0 Hz), 1.88-1.71 (2H, m), 2.82-2.65 (2H, m), 3.45-3.41 (2H, m), 
3.92-3.90 (1H, m), 7.21-7.17 (3H, m), 7.30-7.27 (2H, m), 7.43-7.35 (6H, m), 7.68-7.67 
(4H, m); 13C NMR (100 MHz, CDCl3): δ 19.4, 23.8, 25.1, 26.9, 31.3, 31.7, 37.3, 38.1, 
O
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64.4, 73.1, 73.5, 98.4, 125.7, 127.6, 127.6, 128.3, 128.5, 129.5, 129.6, 133.7, 133.7, 
135.7, 135.7, 142.1; IR (neat): 2929.8 (w), 2857.2 (w), 1427.5 (w), 1376.4 (w), 1157.4 
(m), 821.4 (m), 739.4 (m), 698.2 (m), 503.2 (m), 488.1 (m) cm-1; HRMS-(ESI+) for 
C33H44O3Si [M+Na]: calculated: 525.7598, found: 525.2794. 
 
 3,3-dimethyl-6-phenylhexane-1,2,4-triol (3.78). Prepared 
according the general diboration/oxidation procedure using 4,4-
dimethyl-1-phenylhex-5-en-3-ol (102 mg, 0.500 mmol), 
Cs2CO3  (49 mg, 0.15 mmol), B2(pin)2  (254 mg, 1.00 mmol), methanol (0.34 mL, 8.5 
mmol), and tetrahydrofuran (1 mL).   The crude product was purified on silica gel (25-
100% ethyl acetate in hexanes) to afford the title compound as a white solid (83 mg, 
69%). 
 
1H NMR (500 MHz, CDCl3): δ 0.80 (3H, s), 0.90 (3H, s), 1.89-1.61 (2H, m), 2.33-2.17 
(1H, s), 2.82-2.71 (1H, s), 2.92-2.58 (2H, m), 3.25-3.11 (1H, s), 3.64-3.55 (3H, m), 3.74-
3.67 (1H, m), 7.31-7.26 (2H, m), 7.22-7.16 (3H, m); 13C NMR (100 MHz, CDCl3): δ 
15.7, 21.8, 33.0, 33.3, 40.3, 62.6, 78.2, 79.3, 126.0, 128.5, 128.5, 142.1; IR (neat): 3315.5 
(br, w), 2969.7 (w), 2928.5 (w), 2878.7 (w), 1071.2 (w), 1054.2 (w), 926.7 (w), 893.8 
(w), 745.7 (w), 701.8 (w); HRMS-(ESI+) for C14H22O3 [M+H]: calculated: 239.1647, 
found: 239.1652; Melting point: 90-95 °C. 
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Analysis of Stereochemistry: 
The starting material was subjected to dihydroxylation with OsO4/NMO to give a 
mixture of diastereomers as determined by SFC analysis. Diastereomer ratio from the 
diboration/oxidation sequence was then determined by comparison of the SFC data and 
was found to be >20:1. 
 
SFC (2EP 4.6x250, 35 °C, 3mL/min, 3% MeOH, 100 bar) 
 
 
Proof of Stereochemistry: 
The purified triol was silyl protected and cyclized as an acetonide by the sequence 
shown below.  Absolute stereochemistry was proven using 2D NMR (NOE) 
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tert-butyldiphenyl(((4R,6R)-2,2,5,5-tetramethyl-6-
phenethyl-1,3-dioxan-4-yl)methoxy)silane. An oven-dried 
20 mL vial equipped with a magnetic stirbar was charged 
with 3,3-dimethyl-6-phenylhexane-1,2,4-triol (35 mg, 0.15 mmol) and dichloromethane 
(1.5 mL). The vial was cooled to 0 °C, and imidazole (12 mg, 0.18 mmol) was quickly 
added.  The vial was then charged with tert-butyldiphenylsilyl chloride (40 µL, 0.16 
mmol) and allowed to stir to room temperature. The reaction was quenched with 
saturated aqueous sodium bicarbonate. The layers were separated and the organic layer 
was sequentially washed with water and then brine. The organic layer was separated, 
dried over sodium sulfate, filtered, and concentrated by rotary evaporation. The crude 
product was purified on silica gel (5-10% ethyl acetate in hexanes) to afford a white solid 
(50 mg, 69%). 
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To an oven-dried 20 mL vial equipped with a magnetic stirbar, added the silyl-
protected triol (50 mg, 0.10 mmol), dichloromethane (0.6 mL), and 2,2-
dimethoxypropane (0.18 mL, 1.5 mmol). The vial was cooled to 0 °C, then pyridinium p-
toluenesulfonate (3 mg, 0.01 mmol) was quickly added. The reaction was stirred while 
warming to room temperature, then quenched with triethylamine and concentrated by 
rotary evaporation. The crude material was purified on silica gel (2.5-10% ethyl acetate 
in hexanes) to afford a clear, colorless film (16 mg, 30%). 
 
1H NMR (500 MHz, CDCl3): δ 0.58 (3H, s), 0.72 (3H, s), 1.03 (9H, s), 1.38 (3H, s), 1.43 
(3H, s), 1.70-1.56 (2H, m), 2.51-2.44 (1H, m), 2.85-2.78 (1H, m), 3.34-3.31 (1H, m), 
3.56-3.53 (1H, m), 3.62-3.58 (1H, m), 3.79-3.76 (1H, dd, J = 11.0 Hz, 3.0 Hz), 7.19-7.15 
(3H, m), 7.28-7.24 (2H, m), 7.42-7.32 (6H, m), 7.70-7.65 (4H, m); 13C NMR (100 MHz, 
CDCl3): δ 13.2, 19.2, 19.4, 20.5, 26.8, 29.7, 30.1, 30.2, 32.4, 34.6, 63.9, 76.7, 79.2, 98.5, 
125.7, 127.5, 127.6, 128.2, 128.6, 129.5, 129.6, 133.7, 134.1, 135.7, 135.8, 142.4; IR 
(neat): 2930.7 (w), 2856.3 (w), 1463.3 (w), 1427.6 (w), 1377.8 (w), 1105.5 (m), 1043.4 
(m), 737.7 (m), 698.3 (s), 608.7 (m), 503.4 (s); HRMS-(ESI+) for C33H44O3Si [M+Na]: 
calculated: 539.2957, found: 539.2941. 
 
 2-hexyl-6-phenylhexane-1,2,4-triol (3.90). Prepared according 
to the general diboration procedure using 5-methylene-1-
phenylundecan-3-ol (0.13 g, 0.50 mmol), B2(pin)2 (254 mg, 1.00 mmol), Cs2CO3 (49 mg, 
0.15 mmol), methanol, (0.34 mL, 8.5 mmol) and tetrahydrofuran (1 mL) (50 mg, 64%). 
 
HO
Ph
2
n-hexylHO
OH
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1H NMR (500 MHz, CDCl3): δ 0.87 (3H, t, J = 7.0 Hz), 1.31-1.10 (10H, m), 1.59-1.50 
(2H, m), 1.88-1.67 (2H, m), 2.51 (1H, s), 2.78-2.64 (2H, m), 2.86 (1H, s), 3.13 (1H, s), 
3.48-3.41 (2H, q, J = 10.0 Hz), 4.06-3.99 (1H, m), 7.20-7.15 (3H, m), 7.29-7.25 (2H, m); 
13C NMR (100 MHz, CDCl3): δ 14.1, 22.6, 23.9, 29.9, 31.7, 31.9, 37.5, 40.1, 42.0, 68.2, 
68.7, 74.6, 126.0, 128.4, 128.5, 141.7; IR (neat): 3355.6 (br, m), 2927.7 (m), 2856.8 (m), 
1495.5 (w), 1454.4 (w), 1313.5 (w), 1057.0 (w), 1031.2 (m), 746.5 (w), 698.5 (m); 
HRMS-(ESI+) for C18H30O3 [M+H]: calculated: 295.2273, found: 295.2287. 
 
Analysis of Stereochemistry: 
The starting material was subjected to dihydroxylation with OsO4/NMO to give a 
mixture of diastereomers as determined by 1H NMR. Diastereomer ratio from the 
diboration/oxidation sequence was then determined by comparison of the 1H NMR and 
was found to be 16.7:1. Absolute stereochemistry was assigned by analogy. 
 
 
 
 1-phenylnonane-2,4,5-triol (3.82). The diboration was 
performed according to the representative procedure with (E)-
1-phenylnon-4-en-2-ol (109 mg, 0.5 mmol), B2(pin)2 (254 
OH
Ph n-Bu
OH
OH
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mg, 1.0 mmol), Cs2CO3 (53 mg, 0.15 mmol), methanol, (.34 mL, 8.5 mmol) and 
tetrahydrofuran (1 mL). The crude reaction mixture was purified by column 
chromatography on silica gel (25-100% ethyl acetate in hexanes) to afford a white solid 
(82 mg, 65%). 
 
1H NMR (500 MHz, CDCl3): δ 0.90 (3H, t, J = 7.3 Hz), 1.24 – 1.52 (6H, m), 1.64 – 1.74 
(2H, m), 2.39 (1H, d, J = 6.0 Hz), 2.76 (1H, dd, J = 13.8 Hz, 7.8 Hz), 2.81 (1H, dd, J = 
13.5 Hz, 5.5 Hz), 2.85 (1H, br s), 3.37 – 3.41 (1H, m), 3.60 (1H, d, J = 3.0 Hz), 3.67 – 
3.71 (1H, m), 4.09 – 4.14 (1H, m), 7.21 – 7.26 (3H, m), 7.30 – 7.34 (2H, m); 13C NMR 
(100 MHz, CDCl3): δ 14.0, 22.7, 27.9, 33.3, 39.2, 44.7, 73.1, 74.5, 74.6, 126.7, 128.7, 
129.4, 137.7; IR (neat): 3315.3 (s), 3232.1 (s), 3077.4 (w), 3061.3 (w), 3036.1 (s), 2955.2 
(m), 2914.0 (m), 2871.3 (m), 1497.3 (m), 1449.8 (m), 1093.9 (s), 1041.4 (s), 861.7 (m), 
780.2 (m), 700.2 (s) cm-1; HRMS-(ESI+) for C15H25O3 [M+H]: calculated: 253.1804, 
found: 253.1801. 
 
Analysis of Stereochemistry: 
The diastereoselectivity was attained from SFC analysis, where the products of 
the reaction were compared to those products from an OsO4/NMO dihydroxylation of the 
substrate. 
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SFC (2EP 4.6x250, 35 °C, 3mL/min, 3% MeOH, 100 bar) 
 
 
Proof of Stereochemistry: 
The relative stereochemistry was determined as syn by NOESY NMR of the 1-(6-
benzyl-2- phenyl-1,3-dioxan-4-yl)pentan-1-ol synthesized from the resulting triol in the 
sequence shown below. Similar triols have been cyclized using a similar approach.44 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
44 Esteve, J.; Matas, S.; Pellicena, M.; Romea, P.; Urpi, F.; Velasco, J.; Font-Bardia, M. 
Eur. J. Org. Chem. 2010, 16, 3146 – 3151. 
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1-(6-benzyl-2-phenyl-1,3-dioxan-4-yl)pentan-1-ol. The title 
compound was prepared as shown above using standard 
procedure. 
 
1H NMR (500 MHz, CDCl3): δ 0.91 (3H, t, J = 7.0 Hz), 1.26 – 1.42 (3H, m), 1.44 – 1.63 
(5H, m), 2.36 (1H, d, J = 5.0 Hz), 2.80 (1H, dd, J = 13.5 Hz, 6.5 Hz), 3.10 (1H, dd, J = 14 
Hz, 7 Hz), 3.50 – 3.54 (1H, m), 3.66 – 3.70 (1H, m), 4.01 – 4.06 (1H, m), 5.54 (1H, s), 
7.23 – 7.28 (3H, m), 7.30 – 7.40 (5H, m), 7.48 – 7.51 (2H, m); 13C NMR (150 MHz, 
CDCl3): δ 14.0, 22.7, 27.6, 32.0, 32.3, 42.5, 73.8, 77.4, 79.7, 100.5, 126.1, 126.5, 128.2, 
128.4, 128.8, 129.5, 137.6, 138.4; IR (neat): 3576.7 (w), 3461.4 (w), 2953.7 (m), 2928.6 
(m), 2858.6 (m), 1602.3 (w), 1495.0 (m), 1453.7 (m), 1400.0 (m), 1376.4 (m), 1106.2 (s), 
1011.7 (s), 750.7 (s), 698.2 (s) cm-1; HRMS-(ESI+) for C22H29O3 [M+H]: calculated: 
341.2117, found: 341.2119. 
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 1-phenylnonane-2,4,5-triol (3.84). The diboration was 
performed according to the representative procedure with (Z)-
1-phenylnon-4-en-2-ol (109 mg, 0.500 mmol), B2(pin)2 (254 
mg, 1.00 mmol), Cs2CO3 (49 mg, 0.15 mmol), methanol (0.34 mL, 8.5 mmol) in 
tetrahydrofuran (1 mL). The crude reaction mixture was purified by column 
chromatography on silica gel (25-100% ethyl acetate in hexanes) to afford a white solid 
(0.10 g, 79%). 
 
1H NMR (500 MHz, CDCl3 with one drop of D2O): δ 0.90 (3H, t, J = 7.0 Hz), 1.26 – 1.52 
(6H, m), 1.62 – 1.74 (2H, m), 2.74 (1H, dd, J = 13.3 Hz, 8.3 Hz), 2.84 (1H, dd, J = 13.8 
Hz, 4.3 Hz), 3.59 (1H, pentet, J = 4.3 Hz), 3.78 (1H, dt, J = 9.0 Hz, 3.3 Hz), 4.06 – 4.11 
(1H, m), 4.71 (1H, br s), 7.20 – 7.24 (3H, m), 7.31 – 7.34 (2H); 13C NMR (100 MHz, 
CDCl3): δ 14.0, 22.7, 28.2, 31.6, 36.1, 44.8, 73.3, 74.2, 75.0, 126.8, 128.7, 129.4, 137.6; 
IR (neat): 3319.1 (s), 3246.4 (s), 3088.1 (w), 3060.9 (w), 3031.6 (s), 2950.0 (m), 2913.4 
(m), 2870.8 (m), 1495.9 (m), 1451.8 (m), 1091.1 (s), 1046.9 (s), 853.7 (m), 748.4 (m), 
695.6 (s) cm-1; HRMS-(ESI+) for C15H25O3 [M+H]: calculated: 253.1804, found: 
253.1794. 
 
Analysis/Proof of Stereochemistry: 
The diastereoselectivity was attained from SFC analysis, where the products of 
the reaction were compared to those products from an OsO4/NMO dihydroxylation of the 
substrate. To prove relative stereochemistry, the triol was crystallized out of hexanes and 
methanol (long needle-like crystal). 
OH
Ph n-Bu
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SFC (2EP 4.6x250, 35 °C, 3mL/min, 3% MeOH, 100 bar) 
 
 
 
 
 anti-2-methyl-6-phenylhexane-2,3,5-triol (3.92). The 
diboration was performed according to the representative 
procedure with 5-methyl-1-phenylhex-4-en-2-ol (95 mg, 0.50 
mmol), B2(pin)2  (254 mg, 1.00 mmol), Cs2CO3 (49  mg, 0.15 mmol), methanol (0.34 
mL, 8.5  mmol) in tetrahydrofuran (1 mL). The crude reaction mixture was purified by 
column chromatography on silica gel (50-100% ethyl acetate in hexanes) to afford a 
white solid (62 mg, 55%). 
 
OH
MeMe
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OH
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1H NMR (400 MHz, CDCl3): δ 1.11 (3H, s), 1.16 (3H, s), 1.51 - 1.65 (2H, m), 2.70 – 
2.82 (2H, m), 3.73 (1H, dd, J = 10.0 Hz, 2.8 Hz), 4.09 – 4.15 (1H, m), 7.18 – 7.30 (5H, 
m); 13C NMR (100 MHz, CDCl3): δ 23.4, 26.4, 37.1, 43.9, 70.1, 72.9, 74.6, 76.7, 126.5, 
128.6, 129.4, 138.4; IR (neat): 3385.0 (m), 2971.4 (m), 2921.5 (m), 1496.0 (m), 1377.6 
(m), 1225.4 (m), 1056.9 (s), 743.9 (m), 699.2 (s) cm-1; HRMS-(ESI+) for C13H21O3  
[M+H]: calculated: 225.1491, found: 225.1490. 
 
Analysis/Proof of Stereochemistry: 
The diastereoselectivity was determined from SFC analysis, where the products of 
the reaction were compared to those products from an OsO4/NMO dihydroxylation of the 
substrate. To prove relative stereochemistry, the triol was crystallized out of 
hexanes/ethyl acetate. 
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SFC (2EP 4.6x250, 35 °C, 3mL/min, 3% MeOH, 100 bar) 
 
 
 
 (2R,3S,4R)-3-methyl-6-phenylhexane-1,2,4-triol (3.72). The 
diboration was performed according to the representative 
procedure with (3R,4R)-4-methyl-1-phenylhex-5-en-3-ol (95 
mg, 0.50 mmol), Cs2CO3   (49  mg,  0.15  mmol),  B2(pin)2   (254  mg,  1.00  mmol), 
methanol (0.34 mL, 8.5 mmol), and tetrahydrofuran (1 mL). The crude material was 
OH
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purified on silica gel (30-100% ethyl acetate in hexanes) to afford the title compound as a 
clear, colorless oil (89 mg, 79%). 
 
1H NMR (500 MHz, CDCl3): δ 0.92 (3H, d, J = 12.5 Hz), 1.65 (1H, m), 1.72 (1H, m), 
1.86 (1H, m), 2.64 (1H, m), 2.75 (1H, m), 3.57 (1H, dd, J = 3.5 Hz, 10.5 Hz), 3.65 (1H, 
dd, J = 7.0 Hz, 11.0 Hz), 3.85 (1H, p, J = 3.5 Hz), 3.90 (1H, m), 7.18 (3H, m), 7.26 (2H, 
m);  13C NMR: δ 6.6, 32.7, 37.1, 39.6, 64.7, 74.6, 76.3, 126.2, 1286, 128.7, 141.9; IR 
(neat): 3346.3 (s), 2940.3 (s), 2886.1 (m), 1495.7 (w), 1454.4 (m), 1099.3 (m), 1062.6 
(m), 1028.6 (m), 748.3 (m), 699.3 (s); HRMS-(ESI+) for C13H21O3 [M+H]: calculated: 
225.1491, found: 225.1489. 
 
Analysis of Stereochemistry: 
Diastereomer ratio was determined to be 6.8:1 based on comparison of the 1H 
NMR of the product with triol that was obtained from a non-selective diboration shown 
in the sequence below: 
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    MeOH, THF, 70 °C
2. NaOH, H2O2
3. K2CO3, MeOH
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To an oven-dried 6-dram vial equipped with a magnetic stirbar, added (3R,4R)-4-
methyl-1-phenylhex-5-en-3-ol (190 mg, 1.00 mmol) and Et2O (2 mL), and the reaction 
mixture was cooled to 0°C. Pyridine (0.12 mL, 1.5 mmol) and benzoyl chloride (0.17 
mL, 1.5 mmol) were added. The reaction mixture was allowed to warm to room 
temperature and stir overnight. Then the reaction was quenched with N,N’-
dimethylethylenediamine at 0 °C and extracted with Et2O. The organic layer was washed 
with brine, dried over Na2SO4, filtered and concentrated by rotary evaporation. The crude 
material was purified on silica gel (3% ethyl acetate in hexanes) to afford the Bz-
protected alkene as a colorless oil (0.19 g, 64%). Then the diboration was performed 
according to the representative procedure with Bz-protected alkene (0.19 g, 0.64 mmol) 
followed by treatment of the crude material with K2CO3 (0.88 g, 6.4 mmol) in MeOH 
(6.4 mL) and stirring for 12h. Then the reaction mixture was diluted with water, the 
organic layer was separated, dried over sodium sulfate, filtered, and concentrated by 
rotary evaporation. The crude material was purified on silica gel (3% ethyl acetate in 
hexanes) to give the title compound as a clear, colorless oil (80 mg, 56%) and a mixture 
of diastereomers as determined by 1H NMR. 
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Proof of Stereochemistry: 
The relative stereochemistry was determined to be syn by measuring the coupling 
constants of the carbonyl hydrogen atoms from the 1H 
NMR of the tert-butyldiphenyl(((4R,5S,6R)-2,2,5-trimethyl-6-phenethyl-1,3-
dioxan-4-yl)methoxy)silane synthesized from the sequence shown below. 
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tert-butyldiphenyl(((4R,5S,6R)-2,2,5-trimethyl-6-
phenethyl-1,3-dioxan-4-yl)methoxy)silane. To an oven-
dried 6-dram vial equipped with a magnetic stirbar, added 
(2R,3S,4R)-3-methyl-6-phenylhexane-1,2,4-triol (111 mg, 0.500 mmol), imidazole (41 
mg, 0.6 mmol), and dichloromethane (5ml) under a nitrogen atmosphere. The reaction 
mixture was cooled to 0 °C, and tert-butyldiphenylsilyl chloride (0.14 ml, 0.55 mmol) 
was added. Then the reaction mixture was allowed to warm to room temperature and stir 
for 2 h, at which time the reaction was quenched with saturated aqueous sodium 
bicarbonate.  The organic layer was separated, washed with water and brine, dried over 
sodium sulfate, filtered, and concentrated by rotary evaporation. The crude material was 
purified on silica gel (10% ethyl acetate in hexanes) to afford the TBDPS-protected triol 
(0.17 g, 72%). To a mixture of TBDPS-protected triol (0.17 g, 0.36 mmol) and 2,2-
dimethoxypropane (0.67 mL, 5.4 mmol) in dichloromethane (3.6 mL) at 0 °C, added 
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pyridinium p-toluenesulfonate (9.0 mg, 0.036 mmol). The reaction mixture was allowed 
to warm to room temperature and stir overnight under a nitrogen atmosphere. Then 
triethylamine was added and the reaction mixture was concentrated by rotary 
evaporation. The crude material was purified on silica gel (3% ethyl acetate in hexanes) 
to afford the title compound as a white solid (0.16 g, 89%). 
 
1H NMR (500 MHz, CDCl3): δ 0.79 (3H, d, J = 6.5 Hz), 1.04 (9H, s), 1.36 (6H, s), 1.54 
(1H, m), 1.61 (1H, m), 1.88 (1H, m), 2.59 (1H, m), 2.73 (1H, m), 3.57 (1H, dd, J = 10.5 
Hz, 7.5 Hz), 3.66 (1H, dd, J = 10.5 Hz, 6.5 Hz), 3.82 (1H, m), 3.96 (1H, ddd, J = 1.0 Hz, 
6.5 Hz, 7.5 Hz), 7.17-7.20 (3H, m), 7.26-7.29 (2H, m), 7.33-7.42 (6H, m), 7.64-7.66 (4H, 
m); 13C NMR (100 MHz, CDCl3): δ 5.0, 19.6, 20.0, 27.2, 30.2, 32.0, 32.8, 34.8, 64.6, 
72.6, 74.1, 99.6, 126.6, 128.4, 128.5, 129.2, 129.4, 130.4, 130.5, 134.6, 134.6, 136.5, 
136.5, 143.0; IR(neat): 2932.2 (m), 2857.1 (m), 1427.5 (m), 1378.6 (m), 1197.5 (m), 
1135.6 (m), 1109.7 (s), 938.1 (m), 833.4 (m), 777.7 (m), 739.0 (m), 698.1(s); HRMS-
(ESI+) for C32H42O3SiNa [M+Na]: calculated: 525.7523, found: 525.2803. 
 
 (3R,4S,5S)-4-methyl-1-phenyl-5,6-bis(4,4,5,5-tetramethyl- 
1,3,2-dioxaborolan-2-yl)hexan-3-yl acetate (3.74). The 
diboration was performed according to the representative 
procedure using (3R,4S)-4-methyl-1-phenylhex-5-en-3-ol  (95  mg,  0.50  mmol), Cs2CO3 
(49 mg, 0.15 mmol), B2(pin)2 (254 mg, 1.00 mmol), methanol (0.34 mL, 8.5 mmol), and 
tetrahydrofuran (1 mL) . After the diboration was complete, the reaction mixture was 
concentrated, and dichloromethane (2.5 mL), triethylamine (2.5 mL), and a single crystal 
AcO
Ph
2
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B(pin)
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of 4-(dimethylamino)pyridine were added under a nitrogen atmosphere. Then the reaction 
mixture was cooled to 0 °C, and acetic anhydride (0.1 mL, 1.1 mmol) was added. The 
reaction mixture was allowed to warm to room temperature and stir for 12 h. Then the 
reaction mixture was diluted with 1 M HCl. The organic layer was separated and washed 
with saturated aqueous sodium bicarbonate, dried over sodium sulfate, filtered, and 
concentrated by rotary evaporation. The crude material was purified on silica gel (3% 
ethyl acetate in hexanes) to isolate the title compound as a clear, colorless oil (0.17 g, 
68%). 
 
1H NMR (500 MHz, CDCl3): δ 0.74 (1H, s), 0.75 (2H, d, J = 3 Hz), 0.84 (3H, d, J = 6.5 
Hz), 1.19 (12H, s), 1.22 (12H, d, J = 4.5 Hz), 1.79 (1H, m), 1.91 (2H, m), 2.00 (3H, s), 
2.59 (2H, m), 4.94 (1H, m), 7.14 (3H, m), 7.25 (2H, m); 13C NMR (100 MHz, CDCl3): δ 
13.9, 21.4, 24.8, 25.1, 25.2, 32.3, 33.0, 38.6, 76.3, 83.0, 83.3, 125.9, 128.5, 128.6, 142.4, 
171.0; 11B NMR (CDCl3, 160 MHz): 34.3 (2B); IR(neat): 2977.0 (m), 2931.9 (m), 
1733.0 (m), 1403.3 (s), 1371.0 (s), 1311.9 (s), 1238.5 (s), 1142.7 (s) cm-1; HRMS-(ESI+) 
for C27H48B2NO6 [M+NH4]: calculated: 504.3668, found: 504.3690. 
 
Analysis of Stereochemistry: 
Diastereomer ratio was determined to be >20:1 based on comparison of the 1H NMR of 
the product with bis(boronate) that was obtained from a non-selective diboration shown 
in the sequence below: 
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To an oven-dried 6-dram vial equipped with a magnetic stirbar was added 
(3R,4S)-4-methyl-1-phenylhex-5-en-3-ol (0.10 g, 0.53 mmol), dichloromethane (2.5 mL), 
triethylamine (2.5 mL), and a single crystal of 4-(dimethylamino)pyridine under a 
nitrogen atmosphere. Then the reaction mixture was cooled to 0 °C, and acetic anhydride 
(0.10 mL, 1.1 mmol) was added. The reaction mixture was allowed to warm to room 
temperature and stir for 12 h. Then the reaction mixture was diluted with 1 M HCl. The 
organic layer was separated and washed with saturated aqueous sodium bicarbonate, 
dried over sodium sulfate, filtered, and concentrated by rotary evaporation. The crude 
material was purified on silica gel (3% ethyl acetate in hexanes) to afford the (3R,4S)-4-
methyl-1-phenylhex-5-en-3-yl acetate as colorless oil (80 mg, 65% yield). The diboration 
was performed according to the representative procedure using (3R,4S)-4-methyl-1-
phenylhex-5-en-3-yl acetate (80 mg, 0.35 mmol), Cs2CO3 (36 mg, 0.11 mmol), B2(pin)2 
(0.18 g, 0.70 mmol), methanol (0.24 mL, 6.0 mmol), and tetrahydrofuran (1.4 mL). The 
crude material was purified on silica gel (3% ethyl acetate in hexanes) to give a mixture  
of diastereomers as a clear, colorless oil (0.12 g, 68%) determined by 1H NMR.. 
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Diastereomer ratio from the diboration/oxidation sequence was then determined by 
comparison of the 1H NMR spectra and was found to be greater than 20:1 in the directed 
diboration reaction. 
 
Proof of Stereochemistry: 
The relative stereochemistry was determined to be syn by measuring the coupling 
constants of the carbonyl hydrogens from the 1H NMR of the tert-
butyldiphenyl(((4R,5R,6R)- 2,2,5-trimethyl-6- phenethyl-1,3-dioxan-4-yl)methoxy)silane 
synthesized from the resulting triol.  
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tert-butyldiphenyl(((4R,5R,6R)-2,2,5-trimethyl-6- 
phenethyl-1,3-dioxan-4-yl)methoxy)silane. To an oven-
dried 6-dram vial equipped with a magnetic stirbar was 
added (3R,4S,5S)-4-methyl-1-phenyl-5,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hexan-3-yl  acetate, sodium perborate hydrate (0.5 g, 5 mmol), tetrahydrofuran (3 mL), 
and water (3 mL) were added at room temperature and stirred for 1 h. Then the reaction 
was diluted with ethyl acetate, and the organic layer was separated. The aqueous layer 
was extracted with ethyl acetate (3 x 15 mL), the organic layers were combined and dried 
over sodium sulfate, filtered, and concentrated by rotary evaporation. The crude material 
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was purified on silica gel (20% ethyl acetate in hexanes) to afford the acylated triol (62 
mg, 46% yield). Then to a 6-dram vial was added the acylated triol (62 mg, 0.23 mmol), 
imidazole (19 mg, 0.28 mmol), and dichloromethane (2.5 mL) under a nitrogen 
atmosphere.  The reaction mixture was cooled to 0 °C, and tert-butyldiphenylsilyl 
chloride (0.07 mL, 0.25 mmol) in dichloromethane was added. Then the reaction mixture 
was allowed to warm to room temperature and stir for 2 h, at which time it was quenched 
with saturated aqueous sodium bicarbonate. The organic layer was separated, washed 
with water and brine, dried over sodium sulfate, filtered, and concentrated by rotary 
evaporation. The crude material was purified on silica gel (3% ethyl acetate in hexanes) 
to afford the TBDPS-protected acylated triol (93 mg, 84%). Then, the TBDPS-protected 
acylated triol was placed in a 6-dram vial (93 mg, 0.19 mmol) and was dissolved in 
methanol (2 mL). Potassium carbonate (55 mg, 0.40 mmol) was added at room 
temperature and stirred for 2.5 h. Then the methanol was evaporated and the residue was 
taken up in dichloromethane, washed with water and brine, dried over sodium sulfate, 
filtered, and concentrated by rotary evaporation. The crude material was immediately 
redissolved in dichloromethane (2 mL). 2,2-dimethoxypropane (0.24 mL, 2.0 mmol), and 
pyridinium p-toluenesulfonate (3.0 mg, 0.013 mmol) were added at 0 °C. The reaction 
mixture was allowed to warm to room temperature and stir overnight under nitrogen. 
Then triethylamine was added and the reaction mixture was concentrated by rotary 
evaporation. The crude material was purified on silica gel (3% ethyl acetate in hexanes) 
to afford the title compound as a white solid (61 mg, 93%). 
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1H NMR (500 MHz, CDCl3): δ 0.69 (3H, d, J = 7 Hz), 1.03 (9H, s), 1.36 (3H, s), 1.43 
(3H, s), 1.54 (1H, m), 1.65 (1H, m), 1.91 (1H, m), 2.60 (1H, m), 2.80 (1H, m), 3.38 (1H, 
m), 3.47 (1H, ddd, J = 10.5 Hz, 4.5 Hz, 3.5 Hz), 3.71 (1H, dd, J = 11.5 Hz, 4.5 Hz), 3.74 
(1H, dd, J = 11.0 Hz, 3.5 Hz), 7.16 (3H, m), 7.25 (2H, m), 7.33-7.40 (6H, m), 7.67-7.72 
(4H, m); 13C NMR (100 MHz, CDCl3): δ 12.3, 19.6, 19.8, 27.0, 30.3, 31.4, 34.9, 35.1, 
65.9, 73.1, 75.7, 98.1, 125.8, 127.7, 127.7, 128.4, 128.8, 129.7, 134.1, 134.1, 135.9, 
136.0, 142.7; IR(neat): 2930.4 (m), 2856.5 (m), 1427.7 (m), 1378.5 (m), 1201.1 (m), 
1186.3 (m), 1166.4 (m), 1110.8 (s), 739.8 (m), 699.8 (s) cm-1; HRMS-(ESI+) for 
C32H42O3SiNa [M+Na]: calculated: 525.7523, found: 525.2803. 
 
 3-(hydroxy(phenyl)methyl)cyclohexane-1,2-diol (3.86). The 
diboration was performed according to the representative 
procedure with cyclohex-2-enyl(phenyl)methanol (94 mg, 0.50 
mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 (254  mg, 1.00 mmol),  methanol (0.34 
mL, 8.5 mmol), and tetrahydrofuran (1 mL). The crude material was purified on silica gel 
(30-100% ethyl acetate in hexanes) to afford the title compound as a white solid (0.10 
mg, 94%). 
 
1H NMR (500 MHz, CD3OD): δ 1.27 (1H, ddd, J = 13.0 Hz, 4.0 Hz, 4.0 Hz), 1.51 (1H, 
ddd, J = 12.5 Hz, 8.0 Hz, 4.0 Hz), 1.62 (3H, m), 1.78 (2H, m), 3.37 (1H, ddd, J = 12.0 
Hz, 5.0 Hz, 3.0 Hz), 3.52 (1H, s), 4.73 (1H, d, J = 8.0 Hz), 7.25-7.28 (1H, m), 7.33-7.36 
(2H, m), 7.40-7.41 (2H, m); 13C NMR (100 MHz, CD3OD): δ 20.3, 23.1, 27.6, 48.2, 71.5, 
72.6, 76.4, 127.0, 127.4, 128.3, 144.3; IR (neat): 3360.7, 2936.4, 2861.1, 1449.9, 1093.7, 
Ph
OH
H
OH
OH
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1070.0, 979.2, 762.4, 702.4, 652.4; HRMS-(ESI-) for C13H17O3 [M-H]: calculated: 
221.1178, found: 221.1182. 
 
Analysis of Stereochemistry: 
The starting material was subjected to dihydroxylation with osmium tetroxide and 
4-methylmorpholine N-oxide to give a mixture of diastereomers as determined by 1H 
NMR. Diastereomer ratio from the diboration/oxidation sequence was then determined 
by comparison of the 1H NMR spectra and was found to be greater than 20:1. 
 
Proof of Stereochemistry: 
The relative  stereochemistry was determined as syn by NOESY NMR of the 2,4-
diphenylhexahydro-4H-benzo[d][1,3]dioxin-8-ol synthesized from the resulting triol in  
the sequence shown below. 
! 227 
 
 
2,4-diphenylhexahydro-4H-benzo[d][1,3]dioxin-8-ol. To a 
mixture of 3-(hydroxy(phenyl)methyl)cyclohexane-1,2-diol (45 
mg, 0.20 mmol) and (dimethoxymethyl)benzene (0.1 mL, 0.5 
mmol) in THF (2 mL), added p-toluenesulfonic acid monohydrate 
(2 mg, 0.01 mmol). The reaction mixture was allowed to stir overnight at room 
temperature. Then the reaction mixture was concentrated by rotary evaporation and 
purified on silica gel (10% ethyl acetate in hexanes) to afford the title compound as a 
white solid (36 mg, 58%). 
 
1H NMR (500 MHz, CDCl3): δ 0.94 (1H, m), 1.12 (1H, qt, J = 13.5 Hz, 3.5 Hz), 1.60 
(2H, m), 1.70 (1H, m), 1.77 (2H, m), 2.33 (1H, b), 3.62 (1H, b), 4.32 (1H, s), 5.06 (1H, d, 
J = 2.5 Hz), 5.77 (1H, s), 7.24 (1H, m), 7.32 (4H, m), 7.38-7.43 (3H, m), 7.58-7.61 (2H, 
m); 13C NMR (100 MHz, CDCl3): δ 19.1, 23.0, 30.0, 40.7, 71.9, 79.3, 81.2, 101.9, 125.5, 
126.7, 127.3, 128.3, 128.4, 129.2, 138.8, 139.9; IR(neat): 2938.5 (m), 1449.8 (m), 1404.6 
Ph
OH OH
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H Ph
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(m), 1157.9 (m), 1062.0 (s), 1009.9 (s), 763.2 (m), 719.6 (m), 698.0 (s) cm-1; HRMS-
(ESI+) for C20H23O3 [M+H]: calculated: 311.1647, found: 311.1641. 
 
 1-isopropyl-3,4-bis(4,4,5,5-tetramethyl-1,2,3-dioxaborolan-2-yl)-
cyclopentanol (3.97). The diboration was performed according to 
the general procedure with slight modifications using 1-
isopropylcyclopent-3-en-1-ol (63 mg, 0.50 mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 
(254 mg, 1.00 mmol), methanol (0.34 mL, 8.5 mmol), and THF (1 mL).  No oxidation 
was performed.  The crude reaction mixture was purified on silica gel (5-10% ethyl 
acetate in hexanes) to afford the product as a white solid (116 mg, 61%). 
 
1H NMR (500 MHz, CDCl3): δ 1.94-1.90 (2H, m), 1.66 (2H, dd, J = 14.0 Hz, 6.0 Hz), 
1.46-1.43 (1H, m), 1.25-1.23 (25H, m), 1.20 (1H, d, J = 4.5 Hz), 0.93 (3H, s), 0.92 (3H, 
s); 13C NMR (100 MHz, CDCl3): δ 85.1, 83.3, 42.5, 37.4, 25.0, 24.9, 24.8, 17.7; 11B 
NMR (160 MHz, CDCl3): δ 30.5; IR (neat): 3524.3 (w), 2975.6 (m), 2932.2 (m), 2874.4 
(m), 1378.4 (m), 1307.4 (m), 1143.2 (m), 1007.0 (m), 858.2 (m); HRMS-(ESI+) for 
C20H38B2O5 [M+H−H2O]: calculated: 363.2878, found: 363.2893. 
 
Analysis of Stereochemistry: 
Diastereomer ratio was determined to be greater than 20:1 based on analysis of 1H and 
13C NMR data. 
 
 
OHi-Pr
B(pin)(pin)B
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Proof of Stereochemistry: 
To prove relative stereochemistry, the compound was subjected to standard oxidation 
conditions and the triol was crystallized out of hexanes, ethyl acetate, and methanol (long 
white crystals). 
 
 
 2,2-dimethyl-4,5-bis(4,4,5,5-tetramethyl-1,2,3-dioxaborolan-2- 
yl)cyclohexanol (3.95). The diboration was performed according 
to the general procedure with using 6,6-dimethylcyclohex-3-en-1-
ol (63 mg, 0.50 mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 
(254 mg, 1.00 mmol), methanol (0.34 mL, 8.5 mmol), and THF (1 mL).  No oxidation 
was performed.  The crude reaction mixture was purified on silica gel (5-10% ethyl 
acetate in hexanes) to afford the product as a white solid (0.14 g, 75%). 
 
1H NMR (500 MHz, CDCl3): δ 3.36 (1H, br s), 1.95 (1H, br s), 1.80-1.69 (3H, m), 1.25-
1.20 (26H, m), 0.90 (6H, br s); 13C NMR (100 MHz, CDCl3): δ 83.2, 82.8, 75.0, 31.8, 
25.0, 24.8, 24.6; 11B NMR (160 MHz, CDCl3): δ 34.3; IR (neat): 3490.4 (w), 2976.2 
(m), 2929.6 (m), 2865.4 (m), 1378.4 (m), 1305.1 (m), 1214.1 (m), 967.0 (m), 855.2 (m) 
cm-1; HRMS-(ESI+) for C20H38B2O5  [M+H]: calculated: 381.2984, found: 381.2978. 
OH
Me
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Analysis of Stereochemistry: 
Diastereomer ratio was determined to be greater than 20:1 based on analysis of 1H and 
13C NMR data. 
 
Proof of Stereochemistry: 
Recrystallized from ethyl acetate and hexanes. 
 
 
 nonane-1,2,5-triol (3.64). The diboration was performed 
according to the representative procedure with non-1-en-5-ol 
(36 mg, 0.25 mmol), B2(pin)2 (0.13 g, 0.50 mmol), Cs2CO3 
(26 mg, 0.075 mmol), methanol (0.17 mL, 4.3 mmol) in tetrahydrofuran (1 mL). The 
crude reaction mixture was purified on silica gel (50-100% ethyl acetate in hexanes) to 
afford a white solid (31 mg, 70%). 
 
1H NMR (500 MHz, CDCl3): δ 0.91 (3H, t, J = 7.0 Hz), 1.24 – 1.72 (10H, m), 2.24 (2H, 
br s), 3.03 (1H, br s), 3.48 (1H, dd, J = 11.0 Hz, 7.5 Hz), 3.65 (1H, dd, J = 11.3 Hz, 3.3 
Hz), 3.65 – 3.69 (m, 1H), 3.73 – 3.77 (1H, m); 13C NMR (100 MHz, CDCl3): δ 14.0, 
22.7, 27.9, 29.1, 33.0, 37.1, 66.8, 71.8, 72.1; IR (neat): 3310.7 (m), 2952.7 (m), 2934.5 
n-Bu
OH
OH
OH
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(m), 2871.7 (m), 858.7 (m), 1466.4 (m), 1442.1 (m), 1342.9 (m), 1046.2 (m), 1013.3 (s), 
965.4 (m), 870.6 (m), 504.8 (m) cm-1; HRMS-(ESI+) for C9H21O3 [M+H]: calculated: 
177.1491, found: 177.1488. 
 
Analysis/Proof of Stereochemistry: 
The diastereoselectivity was attained from SFC analysis, where the TBDPS-protected 
products of the reaction were compared to the TBDPS-protected products from an 
OsO4/NMO dihydroxylation of the substrate. To prove relative stereochemistry, the 
TBDPS-protected product was synthesized using asymmetric reactions to make to 
enantioenriched TBDPS- protected product. 
 
Preparation of 1-((tert-butyldiphenylsilyl)oxy)nonane-2,5-diol: 
 
 
The title compound was prepared as shown above using 
standard procedure. 1H NMR (500 MHz, CDCl3): δ 0.90 (3H, 
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t, J = 7.0 Hz), 1.07 (9H, s), 1.20 – 1.67 (10H, m), 3.51 (1H, dd, J = 10.3 Hz, 7.8 Hz), 3.56 
– 3.62 (1H, m), 3.65 (1H, dd, J = 10.5 Hz, 3.5 Hz), 3.76 (1H, sept, J = 4.0 Hz), 7.38 – 
7.46 (6H, m), 7.65 – 7.67 (4H, m); 13C NMR (100 MHz, CDCl3): δ 14.1, 19.2, 22.7, 26.8, 
27.9, 29.4, 33.9, 37.3, 68.0, 71.9, 72.1, 127.8, 129.8, 133.1, 135.5; IR (neat): 3347.2 (w), 
2954.0 (m), 2929.2 (m), 2857.5 (m), 1463.1 (m), 1427.4 (m), 1111.4 (s), 701.0 (s), 613.5 
(m), 504.5 (s) cm-1; C25H35O2Si [M-H2O]: calculated: 395.2406, found: 395.2418. 
 
 
 undecane-1,2,6-triol  (3.66). Prepared according to 
the general diboration/oxidation procedure using 
undec-1-en-6-ol (85 mg, 0.50 mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 (254 mg, 
1.00 mmol), methanol (0.34 mL, 8.5 mmol), and THF (1 mL).  The crude product was 
purified on silica gel (25-50% ethyl acetate in hexanes) to afford the title compound as a 
white solid (79 mg, 77%). 
n-pentyl
OH OH
OH
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1H NMR (500 MHz, CDCl3): δ 0.88 (3H, t, J = 7.0 Hz), 1.26-1.35 (5H, m), 1.37-1.54 
(9H, m), 1.54-1.62 (1H, m), 1.79 (1H, s), 2.05 (1H, s), 3.42-3.46 (1H, m), 3.59-3.61 (1H, 
m), 3.64-3.66 (1H, m), 3.70-3.73 (1H, m); 13C NMR (100 MHz, CDCl3): δ 14.0, 21.5, 
21.6, 22.6, 25.3, 25.3, 31.8, 32.9, 33.0, 36.9, 37.1, 37.5, 37.6, 66.7, 66.8, 71.8, 72.0, 72.1; 
IR (neat): 3331.2 (br, m), 2925.9 (m), 2862.4 (w), 1453.5 (m), 1046.4 (s), 897.2 (m), 
849.2 (m), 746.2 (s), 697.8 (s); HRMS-(ESI+) for C11H24O3 [M+H]: calculated: 
205.1804, found: 205.1806; melting point: 77-80 °C. 
 
Analysis of Stereochemistry: 
The starting material was subjected to dihydroxylation with osmium tetroxide and 
4-methylmorpholine N-oxide to give a mixture of diastereomers as determined by 1H 
NMR. Diastereomer ratio from the diboration/oxidation sequence was then determined 
by comparison of the 1H NMR and was found to be 1:1. 
 
 
! 234 
 tert-butyldimethyl(2-phenyl-3,4-bis(4,4,5,5-tetramethyl-1,3,2- 
dioxaborolan-2-yl)butoxy)silane (3.76). The diboration 
was performed according to the representative procedure using 
2-phenylbut-3-en-1-ol (74 mg, 0.50 mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 (254 
mg, 1.00 mmol), methanol (0.34 mL, 8.5 mmol), and tetrahydrofuran (1 mL) . After the 
diboration was complete, the reaction mixture was concentrated, and dichloromethane 
(2.3 mL) and imidazole (0.30 g, 4.4 mmol), were added to the flask. Then the reaction 
mixture was cooled to 0 °C, and TBSCl (0.22 g, 1.5 mmol) in toluene (0.5 mL) was 
added. The reaction mixture was allowed to warm to room temperature and stir for 12 h. 
Then the reaction mixture was diluted with sat. ammonium chloride (aq) and the aqueous 
layer was extracted with DCM (3x10 mL). The organic layers were combined, dried over 
sodium sulfate, filtered, and concentrated by rotary evaporation. The crude material was 
purified on silica gel (2.5% ethyl acetate in hexanes) to isolate the title compound as a 
white solid (0.15 g, 57%). 
 
1H NMR (400 MHz, CDCl3): δ -0.18 (3H, app t, J = 3.0 Hz), -0.13 (3H, app t, J = 2.8 
Hz), 0.66 (2H, m), 0.74 (9H, app t, J = 2.6 Hz), 1.16 (6H, s), 1.17 (6H, s), 1.21 (6H, s), 
1.23 (6H, s), 0.59 - 0.73 (1H, m), 2.87 (1H, dt, J = 11.3 Hz, 7.5 Hz), 3.69 (1H, dd, J = 9.8 
Hz, 8.6 Hz), 3.85 (1H, dd, J = 9.8 Hz, 5.0 Hz), 7.08 – 7.22 (5H, m); 13C NMR (100 MHz, 
CDCl3): δ -5.5, 18.2, 24.7, 24.9, 24.9, 24.9, 25.8, 51.1, 66.8, 82.7, 83.0, 125.7, 127.7, 
128.9, 143.4; 11B NMR (160 MHz, CDCl3): δ 33.8; IR (neat): 3027.5 (w), 2977.5 (m), 
2928.2 (m), 2856.3 (m), 1602.7 (w), 1493.6 (m), 1369.1 (m), 1369.1 (s), 1312.9 (s), 
TBSO
Ph
B(pin)
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1252.6 (s), 1140.8 (s), 1103.6 (s), 833.8 (s), 773.3 (s), 698.9 (s) cm-1; HRMS- (ESI+) for 
C28H51B2O5Si [M+H]: calculated: 517.3692, found: 517.3712. 
 
Analysis of Stereochemistry: 
The diastereoselectivity was attained from SFC analysis, where the oxidized 
products of the directed diboration reaction were compared to those of an OsO4/NMO 
dihydroxylation of the substrate. 
 
SFC (2EP 4.6x250, 35 °C, 3mL/min, 5% MeOH, 100 bar) 
 
 
Proof of Stereochemistry: 
The reaction sequence shown below was used to form the acetonide, which was 
recrystallized from ethyl acetate and hexanes. 
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 4-phenylbutane-1,2,3-triol (3.62). The diboration was performed 
according to the representative procedure with tetradec-1-en-4-ol 
(37 mg, 0.25 mmol), Cs2CO3 (26 mg, 0.075 mmol), B2(pin)2 (0.13 
g, 0.50 mmol), methanol (0.17 mL, 4.3 mmol), and tetrahydrofuran (0.5 mL). The crude 
material was purified on silica gel (50%-100% EtOAc/Hexanes) to afford the title 
compound was obtained as a mixture of diastereomers (1.8:1) as a clear oil (21 mg, 47%). 
1H NMR (500 MHz, CD3OD): δ 2.62 (1H, dd, J = 14.0 Hz, 9.0 Hz), 3.04 (1H, dd, J = 
13.5 Hz, 3.5 Hz), 3.49 – 3.45 (1H, m), 3.63 – 3.58 (1H, m), 3.72 – 3.71 (1H, m), 3.77 
(1H, dd, J = 11.0 Hz, 3.5 Hz), 7.14 – 7.19 (1H, m), 7.25 – 7.26 (4H, m); 13C NMR (125 
MHz, CD3OD): δ 39.2, 63.3, 72.8, 73.4, 125.6, 127.7, 129.2, 139.1; IR (neat): 3343.1 (s), 
TBSO Bpin
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3061.4 (w), 3027.5 (w), 2924.1 (m), 1603.3 (w), 1495.2 (m), 1453.7 (m), 1063.1 (s), 
1029.9 (s), 745.7 (m), 699.4 (s) cm-1; HRMS- (ESI+) for C10H15O3 [M+H]: calculated: 
183.10212, found: 183.10270. 
 
Determination of diastereoselectivity: 
The diastereoselectivity was determined from SFC analysis, where the products of the 
reaction were compared to products from an OsO4/NMO dihydroxylation of the substrate. 
Diastereomer ratio was determined to be 1.8:1. 
 
SFC (2EP 4.6x250, 35 °C, 3mL/min, 5% MeOH, 100 bar) 
 
 
 4-methoxy-5-phenylpentane-1,2-diol (3.80). The diboration 
was performed according to the representative procedure with 
(2-methoxypent-4-en-1-yl)benzene  (88  mg,  0.50  mmol),  B2(pin)2   (254  mg,  1.00  
mmol), Cs2CO3 (53 mg, 0.15 mmol), methanol (.34 mL, 8.5 mmol) in tetrahydrofuran (1 
Ph
OMe OH
OH
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mL). The crude reaction mixture was purified by on silica gel (50-100% ethyl acetate in 
hexanes) to afford a clear, colorless oil (80 mg, 76%). 
 
1H NMR (500 MHz, CDCl3): δ 1.45 (0.5H, ddd, J = 16.0 Hz, 8.3 Hz, 3.3 Hz), 1.51-1.69 
(1.5H, m), 2.71 (1H, ddd, J = 13.5 Hz, 8.3 Hz, 7.3 Hz), 2.98 (1H, dt, J = 13.5 Hz, 5.0 Hz), 
3.36 – 3.42 (0.5H, m), 3.37 (1.5H, s), 3.42 (1.5H, s), 3.51 (0.5H, dd, J = 11.5, 4.0 Hz), 
3.55 (0.5H, dd, J = 11.5 Hz, 3.5 Hz), 3.64 - 3.73 (1H, m), 3.80 - 3.85 (0.5H, m), 3.94 - 
3.98 (0.5H, m), 7.17 - 7.23 (3H, m), 7.26 - 7.31 (2H, m); 13C NMR (100 MHz, CDCl3): δ 
24.8, 36.1, 36.7, 39.7, 39.8, 56.7, 57.3, 66.6, 66.9, 69.3, 71.7, 80.0, 82.8, 126.3, 126.4, 
128.4, 128.5, 129.4, 129.5, 137.7, 138.2; IR (neat): 3380.4 (m), 2931.0 (m), 2828.0 (w), 
1602.9 (w), 1495.1 (m), 1453.8 (m), 1082.7 (s), 746.3 (m), 700.1 (s) cm-1; HRMS-(ESI+) 
for C12H19O3 [M+H]: calculated: 211.1334, found: 211.1336. 
Analysis of Stereochemistry: 
Diastereomer ratio was determined to be 1:1 based on analysis of the 1H NMR spectrum. 
 
 syn-tetradecane-1,2,4-triol. The diboration was performed 
according to the representative procedure with tetradec-1-en-
4-ol (0.11 g, 0.50 mmol), Cs2CO3 (49 mg, 0.15 mmol), B2(pin)2 (254 mg, 1.00 mmol), 
methanol (0.34 mL, 8.5 mmol), and tetrahydrofuran (1 mL). The crude material was 
purified on silica gel (50%-100% EtOAc/Hexanes) to afford the title compound was 
obtained as a white solid (56 mg, 53%). 1H NMR (500 MHz, CDCl3/drop of D2O): δ -
0.88 (3H, t, J = 6.9 Hz), 1.22 – 1.34 (14H, m), 1.35 – 1.42 (1H, m), 1.43 – 1.52 (2H, m), 
1.53 – 1.59 (2H, m), 1.60 – 1.70 (1H, m), 3.47 (1H, dd, J = 11.3 Hz, 6.4 Hz), 3.63 (1H, 
n-decyl
OH OH
OH
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dd, J = 11.0 Hz, 3.2 Hz), 3.86 – 3.93 (1H, m), 3.93 – 3.99 (1H, m); 13C NMR (125 MHz, 
CDCl3): δ 14.1, 22.7, 25.3, 29.3, 29.6, 29.6, 31.9, 38.3, 39.0, 66.8, 72.5, 72.6; IR (neat): 
3356.4 (m), 2955.6 (m), 2921.3 (s), 2852.0 (s), 1655.3 (w), 1465.4 (m), 1065.0 (s), 587.3 
(s), 504.3 (s) cm-1; HRMS- (ESI+) for C14H29O2 [M+H-H2O]: calculated: 229.21675, 
found: 229.21716. 
 
Analysis of Diastereoselectivity:   
Diastereomer ratio from the diboration/oxidation sequence was determined by 1H 
NMR spectra and was found to be 8.5:1. 
 
3.11.5 Fragment Synthesis 
 (R)-1-((tert-butyldiphenylsilyl)oxy)-5-methylhex-5-en-3-ol 
(3.111). To an oven-dried 16-mL vial with magnetic stir bar in 
the dry box was added Pt(dba)3 (4.5 mg, 5.0 µmol), (R,R)-3,5-di-iso-propylphenyl-
TADDOLPPh (5.5 mg, 6.0 µmol), B2(pin)2  (133 mg, 525 µmol) and tetrahydrofuran (0.5 
mL). The vial was sealed with a teflon septum cap, removed from the dry box, and heated 
to 80 °C in an oil bath for 20 minutes. The vial was cooled to room temperature, returned 
to the dry box and charged with (but-3-en-1-yloxy)(tert-butyl)diphenylsilane (155 mg, 
500 µmol). The vial was sealed, removed from the dry box and stirred at 60 °C for 3 h. 
The vial was cooled to room temperature, returned to the dry box and charged with solid 
potassium hydroxide (84.2 mg, 1.50 mmol), Pd(OAc)2 (3.1 mg, 12.5 µmol)/RuPhos (7 
mg, 15 µmol) (added as a 1:1.2 solution in THF (1 mL)), tetrahydrofuran (3.05 mL) and 
2-chloroprop-1-ene (65 µL, 750 µmol). The vial was sealed, removed from the dry box, 
TBDPSO OH Me
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and H2O (sparged with N2 for 30 min, 0.45 mL) was added through the teflon septum 
cap. The vial was heated to 70 °C and stirred for 12 h. The reaction mixture was 
transferred to a 50-mL round bottom flask and cooled to 0 °C (ice/water) and charged 
with 3 M sodium hydroxide (2 mL), and 30% hydrogen peroxide (1 mL). The reaction 
was gradually warmed to room temperature and allowed to stir for 4 h at which time the 
vial was cooled to 0 °C and saturated aqueous sodium thiosulfate was added dropwise 
over 5 min. The reaction mixture was diluted with ethyl acetate and the aqueous and 
organic layers were separated. The aqueous layer was extracted with ethyl acetate (3 x 20 
mL) and the combined organics were dried over Na2SO4, filtered, and concentrated by 
rotary evaporation. The crude reaction mixture was purified by column chromatography 
on silica gel (2.5-5% ethyl acetate/hexanes, Rf = 0.4 in 10% ethyl acetate/hexanes, stain 
in KMnO4) to afford a clear, colorless oil (165 mg, 90%).  
 
1H NMR (500 MHz, CDCl3): δ 1.06 (9H, s), 1.68 – 1.74 (2H, m), 1.77 (3H, s), 2.18 (1H, 
dd, J = 13.8 Hz, 5.3 Hz), 2.25 (1H, dd, J = 13.8 Hz, 7.8 Hz), 2.99 (1H, d, J = 2.0 Hz), 
3.83 – 3.92 (2H, m), 4.04 – 4.10 (1H, m), 4.78 (1H, s), 4.85 (1H, s), 7.38 – 7.46 (6H, m), 
7.68 – 7.70 (4H, m); 13C NMR (125 MHz, CDCl3): δ 19.1, 22.5, 26.8, 38.3, 46.1, 63.0, 
68.7, 113.0, 127.7, 129.8, 133.1, 135.5, 142.8; IR (neat): 3449.9 (w), 3071.2 (w), 2930.3 
(m), 2856.9 (m), 1647.2 (w), 1589.5 (w), 1471.6 (m), 1427.3 (m), 1107.8 (s), 1076.3 (s), 
736.0 (s), 699.5 (s), 613.0 (s), 502.2 (s), 487.3 (s) cm-1; HRMS-(ESI+) for C23H33O2Si 
[M+H]: calculated: 369.22498, found: 369.22487. [α]D = -2.459 (c = 0.4875, CH2Cl2, l = 
50 nm). 
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Analysis of Stereochemistry: 
The title compound was compared to the racemic analogue derived from the racemic 
diboration of (but-3-en-1-yloxy)(tert-butyl)diphenylsilane. The resulting racemic diboron 
was transformed into 1-((tert-butyldiphenylsilyl)oxy)-5-methylhex-5-en-3-ol as described 
above for the enantioenriched variant. 
 
Chiral  SFC  (Chiracel,  OD-H,  35  °C,  3  mL/min,  3%  Isopropanol,  100  bar,  210-
270nm) – analysis of 1-((tert-butyldiphenylsilyl)oxy)-5-methylhex-5-en-3-ol. 
 
 
 (3S,5R)-1-((tert-butyldiphenylsilyl)oxy)-5-methyloct-7-
ene-3,5- diol (3.113). To an oven-dried 16-mL vial with 
magnetic stir bar in the dry box was added 1-((tert-butyldiphenylsilyl)oxy)-5-methylhex-
5-en-3-ol  (90  mg,  240  µmol),  Cs2CO3   (25  mg,  7.0  µmol),  B2(pin)2   (94  mg,  370  
µmol)  and tetrahydrofuran (1 mL). The vial was sealed with a teflon septum cap and 
removed from the dry box. To the vial was added methanol (0.17 mL, 4.2 mmol). The 
reaction mixture was heated to 70 °C in an oil bath overnight. The vial was cooled to 
TBDPSO HO Me OH
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room temperature and concentrated by rotary evaporation within the vial. The residue 
was then put on hi-vac for 1 hour to ensure the evaporation of methanol. The vial was 
then brought into the dry box and charged with potassium tert-butoxide (162 mg, 1.44 
mmol), Pd(OAc)2 (1.5 mg, 6.0 µmol)/RuPhos (2.8 mg, 6.0 µmol) (added as a 1:1 solution 
in THF (1 mL)), tetrahydrofuran (1.3 mL) and 1,2-dichloroethane (57 µL, 0.72 mmol). 
The vial was sealed, removed from the dry box, and H2O (sparged with N2 for 30 min, 
0.23 mL) was added through the teflon septum cap. The vial was heated to 70 °C and 
stirred for 12 h. The reaction mixture was transferred to a 50-mL round bottom flask and 
cooled to 0 °C (ice/water) and charged with 3 M sodium hydroxide (1 mL), and 30% 
hydrogen peroxide (0.5 mL). The reaction was gradually warmed to room temperature 
and allowed to stir for 4 h at which time the vial was cooled to 0 °C and saturated 
aqueous sodium thiosulfate was added dropwise over 5 min. The reaction mixture was 
diluted with ethyl acetate and the aqueous and organic layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 x 20 mL) and the combined organics 
were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude 
reaction mixture was purified by column chromatography on silica gel (5-20% ethyl 
acetate/hexanes, Rf = 0.3 in 30% ethyl acetate/hexanes, stain in KMnO4) to afford a clear, 
colorless oil (44 mg, 44%). 
 
1H NMR (500 MHz, CDCl3): δ 1.06 (9H, s), 1.30 (3H, s), 1.44 (1H, dd, J = 14.3 Hz, 2.25 
Hz), 1.58 – 1.63 (1H, m), 1.72 (1H, dd, J = 14.5 Hz, 11.0 Hz), 1.75 – 1.82 (1H, m), 2.20 
– 2.28 (2H, m), 3.72 (1H, s), 3.84 – 3.91 (2H, m), 3.93 (1H, s), 4.32 (1H, t, J = 9.8 Hz), 
5.07 – 5.13 (2H, m), 5.87 – 5.94 (1H, m), 7.39 – 7.47 (6H, m) 7.67 – 7.69 (4H, m); 13C 
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NMR (125 MHz, CDCl3): δ 19.0, 25.9, 26.8, 39.2, 45.9, 48.7, 63.0, 69.4, 72.4, 118.1, 
127.8, 129.9, 133.0, 134.3, 135.5; IR (neat): 3351.1 (w), 3071.3 (w), 2930.6 (m), 2857.0 
(m), 1640.2 (w), 1589.3 (w), 1427.1 (m), 1106.7 (s), 1085.4 (s), 735.8 (s), 699.6 (s), 
687.6 (s), 613.0 (s), 502.7 (s), 487.4 (s) cm-1; HRMS-(ESI+) for C25H37O3Si [M+H]: 
calculated: 413.2512, found: 413.2496. [α]D CH2Cl2, l = 50 nm). 
 
Analysis of Stereochemistry: 
The title compound was subjected to the reactions below, which gave a previously 
characterized compound, which served as proof of stereochemistry. 45  The 
diastereoselectivity of the diboration was determined by a directed diboration and 
oxidation of 1-((tert-butyldiphenylsilyl)oxy)-5-methylhex-5-en-3-ol. The product of this 
reaction was compared to those products from an OsO4/NMO dihydroxylation of 1-((tert-
butyldiphenylsilyl)oxy)-5-methylhex-5-en-3-ol. 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
45 Allais, F.; Cossy, J. Org. Lett. 2006, 8, 3655 – 3657. 
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 (2S,4S)-6-((tert-butyldiphenylsilyl)oxy)-2-methylhexane-
1,2,4-triol. The diboration was performed according to 
the representative   procedure   with   1-((tert-butyldiphenylsilyl)oxy)-5-methylhex-5-en-
3-ol (69 mg, 0.19 mmol), B2(pin)2 (71 mg, 1.5 mmol), Cs2CO3 (20 mg, 0.057 mmol), 
methanol (0.13 mL, 3.23 mmol) in tetrahydrofuran (0.76 mL, 0.25 M). The crude 
reaction mixture was purified by column chromatography on silica gel (25-100% ethyl 
acetate/hexanes, Rf = 0.25 in 75% ethyl acetate/hexanes, stain in KMnO4) to afford a 
clear, colorless oil (48 mg, 65%).  
 
1H NMR (500 MHz, CD3OD): δ 1.04 (9H, s), 1.21 (3H, s), 1.56 – 1.65 (2H, m), 1.67 – 
1.78 (2H, m), 3.36 (2H, q, J = 17.3 Hz, 11.3 Hz), 3.75 – 3.85 (2H, m), 4.21 – 4.26 (1H, 
m), 7.38 – 7.44 (6H, m) 7.66 – 7.69 (4H, m); 13C NMR (125 MHz, CD3OD): δ 18.6, 23.0, 
25.9, 40.7, 43.8, 60.6, 65.6, 69.8, 72.7, 127.4, 129.4, 133.5, 135.3; IR (neat): 3382.5 (m), 
3070.6 (w), 3048.6 (w), 2930.4 (m), 2856.9 (m), 1589.2 (w), 1471.5 (m), 1187.5 (m), 
1106.9 (s), 1087.5 (s), 822.20 (m), 736.3 (s), 700.6 (s), 613.0 (s), 503.6 (s), 488.6 (s) cm-
1; HRMS-(ESI+) for C23H35O4Si [M+H]: calculated: 403.2305, found: 403.2319. 
  
TBDPSO HO Me OH
OH
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3.11.6 Spectral Data 
For all published spectral data see the following link: 
http://pubs.acs.org/doi/suppl/10.1021/ja504228p  
See below for examples of 1H and 13C spectra: 
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Chapter 4: The Stereo- and Regiospecific, Hydroxyl-Directed 
Cross-Coupling of Secondary Boronates 
 
4.1 Introduction 
 With the ongoing development of novel borylation transformations (Chapter 3), 
efficient methods for the formation of C-C bonds from these organoboronates, especially 
in a stereospecific manner, are necessary. Over the past three decades, the Suzuki-
Miyaura cross-coupling reaction has been developed as one such method.  While the 
Suzuki reaction has been developed broadly, the cross-coupling of congested alkyl 
organoboronates, such as secondary and tertiary boronates, has been, until recently, an 
underdeveloped area of research.  These substrates pose a handful of mechanistic 
challenges (Scheme 4.1).  For one, the rate of transmetallation for secondary and, to a 
larger degree, tertiary organoboronates is much slower then that of a primary 
organoboronate.  For this precise reason, many research groups have utilized 
organotrifluoroboronates, compounds that undergo a rapid transmetallation without 
substantial protodeborylation. Secondly, the transmetallation can occur with either 
retention or inversion of stereochemistry; 1  if both pathways are competitive, the 
enantiopurity of the product is likely to be diminished.  Finally, the intermediate after 
transmetallation can either undergo a productive reductive elimination, furnishing the 
coupled product, or β-hydride elimination, creating olefin-containing byproducts.  For 
bulkier organoboronates containing β-hydrides, a slow reductive elimination may instead !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 For early mechanistic studies relating to stereochemical consideration for the Suzuki-
Miyaura cross-coupling reaction, see: (a) Ridgway, B. H.; Woerpel, K. A. J. Org. Chem.  
1998, 63, 458 – 460. (b) Matos, K.; Soderquist, J. J. Org. Chem. 1998, 63, 461 – 470. 
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result in a more favorable β-hydride elimination.  Recently, in an effort to overcome these 
difficulties, many research groups have developed reactions, both transition-metal 
catalyzed and not, for the stereospecific coupling of secondary and tertiary 
organoboronates.2 
 
Scheme 4.1 Catalytic Cycle of the Suzuki-Miyaura Cross-Coupling Reaction 
 
 
4.2 Early Examples of the Pd-Catalyzed Cross-Couplings of Secondary 
Organoboronates 
 With the development of catalytic Csp2-Csp2 Suzuki-Miyaura cross-coupling 
procedures, some research groups began to investigate whether these methods could be 
adapted to Csp2-Csp3 couplings with secondary alkyl organoboronates.  In 2000, Fu and !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 For an excellent recent review see: Leonori, D.; Aggarwal, V. K. Angew. Chem., Int. 
Ed., 2015, 54, 1082 – 1096. 
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coworkers3 reported an isolated example of boronic acid 4.1 undergoing Pd-catalyzed 
coupling with 4.2 to furnish the coupled product 4.3 in good yield (Scheme 4.2, Eq. 1).  
Similarly, Hartwig and coworkers4 disclosed an isolated example of the acyclic boronic 
acid 4.4 participating in Pd-catalyzed cross-coupling with 4.5 to furnish the coupled 
product 4.6 in 55% yield (Scheme 4.2, Eq. 2).  Interestingly, the ferrocene-derived ligand 
4.7 also proved effective for Csp2-Csp2, Csp2-N, and Csp2-O bond forming cross-
coupling reactions.  In 2008, Van der Hoogenband and coworkers5 reported a RuPhos-
mediated coupling reaction of secondary organotrifluoroboronates.  The coupling of 4.8 
and 4.9 generates the coupled product 4.10 in 70% yield (Scheme 4.2, Eq. 3).  The cross-
coupling of an acyclic organotrifluoroboronate proceeds slower and is hampered by a 
competitive β-hydride elimination.  Later that year, Molander and coworkers6 published 
similar conditions for the coupling of secondary organotrifluoroboronates, improving the 
coupling of acyclic substrates. 
 
 
 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 Littke, A. F.; Dai, C.; Fu, G. C. J. Am. Chem. Soc. 2000, 122, 4020 – 4028. 
4 Kataoka, N.; Shelby, Q.; Stambuli, J. P.; Hartwig, J. F. J. Org. Chem. 2002, 67, 5553 – 
5566. 
5 van der Hoogenband, A.; Lange, J.; Terpstra, J.; Koch, M.; Visser, G.; Visser, M.; 
Korstanje, T.; Jastrzebski, J. Tetrahedron Lett. 2008, 49, 4122 – 4124. 6!Dreher, S. D.; Dormer, P. G.; Sandrock, D. L.; Molander, G. A. J. Am. Chem. Soc. 
2008, 130, 9257 – 9259.!
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Scheme 4.2 Early Examples of Suzuki-Miyaura Cross-Coupling of Secondary Boronates 
 
 
4.3 Stereospecific, Pd-Catalyzed Cross-Coupling of Secondary Organoboronates 
4.3.1 Cyclopropyl Boronates 
 Early studies of the stereospecific cross-coupling of secondary boronates involved 
the use of cyclopropyl boronic acids and esters.  This privileged set of substrates 
undergoes a relativity efficient transmetallation due to the carbons of the cyclopropyl 
group having sp2-like hybridization.  Additionally, these substrates are less likely to 
undergo β-hydride elimination.  In 1998, Deng and coworkers7 reported the coupling of 
enantioenriched cyclopropylboronic acids with aryl and acryloyl halides.  Using 3% 
Pd(PPh3)4, the reaction of 4.11 with 4.12 produced the coupled product 4.13 in 90% yield 
with complete retention of stereochemistry (Scheme 4.3).  The enriched !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
7 Zhou, S.-M.; Deng, M.-Z.; Xia, L.-J.; Tang, M.-H. Angew. Chem., Int. Ed. 1998, 37, 
2845 – 2847. 
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cyclopropylboronic acids were synthesized from a cyclopropanation of the vinyl boronate 
esters of N,N,N',N'-tetramethyltartaric acid diamide followed by hydrolysis.  Notably, the 
reaction with the auxiliary-containing cyclopropyl boronate ester was sluggish under the 
reaction conditions.  Therefore, a hydrolysis of the auxiliary was necessary. 
 
Scheme 4.3 Stereospecific Cross-Coupling of Cyclopropyl Borinic Acids 
 
 
4.3.2 Benzylic Boronates 
In addition to cyclopropylborons, secondary benzylic boronates are an active 
substrate for Suzuki cross-coupling. Crudden and coworkers8 developed a stereoretentive 
coupling of benzylic boronate esters and aryl iodides. In the presence of Pd2dba3 and 
PPh3, arene 4.15 reacts with excess 4.14 to yield the coupled product 4.16 in 63% yield 
and 92% enantiospecificity (es) (Scheme 4.4).  The starting boronates are easily accessed 
from enantioselective hydroboration of the subsequent styrene. 9   Using similar 
conditions, the authors have extended the reaction to dibenzylic boronic ester substrates, 
developing an effective way to synthesize enantioenriched triarylmethanes.10 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
8 Imao, D.; Glasspoole, B. W.; Laberge, V. S.; Crudden, C. M. J. Am. Chem. Soc. 2009, 
131, 5024 – 5025. 
9 Crudden, C. M.; Hleba, Y. B; Chen, A. C. J. Am. Chem. Soc. 2004, 126, 9200 – 9201. 
10 Matthew, S. C.; Glasspoole, B. W.; Eisenberger, P.; Crudden, C. M. J. Am. Chem. Soc.  
2014, 136, 5828 – 5831. 
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Scheme 4.4 Stereospecific Cross-Coupling of Secondary Benzylic Boronates 
 
 
4.3.3 Amide-Assisted Cross-Coupling 
Suginome and coworkers11 disclosed the first ever Suzuki coupling to occur with 
stereoinversion.  The benzyl boronate 4.17 and 4.18 undergo coupling, furnishing 4.19 in 
80% yield and 96% es (Scheme 4.5, 1).  The inversion of stereochemistry is rationalized 
by chelation of the amide carbonyl to the boronate, as shown in transition state 4.22, 
allowing for an outer-sphere transmetallation (SE2 pathway).  Fascinatingly, with the 
addition of Lewis acids (such as Zr(Oi-Pr)4), the selectivity is overturned and the 
coupling occurs with retention.12  It is proposed that the Lewis acid additive disrupts the 
intramolecular chelation between the carbonyl and boronate, allowing for a retentive 
coupling, similar to the reaction reported by Crudden (Scheme 4.4).   
Using a similar β-carbonyl activating strategy, Molander and coworkers 13 
reported the first stereospecific cross-coupling of secondary, nonbenzylic 
organotrifluoroboronates.  The coupling of 4.20 and chlorobenzene in cyclopentyl methyl 
ether (CPME) and water proceeds with excellent enantiospecificity, yielding the inverted 
product 4.21 in 87% yield (Scheme 4.5, 2).  Unlike the substrates studied by Suginome, 
4.20 is vulnerable to β-hydride elimination.  However, it is proposed that the carbonyl !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
11 Ohmura, T.; Awano, T.; Suginome, M. J. Am. Chem. Soc. 2010, 132, 13191 – 13193.  
12 Awano, T.; Ohmura, T.; Suginome, M. J. Am. Chem. Soc. 2011, 133, 20738 – 20741. 
13 Sandrock, D. L.; Jean-Gérard, L.; Chen, C.; Dreher, S. D.; Molander, G. A. J. Am. 
Chem. Soc. 2010, 132, 17108 – 17110.   
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stabilizes the alkyl Pd complex after transmetallation, preventing it from adopting 
conformations necessary for β-hydride elimination (syn-periplanar to the β-hydrogen 
atoms). 
 
Scheme 4.5 Amide-Assisted Stereospecific Cross-Coupling of Secondary Boronates 
 
 
 4.3.4 α-Alkoxy Boronates 
In 2012, Molander and coworkers14 published the cross-coupling of α-alkoxy 
organotrifluoroboronates with a variety of aryl chlorides.  The starting 
organotrifluoroboronates were prepared in high enantioselectivity through a Matteson 
homologation of the primary (S,S)-dicyclohexylethanediol (DICHED) boronate.  Using 
precatalyst 4.26, the coupling of 4.23 and 4.24 occurs with complete stereospecificity, 
affording 4.25 with retention of configuration (Scheme 4.6).  It is proposed that β-hydride 
elimination is circumvented due to a benzyl stabilization of the alkyl Pd complex after 
transmetallation. 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
14 Molander, G. A.; Wisniewski, S. R. J. Am. Chem. Soc. 2012, 134, 16856 – 16868. 
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Scheme 4.6 Stereospecific Cross-Coupling of Secondary α-Alkoxy 
Organotrifluoroboronates. 
 
 
4.3.5 1,1-Bis(boronates) 
Shibata and coworkers15 disclosed the ability of 1,1-bis(boronates) to partake in 
cross-coupling with aryl bromides at ambient temperature.  The coupling of 4.27 and 
bromobenzene furnishes the secondary boronate 4.28 in 74% yield (Scheme 4.7).  It is 
suggested that with a second boronate present, the amount of anionic borate species is 
increased, speeding up transmetallation.  Additionally, the empty p orbital stabilizes the 
alkyl-Pd σ-bond, mitigating the likelihood of β-hydride elimination. 
 
Scheme 4.7 Cross-Coupling of 1,1-Bis(boronates). 
 
In an effort to expand on the use of 1,1-diborons as nucleophiles, Hall and 
coworkers16 reported the cross-coupling of chiral 3,3-diboronyl carboxyesters with aryl 
and vinyl bromides.  These differentiated diboryl species are synthesized from the 
asymmetric conjugate borylation of 1,8-diaminonaphthalenyl boronylacrylates using !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
15 Endo, K.; Ohkubo, T.; Hirokami, M.; Shibata, T. J. Am. Chem. Soc. 2010, 132, 11033 
– 11035. 
16 Lee, J. C. H.; McDonald, R.; Hall, D. G. Nature Chem. 2011, 3, 894 – 899. 
Ph OBn
BF3K Cl
MeO
+
7.5% 4.26
3 equiv CsOH•H2O
CPME/H2O, 105 °C Ph OBn
87%
99% ee
100% es Pd NH2Cl
PAd2nBu4.23 4.24
4.25
4.26
OMe
Ph
B(pin)
B(pin)
4
Ph
Ph
B(pin)
4
+
Br
5% Pd[P(t-Bu)3]2
4.5 equiv KOH
dioxane, RT
4.28
74%
4.27
1.5 equiv
1.0 equiv
! 260 
B2(pin)2.  The coupling of 4.29 and iodobenzene yields the product 4.30 with complete 
stereoinversion (Scheme 4.8).  Similar to the observations of Suginome and Molander, 
the inversion of stereochemistry is due to intramolecular chelation between the ester 
carbonyl oxygen and the boron atom, allowing for an outer-sphere transmetallation. 
 
Scheme 4.8 Ester-Assisted Cross-Coupling of 1,1-Bis(boronates). 
 
Chiral organoboronates can be attained through the enantioselective cross-
coupling of achiral 1,1-bis(boronates).  Morken and coworkers17 reported the coupling of 
1,1-bis(pinacolboronate) esters with aryl halides using phosphoramidite ligand 4.34.  The 
cross-coupling of 4.31 and 4.32 affords 4.33 in 82% yield and 88% ee (Scheme 4.9).  The 
scope of electrophiles was extended to vinyl halides using a Josiphos-type ligand.18  
Interestingly, through isotope-labeling experiments, the transmetallation was shown to 
occur with inversion of stereochemistry.  It is possible that the transmetallation could 
occur through a desymmetrization of the 1,1-bis(boronates) or a dynamic kinetic 
resolution of the product of a mono-hydrolysis. 
 
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
17 Sun, C.; Potter, B.; Morken, J. P. J Am. Chem. Soc. 2014, 136, 17918 – 17921. 
18 Potter, B.; Szymaniak, A. A.; Edelstein, E. K.; Morken, J. P. J. Am. Chem. Soc. 2014, 
136, 17918 – 17921. 
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Scheme 4.9 Enantioselective Cross-Coupling of Achiral 1,1-Bis(boronates). 
 
4.3.6 Unactivated Secondary Alkyl Boronates 
In 2014, Biscoe and coworkers19 published the first stereospecific cross-coupling 
of unactivated secondary alkyl boronates.  Using precatalyst 4.37, the reaction of 
chlorobenzene with excess chiral organotrifluoroboronate 4.35 yielded the coupled 
product 4.36 in excellent yield and stereospecificity (Scheme 4.10).  4.35 was synthesized 
using Brown’s chiral auxiliary approach20 in a 25% yield from (+)-α-pinene.  The authors 
report that the reaction proceeds with inversion of stereochemistry.  To rationalize this 
observation, the authors draw parallels between the transmetallation of unactivated 
secondary alkyl boronates and the invertive electrophilic substitution reaction using 
secondary boranes.21   
 
Scheme 4.10 Stereospecific Cross-Coupling of Unactivated Secondary Boronates 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
19 Li, L.; Zhao, S.; Joshi-Pangu, A.; Diane, M.; Biscoe, M. R. J. Am. Chem. Soc. 2014, 
136, 14027 – 14030. 
20 Joshi N. N.; Pyun, C.; Mahindroo, V.; Singaram, B.; Brown, H. C. J. Org. Chem. 
1992, 57, 504 – 511.!
21 (a) Kabalka, G. W.; Gooch, E. E. J. Org. Chem. 1980, 45, 3578 – 3580. (b) Larouche-
Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Soc. Chem. 2011, 133, 16794 – 
16797. 
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4.4 Transition-Metal Free Couplings of Secondary and Tertiary Boronates 
Although the Suzuki-Miyaura cross-coupling of secondary boronates has 
advanced greatly in the last decade, the reaction is not general and, in many cases, 
requires excess chiral boronate.  For these reasons, some research groups have developed 
transition-metal free couplings.  These methods capitalize on the ability of 
organoboronates to form characterizable tetracoordinate complexes and to undergo 
stereoretentive 1,2-migrations. 
Expanding on work first reported by Zweifel22, Evans and coworkers23 developed 
the stereospecific coupling of boronic esters and vinyl lithiums, also known as the 
Zweifel olefination.  Subjection of 4.38 to vinyl lithium 4.39, followed by iodine and 
methoxide base, furnishes 4.40 in 58% yield (Scheme 4.11).  4.38 and 4.39 are presumed 
to form ate complex 4.41, which, in the presence of I2, forms iodonium ion 4.42.  This 
intermediate undergoes a 1,2-migration followed by base-catalyzed elimination to afford 
olefin product 4.40.  The isolation of the trans product is evidence of an anti elimination 
of the alkyl iodide intermediate 4.43. 
 
 
 
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
22 Zweifel, G.; Arzoumanian, H.; Whitney, C. C. J. Am. Chem. Soc. 1967, 89, 3652 – 
3653.   
23 Evans, D. A.; Crawford, T. C.; Thomas, R. C.; Walker, J. A. J. Org. Chem. 1976, 41, 
3947 – 3953. 
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Scheme 4.11 Zweifel Olefination 
 
 This idea of electrophile-mediated 1,2-migration has been expanded upon by 
Aggarwal and coworkers 24  through the coupling of secondary and tertiary chiral 
boronates with lithiated arenes.  Reaction of 4.44 and 4.45, followed by addition of 
N-bromosuccinimide, affords 4.46 in 83% yield and 96% ee with complete retention of 
stereochemistry (Scheme 4.12).  The reaction mechanism features a temporary 
bromination of the ate complex 4.47, to furnish the zwitterionic intermediate 4.48.  A 
1,2-migration followed by an elimination results in the stereodefined product 4.46.  
Although a great complement to Suzuki coupling methodologies, the reaction scope for 
arenes is limited.  Of course, like any aromatic electrophilic substitution reaction, the 
arenes used must be electron-rich.  Furthermore, arenes containing electron-donating 
groups at the ortho and para positions are not tolerated.  
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
24 Bonet, A.; Odachowski, M.; Leonori, D.; Essafi, S.; Aggarwal, V. K. Nature Chem. 
2014, 6, 584 – 589. 
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Scheme 4.12 Transition-Metal Free Couplings of Secondary and Tertiary Boronates 
 
 
4.5 Borylation/Cross-Coupling Cascades 
 The combination of borylation and cross-coupling methods has been an effective 
way of generating molecular complexity from simple starting materials.25  Morken and 
coworkers26 developed a diboration/cross-coupling (DCC) strategy for the synthesis of a 
variety of chiral molecules from simple terminal olefins.  4.50 is subjected to 
Pt-catalyzed diboration (Section 3.3), followed by a regioselective cross-coupling of the 
primary boronate and oxidation of the secondary boronate to afford 4.51 in excellent 
yield and enantioselectivity (Scheme 4.13).  In addition to aryl halides, vinyl chlorides 
participate in the coupling reaction, yielding valuable chiral homoallylic boronates.  
Intriguingly, these cross-coupling conditions are specific for 1,2-bis(boronates), with !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
25 Examples of one-pot hydroboration/cross-coupling strategies: (a) Collier, P.; Campbell, 
A.; Patel, I.; Raynham, T.; Taylor, R. J. Org. Chem. 2002, 67, 1802 – 1815. (b) Konno, 
T; Chae, J; Tanaka, T; Ishihara, T. Chem. Commun. 2004, 690 – 691. 
26 Mlynarski, S. N.; Schuster, C. H.; Morken, J. P. Nature 2014, 505, 386 – 390. 
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simple primary boronates not undergoing coupling.  This enhanced reactivity is attributed 
to the neighboring boronate possibly coordinating to one of the pinacol oxygen atoms, 
enhancing the Lewis acidity of the primary boronate.  To demonstrate the applicability of 
the DCC strategy, the secondary boronate products were subjected to oxidation, 
amination and homologation conditions to synthesize a variety of useful enantioenriched 
compounds. 
 
Scheme 4.13 Diboration/Cross-Coupling (DCC) Strategy 
 
 
4.6 Directed Diboration/Cross-Coupling Cascade27 
 Inspired by the efficiency of the DCC strategy, we began to investigate whether 
directed diboration methodology (Chapter 3) could be combined with a cross-coupling 
transformation in a similar fashion.  The directed diboration of homoallylic alcohol 4.52 
afforded the expected 1,2-bis(boronate) after solvent removal.  The crude vicinal 
boronate was subjected to a sequential cross-coupling with bromobenzene and 
subsequent oxidation.  Surprisingly, this sequence afforded the 1,4-diol product 4.53 in 
67% yield (Scheme 4.14).  Most notably, the regiochemical outcome of the cross-
coupling was opposite to that of the DCC strategy.  This was unforeseen due to the 
secondary boronate having inherently less reactivity than its primary counterpart.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
27 Blaisdell, T. P.; Morken, J. P. J. Am. Chem. Soc. 2015, accepted. (DOI: 
10.1021/jacs.5b05477) 
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Furthermore, the transmetallation appeared to have occurred with retention of 
configuration.  The most noticeable difference between this coupling and the DCC 
coupling is the presence of a hydroxyl group.  As discussed in Section 4.3.3, the presence 
of a Lewis basic group β to an organoboronate can facilitate cross-coupling.  However, 
these cross-couplings almost always occur with inversion of stereochemistry.  Therefore, 
it is believed that this unusual reactivity is independent of the internal chelation between 
hydroxyl and boronate.  Instead, it is possible that, under basic conditions, the alkoxide of 
the substrate covalently directs the Pd-catalyst during transmetallation.  A strong 
association between substrate and catalyst could possibly explain the regiochemical 
outcome, with the catalyst being delivered in close proximity to the secondary boronate. 
 
Scheme 4.14 Directed Diboration/Cross-Coupling of 4.52 
 
 
4.7 Examples of Directed Cross-Coupling 
 Although common for C-H activation methodologies, the use of substrate 
directing groups to control the reactivity and selectivity of cross-coupling reactions is not 
as common.28  In one tangentially related process, Denmark and coworkers29 reported the 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
28 Olefin directed Negishi cross-coupling: Nielsen, D. K.; Huang, C.-Y.; Doyle, A. G. J. 
Am. Chem. Soc. 2013, 135, 13605 – 13609. 
29 (a) Denmark, S. E.; Werner, N. S. J. Am. Chem. Soc. 2008, 130, 16382 – 16393. (b) 
Denmark, S. E.; Werner, N. S. J. Am. Chem. Soc. 2010, 132, 3612 – 3620. Related work: 
(c) Tymonko, S. A.; Smith, R. C.; Ambrosi, A.; Ober, M. H.; Wang, H.; Denmark, S. E. 
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coupling of allylic silanolates and aryl bromides.  Using a Pd catalyst, 4.54 and 
bromobenzene react to afford 4.55 in 76% yield with complete enantiospecificity 
(Scheme 4.15).  The oxygen atom of the silanolate is presumed to bind to Pd through 
halide displacement.  This substrate/catalyst species undergoes a chair-like syn SE’ 
transmetallation 4.56, yielding an alkyl aryl PdII species which, upon reductive 
elimination, yields 4.55. 
 
Scheme 4.15 Cross-Coupling of Allylic Silanolates and Aryl Bromides 
 
Recently, Takacs and coworkers 30  have disclosed the amide-directed cross-
coupling of organotrifluoroboronates.  The coupling of 4.57 and 4.58 furnishes 4.59 in 
69% yield and 94:6 diastereoselectivity (Scheme 4.16).  However, what separates this 
methodology from the work of Suginome and Molander (Scheme 4.5) is that the cross-
coupling occurs with retention of stereochemistry.  As previously mentioned, if the 
oxygen atom of the carbonyl chelates to the boronate, an outer-sphere transmetallation 
would be expected, affording the product with stereoinversion.  Although the mechanism 
is unclear, it is possible that the transmetallation is directed by the covalent association of 
the Pd catalyst with the nitrogen atom of amide. 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
J. Am. Chem Soc. 2015, 137, 6200 – 6218. (d) Tymonko, S. A.; Smith, R. C.; Ambrosi, 
A.; Denmark, S. E. J. Am. Chem. Soc. 2015, 137, 6192 – 6199. 
30 Hoang, G. L.; Yang, Z.-D.; Smith, S. M.; Pal, R.; Miska, J. L.; Pérez, D., E.; Pelter, L. 
S. W.; Zeng, X. C.; Takacs, J. M. Org. Lett. 2015, 17, 940 – 943.!
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Scheme 4.16 Amide-Directed Cross-Coupling of Organotrifluoroboronates 
 
 
4.8 Further Exploration of Directing Effect 
 In an effort to further investigate the effect of a free alcohol group on the cross-
coupling of organoboronates, a series of hydroxyl-containing boronates were synthesized.  
Due to the instability of the alcohol-containing boronates to silica chromatography, 
borylated alkyl silyl ethers were synthesized and subjected to a sequential TBS 
deprotection, Suzuki coupling and oxidation strategy (Table 4.1).  Through this reaction 
sequence, 4.61 afforded the 1,4-diol 4.62 in 72% yield (Table 4.1, Entry 1).  For more 
sterically congested boronate 4.63, the coupling occurred at the primary boronate, 
yielding 4.64 in poor yield (Table 4.1, Entry 2).  This observation was in agreement with 
the regioselectivity observed during the synthesis of 3.113 (Scheme 3.20).  With the 
directing group at the α-position (4.65) or the γ-position (4.67) with respect to the 1,2-
bis(boronate), the secondary boronate remained unreacted (Table 4.1, Entries 3-4).  
Interestingly, when compared to 4.67, the amplified ability of 4.65 to undergo a primary-
selective coupling was justified by the presence of an alcohol group at the β-position. 
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Table 4.1 Hydroxyl-Directed Cross-Coupling of 1,2-Bis(boronates) 
 
 Due to the neighboring effect observed in the DCC methodology, we began to 
investigate the generality of the directing effect by examining the reactivity of boronate 
substrates outside of the 1,2-diboryl motif (Table 4.2).  Gratifyingly, 4.69 underwent the 
deprotection/coupling sequence to yield 4.70 in 70% yield (Table 4.2, Entry 1).  Again, 
the tertiary boronate 4.71 remained unreactive to cross-coupling conditions (Table 4.2, 
Entry 2).  Similar to the related 1,2-bis(boronates), 4.72 and 4.73 did not undergo cross-
coupling as well, emphasizing the necessity of the hydroxyl group to be at the β-position 
with respect to the organoboronate (Table 4.2, Entries 3-4).   
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+
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4.67 4.68
aYield determined by 1H NMR versus 1,3,5-trimethoxybenzene
as an internal standard.
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Table 4.2 Hydroxyl-Directed Cross-Coupling of Secondary Boronates 
 
 
4.9 Reaction Optimization 
 As demonstrated above, a combination of toluene, tetrahydrofuran (1:1) and water 
as the solvent, was found effective for the cross-coupling reaction.  Further investigation 
of this observation revealed that the solvent used was a critical feature to the success of 
the reaction.  This observation was most noticeable when cross-coupling with sterically 
bulky and electron-deficient arenes (Table 4.3).  For example, when homoallylic alcohol 
4.52 was subjected to a diboration/coupling/silyl protection sequence with aryl bromides 
4.77 and 4.78 in THF as the organic solvent, the coupling proceeded with full 
consumption of the 1,2-bis(boronate), but afforded substantial amounts of 4.75 and 4.76 
(Table 4.3, Entries 1 and 5).  4.75 is assumed to originated from a second cross-coupling 
of product 4.74.  4.76 is believed to arrive from a β-deborylation event after 
70%Ph
B(pin)TBSO
PhTBSO
B(pin)
Ph
B(pin)
TBSO
Ph
B(pin)TBSO Me
Ph
PhHO
no reaction
no reaction
no reaction
-
-
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! 271 
transmetallation occurs.  It is likely that 4.76 does not arrive from the silylation of 
unreacted 4.52 due to the diboration proceeding with full conversion of olefin.  
Noticeably, when using toluene as the reaction solvent, the amount of 4.75 surged while 
the β-deborylation product 4.76 was nonexistent (Table 4.3, Entries 2 and 6).  In both 
cases above, when a 1:1 mixture of THF and toluene was used, 4.74 became the major 
product (Table 4.3, Entries 3 and 7).  In the case of 4.77, the amount of bis-coupling 
observed was diminished by lowering the amount of 4.77 added (1.5 equivalents to 1.1 
equivalents) (Table 4.3, Entry 4).  In the case of 4.78, a considerable amount of 4.76 was 
observed, whereas 4.75 was undetected (Table 4.3, Entry 7). 
 
Table 4.3 Effect of Solvent on Reaction Outcome 
 
 In addition to bis-coupling and β-deborylation byproducts, some substrates 
participated in Pd-catalyzed oxidation of the hydroxyl group.  As previously 
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demonstrated31, aryl halides can act as terminal oxidants for the Pd-catalyzed oxidations 
of alcohols.  One such substrate that was prone to oxidation was the diboronate 4.79.  As 
mentioned in Chapter 3, 4.79 can be isolated with no need for oxidation or protection of 
the alcohol, making it an ideal substrate to study the cross-coupling reaction.  Using 1.05 
equivalents of bromobenzene, the coupling of 4.79 afforded a mixture of 4.80, 4.81, and 
4.82 (Scheme 4.17).  With two equivalents of bromobenzene added, full conversion of 
4.79 was attained, displaying a 60:40 ratio of 4.80 to 4.81.  From the product mixtures of 
both experiments, it was apparent that the cross-coupling reaction outcompetes the 
oxidation reaction.  However, under these conditions, 4.80 was prone to undergo 
oxidation in the presence of excess aryl bromide.  Although seemingly unavoidable 
during the cross-coupling of 4.79, this oxidation reaction was undetected for the majority 
of substrates screened. 
 
Scheme 4.17 Pd-Catalyzed Oxidation 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
31 (a) Tamaru, Y.; Yamamoto, Y.; Yamada, Y.; Yoshida, Z. Tetrahedron Lett. 1979, 20, 
1401 – 1404.  (b) Tamaru, Y.; Yamada, Y.; Inoue, K.; Yamamoto, Y.; Yoshida, Z. J. Org. 
Chem. 1983, 48, 1286 – 1292.  (c) Bei, X.; Hagemeyer, A.; Volpe, A.; Saxton, R.; Turner, 
H.; Guram, A. J. Org. Chem. 2004, 69, 8626 – 8633.  For a review, see:  Muzart, J. 
Tetrahedron 2003, 59, 5789 – 5816. 
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4.10 Substrate Scope 
 Due to the ability of the directed diboration and directed cross-coupling 
methodologies to be merged together, the two transformations were investigated as a 
reaction cascade starting from homoallylic alcohols.  The products of this sequence were 
subjected to silylation or acylation conditions prior to isolation. This diboration/cross-
coupling/protection sequence was performed on 4.52, in an effort to investigate what 
electrophiles participated in the coupling reaction (Table 4.4).  Aryl bromides, iodides 
and triflates all underwent cross-coupling to furnish 4.83 after TBS protection (Table 4.4, 
Entries 1-3).  Aryl chlorides and tosylates did not participate in the reaction.  Both 
electron-rich and electron-poor arenes furnished the corresponding products in good 
isolated yields over the three-step sequence (Table 4.4, Entries 4-5).  The sterically 
encumbered arene 4.78 underwent the coupling efficiently, forming 4.87 in 72% yield 
(Table 4.4, Entry 6).  The coupling of heteroaromatic coupling partners 4.88, 4.90, and 
4.92 furnished products 4.89, 4.91, and 4.93 in moderate yield (Table 4.4, Entries 7-9). 
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Table 4.4 Scope of Hydroxyl-Directed Cross-Coupling: Aryl Halides 
 
 In an effort to expand the scope of tolerated coupling partners, the use of vinyl 
halides as coupling partners was studied.  4.94, prepared in situ from 1,2-dichloroethane, 
successfully underwent coupling with the diboronate of 4.52 to furnish 4.95 in 75% yield 
(Table 4.5, Entry 1).  Vinyl chlorides 4.96 and 4.98 both participated in the coupling 
reaction, yielding products 4.97 and 4.99, respectively, in good yields over the three 
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0.5% Pd2dba3
1.0% RuPhos
ArX, 3 equiv KOH
THF/toluene/H2O
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! 275 
reactions (Table 4.5, Entries 2-3).  Couplings with 4.100, 4.101, and 4.103 were also 
achieved, albeit requiring higher catalyst loadings (Table 4.5, Entries 4-6). 
 
Table 4.5 Scope of Hydroxyl-Directed Cross-Coupling: Vinyl Halides 
 
 Next, the cross-coupling of bromobenzene and a variety of different 1,2-
bis(boronates) were examined (Table 4.6).  Phenyl-substituted olefin 4.105 underwent 
diboration/cross-coupling/silylation to yield 4.106 in 68% yield (Table 4.6, Entry 1). 
Substituted homoallylic alcohols 4.107, 4.109, and 4.111 all participated in the reaction 
sequence, producing 4.108, 4.110, and 4.112, respectively, in good yields (Table 4.6, 
Entries 2-4).  Internal diboronates, derived from olefins 4.113 and 4.115, underwent 
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cross-coupling, affording 4.114 and 4.116, respectively, in moderate yields (Table 4.6, 
Entries 5-6).  The diastereoselectivities resembled the selectivities observed in Tables 3.3 
and 3.4. 
 
Table 4.6 Scope of Hydroxyl-Directed Cross-Coupling: 1,2-Bis(boronates) 
 
 
4.11 Proposed Catalytic Cycle 
 The totality of the experiments described above suggests that the regio- and 
stereoselectivity of a Suzuki cross-coupling reaction can be controlled by the presence of 
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a hydroxyl group (Scheme 4.18).  This control suggests an association between substrate 
and catalyst, similar to that shown in 4.119.  This species can be attained through a halide 
displacement from complex 4.117 by 4.118.  It is proposed that 4.119 undergoes a 
hydroxyl-directed transmetallation perhaps via 4.120 affording borate 4.121.  Reductive 
elimination and dissociation of the borate (presumably with KOH), furnishes the coupled 
product 4.122. 
 
Scheme 4.18 Hydroxyl-Directed Cross-Coupling Catalytic Cycle 
 
 As described in Section 4.9, the cross-coupling of hydroxyl-containing substrates 
can be hampered by an oxidation reaction of the free alcohol to the ketone.  This 
oxidation reaction is suspected to occur through the formation of Pd-product complex 
4.123 (Scheme 4.19).  As previously observed, the oxidation of the product is much more 
LnPd0
LnPdII
R
O
Pd
B(pin)
L Ar
B(pin)
R
(pin)BO Pd
B(pin)
L Ar Ar
X
R
OH B(pin)
B(pin)
HX
ArX
R
HO Ar
B(pin)
Oxidative
Addition
Hydroxyl-Directed
Transmetallation
Substrate/Pd
Association
Reductive
Elimination
R
O B(pin)
B(pin)
H
Pd
L Ar
4.117
4.118
4.119
4.120
4.121
4.122
! 278 
likely to occur than the oxidation of the uncoupled starting diboronate.  Unable to 
participate in a directed cross-coupling reaction, 4.123 is vulnerable to β-hydride 
elimination yielding ketone 4.124 and 4.125, which can undergo reductive elimination to 
yield Pd0 and 4.126.   
 Unlike this infrequent oxidation reaction, the presence of β-deborylation was 
detected in most substrates classes, especially for electron-poor electrophiles as well as 
sterically hindered electrophiles and boronates.  β-deborylation is believed to occur from 
PdII complex 4.121, yielding homoallylic alcohol 4.127 and 4.128 (Scheme 4.19).  4.128 
can undergo reductive elimination to afford Pd0 and aryl boronate 4.129. 32   The 
intramolecular chelation of Pd by the borate is believed to help mitigate β-deborylation 
by preventing the ability of 4.121 to adapt a conformation associated with elimination 
(syn-periplanar to the primary boronate).  This could explain why switching solvents 
from THF to toluene helps to alleviate β-deborylation.  THF diminishes this 
intramolecular chelation by competing for coordination sites on the palladium atom.  
Conversely, non-polar solvents, such as toluene, do not coordinate to the palladium atom, 
amplifying the chelation of the borate. Additionally, coupling partners associated with a 
slower reductive elimination (hindered and electron-deficient aryl halides) are more 
susceptible to β-deborylation.  It is posited that a slower reductive elimination allows for 
β-deborylation to become more competitive. 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
32 4.129 can be detected by the crude 1H NMR. 
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Scheme 4.19 Side Reactions in Cross-Coupling Catalytic Cycle 
 
 
4.12 Synthetic Applications 
 The combination of directed diboration and cross-coupling methods allows for 
rapid and efficient functionalization of homoallylic alcohols.  We envisioned that this 
complexity-generating sequence of reactions could aid in the synthesis of 
pharmaceuticals and natural products.  In particular, we imagined the ability to access 
molecules with β-oxygenation relative to a stereocenter. 
 
4.12.1 CCR-1 Antagonist 
 CC-chemokine receptor-1 antagonist 4.134 was discovered by Pfizer for the 
treatment of autoimmune diseases and organ transplant rejection.33  We proposed an 
efficient synthesis of γ-lactone 4.133, a known intermediate to 4.134 (Scheme 4.20).  
Homoallylic alcohol 4.130 was assembled by the reduction and allylation of Boc-L-
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
33 Kath, J. C.; Brissette, W. H.; Brown, M. F.; Conklyn, M.; DiRico, A. P.; Dorff, P.; 
Gladue, R. P.; Lillie, B. M.; Lira, P. D.; Mairs, E. N.; Martin, W. H.; McElroy, E. B.; 
McGlynn, M. A.; Paradis, T. J.; Poss, C. S.; Stock, I. A.; Tylaska, L. A.; Zheng, D. 
Bioorg. Med. Chem. Lett. 2004, 14, 2169 – 2173. 
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Phenylalanine.34  Directed diboration, cross-coupling with 4.131 and oxidation yielded 
the expected 1,4-diol, which upon oxidation yielded the unsaturated lactone 4.132, in 
67% yield over the four steps.  A near quantitative hydrogenation of the trisubstituted 
olefin furnished 4.133.  4.133 can be further transformed into CCR1 antagonist 4.134 in 
three steps following literature procedure.32 
 
Scheme 4.20 Synthesis of CCR-1 Antagonist 
 
 
4.12.2 Vitronectin Receptor Antagonist 
In addition to being combined with directed diboration methodologies, the 
directed coupling reaction can be used in tandem with the DCC sequence.  This 
combination allows for the formation of contiguous C-C bonds in a stereo- and 
regioselective manner.  Such a strategy would allow access to 1,2-bisarylated compounds 
such as 4.137, a potential precursor to vitronectin receptor antagonists 4.138 (Scheme !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
34 Diaz, L. C.; Diaz, G.; Ferreira, A. A.; Meira, P. R. R.; Ferreira, E. Synthesis 2003, 4, 
603 – 622. 
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4.21).35  Silyl ether 4.135 undergoes asymmetric diboration and cross-coupling with 4-
bromoanisole to furnish organoboronate 4.136.  Without purification, 4.136 is subjected 
to a TBS deprotection and cross-coupling with 4-bromobenzotrifluoride to afforded 4.137 
in 64% yield over four steps and 91% ee. 
 
Scheme 4.21 Synthesis of Vitronectin Receptor Antagonist 
 
 
4.12.3 Debromohamigeran E 
Finally, to demonstrate the synthetic usefulness of the directed cross-coupling 
methodology, the total synthesis of debromohamigeran E was performed.  The 
hamigerans are a family of natural products containing a highly substituted cyclopentane 
ring with three or four contiguous stereocenters (Scheme 4.22, A). Isolated from the 
poecliosclerid sponge Hamigera tarangaensis in 1995, the hamigerans have shown to be 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
35 Manley, P. J.; Miller, W. H.; Uzinskas, I. N. (SmithKline Beecham Corporation) Patent 
EP1218005 A2, July 3, 2002 
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moderately cytotoxic toward cancer cells and exert antiviral activity.36  Because it hasn’t 
been addressed by total synthesis 37  and because of its interesting structure, 
debromohamigeran E became the focus of our synthetic efforts.  The construction of the 
cis substituents at C5 and C6 were anticipated through consecutive functionalizations of 
bis(boronate) 4.140 with 4.139 and 4.141 (Scheme 4.22, B).  A site-selective directed 
cross-coupling reaction was planned as a means of differentiating the two secondary 
organoboronates. 
 
Scheme 4.22 The Hamigerans and Retrosynthetic Analysis of Debromohamigeran E 
 
Naturally, diboronate 4.140 was expected to be derived from a directed diboration 
of 4.146.  The racemic, five-step synthesis of 4.146 is shown in Scheme 4.23. The 
methylation of β-keto ester 4.142 afforded 4.143 in good yield.  A ketone reduction and 
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36 (a) Cambie, R. C.; Lal, A. R.; Kernan, M. R.; Bergquist, P. R. J. Nat. Prod. 1995, 58, 
940 – 942. (b) Wellington, K. D.; Cambie, R. C.; Rutledge, P. S.; Bergquist, P. R. J. Nat. 
Prod. 2000, 63, 79 – 85. 
37 Debromohamigeran E has never been synthesized, while hamigeran E has been 
synthesized once: Nicolaou, K. C.; Gray, D. L. F.; Tae, J. J. Am. Chem. Soc. 2004, 126, 
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mesylation of the subsequent alcohol yielded mesylate 4.144 in 74% yield.  DBU-
promoted elimination furnished 4.145 in 50% yield.  Finally, 4.146 was isolated from an 
LAH reduction of 4.145. 
 
Scheme 4.23 Synthesis of  Homoallylic Alcohol 4.146 
 
 The most suitable aryl coupling partner was found to be triflate 4.151 (vide infra), 
which was synthesized from diphenol 4.147 in five steps (Scheme 4.24).  Carboxylation 
of 4.147 afforded carboxylic acid 4.148 in 78% yield.  Cyclization of 4.148 with acetone 
yielded 4.149 in 71% yield.  Triflate 4.150 was smoothly formed using Tf2O.  Lastly, 
4.150 was reduced with LiBH4 and cyclized to form acetonide 4.151 in moderate yield 
over two steps. 
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Scheme 4.24 Synthesis of 4.151 
 
 With 4.146 and 4.151 in hand, the diboration/coupling/protection sequence was 
investigated (Scheme 4.25).  Gratifyingly, the 1,2-bis(boronate) of 4.146 and 4.151 
underwent coupling and furnished 4.152 in 42% yield after TBS protection. Moreover, 
the yield of the reaction sequence was identical when run on larger scale, affording 2.70 
grams of 4.152.  Although only a moderate yield was observed for the coupling with 
4.151 (and related aryl bromides 4.153, 4.154, and 4.155), other possible coupling 
partners (4.156, 4.157, 4.158 and 4.159) did not participate in the cross-coupling reaction.  
It is presumed that the unhindered nature of 4.151 was crucial for the success of the 
coupling.  
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Scheme 4.25 Diboration/Cross-Coupling/Protection of 4.146 
 
 With a reliable means of accessing 4.152, a stereoretentive method for the 
installation of a propenyl group (as a precursor to an isopropyl group) was desired.  In 
initial experiments, 4.160 was shown to react during a homologation/oxidation sequence, 
providing primary alcohol 4.161 (Scheme 4.26, Eq. 1).  With this in mind, a Zweifel 
olefination with lithium species 4.162 was attempted, affording 4.163 in excellent yield 
(Scheme 4.26, Eq. 2).   Similar to diboration/coupling sequence, the olefination reaction 
was effective on a larger scale, yielding 2.10 grams of 4.163.   
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Scheme 4.26 Zweifel Olefination of 4.152 
 
A sequential Pt-catalyzed hydrogenation and desilylation of 4.163 yielded 4.164 
in 71% yield (Scheme 4.27, Eq. 1).  A variety of Pd-catalyzed hydrogenation conditions 
lead to olefin isomerization to the unreactive tetrasubstituted olefin byproduct 4.165 
(Scheme 4.27, Eq. 2).  Hydrogenation of 4.163 using PtO2 resulted in only 10-15% 
isomerization to the tetrasubstituted olefin, which could be separated after TBAF 
deprotection.  Efforts to hydrogenate the isomerized byproduct 4.165 failed to yield 
4.164. 
 
Scheme 4.27 Hydrogenation of 4.163 
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 Next, 4.164 was subjected to Ru-catalyzed bis-oxidation resulting in 4.166 in a 
moderate yield (Scheme 4.28).  A simple hydrolysis of 4.166 afforded 
debromohamigeran E in 93% yield.  This 11-step (longest linear) sequence is the first 
synthesis of debromohamigeran E.  Esterification of debromohamigeran E with ethyl 
iodide furnished the diester, which was in accord with spectral data, previously reported 
during isolation. 
 
Scheme 4.28 Endgame Synthesis of Debromohamigeran E 
 
 
4.13 Conclusion 
 Alcohol-containing organoboronate esters have been shown to undergo an 
unprecedented Suzuki-Miyaura cross-coupling reaction.  Alkoxide association with the 
Pd catalyst allows for a directed transmetallation that occurs with retention of 
stereochemistry.  A transmetallation with retention of stereochemistry separates this 
methodology from other cross-coupling reactions that highlight internal Lewis basic 
activation of the organoboronate.  The directed coupling methodology can be combined 
with the directed diboration transformation described in Chapter 3, producing a valuable, 
complexity-generating sequence of reactions.  This series of reactions was employed 
during the synthesis of debromohamigeran E and other synthetic targets of interest. 
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4.14 Experimental Section 
4.14.1 General Considerations 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), or a 
Varian Inova-500 (500 MHz) spectrometer. Chemical shifts are reported in ppm with the 
solvent resonance as the internal standard (CDCl3: 7.26 ppm). Data are reported as 
follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, br = broad, m = multiplet, app = apparent), and coupling constants 
(Hz). 13C NMR spectra were recorded on either a Varian Gemini-500 (125 MHz), or a 
Varian Inova-500 (125 MHz) spectrometer with complete proton decoupling. Chemical 
shifts are reported in ppm with the solvent resonance as the internal standard (CDCl3: 
77.0 ppm). Infrared (IR) spectra were recorded on a Bruker alpha spectrophotometer. 
Bands are characterized as broad (br), strong (s), medium (m), and weak (w) (ν max cm-
1). High resolution mass spectrometry (DART) was performed at the Mass Spectrometry 
Facility, Boston College.  
Liquid Chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 230×450 Mesh) purchased from Silicycle. Thin Layer 
Chromatography was performed on 25 µm silica gel plates purchased from Silicycle. 
Visualization was performed using ultraviolet light (254 nm), potassium permanganate 
(KMnO4) in water, ninhydrin with acetic acid in ethanol, phosphomolybdic acid (PMA) 
in ethanol, or phosphomolybdic acid and cerium(IV) sulfate in ethanol with sulfuric acid 
(Seebach). Analytical chiral supercritical fluid chromatography (SFC) was performed on 
a Thar Supercritical Chromatograph equipped with an auto sampler and a Waters 
photodiode array detector with isopropanol as the modifier. 
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All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran, toluene, diethyl ether and 
dichloromethane were purified using Pure Solv MD-4 solvent purification system, from 
Innovative Technology, Inc., by passing the solvent through two activated alumina 
columns after being purged with argon. 
 
4.14.2 Preparation of Substrates 
Preparation of Bis(boronates) 4.61, 4.63, 4.65, and 4.67: 
 
To an oven-dried 50 mL round bottom flask with magnetic stir bar was added 
B2(pin)2 (2.54 g, 10 mmol), Cs2CO3 (0.53 g, 1.50 mmol) and THF (10 mL). The alkenol 
(5.00 mmol) and methanol (3.44 mL, 85.0 mmol) were added sequentially to the reaction 
flask.  The flask was sealed with a rubber septum and sealed with electrical tape.  The 
flask was heated at 70 °C and allowed to stir for 6 hours.  The reaction was cooled to 
room temperature and concentrated in vacuo (ensuring that all methanol has been 
removed from the residue).  To the residue was added dichloromethane (23 mL) and 
imidazole (3.02 g, 44.4 mmol).  The reaction mixture was cooled to 0 °C and a solution 
of TBSCl (2.24 g, 14.9 mmol) in toluene (5 mL).  The reaction was sealed and allowed to 
warm to room temperature overnight.  The reaction mixture was quenched with NH4Cl 
(15 mL).  The layers were allowed to separate and the aqueous layer was extracted with 
TBSO
B(pin)
B(pin)n
HO
n
1. B2(pin)2, Cs2CO3
    MeOH, THF, 70 °C
2. TBSCl, imidazole
    DCM/toluene
    0 °C to rt
n=1 30% (2 steps)
n=2 84% (2 steps)
n=3 57% (2 steps)
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dichloromethane (3 x 30 mL). The combined organics were dried over Na2SO4, filtered, 
and concentrated in vacuo. The crude material was purified on SiO2. 
 
 (3,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butoxy)(tert-butyl)dimethylsilane. (4.61) Prepared 
according to the general procedure using 3-buten-1-ol (0.43 mL, 5.00 mmol). The crude 
material was purified on SiO2 (2.5% to 10% EtOAc/hexanes, stain with CAM) to afford 
the title compound as a colorless oil (1.86 g, 84% yield).  
 
1H NMR (500 MHz, CDCl3): δ 0.03 (6H, s), 0.88 (9H, s), 0.80-0.90 (2H, m), 1.13-1.19 
(1H, m), 1.22 (24H, s), 1.51-1.58 (1H, m), 1.68-1.75 (1H, m), 3.57-3.66 (2H, m); 13C 
NMR (125 MHz, CDCl3): δ -5.2, 18.4, 24.7, 24.8, 24.8, 24.9, 26.0, 36.6, 62.9, 82.8, 82.8; 
11B NMR (160 MHz, CDCl3): δ 34.2; IR (neat): 2977.5 (w), 2928.8 (w), 2857.2 (w), 
1470.9 (w), 1369.7 (s), 1311.1 (s), 1253.5 (m), 1140.6 (s), 1092.8 (s), 967.6 (m), 833.2 
(s), 773.7 (s), 667.8 (m) cm-1; HRMS-(DART-TOF) for C22H47B2O5Si [M+H]: 
calculated: 441.3379, found: 441.3387. 
 
 tert-butyldimethyl(3-methyl-3,4-bis(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butoxy)silane. (4.63) Prepared 
according to the general procedure using 3-methylbut-3-en-1-ol (0.50 mL, 5.00 mmol). 
The crude material was purified on SiO2 (2.5% to 10% EtOAc/hexanes, stain with CAM) 
to afford the title compound as a colorless oil (1.40 g, 62% yield). 
 
B(pin)
B(pin)TBSO
B(pin)
B(pin)TBSO Me
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1H NMR (500 MHz, CDCl3): δ 0.04 (6H, s), 0.72 (1H, d, J = 15.7 Hz), 0.88 (9H, s), 0.95 
(1H, d, J = 15.7 Hz), 0.98 (3H, s), 1.21 (6H, s), 1.22 (6H, s), 1.23 (12H, s), 1.53-1.59 
(1H, m), 1.62-1.68 (1H, m), 3.64 (2H, t, J = 8.8 Hz); 13C NMR (125 MHz, CDCl3): δ -
5.2, -5.1 18.4, 24.5, 24.7, 24.8, 24.8, 25.0, 26.0, 44.5, 61.4, 82.8, 82.9; 11B NMR (160 
MHz, CDCl3): δ 34.0; IR (neat): 2977.3 (w), 2955.7 (w), 2929.0 (w), 2857.2 (w), 1463.6 
(w), 1360.2 (s), 1307.7 (s), 1253.1 (m), 1214.0 (w), 1139.7 (s), 1086.0 (s), 939.5 (s), 
833.7 (m), 773.5 (m), 664.2 (s) cm-1; HRMS-(DART-TOF) for C23H49B2O5Si [M+H]: 
calculated: 455.3535, found: 455.3517. 
 
 (2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propoxy)(tert-butyl)dimethylsilane. (4.65) Prepared according to 
the general procedure using allyl alcohol (0.14 mL, 2.00 mmol). The 
crude material was purified on SiO2 (2.5% to 10% EtOAc/hexanes, stain with CAM) to 
afford the title compound as a colorless oil (0.23 g, 30% yield).  
 
1H NMR (500 MHz, CDCl3): δ 0.01 (6H, s), 0.86 (9H, s), 0.79-0.93 (2H, m), 1.22 (24H, 
s), 1.34-1.37 (1H, m), 3.64 (2H, d, J = 6.9 Hz); 13C NMR (125 MHz, CDCl3): δ -5.4, 
18.3, 24.7, 24.7, 24.8, 24.8, 24.8, 24.9, 26.0, 66.5, 82.8, 82.8; 11B NMR (160 MHz, 
CDCl3): δ 34.1; IR (neat): 2977.8 (w), 2929.0 (w), 2856.4 (w), 1470.6 (w), 1369.6 (s), 
1313.3 (s), 1255.3 (m), 1214.0 (w), 1142.0 (s), 1087.2 (s), 1004.8 (s), 938.1 (m), 835.4 
(s), 774.6 (m) cm-1; HRMS-(DART-TOF) for C21H45B2O5Si [M+H]: calculated: 
427.3222, found: 427.3244. 
 
B(pin)TBSO
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 ((4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentyl)oxy)(tert-butyl)dimethylsilane. (4.67)   Prepared 
according to the general procedure using 4-penten-1-ol (0.52 
mL, 5.00 mmol). The crude material was purified on SiO2 (2.5% to 10% EtOAc/hexanes, 
stain with CAM) to afford the title compound as a colorless oil (1.30 g, 57% yield).  
 
1H NMR (500 MHz, CDCl3): δ 0.03 (6H, s), 0.88 (9H, s), 0.77-0.90 (2H, m), 1.08-1.14 
(1H, m), 1.22 (24H, s), 1.29-1.36 (1H, m), 1.41-1.48 (1H, m), 1.50-1.56 (1H, m), 3.57 
(2H, t, J = 6.9 Hz); 13C NMR (125 MHz, CDCl3): δ -5.2, 18.4, 24.7, 24.8, 24.8, 24.9, 
26.0, 29.9, 32.3, 63.7, 82.8, 82.8; 11B NMR (160 MHz, CDCl3): δ 34.0; IR (neat): 2977.5 
(w), 2929.1 (w), 2857.0 (w), 1470.7 (w), 1369.6 (s), 1311.1 (s), 1251.0 (m), 1141.1 (s), 
1097.1 (s), 968.2 (m), 834.0 (s), 774.1 (s) cm-1; HRMS-(DART-TOF) for C23H49B2O5Si 
[M+H]: calculated: 455.3535, found: 455.3544. 
 
Procedure for Preparation of Substrates 4.69, 4.71, 4.72, and 4.73: 
 
To an oven-dried 25 mL round bottom flask with magnetic stir bar in the dry box was 
added the 1,2-bis(boronate) (1.00 mmol), tetrahydrofuran (9.1 mL), potassium hydroxide 
(168 mg, 3.00 mmol), Pd(OAc)2 (2.4 mg, 10 µmol), RuPhos (5.6 mg, 12 µmol) and 
bromobenzene (158 µL, 1.50 mmol). The flask was sealed with a rubber septum, 
TBSO
B(pin)
B(pin)n
PhBr, Pd(OAc)2
RuPhos, KOH
THF/H2O, 70 °C
TBSO
B(pin)
Phn
n=1 61%
n=2 82%
n=3 80%
B(pin)
B(pin)
TBSO
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removed from the dry box, and heated to 70 ºC in an oil bath for 12 hours. The reaction 
mixture was cooled to room temperature and H2O (10 mL) was added. The layers were 
allowed to separate and the aqueous layer was extracted with dichloromethane (3 x 10 
mL). The combined organics were dried over Na2SO4, filtered, and concentrated by 
rotary evaporation. The crude material was purified on SiO2. 
 
tert-butyldimethyl(4-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)butoxy)silane. (4.69) Prepared according to 
the general procedure using (3,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butoxy)(tert-butyl)dimethylsilane (0.44 g, 1.00 mmol). The crude material was 
purified on SiO2 (2.5% to 5% EtOAc/hexanes, stain with CAM) to afford the title 
compound as a colorless oil (0.32 g, 82% yield). 
 
1H NMR (500 MHz, CDCl3): δ 0.02 (3H, s), 0.03 (3H, s), 0.88 (9H, s), 1.13 (6H, s), 1.16 
(6H, s), 1.38-1.46 (1H, m), 1.58-1.71 (2H, m), 2.67 (1H, dd, J = 13.7 Hz, 7.8 Hz), 2.73 
(1H, dd, J = 13.7 Hz, 8.3 Hz), 3.54-3.59 (1H, m), 3.62-3.67 (1H, m), 7.11-7.15 (1H, m), 
7.19-7.24 (4H, m); 13C NMR (125 MHz, CDCl3): δ -5.3, -5.2, 18.4, 24.7, 24.8, 26.0, 34.1, 
37.1, 62.9, 83.0, 125.6, 128.0, 128.9, 142.1; 11B NMR (160 MHz, CDCl3): δ 34.2; IR 
(neat): 2954.6 (w), 2928.1 (w), 2856.5 (w), 1471.2 (w), 1378.7 (m), 1318.5 (m), 1251.8 
(m), 1143.3 (s), 1096.2 (s), 833.9 (s), 774.6 (s), 743.5 (w), 698.2 (m) cm-1; HRMS-
(DART-TOF) for C22H40BO3Si [M+H]: calculated: 391.2840, found: 391.2849. 
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 tert-butyldimethyl(3-methyl-4-phenyl-3-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butoxy)silane. (4.71) Prepared according 
to the general procedure using tert-butyldimethyl(3-methyl-3,4-bis(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butoxy)silane (454 mg, 1.00 mmol). The crude material was 
purified on SiO2 (2.5% to 5% EtOAc/hexanes, stain with CAM) to afford the title 
compound as a colorless oil (263 mg, 65% yield). 
 
1H NMR (500 MHz, CDCl3): δ 0.05 (6H, s), 0.89 (9H, s), 0.91 (3H, s), 1.19 (6H, s), 1.22 
(6H, s), 1.48-1.54 (1H, m), 1.72-1.78 (1H, m), 2.53 (1H, d, J = 13.2 Hz), 2.78 (1H, d, J = 
13.2 Hz), 3.69 (2H, t, J = 7.8 Hz), 7.14-7.17 (1H, m), 7.19-7.24 (4H, m); 13C NMR (125 
MHz, CDCl3): δ -5.3, 18.3, 21.7, 24.8, 25.0, 26.0, 42.0, 45.3, 61.2, 83.1, 125.6, 127.6, 
130.4, 139.8; 11B NMR (160 MHz, CDCl3): δ 34.1; IR (neat): 2954.7 (w), 2928.4 (w), 
2856.1 (w), 1463.0 (w), 1370.4 (m), 1310.1 (m), 1141.1 (s), 1086.5 (s), 832.9 (s), 773.4 
(s), 738.1 (w), 701.3 (m), 664.0 cm-1; HRMS-(DART-TOF) for C23H42BO3Si [M+H]: 
calculated: 405.2996, found: 405.3007. 
 
tert-butyldimethyl(3-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propoxy)silane. (4.72) Prepared according to the 
general procedure using (3,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)butoxy)(tert-butyl)dimethylsilane (87 mg, 0.20 mmol). The crude material was 
purified on SiO2 (2.5% to 5% EtOAc/hexanes, stain with CAM) to afford the title 
compound as a colorless oil (46 mg, 61% yield). 
 
PhTBSO
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1H NMR (500 MHz, CDCl3): δ 0.02 (6H, s), 0.89 (9H, s), 1.16 (6H, s), 1.17 (6H, s), 1.57 
(1H, quintet, J = 7.33 Hz), 2.72 (1H, dd, J = 13.7 Hz, 7.8 Hz), 2.79 (1H, dd, J = 13.7 Hz, 
7.8 Hz), 3.62 (1H, dd, J = 9.8 Hz, 6.4 Hz), 3.67 (1H, dd, J = 9.8 Hz, 6.9 Hz), 7.12-7.15 
(1H, m), 7.20-7.25 (4H, m); 13C NMR (125 MHz, CDCl3): δ -5.4, 18.3, 24.8, 24.8, 25.9, 
33.2, 63.6, 83.1, 125.5, 128.0, 129.0, 142.0; 11B NMR (160 MHz, CDCl3): δ 33.8; IR 
(neat): 3027.3 (w), 2978.0 (w), 2953.9 (w), 2856.1 (w), 1471.1 (w), 1388.6 (m), 1369.4 
(m), 1319.9 (m), 1143.4 (s), 1092.9 (s), 1004.8 (m), 832.7 (s), 773.5 (s), 743.7 (m), 697.5 
(s) cm-1; HRMS-(DART-TOF) for C21H38BO3Si [M+H]: calculated: 377.2683, found: 
377.2683. 
 
tert-butyldimethyl((5-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pentyl)oxy)silane. (4.73) Prepared according 
to the general procedure using ((4,5-bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pentyl)oxy)(tert-butyl)dimethylsilane (0.45 g, 1.00 mmol). The crude 
material was purified on SiO2 (2.5% to 5% EtOAc/hexanes, stain with CAM) to afford 
the title compound as a colorless oil (0.32 g, 80% yield). 
 
1H NMR (500 MHz, CDCl3): δ 0.03 (6H, s), 0.88 (9H, s), 1.13 (6H, s), 1.16 (6H, s), 1.36 
(1H, q, J = 7.3 Hz), 1.43 (2H, q, J = 7.7 Hz), 1.48-1.61 (2H, m), 2.66 (1H, dd, J = 13.7 
Hz, 7.3 Hz), 2.72 (1H, dd, J = 13.7 Hz, 8.3 Hz), 3.57 (2H, t, J = 6.6 Hz), 7.11-7.15 (1H, 
m), 7.18-7.24 (4H, m); 13C NMR (125 MHz, CDCl3): δ -5.3, 18.3, 24.7, 24.8, 26.0, 27.2, 
32.4, 37.3, 63.4, 83.0, 125.5, 128.0, 128.8, 142.2; 11B NMR (160 MHz, CDCl3): δ 33.8; 
IR (neat): 2977.4 (w), 2928.5 (w), 2856.1 (w), 1495.0 (w), 1385.0 (m), 1318.8 (m), 
Ph
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1251.5 (m), 1143.0 (s), 1098.2 (s), 1005.6 (w), 832.9 (s), 773.6 (s), 743.3 (w), 697.7 (s) 
cm-1; HRMS-(DART-TOF) for C23H42BO3Si [M+H]: calculated: 405.2996, found: 
405.2991. 
 
2,2-dimethyl-4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)cyclohexan-1-ol. (4.79) Prepared according to the literature 
procedure.38 All spectral data are in accord with the literature. 
 
Preparation of Substrates used for Scheme 3: 
 
 
The substrates in Scheme 3 were prepared according to literature procedures.38 
 
 
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!38!T. P. Blaisdell, T. C. Caya, L. Zhang, A. Sanz-Marco, and J. P. Morken J. Am. Chem. 
Soc. 2014, 136, 9264  – 9267.!
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4.14.3 Procedures 
Experimental Procedure for Diboration/Cross-Coupling/Oxidation (Synthesis of 4.53) 
To an oven-dried 2-dram vial with magnetic stir bar was added homoallylic alcohol (0.25 
mmol), Cs2CO3 (26 mg, 75 µmol), B2(pin)2 (95 mg, 0.38 mmol), tetrahydrofuran (1 mL, 
[substrate] = 0.25 M) and methanol (0.17 mL, 4.25 mmol). The vial was sealed with a 
teflon septum cap and heated to 70 ºC for 6 h. The reaction was cooled to room 
temperature and concentrated in vacuo (ensuring that all methanol has been removed 
from the residue).  The flask was brought to a dry box and charged with solid potassium 
hydroxide (42 mg, 0.75 mmol), Pd2(dba)3/RuPhos (added as a 1:2 solution in THF (0.005 
M); 0.25 mL for 0.5 mol% Pd2(dba)3), tetrahydrofuran (0.95 mL), toluene (1.2 mL) and 
electrophile (0.38 mmol). The vial was sealed, removed from the dry box, and H2O 
(sparged with N2 for 30 min, 0.23 mL) was added through the teflon septum cap. The vial 
was heated to 70 ºC and stirred for 12 h. The reaction mixture was transferred to a 25-mL 
round bottom flask and cooled to 0 ºC (ice/water) and charged with 3 M sodium 
hydroxide (0.5 mL), and 30% hydrogen peroxide (0.5 mL). The reaction was gradually 
warmed to room temperature and allowed to stir for 4 h at which time the vial was diluted 
with ethyl acetate and the aqueous and organic layers were separated. The aqueous layer 
was extracted with ethyl acetate (3 x 10 mL) and the combined organics were dried over 
Na2SO4, filtered, and concentrated by rotary evaporation. The crude material was purified 
on SiO2. 
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Experimental Procedure for Deprotection/Cross-Coupling/Oxidation (Tables 4.1-4.2) 
To an oven-dried 4-dram vial with magnetic stir bar was added the silyl ether (0.25 
mmol), methanol (2 mL) and pTsOH (cat.). The reaction mixture was stirred at room 
temperature for 2 hours. The reaction was concentrated in vacuo (ensuring that all 
methanol has been removed from the residue).  The flask was brought to a dry box and 
charged with solid potassium hydroxide (42 mg, 0.75 mmol), Pd2(dba)3/RuPhos (added 
as a 1:2 solution in THF (0.005 M); 0.25 mL for 0.5 mol% Pd2(dba)3), tetrahydrofuran 
(0.95 mL), toluene (1.2 mL) and bromobenzene (28 µL, 0.253 mmol). The vial was 
sealed, removed from the dry box, and H2O (sparged with N2 for 30 min, 0.23 mL) was 
added through the teflon septum cap. The vial was heated to 70 ºC and stirred for 12 h. 
The reaction mixture was transferred to a 25-mL round bottom flask and cooled to 0 ºC 
(ice/water) and charged with 3 M sodium hydroxide (0.5 mL), and 30% hydrogen 
peroxide (0.5 mL). The reaction was gradually warmed to room temperature and allowed 
to stir for 4 h at which time the vial was diluted with ethyl acetate and the aqueous and 
organic layers were separated. The aqueous layer was extracted with ethyl acetate (3 x 10 
mL) and the combined organics were dried over Na2SO4, filtered, and concentrated by 
rotary evaporation.  
 
Experimental Procedure for Cross-Coupling of Cyclic Bis(boronate) 4.79. 
A oven-dried flask was brought to a dry box and charged with 2,2-dimethyl-4,5-
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexan-1-ol (95 mg, 0.25 mmol), 
solid potassium hydroxide (42 mg, 0.75 mmol), Pd2(dba)3/RuPhos (added as a 1:2 
solution in THF (0.005 M); 0.25 mL for 0.5 mol% Pd2(dba)3), tetrahydrofuran (0.95 mL), 
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toluene (1.2 mL) and bromobenzene (0.26 or 0.50 mmol). The vial was sealed, removed 
from the dry box, and H2O (sparged with N2 for 30 min, 0.23 mL) was added through the 
teflon septum cap. The vial was heated to 70 ºC and stirred for 12 h. The reaction mixture 
was cooled to room temperature and H2O (5 mL) was added. The layers were allowed to 
separate and the aqueous layer was extracted with dichloromethane (3 x 10 mL). The 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude product was purified on silica gel (5% ethyl acetate in hexanes). 
 
Experimental Procedure for Diboration/Cross-Coupling/Protection (Tables 4.4-4.6) 
To an oven-dried 2-dram vial with magnetic stir bar was added homoallylic alcohol (0.25 
mmol), Cs2CO3 (26 mg, 75 µmol), B2(pin)2 (95.0 mg, 0.38 mmol), tetrahydrofuran (1 
mL, [substrate] = 0.25 M) and methanol (0.17 mL, 4.25 mmol). The vial was sealed with 
a teflon septum cap and heated to 70 ºC for 6 h. The reaction was cooled to room 
temperature and concentrated in vacuo (ensuring that all methanol has been removed).  
The flask was brought to a dry box and charged with solid potassium hydroxide (42 mg, 
0.75 mmol), Pd2(dba)3/RuPhos (added as a 1:2 solution in THF (0.005 M); 0.25 mL for 
0.5 mol% Pd2(dba)3), tetrahydrofuran (0.95 mL), toluene (1.2 mL) and electrophile (39 
µL, 0.38 mmol). The vial was sealed, removed from the dry box, and H2O (sparged with 
N2 for 30 min, 0.23 mL) was added through the teflon septum cap. The vial was heated to 
70 ºC and stirred for 12 h. The reaction mixture was cooled to room temperature and H2O 
(5 mL) was added. The layers were allowed to separate and the aqueous layer was 
extracted with dichloromethane (3 x 10 mL). The combined organics were dried over 
Na2SO4, filtered, and concentrated by rotary evaporation in a 4-dram vial.  
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TBSCl Protection 
To the crude residue was added dichloromethane (1.2 mL) and imidazole (151 mg, 2.22 
mmol).  The reaction mixture was cooled to 0 °C and a solution of TBSCl (112 mg, 0.74 
mmol) in toluene (0.25 mL).  The reaction was sealed and allowed to warm to room 
temperature and stirred for 4 hours.  The reaction mixture was quenched with aq. NH4Cl 
(5 mL).  The layers were allowed to separate and the aqueous layer was extracted with 
dichloromethane (3 x 5 mL). The combined organics were dried over Na2SO4, filtered, 
and concentrated by rotary evaporation. The crude material was purified on SiO2. 
 
Ac2O Protection 
To the residue was added dichloromethane (1.2 mL), triethylamine (1.2 mL), and a single 
crystal of 4-(dimethylamino)pyridine under a nitrogen atmosphere. The reaction mixture 
was cooled to 0 °C and acetic anhydride (52 µL, 0.55 mmol) was added. The reaction 
mixture was allowed to warm to room temperature and stirred for 12 h. The reaction 
mixture was diluted with 1 M HCl. The organic layer was separated and washed with 
saturated aqueous NaHCO3, dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude material was purified on SiO2. 
 
4.14.4 Full Characterization 
2,6-diphenylhexane-1,4-diol. (4.53) Prepared according the 
general diboration/cross-coupling/oxidation procedure using 1-
phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and bromobenzene 
Ph
OH Ph
OH
2
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(39 µL, 0.38 mmol). The crude product was purified on silica gel (40% ethyl acetate in 
hexanes) to afford the title compound as a colorless oil (45 mg, 67%). 
 
1H NMR (500 MHz, CDCl3): δ 1.75-1.88 (3H, m), 1.92-1.98 (1H, m), 2.60-2.66 (1H, m), 
2.74-2.79 (1H, m), 3.01 (1H, quintet, J = 6.4 Hz), 3.71-3.80 (3H, m), 7.15-7.18 (3H, m), 
7.20-7.22 (3H, m), 7.24-7.28 (2H, m), 7.30-7.33 (2H, m); 13C NMR (125 MHz, CDCl3): 
δ 24.8, 32.0, 38.8, 40.6, 44.9, 67.2, 69.5, 125.8, 126.9, 127.8, 128.4, 128.4, 128.8, 142.0, 
142.6; IR (neat): 3330.5 (br), 3026.4 (w), 2928.8 (w), 1602.0 (w), 1493.9 (w), 1452.9 
(w), 1265.3 (w), 1029.4 (m), 734.9 (s), 697.7 (s), 604.2 (m), 549.6 (m), 528.7 (m) cm-1; 
HRMS-(DART-TOF) for C18H22O2 [M+H]: calculated: 271.1698, found: 271.1699. 
 
Proof of Stereochemistry: The relative stereochemistry was determined by NOESY 
NMR of the corresponding lactone derived from the 1,4-diol (as shown below). 
 
 
 
2-phenylbutane-1,4-diol. (4.62) Prepared according the general 
deprotection/cross-coupling/oxidation procedure using (3,4-
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bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy)(tert-butyl)dimethyl-silane (110 
mg, 0.25 mmol).  The NMR yield was determined using 1,3,5-trimethoxybenzene as an 
internal standard.  All spectral data are in accord with the literature.39 
 
3-methyl-4-phenylbutane-1,3-diol. (4.64) Prepared according the 
general deprotection/cross-coupling/oxidation procedure using tert-
butyldimethyl(3-methyl-3,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy)-
silane (114 mg, 0.25 mmol).  The NMR yield was determined using 1,3,5-
trimethoxybenzene as an internal standard.  All spectral data are in accord with the 
literature.40 
 
3-phenylpropane-1,2-diol. (4.66) Prepared according the general 
deprotection/cross-coupling/oxidation procedure using (2,3-bis(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propoxy)(tert-butyl)dimethylsilane (87 mg, 0.20 
mmol).  The NMR yield was determined using 1,3,5-trimethoxybenzene as an internal 
standard.  All spectral data are in accord with the literature.41 
 
5-phenylpentane-1,4-diol. (4.68) Prepared according the general 
deprotection/cross-coupling/oxidation procedure using ((4,5-
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentyl)oxy)(tert-butyl)dimethylsilane 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
39 Gotoh, H.; Masui, R.; Ogino, H.; Shoji, M.; Hayashi, Y. Angew. Chem. Int. Ed., 2006, 
45, 6853 – 6856. 
40 Frye, S. V.; Eliel, E. L. J. Org. Chem. 1985, 50, 3402 – 3404. 
41 Kwon, M. S.; Park, I. S.; Jang, J. S.; Lee, J. S.; Park, J. Org. Lett. 2007, 9, 3417 – 
3419. 
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(114 mg, 0.25 mmol).  The NMR yield was determined using 1,3,5-trimethoxybenzene as 
an internal standard.  All spectral data are in accord with the literature.42 
 
3,4-diphenylbutan-1-ol. (4.70) Prepared according the general 
deprotection/cross-coupling/oxidation procedure using tert-
butyldimethyl(4-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy)silane (49 
mg, 0.13 mmol).  The NMR yield was determined using 1,3,5-trimethoxybenzene as an 
internal standard.  All spectral data are in accord with the literature.43 
 
2,2-dimethyl-5-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)cyclohexan-1-ol. (4.80)  Prepared according the procedure for 
cross-coupling of cyclic bis(boronate). 
 
1H NMR (600 MHz, CDCl3): δ 0.90 (6H, s), 1.00 (3H, s), 1.02 (6H, s), 1.04 (3H, s), 1.65-
1.71 (2H, m), 1.81 (1H, dd, J = 12.9 Hz, 1.8 Hz), 2.00 (1H, d, J = 12.3 Hz), 2.22 (1H, q, J 
= 11.7 Hz), 2.84 (1H, dt, J = 12.3 Hz, 3.5 Hz), 3.47 (1H, dd, J = 11.2 Hz, 4.1 Hz), 7.10-
7.13 (1H, m), 7.21-7.24 (2H, m), 7.27-7.29 (2H, m); 13C NMR (125 MHz, CDCl3): δ 
19.5, 24.1, 24.8, 29.3, 33.3, 35.7, 41.6, 42.8, 78.7, 82.6, 82.7, 125.4, 127.4, 127.5, 127.7, 
145.3; IR (neat): 3398.0 (w), 2975.9 (m), 2946.0 (m), 2866.6 (m), 1388.6 (m), 1370.5 
(m), 1316.3 (s), 1142.0 (s), 965.5 (m), 858.8 (m), 751.2 (m), 696.5 (s) cm-1; HRMS-
(DART-TOF) for C20H32BO3 [M+H]: calculated: 331.2445, found: 331.2458. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
42 Kelly, B. D.; Lambert, T. H. Org. Lett. 2011, 13, 740 – 743. 
43 Ito, H.; Nagahara, T.; Ishihara, K.; Saito, S.; Yamamoto, H. Angew. Chem. Int. Ed. 
2004, 43, 994 – 997.!
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2,2-dimethyl-5-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)cyclohexan-1-one. (4.81) Prepared according the procedure for 
cross-coupling of cyclic bis(boronate). 
 
1H NMR (600 MHz, CDCl3): δ 1.04 (6H, s), 1.14 (6H, s), 1.19 (3H, s), 1.22 (3H, s), 1.73 
(1H, dd, J = 13.5 Hz, 2.9 Hz), 1.93-2.01 (2H, m), 2.71 (1H, dd, J = 14.7 Hz, 4.7 Hz), 2.83 
(1H, dd, J = 14.7 Hz, 6.5 Hz), 3.61 (1H, q, J = 4.7 Hz), 7.13-7.17 (3H, m), 7.21-7.24 (2H, 
m); 13C NMR (125 MHz, CDCl3): δ 24.6, 25.0, 25.6, 26.0, 37.9, 43.5, 44.0, 45.1, 83.3, 
126.4, 128.0, 128.3, 143.7, 217.2; IR (neat): 2975.3 (m), 2925.0 (w), 2866.2 (w), 1701.4 
(s), 1371.6 (s), 1323.3 (s), 1111.5 (s), 967.1 (s), 851.9 (m), 694.4 (m) cm-1; HRMS-
(DART-TOF) for C20H30BO3 [M+H]: calculated: 329.2288, found: 329.2304. 
 
Proof of Stereochemistry: The relative stereochemistry was determined by crystal 
structure determination (as shown below). 
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tert-butyl((-1,5-diphenyl-6-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hexan-3-yl)oxy)dimethylsilane. (4.83) 
Prepared according the general diboration/cross-
coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and 
bromobenzene (39 µL, 0.38 mmol). The crude product was purified on silica gel (100% 
hexanes to 50% DCM in hexanes) to afford the title compound as a colorless oil (57 mg, 
85%). 
 
1H NMR (500 MHz, CDCl3): δ -0.11 (3H, s), -0.06 (3H, s), 0.87 (9H, s), 1.09 (6H, s), 
1.10 (6H, s), 1.07-1.12 (1H, m), 1.18 (1H, dd, J = 15.2 Hz, 6.9 Hz), 1.67-1.74 (1H, m), 
1.78-1.88 (3H, m), 2.53 (1H, dd, J = 11.3 Hz, 5.4 Hz), 2.73 (1H, dd, J = 13.7 Hz, 5.4 Hz), 
2.86 (1H, quintet, J = 8.3 Hz), 3.43 (1H, quintet, J = 6.4 Hz), 7.13-7.18 (6H, m), 7.22-
7.29 (4H, m); 13C NMR (125 MHz, CDCl3): δ -4.6, -4.4, 18.1, 24.7, 24.7, 25.9, 31.2, 
38.1, 38.2, 46.6, 69.8, 82.9, 125.5, 125.9, 127.3, 128.2, 128.3, 128.4, 143.0, 146.9; 11B 
NMR (160 MHz, CDCl3): δ 33.4; IR (neat): 2977.1 (w), 2928.3 (w), 2856.2 (w), 1453.7 
(w), 1369.4 (s), 1318.4 (s), 1253.5 (m), 1143.9 (s), 1066.4 (s), 967.1 (m), 881.5 (m), 
832.9 (s), 772.4 (s), 697.8 (s) cm-1; HRMS-(DART-TOF) for C30H48BO3Si [M+H]: 
calculated: 495.3466, found: 495.3477. 
 
tert-butyl((-5-(4-methoxyphenyl)-1-phenyl-6-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-yl)oxy)-
dimethylsilane. (4.85) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-
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phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and 4-bromoanisole (47 µL, 0.38 mmol). The 
crude product was purified on silica gel (100% hexanes to 50% DCM in hexanes) to 
afford the title compound as a colorless oil (101 mg, 77%). 
 
1H NMR (500 MHz, CDCl3): δ -0.09 (3H, s), -0.05 (3H, s), 0.88 (9H, s), 1.06 (1H, dd, J = 
15.7 Hz, 8.8 Hz), 1.10 (6H, s), 1.11 (6H, s), 1.15 (1H, dd, J = 15.2 Hz, 6.8 Hz), 1.66-1.73 
(1H, m), 1.79 (2H, t, J = 7.9 Hz), 1.78-1.87 (1H, m), 2.53 (1H, dd, J = 13.7 Hz, 4.9 Hz), 
2.73 (1H, dd, J = 13.7 Hz, 5.4 Hz), 2.82 (1H, quintet, J = 7.3 Hz), 3.43 (1H, sextet, J = 
3.9 Hz), 3.78 (3H, s), 6.79-6.80 (2H, m), 7.07-7.09 (2H, m), 7.16-7.19 (3H, m), 7.26-7.29 
(2H, m); 13C NMR (125 MHz, CDCl3): δ -4.6, -4.4, 18.1, 24.7, 24.7, 25.9, 31.2, 37.2, 
38.2, 46.7, 55.3, 69.8, 82.9, 113.6, 125.5, 128.1, 128.3, 128.4, 139.0, 143.1, 157.7; 11B 
NMR (160 MHz, CDCl3): δ 33.6; IR (neat): 2977.0 (w), 2928.6 (w), 2855.9 (w), 1510.7 
(m), 1462.2 (w), 1369.0 (s), 1318.6 (m), 1245.6 (s), 1143.6 (s), 967.2 (m), 830.5 (s), 
807.6 (s), 772.8 (m), 698.4 (m) cm-1; HRMS-(DART-TOF) for C31H50BO4Si [M+H]: 
calculated: 525.3571, found: 525.3589. 
 
tert-butyldimethyl((1-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-5-(4-(trifluoromethyl)-phenyl)hexan-
3-yl)oxy)silane. (4.86) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-
phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and 4-bromobenzotrifluoride (39 µL, 0.275 
mmol). The crude product was purified on silica gel (100% hexanes to 50% DCM in 
hexanes) to afford the title compound as a colorless oil (110 mg, 78%). 
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1H NMR (500 MHz, CDCl3): δ -0.08 (3H, s), -0.05 (3H, s), 0.88 (9H, s), 1.05-1.11 (1H, 
m), 1.09 (12H, s), 1.19 (1H, dd, J = 15.2 Hz, 6.4 Hz), 1.67-1.74 (1H, m), 1.78-1.84 (1H, 
m), 1.83 (2H, t, J = 6.4 Hz), 2.54 (1H, dd, J = 11.2 Hz, 5.9 Hz), 2.70 (1H, dd, J = 13.7 Hz, 
5.4 Hz), 2.95 (1H, quintet, J = 7.8 Hz), 3.44 (1H, sextet, J = 4.4 Hz), 7.14-7.19 (3H, m), 
7.25-7.28 (4H, m), 7.49-7.51 (2H, m); 13C NMR (125 MHz, CDCl3): δ -4.5, -4.5, 18.1, 
24.6, 24.7, 25.9, 31.1, 37.9, 38.4, 46.2, 69.5, 83.1, 125.1 (q, J = 3.9 Hz), 125.6, 127.7, 
128.3, 128.3, 142.7, 151.3; 11B NMR (160 MHz, CDCl3): δ 33.5; IR (neat): 2977.9 (w), 
2929.8 (w), 2857.1 (w), 1471.4 (m), 1370.2 (m), 1322.9 (s), 1254.3 (m), 1163.1 (m), 
1123.2 (s), 1067.2 (s), 833.2 (s), 773.1 (s), 745.6 (m), 698.5 (m), 606.5 (m) cm-1; HRMS-
(DART-TOF) for C31H46BF3O3Si [M+H]: calculated: 563.3340, found: 563.3345. 
 
tert-butyldimethyl((1-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-5-(o-tolyl)hexan-3-yl)oxy)silane. (4.87) 
Prepared according the general diboration/cross-
coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and 2-
bromotoluene (45 µL, 0.38 mmol). The crude product was purified on silica gel (100% 
hexanes to 50% DCM in hexanes) to afford the title compound as a colorless oil (92 mg, 
72%). 
 
1H NMR (500 MHz, CDCl3): δ -0.05 (3H, s), 0.00 (3H, s), 0.90 (9H, s), 1.04 (12H, s), 
1.05 (1H, dd, J = 15.2 Hz,, 9.3 Hz), 1.16 (1H, dd, J = 15.7 Hz, 6.4 Hz), 1.67-1.86 (4H, 
m), 2.35 (3H, s), 2.56 (1H, dd, J = 11.3 Hz, 4.9 Hz), 2.68 (1H, dd, J = 13.7 Hz, 5.9 Hz), 
3.24 (1H, quintet, J = 6.8 Hz), 3.58 (1H, quintet, J = 5.9 Hz), 7.02-7.09 (2H, m), 7.14-
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7.18 (4H, m), 7.22-7.28 (3H, m); 13C NMR (125 MHz, CDCl3): δ -4.5, -4.5, 18.1, 19.9, 
24.5, 24.7, 25.9, 31.3, 32.1, 39.3, 46.3, 69.8, 82.8, 125.4, 125.5, 126.0, 126.0, 128.3, 
128.3, 130.0, 135.5, 142.9, 145.5; 11B NMR (160 MHz, CDCl3): δ 33.4; IR (neat): 2976.4 
(w), 2952.2 (w), 2928.1 (w), 2856.3 (w), 1461.9 (w), 1367.0 (s), 1317.8 (s), 1254.0 (m), 
1144.1 (s), 1066.3 (m), 967.6 (m), 833.2 (s), 772.6 (s), 698.1 (m) cm-1; HRMS-(DART-
TOF) for C31H50BO3Si [M+H]: calculated: 509.3622, found: 509.3641. 
 
3-(4-((tert-butyldimethylsilyl)oxy)-6-phenyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-yl)pyridine. 
(4.89) Prepared according the general diboration/cross-
coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and 3-
bromopyridine (36 µL, 0.38 mmol). The crude product was purified on silica gel (2% 
MeOH in DCM) to afford the title compound as a colorless oil (64 mg, 52%). 
 
1H NMR (500 MHz, CDCl3): δ -0.08 (3H, s), -0.06 (3H, s), 0.87 (9H, s), 1.09 (12H, s), 
1.04-1.12 (1H, m), 1.21 (1H, dd, J = 15.6 Hz, 6.4 Hz), 1.68-1.75 (1H, m), 1.79-1.87 (3H, 
m), 2.51-2.57 (1H, m), 2.67-2.73 (1H, m), 2.92 (1H, quintet, J = 7.7 Hz), 3.46 (1H, 
quintet, J = 5.9 Hz), 7.15-7.20 (4H, m), 7.25-7.28 (2H, m), 7.49-7.50 (1H, m), 8.41-8.44 
(2H, m); 13C NMR (125 MHz, CDCl3): δ -4.5, -4.5, 18.0, 24.7, 24.7, 25.9, 31.1, 35.4, 
38.5, 46.2, 69.6, 83.1, 123.2, 125.6, 128.3, 134.4, 142.2, 142.7, 147.5, 149.6; 11B NMR 
(160 MHz, CDCl3): δ 34.2; IR (neat): 3026.6 (w), 2977.1 (w), 2928.8 (m), 2856.2 (w), 
1369.7 (s), 1317.3 (m), 1252.3 (m), 1143.2 (s), 1068.2 (m), 833.2 (s), 772.9 (s), 715.1 
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(m), 698.6 (m) cm-1; HRMS-(DART-TOF) for C29H47BNO3Si [M+H]: calculated: 
496.3418, found: 496.3435. 
 
5-(4-((tert-butyldimethylsilyl)oxy)-6-phenyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-
yl)quinolone. (4.91) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 
mmol) and 5-bromoquinoline (78 µL, 0.38 mmol). The crude product was purified on 
silica gel (2% MeOH in DCM) to afford the title compound as a colorless oil (90 mg, 
66%). 
 
1H NMR (500 MHz, CDCl3): δ -0.03 (3H, s), 0.04 (3H, s), 0.88 (6H, s), 0.93 (9H, s), 0.96 
(6H, s), 1.24-1.29 (1H, m), 1.35 (1H, dd, J = 15.7 Hz, 5.4 Hz), 1.69-1.79 (2H, m), 1.86 
(1H, quintet, J = 6.4 Hz), 2.00 (1H, quintet, J = 6.85 Hz), 2.46-2.52 (1H, m), 2.56-2.63 
(1H, m), 3.64 (1H, quintet, J = 5.9 Hz), 3.85 (1H, s), 7.07 (2H, d, J = 7.5 Hz), 7.15 (1H, t, 
J = 7.0 Hz), 7.23 (2H, t, J = 7.0 Hz), 7.39 (1H, dd, J = 9.0 Hz, 4.0 Hz), 7.50 (1H, d, J = 
7.0), 7.66 (1H, t, J = 7.5 Hz), 7.95 (1H, d, J = 8.5 Hz), 8.63 (1H, d, J = 8.5 Hz), 8.90 (1H, 
dd, J = 4.0 Hz, 1.5 Hz); 13C NMR (125 MHz, CDCl3): δ -4.4, -4.4, 18.1, 24.4, 24.5, 24.7, 
26.0, 31.1, 39.2, 46.6, 69.8, 82.9, 120.4, 123.7, 125.6, 126.8, 127.6, 128.2, 128.3, 129.0, 
132.5, 142.5, 144.3, 148.6, 149.7; 11B NMR (160 MHz, CDCl3): δ 33.5; IR (neat): 3063.6 
(w), 3027.1 (w), 2976.0 (w), 2951.8 (m), 2928.3 (m), 2856.1 (w), 1594.9 (m), 1572.5 
(m), 1499.3 (m), 1470.8 (m), 1361.3 (s), 1323.6 (m), 1252.5 (m), 1142.9 (s), 1060.6 (m), 
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832.9 (s), 800.0 (s), 773.0 (s), 739.2 (m), 698.4 (m) cm-1; HRMS-(DART-TOF) for 
C33H49BNO3Si [M+H]: calculated: 546.3575, found: 546.3598. 
 
tert-butyl((5-(furan-2-yl)-1-phenyl-6-(4,4,5,5-tetra-
methyl-1,3,2-dioxaborolan-2-yl)hexan-3-yl)oxy)dimethyl-
silane. (4.93) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 
mmol) and 2-bromofuran (33 µL, 0.38 mmol). The crude product was purified on silica 
gel (100% hexanes to 50% DCM in hexanes) to afford the title compound as a colorless 
oil (62 mg, 51%). 
 
1H NMR (500 MHz, CDCl3): δ -0.02 (3H, s), 0.00 (3H, s), 0.89 (9H, s), 1.12 (2H, t, J = 
6.36 Hz), 1.17 (6H, s), 1.17 (6H, s), 1.67-1.76 (2H, m), 1.81-1.94 (2H, m), 2.57 (1H, dd, J 
= 11.2 Hz, 4.9 Hz), 2.73 (1H, dd, J = 13.7 Hz, 5.4 Hz), 3.02 (1H, quintet, J = 7.8 Hz), 
3.59 (1H, quintet, J = 5.4 Hz), 5.93 (1H, d, J = 2.9 Hz), 6.23 (1H, t, J = 2.5 Hz), 7.15-7.19 
(3H, m), 7.25-7.28 (3H, m); 13C NMR (125 MHz, CDCl3): δ -4.6, -4.5, 18.1, 24.7, 24.8, 
25.9, 31.3, 31.4, 38.5, 44.0, 69.8, 83.0, 104.0, 109.7, 125.5, 128.3, 128.4, 140.4, 142.9, 
160.0; 11B NMR (160 MHz, CDCl3): δ 33.6; IR (neat): 2977.3 (w), 2950.9 (w), 2928.7 
(w), 2856.3 (w), 1461.5 (w), 1368.3 (s), 1318.5 (m), 1253.7 (m), 1143.9 (s), 1068.0 (m), 
1006.3 (m), 967.5 (m), 833.3 (s), 773.1 (s), 728.0 (m), 698.2 (m) cm-1; HRMS-(DART-
TOF) for C28H46BO4Si [M+H]: calculated: 485.3258, found: 485.3274. 
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tert-butyldimethyl((1-phenyl-5-((4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)methyl)hept-6-en-3-yl)oxy)-
silane. (4.95) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 
mmol) and 1,2-dichloroethane (59 µL, 0.75 mmol). KOt-Bu (168 mg, 1.5 mmol) was 
used instead of KOH.  The crude product was purified on silica gel (100% hexanes to 
50% DCM in hexanes) to afford the title compound as a colorless oil (83 mg, 75%). 
 
1H NMR (500 MHz, CDCl3): δ 0.05 (6H, s), 0.79-0.91 (2H, m), 0.91 (9H, s), 1.22 (12H, 
s), 1.49-1.58 (2H, m), 1.64-1.71 (1H, m), 1.80-1.87 (1H, m), 2.33 (1H, q, J = 6.9 Hz), 
2.59 (1H, td, J = 13.7 Hz, 5.4 Hz), 2.75 (1H, td, J = 13.2 Hz, 5.4 Hz), 3.72 (1H, quintet, J 
= 6.4 Hz), 4.89 (1H, dd, J = 10.3 Hz, 1.5 Hz), 4.93 (1H, d, J = 17.1 Hz), 5.67 (1H, 
quintet, J = 9.2 Hz), 7.15-7.20 (3H, m), 7.26-7.29 (2H, m); 13C NMR (125 MHz, CDCl3): 
δ -4.4, -4.3, 18.1, 24.9, 26.0, 31.3, 36.6, 38.3, 44.5, 70.0, 83.0, 113.1, 125.5, 128.2, 128.4, 
143.1, 144.1; 11B NMR (160 MHz, CDCl3): δ 33.4; IR (neat): 2977.4 (w), 2952.9 (w), 
2928.1 (m), 2856.4 (w), 1471.2 (w), 1368.3 (s), 1318.6 (m), 1254.4 (m), 1144.2 (s), 
1061.3 (s), 967.6 (m), 833.8 (s), 772.9 (s), 698.1 (m) cm-1; HRMS-(DART-TOF) for 
C26H46BO3Si [M+H]: calculated: 445.3309, found: 445.3320. 
 
tert-butyldimethyl(((E)-1-phenyl-5-((4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl) methyl)tridec-6-en-3-yl)oxy)-
silane. (4.97) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 
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mmol) and (E)-1-chlorooct-1-ene (63 µL, 0.38 mmol). The crude product was purified on 
silica gel (100% hexanes to 50% DCM in hexanes) to afford the title compound as a 
colorless oil (71 mg, 54%). 
 
1H NMR (500 MHz, CDCl3): δ 0.05 (6H, s), 0.77-0.90 (2H, m), 0.89 (3H, t, J = 6.8 Hz), 
0.91 (9H, s), 1.22 (12H, s), 1.24-1.34 (8H, m), 1.43-1.56 (2H, m), 1.67 (1H, sextet, J = 
5.9 Hz), 1.81-1.87 (1H, m), 1.93-1.95 (2H, m), 2.21-2.27 (1H, m), 2.57 (1H, td, J = 13.7 
Hz, 4.9 Hz), 2.76 (1H, td, J = 13.7 Hz, 5.4 Hz), 3.71 (1H, septet, J = 3.9 Hz), 5.22 (1H, 
dd, J = 15.2 Hz, 8.3 Hz), 5.33 (1H, dt, J = 15.2 Hz, 6.9 Hz), 7.15-7.20 (3H, m), 7.26-7.29 
(2H, m); 13C NMR (125 MHz, CDCl3): -4.4, -4.2, 14.1, 18.1, 22.6, 24.8, 24.9, 24.9, 25.0, 
26.0, 28.9, 29.6, 31.4, 31.8, 32.5, 35.5, 38.2, 45.2, 70.2, 82.9, 125.5, 128.2, 128.4, 129.3, 
135.5, 143.1; 11B NMR (160 MHz, CDCl3): δ 33.5; IR (neat): 2954.5 (w), 2926.0 (m), 
2855.3 (w), 1461.7 (w), 1369.6 (m), 1317.2 (m), 1253.6 (m), 1144.3 (m), 1079.2 (m), 
1059.8 (m), 967.7 (m), 833.3 (s), 772.6 (s), 697.9 (m) cm-1; HRMS-(DART-TOF) for 
C32H58BO3Si [M+H]: calculated: 529.4248, found: 529.4262. 
 
tert-butyldimethyl(((Z)-1-phenyl-5-((4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)methyl)oct-6-en-3-yl)oxy)silane. 
(4.99) Prepared according the general diboration/cross-
coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 mmol) and (Z)-
1-chloroprop-1-ene (31 µL, 0.38 mmol). The crude product was purified on silica gel 
(100% hexanes to 50% DCM in hexanes) to afford the title compound as a colorless oil 
(78 mg, 68%). 
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1H NMR (500 MHz, CDCl3): δ 0.05 (3H, s), 0.06 (3H, s), 0.75 (1H, dd, J = 15.7 Hz, 8.3 
Hz), 0.86 (1H, dd, J = 15.2 Hz, 5.7 Hz), 0.91 (9H, s), 1.21 (12H, s), 1.43-1.49 (1H, m), 
1.56 (1H, t, J = 3.9 Hz), 1.59 (3H, dd, J = 6.9 Hz, 1.5 Hz), 1.67 (1H, sextet, J = 5.4 Hz), 
1.79-1.86 (1H, m), 2.56 (1H, td, J = 11.7 Hz, 4.9 Hz), 2.62 -2.69 (1H, m), 2.76 (1H, td, J 
= 13.7 Hz, 5.4 Hz), 3.65 (1H, septet, J = 4.4 Hz), 5.17 (1H, td, J = 10.3 Hz, 1.5 Hz), 5.34-
5.40 (1H, m), 7.15-7.19 (3H, m), 7.26-7.29 (2H, m); 13C NMR (125 MHz, CDCl3): -4.4, -
4.2, 13.2, 18.1, 24.8, 24.9, 26.0, 29.6, 31.6, 38.7, 45.5, 70.3, 82.9, 122.3, 125.5, 128.3, 
128.4, 136.6, 143.1; 11B NMR (160 MHz, CDCl3): δ 33.6; IR (neat): 2977.5 (w), 2952.4 
(w), 2928.5 (m), 2856.6 (w), 1461.9 (w), 1405.7 (s), 1362.2 (m), 1320.3 (m), 1253.9 (m), 
1144.2 (s), 1062.9 (s), 967.8 (m), 833.5 (s), 772.4 (s), 730.7 (m), 697.7 (m) cm-1; HRMS-
(DART-TOF) for C27H48BO3Si [M+H]: calculated: 459.3466, found: 459.3489. 
 
tert-butyldimethyl((6-methyl-1-phenyl-5-((4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)hept-6-en-
3-yl)oxy)silane. (4.102) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 
mmol) and 2-chloroprop-1-ene (32 µL, 0.38 mmol). Cross-coupling run with 10 mol % 
Pd(OAc)2 and 12 mol % RuPhos. The crude product was purified on silica gel (100% 
hexanes to 50% DCM in hexanes) to afford the title compound as a colorless oil (80 mg, 
70%). 
 
1H NMR (500 MHz, CDCl3): δ 0.04 (3H, s), 0.05 (3H, s), 0.91 (9H, s), 0.82-0.93 (2H, 
m), 1.21 (12H, s), 1.47-1.52 (1H, m), 1.57-1.64 (1H, m), 1.66 (3H, s), 1.69 (1H, quintet, J 
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= 5.9 Hz), 1.80-1.87 (1H, m), 2.36-2.43 (1H, m), 2.58 (1H, td, J = 11.7 Hz, 4.9 Hz), 2.75 
(1H, td, J = 12.7 Hz, 5.2 Hz), 3.61-3.65 (1H, m), 4.66 (1H, s), 4.68 (1H, s), 7.15-7.19 
(3H, m), 7.26-7.28 (2H, m); 13C NMR (125 MHz, CDCl3): -4.4, -4.3, 18.1, 18.2, 24.8, 
24.9, 25.9, 31.1, 38.2, 39.5, 42.8, 70.1, 83.0, 110.4, 125.5, 128.2, 128.4, 143.2, 149.1; 11B 
NMR (160 MHz, CDCl3): δ 33.5; IR (neat): 2977.3 (w), 2928.8 (w), 2856.5 (w), 1461.5 
(w), 1361.9 (m), 1317.1 (m), 1253.5 (m), 1144.1 (s), 1061.5 (m), 967.7 (m), 833.0 (s), 
772.3 (s), 697.9 (m) cm-1; HRMS-(DART-TOF) for C27H48BO3Si [M+H]: calculated: 
459.34658, found: 459.34576. 
 
tert-butyl((5-(cyclopent-1-en-1-yl)-1-phenyl-6-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-yl)oxy)di-
methylsilane. (4.104) Prepared according the general 
diboration/cross-coupling/protection procedure using 1-phenylhex-5-en-3-ol (44 mg, 0.25 
mmol) and 1-chlorocyclopent-1-ene (37 µL, 0.38 mmol). Cross-coupling run with 10 mol 
% Pd(OAc)2 and 12 mol % RuPhos. The crude product was purified on silica gel (100% 
hexanes to 50% DCM in hexanes) to afford the title compound as a colorless oil (62 mg, 
51%). 
 
1H NMR (500 MHz, CDCl3): δ 0.03 (3H, s), 0.04 (3H, s), 0.90 (9H, s), 0.83-0.94 (2H, 
m), 1.20 (12H, s), 1.48-1.53 (1H, m), 1.59-1.70 (2H, m), 1.77-1.87 (3H, m), 2.23 (2H, t, J 
= 7.8 Hz), 2.14-2.27 (2H, m), 2.52-2.60 (1H, m), 2.59 (1H, td, J = 11.7 Hz, 4.9 Hz), 2.74 
(1H, td, J = 13.2 Hz, 4.9 Hz), 3.61 (1H, septet, J = 4.9 Hz), 5.30 (1H, s), 7.15-7.19 (3H, 
m), 7.25-7.28 (2H, m); 13C NMR (125 MHz, CDCl3): -4.5, -4.3, 18.1, 23.4, 24.8, 24.8, 
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26.0, 31.1, 31.2, 32.0, 33.6, 38.2, 43.4, 70.2, 82.9, 123.6, 125.5, 128.2, 128.4, 143.1, 
148.6; 11B NMR (160 MHz, CDCl3): δ 33.6; IR (neat): 2976.9 (w), 2928.1 (w), 2855.3 
(w), 1461.7 (w), 1368.6 (s), 1313.4 (m), 1252.9 (m), 1144.2 (m), 1031.1 (w), 967.7 (w), 
938.5 (w), 808.4 (s), 772.5 (s), 746.7 (w), 698.1 (m) cm-1; HRMS-(DART-TOF) for 
C29H50BO3Si [M+H]: calculated: 485.3622, found: 485.3627. 
 
tert-butyl(1,3-diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxa-
borolan-2-yl)butoxy)dimethylsilane. (4.106) Prepared 
according the general diboration/cross-coupling/protection procedure using 1-phenylbut-
3-en-1-ol (44 mg, 0.25 mmol) and bromobenzene (39 µL, 0.38 mmol). The crude product 
was purified on silica gel (100% hexanes to 50% DCM in hexanes) to afford the title 
compound as a colorless oil (80 mg, 68%). 
 
1H NMR (500 MHz, CDCl3): δ -0.27 (3H, s), -0.08 (3H, s), 0.81 (9H, s), 1.03 (6H, s), 
1.05 (6H, s), 1.02-1.07 (1H, m), 1.17 (1H, dd, J = 15.2 Hz, 6.36 Hz), 1.96 (1H, quintet, J 
= 6.85 Hz), 2.12 (1H, quintet, J = 6.16 Hz), 2.73 (1H, quintet, J = 7.33 Hz), 4.39 (1H, t, J 
= 6.36 Hz), 7.13-7.16 (1H, m), 7.18-7.19 (2H, m), 7.21-7.24 (4H, m), 7.25-7.29 (3H, m); 
13C NMR (125 MHz, CDCl3): δ -5.0, -4.7, 18.1, 24.6, 24.7, 25.8, 37.5, 49.9, 73.3, 82.8, 
125.8, 126.9, 127.9, 128.1, 145.3, 147.0; 11B NMR (160 MHz, CDCl3): δ 33.2; IR (neat): 
2977.1 (w), 2954.5 (w), 2928.5 (w), 2856.2 (w), 1453.8 (w), 1369.0 (s), 1318.9 (m), 
1252.7 (m), 1144.2 (s), 1068.9 (m), 967.8 (m), 834.1 (s), 774.0 (s), 697.6 (s) cm-1; 
HRMS-(DART-TOF) for C28H42BO3Si [M+H]: calculated: 465.2996, found: 466.3014. 
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 (3R,4S,5S)-4-methyl-1,5-diphenyl-6-(4,4,5,5-tetra-
methyl-1,3,2-dioxaborolan-2-yl)hexan-3-yl acetate. 
(4.108) Prepared according the general diboration/cross-coupling/protection procedure 
using (3R,4S)-4-methyl-1-phenylhex-5-en-3-ol (48 mg, 0.25 mmol) and bromobenzene 
(39 µL, 0.38 mmol). The crude product was purified on silica gel (100% hexanes to 50% 
DCM in hexanes) to afford the title compound as a white solid (80 mg, 73%). 
 
1H NMR (500 MHz, CDCl3): δ 0.95 (3H, d, J = 6.85 Hz), 0.98 (6H, s), 0.99 (6H, s), 1.04 
(1H, dd, J = 15.2 Hz, 11.2 Hz), 1.24 (1H, dd, J = 15.2 Hz, 4.4 Hz), 1.76-1.81 (2H, m), 
1.99 (3H, s), 2.02-2.08 (1H, m), 2.29-2.35 (1H, m), 2.48-2.54 (1H, m), 2.68-2.73 (1H, 
m), 4.59 (1H, quintet, J = 4.4 Hz), 7.07-7.08 (2H, m), 7.13-7.17 (4H, m), 7.23-7.26 (4H, 
m); 13C NMR (125 MHz, CDCl3): δ 11.7, 21.2, 24.5, 24.6, 24.6, 30.6, 32.3, 43.2, 43.7, 
75.9, 82.9, 125.8, 126.1, 127.9, 128.1, 128.3, 128.3, 141.9, 144.9, 170.6; 11B NMR (160 
MHz, CDCl3): δ 33.5; IR (neat): 3027.0 (w), 2975.9 (m), 2931.7 (w), 1732.0 (s), 1495.1 
(w), 1453.4 (m), 1365.8 (s), 1319.4 (m), 1234.8 (s), 1143.6 (s), 988.4 (m), 966.6 (m), 
846.6 (m), 747.8 (m), 698.0 (s) cm-1; HRMS-(DART-TOF) for C27H38BO4 [M+H]: 
calculated: 437.2863, found: 437.2853. 
 
 (3R,4R,5S)-4-methyl-1,5-diphenyl-6-(4,4,5,5-tetra-
methyl-1,3,2-dioxaborolan-2-yl)hexan-3-yl acetate. 
(4.110) Prepared according the general diboration/cross-coupling/protection procedure 
using (3R,4R)-4-methyl-1-phenylhex-5-en-3-ol (48 mg, 0.25 mmol) and bromobenzene 
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(39 µL, 0.38 mmol). The crude product was purified on silica gel (100% hexanes to 50% 
DCM in hexanes) to afford the title compound as a white solid (83 mg, 76%). 
 
1H NMR (500 MHz, CDCl3): δ 0.75 (3H, d, J = 6.85 Hz), 0.97 (6H, s), 0.99 (6H, s), 1.11 
(1H, dd, J = 15.2 Hz, 10.8 Hz), 1.33 (1H, dd, J = 15.2 Hz, 4.9 Hz), 1.80-1.90 (2H, m), 
1.99 (3H, s), 1.96-2.04 (1H, m), 2.58-2.65 (2H, m), 2.72-2.77 (1H, m), 5.19 (1H, septet, J 
= 2.93 Hz), 7.09-7.15 (3H, m), 7.17-7.24 (5H, m), 7.26-7.30 (2H, m); 13C NMR (125 
MHz, CDCl3): δ 11.8, 21.2, 24.5, 24.6, 32.2, 34.3, 42.8, 44.0, 74.7, 82.8, 125.9, 125.9, 
128.0, 128.1, 128.2, 128.3, 128.3, 128.4, 141.7, 145.4, 170.9; 11B NMR (160 MHz, 
CDCl3): δ 33.4; IR (neat): 3060.4 (w), 3027.6 (w), 2976.9 (w), 2931.1 (w), 1731.1 (s), 
1368.2 (s), 1320.8 (m), 1237.0 (s), 1143.4 (s), 966.3 (m), 908.8 (m), 846.8 (m), 735.2 (s), 
698.7 (s) cm-1; HRMS-(DART-TOF) for C27H38BO4 [M+H]: calculated: 437.2863, 
found: 437.2868. 
 
tert-butyl(2,3-diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)butoxy)dimethylsilane. (4.112) Prepared 
according the general diboration/cross-coupling/protection procedure using 2-phenylbut-
3-en-1-ol (37 mg, 0.25 mmol) and bromobenzene (39 µL, 0.38 mmol). The crude product 
was purified on silica gel (100% hexanes to 50% DCM in hexanes) to afford the title 
compound as a white solid (62 mg, 53%). 
 
1H NMR (500 MHz, CDCl3): δ -0.28 (3H, s), -0.24 (3H, s), 0.73 (9H, s), 0.89 (6H, s), 
0.92 (6H, s), 0.89-0.97 (2H, m), 2.81 (1H, quintet, J = 4.9 Hz), 3.24 (1H, sextet, J = 5.4 
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Hz), 3.48-3.51 (2H, m), 7.14-7.21 (2H, m), 7.23-7.28 (8H, m); 13C NMR (125 MHz, 
CDCl3): δ -5.8, -5.7, 18.2, 24.3, 24.6, 25.8, 42.8, 56.5, 65.5, 82.7, 126.0, 126.1, 127.8, 
127.9, 128.3, 129.2, 142.9, 145.4; 11B NMR (160 MHz, CDCl3): δ 33.5; IR (neat): 3028.1 
(w), 2977.0 (w), 2954.0 (w), 2928.0 (m), 2895.9 (w), 2856.1 (w), 1601.8 (w), 1494.2 (w), 
1470.3 (w), 1452.8 (w), 1361.3 (m), 1322.4 (m), 1252.1(m), 1144.5 (m), 1105.5 (s), 
834.1 (s), 773.4 (m), 756.2 (m), 698.1 (s) cm-1; HRMS-(DART-TOF) for C28H44BO3Si 
[M+H]: calculated: 467.3153, found: 467.3156. 
 
Proof of Stereochemistry: The relative stereochemistry was determined by crystal 
structure determination (as shown below).   
 
 
 
 
 
 
 
tert-butyl((1,4-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)nonan-2-yl)oxy)dimethylsilane. (4.114) 
Prepared according the general diboration/cross-
coupling/protection procedure using (Z)-1-phenylnon-4-en-2-ol (55 mg, 0.25 mmol) and 
bromobenzene (39 µL, 0.38 mmol). The crude product was purified on silica gel (100% 
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hexanes to 50% DCM in hexanes) to afford the title compound as a colorless oil (85 mg, 
63%). 
 
1H NMR (500 MHz, CDCl3): δ -0.71 (3H, s), -0.40 (3H, s), 0.68 (9H, s), 0.75 (3H, t, J = 
6.35 Hz), 1.01-1.14 (3H, m), 1.14-1.22 (3H, m), 1.26-1.29 (1H, m), 1.29 (12H, s), 1.76 
(1H, ddd, J = 13.7 Hz, 10.3 Hz, 3.4 Hz), 1.90 (1H, td, J = 12.7 Hz, 2.9 Hz), 2.35 (1H, dd, 
J = 13.7 Hz, 9.29 Hz), 2.67 (1H, td, J = 13.7 Hz, 3.4 Hz), 2.99 (13.7 Hz, 1.96 Hz), 3.27 
(1H, t, J = 9.78), 7.00-7.01 (2H, m), 7.09-7.12 (1H, m), 7.16-7.21 (5H, m), 7.29-7.32 
(2H, m); 13C NMR (125 MHz, CDCl3): δ -5.7, -5.1, 13.9, 17.8, 22.7, 25.0, 25.1, 25.8, 
29.3, 31.3, 42.5, 44.7, 45.4, 72.2, 83.2, 125.7, 126.1, 127.8, 128.0, 128.3, 129.9, 140.1, 
144.7; 11B NMR (160 MHz, CDCl3): δ 34.6; IR (neat): 2954.6 (w), 2927.2 (m), 2856.0 
(w), 1454.1 (w), 1405.0 (m), 1317.5 (m), 1254.1 (m), 1142.6 (s), 1079.8 (m), 1066.5 (m), 
830.4 (s), 809.2 (m), 773.9 (s), 698.9 (s) cm-1; HRMS-(DART-TOF) for C33H54BO3Si 
[M+H]: calculated: 537.3935, found: 537.3924. 
 
tert-butyldimethyl((5-methyl-1,4-diphenyl-5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-yl)oxy)-
silane. (4.116) Prepared according the general diboration/cross-coupling/protection 
procedure using 5-methyl-1-phenylhex-4-en-2-ol (48 mg, 0.25 mmol) and bromobenzene 
(39 µL, 0.38 mmol). The crude product was purified on silica gel (100% hexanes to 50% 
DCM in hexanes) to afford the title compound as a white solid (58 mg, 46%). 
 
Ph
TBSO Ph
B(pin)
Me Me
! 320 
1H NMR (500 MHz, CDCl3): δ -0.13 (3H, s), -0.10 (3H, s), 0.72 (3H, s), 0.76 (3H, s), 
0.91 (9H, s), 1.14 (6H, s), 1.17 (6H, s), 1.50-1.54 (1H, m), 1.97 (1H, td, J = 13.2 Hz, 2.0 
Hz), 2.54 (1H, dd, J = 13.2 Hz, 7.8 Hz), 2.70 (1H, dd, J = 13.2 Hz, 4.4 Hz), 2.86 (1H, dd, 
J = 12.2 Hz, 2.0 Hz), 3.49 (1H, m), 6.88-6.89 (2H, m), 7.02-7.03 (2H, m), 7.12-7.15 (3H, 
m), 7.15-7.18 (1H, m), 7.20-7.23 (2H, m); 13C NMR (125 MHz, CDCl3): δ -4.6, -4.1, 
18.1, 20.7, 24.2, 24.6, 24.8, 26.0, 38.3, 45.3, 48.6, 71.9, 82.9, 125.7, 125.8, 127.2, 128.0, 
129.7, 130.1, 138.9, 141.6; 11B NMR (160 MHz, CDCl3): δ 34.2; IR (neat): 3027.3 (w), 
2953.2 (m), 2928.5 (m), 2889.4 (w), 2856.3 (w), 1471.2 (m), 1370.7 (m), 1343.8 (m), 
1306.1 (m), 1252.8 (m), 1135.3 (s), 1083.2 (s), 1063.6 (s), 964.5 (m), 832.8 (s), 772.9 (s), 
743.2 (s), 698.7 (s) cm-1; HRMS-(DART-TOF) for C31H50BO3Si [M+H]: calculated: 
509.3622, found: 509.3610. 
 
4.14.5 Synthesis of CCR-1 Antagonist 
tert-Butyl (S)-(1-oxo-3-phenylpropan-2-yl)carbamate and tert-butyl ((2S,3S)-3-hydroxy-
1-phenylhex-5-en-2-yl)carbamate (4.130) were prepared following literature procedures 
(shown below). All spectral data are in accord with the literature.44 
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tert-butyl ((S)-1-((2S,4S)-4-(2-methylprop-1-en-1-yl)-5-
oxotetrahydrofuran-2-yl)-2-phenylethyl)carbamate. 
(4.132) To an oven-dried 2-dram vial with magnetic stir 
bar was added tert-butyl ((2S,3S)-3-hydroxy-1-phenylhex-5-en-2-yl)carbamate (73 mg, 
0.25 mmol), Cs2CO3 (26 mg, 75 µmol), B2(pin)2 (95 mg, 0.38 mmol), tetrahydrofuran (1 
mL, [substrate] = 0.25 M) and methanol (0.17 mL, 4.25 mmol). The vial was sealed with 
a teflon septum cap and heated to 70 ºC for 12 h. The reaction was cooled to room 
temperature and concentrated in vacuo (ensuring that all methanol has been removed 
from the residue).  The flask was brought to a dry box and charged with solid potassium 
hydroxide (42 mg, 0.75 mmol), Pd(OAc)2/RuPhos (added as a 1:1.2 solution in THF 
(0.025 M); 0.25 mL for 2.5 mol% Pd(OAc)2), tetrahydrofuran (0.95 mL), toluene (1.2 
mL) and 1-chloro-2-methylpropene (37 µL, 0.38 mmol). The vial was sealed, removed 
from the dry box, and H2O (sparged with N2 for 30 min, 0.23 mL) was added through the 
teflon septum cap. The vial was heated to 70 ºC and stirred for 12 h. The reaction mixture 
was transferred to a 25-mL round bottom flask and cooled to 0 ºC (ice/water) and charged 
with 3 M sodium hydroxide (0.5 mL), and 30% hydrogen peroxide (0.5 mL). The 
reaction was gradually warmed to room temperature and allowed to stir for 4 h at which 
time the vial was diluted with ethyl acetate and the aqueous and organic layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 x 10 mL) and the 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation into 20 mL vial.  To the residue was added DCM (2.8 mL), H2O (0.83 mL), 
PhI(OAc)2 (0.36 g, 1.10 mmol), and TEMPO (8 mg, 0.05 mmol).  The reaction was 
allowed to stir for 4 h at room temperature.  The reaction  mixture was quenched with sat. 
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NaHCO3 (4 mL).  The layers were allowed to separate and the aqueous layer was 
extracted with DCM (3 x 10 mL).  The combined organic layers were washed with brine, 
dried with Na2SO4, filtered and concentrated with rotatory evaporation.  The crude 
material was purified on SiO2 (5% to 15% EtOAc/hexanes, stain with KMnO4) to afford 
the title compound as a colorless oil (60 mg, 67% yield). 
 
1H NMR (500 MHz, CDCl3): δ 1.39 (9H, s), 1.69 (3H, s), 1.73 (3H, s), 1.92-1.98 (1H, 
m), 2.40-2.46 (1H, m), 2.86-2.94 (2H, m), 3.52 (1H, q, J = 8.8 Hz), 4.03 (1H, q, J = 7.8 
Hz), 4.50 (1H, t, J = 6.9 Hz), 4.56 (1H, d, J = 9.3 Hz), 5.04 (1H, d, J = 8.8 Hz), 7.23-7.26 
(3H, m), 7.29-7.32 (2H, m); 13C NMR (100 MHz, CDCl3): 18.3, 25.6, 28.0, 28.2, 32.0, 
39.2, 39.6, 54.6, 78.1, 80.0, 119.7, 126.7, 128.6, 129.3, 137.1, 137.8, 155.8, 178.7; IR 
(neat): 3330.1 (br), 2975.5 (w), 2931.3 (w), 1767.7 (s), 1691.6 (s), 1517.3 (m), 1365.1 
(m), 1246.4 (m), 1159.8 (s), 1060.9 (m), 960.9 (w), 736.5 (w), 699.4 (s) cm-1; HRMS-
(DART-TOF) for C21H33N2O4 [M+NH4]: calculated: 377.2440, found: 377.2438. 
 
tert-butyl ((S)-1-((2S,4R)-4-isobutyl-5-oxotetrahydro-
furan-2-yl)-2-phenylethyl)-carbamate. (4.133) To an 
oven-dried 10 mL round bottom flask was added Pd/C (4.2 
mg).  A solution of tert-butyl ((S)-1-((2S,4S)-4-(2-methylprop-1-en-1-yl)-5-
oxotetrahydro-furan-2-yl)-2-phenylethyl)carbamate (14 mg, 39 µmol) and methanol (1.5 
mL) were added to the flask and it was sealed with a rubber septum.  The flask was 
evacuated and refilled with H2 gas three times and allowed to stir for 1 h at room 
temperature under 1 atm of H2.  The reaction mixture was filtered through a plug of celite 
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and washed with EtOAc.  The solution was concentrated with rotatory evaporation to 
afford the title compound cleanly as a colorless oil (13.8 mg, 98% yield). All spectral 
data are in accord with the literature.45 
 
4.14.6 Synthesis of Vitronectin Receptor Antagonist 
 (S)-4-(4-methoxyphenyl)-3-(4-(trifluoromethyl)-
phenyl)-butan-1-ol. (4.137) To an oven-dried 16-mL vial 
with magnetic stir bar in the dry box was added Pt(dba)3 
(4.5 mg, 5.0 µmol), (S,S)-3,5-di-iso-
propylphenylTADDOLPPh (5.5 mg, 6.0 µmol), B2(pin)2 (133 mg, 525 µmol) and 
tetrahydrofuran (0.5 mL). The vial was sealed with a teflon septum cap, removed from 
the dry box, and heated to 80 °C in an oil bath for 20 minutes. The vial was cooled to 
room temperature, returned to the dry box and charged with (but-3-en-1-yloxy)(tert-
butyl)dimethylsilane (115 µL, 500 µmol). The vial was sealed, removed from the dry box 
and stirred at 60 °C for 3 h. The vial was cooled to room temperature, returned to the dry 
box and charged with solid potassium hydroxide (84 mg, 1.50 mmol), Pd(OAc)2 (1.1 mg, 
5.0 µmol)/RuPhos (2.3 mg, 6.0 µmol) (added as a 1:1.2 solution in THF (1 mL)), 
tetrahydrofuran (3.05 mL) and 4-bromoanisole (66 µl, 525 µmol). The vial was sealed, 
removed from the dry box, and H2O (sparged with N2 for 30 min, 0.45 mL) was added 
through the teflon septum cap. The vial was heated to 70 °C and stirred for 12 h. The 
reaction mixture was cooled to room temperature and water (4 mL) was added. The 
layers were allowed to separate and the aqueous layer was extracted with 
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dichloromethane (3 x 10 mL). The combined organics were dried over Na2SO4, filtered, 
and concentrated by rotary evaporation in a 4-dram vial. The crude boronate was 
dissolved in MeOH (4 mL) and p-TsOHxH2O (5 mg).  The vial was capped and stirred at 
room temperature for 1 hour and concentrated, ensuring all the methanol was removed.  
The crude deprotected intermediate was returned to the dry box and charged with solid 
potassium hydroxide (84.0 mg, 1.50 mmol), Pd2(dba)3/RuPhos (added as a 1:2 solution in 
THF (0.01 M); 0.25 mL for 0.5 mol% Pd2(dba)3, tetrahydrofuran (2.0 mL), toluene (2.3 
mL) and 4-bromobenzotrifluoride (77 µL, 0.55 mmol). The vial was sealed, removed 
from the dry box, and H2O (sparged with N2 for 30 min, 0.45 mL) was added through the 
teflon septum cap. The vial was heated to 70 ºC and stirred for 16 h. The reaction mixture 
was cooled to room temperature and sat. NH4Cl (aq.) (3 mL) was added. The layers were 
allowed to separate and the aqueous layer was extracted with dichloromethane (3 x 10 
mL). The combined organics were dried over Na2SO4, filtered, and concentrated by 
rotary evaporation.  The crude material was purified on SiO2 (10% to 25% 
EtOAc/hexanes, stain with CAM) to afford the title compound as a colorless oil (101 mg, 
62% yield). 
 
1H NMR (600 MHz, CDCl3): δ 1.82 – 1.88 (1H, m), 1.98 – 2.04 (1H, m), 2.83 (1H, dd, J 
= 13.5 Hz, 8.2 Hz), 2.88 (1H, dd, J = 14.1 Hz, 7.0 Hz), 3.04 – 3.09 (1H, m), 3.38 – 3.42 
(1H, m), 3.51 – 3.55 (1H, m), 3.76 (3H, s), 6.75 (2H, d, J = 8.2 Hz), 6.92 (2H, d, J = 8.8 
Hz), 7.23 (2H, d, J = 8.2), 7.51 (2H, d, J = 8.2 Hz); 13C NMR (150 MHz, CDCl3): 38.0, 
42.6, 44.3, 55.2, 60.7, 113.6, 125.3, 125.3, 125.3, 125.3, 128.1, 130.0, 131.6, 148.6, 
157.9; 19F NMR (564 MHz, CDCl3): -62.3; IR (neat): 3365.8 (w), 2935.4 (m), 2837.7 
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(w), 1613.8 (m), 1511.3 (s), 1323.3 (s), 1244.9 (s), 1161.4 (s), 1113.9 (s), 1068.1 (s), 
1035.2 (s), 1017.1 (s), 837.6 (m) cm-1; HRMS-(DART-TOF) for C18H23F3NO2 [M+NH4]: 
calculated: 342.1681, found: 342.1667. [α]D20 = -33.4 (c = 1.02, CHCl3, l= 50 nm). 
 
Analysis of Stereochemistry: The title compound was compared to the racemic analogue 
derived from the racemic diboration of (but-3-en-1-yloxy)(tert-butyl)dimethylsilane. The 
resulting racemic diboron was transformed into 4-(4-methoxyphenyl)-3-(4-
(trifluoromethyl)phenyl)butan-1-ol.   as described for the enantioenriched variant.  
 
Chiral SFC (Chiracel, OD-H, 35 °C, 3 mL/min, 5% Isopropanol, 100 bar, 210-270nm) – 
analysis of (S)-4-(4-methoxyphenyl)-3-(4-(trifluoromethyl)phenyl)butan-1-ol.   
 
                       Reaction Products                                                Racemic 
 
         
 
 
! 326 
4.14.7 Synthesis of Debromohamigeran E 
ethyl 1-methyl-2-oxocyclopentane-1-carboxylate. (4.143) To an 
oven-dried round-bottomed flask with magnetic stir bar and septum 
was added ethyl 2-oxocyclopentanecarboxylate (4.45 mL, 30 mmol) 
and acetone (99 mL). Add potassium carbonate (8.29 g, 60.0 mmol) and MeI (3.74 mL, 
60.0 mmol) to the flask. Heat the reaction to reflux for 4 hours.  Add MeI (3.74 mL, 60.0 
mmol).  Stir the reaction overnight at reflux.  Cool the flask to room temperature and 
filter the reaction mixture through a plug of SiO2 and wash with acetone.  The collected 
organic fraction was concentrated with rotatory evaporation.  The crude material was 
purified on SiO2 (2.5% to 10% EtOAc in hexanes, stained with CAM) to afford the title 
compound as a colorless oil (4.44 g, 87% yield).  All spectral data are in accord with the 
literature.46 
 
ethyl 1-methyl-2-((methylsulfonyl)oxy)cyclopentane-1-
carboxylate. (4.144) To an oven-dried round-bottomed flask with 
magnetic stir bar and septum was added MeOH (31 mL) and NaBH4 
(1.18 g, 31.3 mmol).  Cool the flask to -78 ºC and add ethyl 1-methyl-2-oxocyclopentane-
1-carboxylate (4.44 g, 26.1 mmol) in MeOH (51 mL). Slowly warm the reaction to room 
temperature and stir for two hours.  Quench the reaction with brine.  The layers were 
allowed to separate and the aqueous layer was extracted with DCM (3 x 60 mL).  The 
combined organic layers was dried with Na2SO4, filtered and concentrated with rotatory 
evaporation.  The crude alcohol was taken up in DCM (57 mL) and cooled to 0 ºC.  Add !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
46 Pichlmair, S.; de Lera Ruiz, M.; Basu, K.; Paquette, L. A. Tetrhedron 2006, 62, 5178 – 
5194.  
O
O
OEt
Me
MsO
O
OEt
Me
! 327 
Et3N (10.9 mL, 78.3 mmol) and MsCl (2.63 mL, 33.9 mmol) to the flask dropwise.  
Allow the reaction to stir at 0 ºC for two hours.  Quench the reaction with water.  The 
layers were allowed to separate and the aqueous layer was extracted with DCM (3 x 30 
mL).  The combined organic layers was dried with Na2SO4, filtered and concentrated 
with rotatory evaporation.  The crude material was purified on SiO2 (15% to 30% EtOAc 
in hexanes, stained with CAM) to afford the title compound as a colorless oil (4.54 g, 
74% yield).  All spectral data are in accord with the literature.48 
 
ethyl 1-methylcyclopent-2-ene-1-carboxylate. (4.145) Prepared 
following literature procedures from ethyl 1-methyl-2-
((methylsulfonyl)oxy)cyclopentane-1-carboxylate.48 All spectral data 
are in accord with the literature. 48 
 
 (1-methylcyclopent-2-en-1-yl)methanol. (4.146) Prepared following 
literature procedures from ethyl 1-methylcyclopent-2-ene-1-
carboxylate.12 All spectral data are in accord with the literature. 48 
 
2,6-dihydroxy-4-methylbenzoic acid. (4.148)  Prepared following 
literature procedures. 47  All spectral data are in accord with the 
literature. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
47 Crombie, L.; Games, D. E.; James, A. W. G. J. Chem. Soc., Perkin Trans. 1, 1996, 22, 
2715 – 2724. 
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5-hydroxy-2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-4-one. (4.149) 
To an oven-dried vial with magnetic stir bar and a teflon septum cap 
was added 2,6-dihydroxy-4-methylbenzoic acid (5.80 g, 34.5 mmol), 
DMAP (0.21 g, 1.72 mmol) and 1,2-dimethoxyethane (26 mL, 
[substrate] = 1.33 M) under N2. The vial was cooled to 0 ºC and added acetone (3.29 mL, 
44.8 mmol) and SOCl2 (3.26 mL, 44.8 mmol). Stir at 0 ºC for 1 hour and allowed to 
warm to room temperature.  Stir at room temperature for 23 hours.  Quench the reaction 
with sat. NaHCO3.  The layers were allowed to separate and the aqueous layer was 
extracted with Et2O (3 x 40 mL).  The combined organic layers was dried with MgSO4, 
filtered and concentrated with rotatory evaporation.  The crude material was purified on 
SiO2 (2.5% to 10% EtOAc in hexanes, stained with CAM) to afford the title compound as 
a white solid (5.06 g, 71% yield).  All spectral data are in accord with the literature.48 
 
2,2,7-trimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl trifluoro-
methanesulfonate. (4.150) To an oven-dried vial with magnetic 
stir bar and a teflon septum cap was added 5-hydroxy-2,2,7-
trimethyl-4H-benzo[d][1,3]dioxin-4-one (5.71 g, 27.4 mmol) and 
dichloromethane (27.4 mL, [substrate] = 1.0 M) under N2. The vial was cooled to 0 ºC 
and added pyridine (7.95 mL, 98.7 mmol) and Tf2O (7.50 mL, 32.91 mmol). Stir at 0 ºC 
for 1.5 hours.  Quench the reaction with H2O.  The layers were allowed to separate and 
the aqueous layer was extracted with Et2O (3 x 30 mL).  The combined organic layers 
was dried with MgSO4, filtered and concentrated with rotatory evaporation.  The crude 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
48 Blencowe, P. S.; Barrett, A. G. M. Eur. J. Org. Chem., 2014, 22, 4844 – 4853. 
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material was purified on SiO2 (5% to 10% EtOAc in hexanes, stained with CAM) to 
afford the title compound as a white solid (8.86 g, 95% yield).   
 
1H NMR (600 MHz, CDCl3): δ 1.71 (6H, s), 2.41 (3H, s), 6.78 (1H, s), 6.84 (1H, s); 13C 
NMR (150 MHz, CDCl3): 22.0, 25.4, 105.5, 106.7, 117.4, 118.0, 118.7 (q, J = 321 Hz), 
148.4, 148.7, 157.2; IR (neat): 1744.4 (s), 1630.0 (s), 1425.0 (s), 1282.9 (s), 1197.4 (s), 
1159.5 (s), 1135.9 (s), 1048.8 (s), 987.0 (s), 854.8 (s), 600.2 (s) cm-1; 19F NMR (564 
MHz, CDCl3): -73.2; HRMS-(DART-TOF) for C12H12F3O6S [M+H]: calculated: 
341.03067, found: 341.03106. 
 
2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-5-yl trifluoromethane-
sulfonate. (4.151) To an oven-dried vial with magnetic stir bar 
and a teflon septum cap was added 2,2,7-trimethyl-4-oxo-4H-
benzo[d][1,3]dioxin-5-yl trifluoromethanesulfonate (8.65 mg, 
25.4 mmol) and THF (150 mL) under N2. The vial was cooled to -78 ºC and added 2M 
LiBH4 in THF (50.8 mL, 102 mmol). Slowly warm the reaction to room temperature and 
stir overnight.  Quench the reaction 1M HCl (aq.).  The layers were allowed to separate 
and the aqueous layer was extracted with EtOAc (3 x 50 mL).  The combined organic 
layers was dried with Na2SO4, filtered and concentrated with rotatory evaporation.  The 
crude material was put through a plug of SiO2 and wash with EtOAc.  To an oven-dried 
vial with magnetic stir bar and a teflon septum cap was added the crude alcohol and 
DCM (254 mL, [substrate] = 0.1 M) under N2. Add 2,2-dimethoxypropane (15.57 mL, 
127.1 mmol) and p-TsOH (cat.). Stir the reaction at room temperature for 1 hour.  
TfO O
Me
O Me
Me
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Quench the reaction with sat. NaHCO3.  The layers were allowed to separate and the 
aqueous layer was extracted with DCM (3 x 30 mL).  The combined organic layers was 
dried with Na2SO4, filtered and concentrated with rotatory evaporation.  The crude 
material was purified on SiO2 (2.5% to 10% EtOAc in hexanes, stained with CAM) to 
afford the title compound as a colorless oil (3.90 g, 47% yield).   
 
1H NMR (500 MHz, CDCl3): δ 1.54 (3H, s). 1.55 (3H, s), 2.32 (3H, s), 4.86 (2H, s), 6.68 
(2H, s); 13C NMR (150 MHz, CDCl3): 21.3, 24.5, 57.1, 100.1, 110.1, 113.4, 117.5, 118.6 
(q, J = 320 Hz), 139.4, 145.0, 152.5; 19F NMR (470 MHz, CDCl3): -73.7; IR (neat): 
1635.2 (w), 1578.1 (w), 1455.3 (m), 1207.3 (s), 1138.0 (s), 975.0 (m), 842.3 (m), 824.6 
(m), 610.9 (m) cm-1; HRMS-(DART-TOF) for C12H13F3O5S [M]: calculated: 326.04358, 
found: 326.04474. 
 
tert-butyldimethyl((1-methyl-3-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-2-(2,2,7-trimethyl-4H-benzo-
[d][1,3]-dioxin-5-yl)cyclopentyl)methoxy)silane. (4.152) 
To an oven-dried 2-dram vial with magnetic stir bar was 
added (1-methylcyclopent-2-en-1-yl)methanol (1.34 g, 12.0 mmol), Cs2CO3 (1.17 g, 3.58 
mmol), B2(pin)2 (4.55 g, 17.9 mmol), tetrahydrofuran (23.9 mL, [substrate] = 0.5 M) and 
methanol (8.23 mL, 203 mmol). The vial was sealed with a teflon septum cap and heated 
to 70 ºC for 12 h. The reaction was cooled to room temperature and concentrated in 
vacuo (ensuring that all methanol has been removed from the residue).  The flask was 
brought to a dry box and charged with solid potassium hydroxide (2.01 g, 35.9 mmol), 
OTBS
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Pd2(dba)3 (274 mg, 0.30 mmol), RuPhos (279 mg, 0.60 mmol), tetrahydrofuran (54 mL), 
toluene (54 mL) and 2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-5-yl trifluoromethane-
sulfonate (3.90 g, 12.0 mmol). The vial was sealed, removed from the dry box, and H2O 
(sparged with N2 for 30 min, 10.8 mL) was added through the teflon septum cap. The vial 
was heated to 70 ºC and stirred for 12 h. The reaction mixture was cooled to room 
temperature and sat. NH4Cl (aq.) (15 mL) was added. The layers were allowed to 
separate and the aqueous layer was extracted with dichloromethane (3 x 40 mL). The 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation in a 4-dram vial. To the residue was added dichloromethane (54 mL) and 
imidazole (7.22 g, 106 mmol).  The reaction mixture was cooled to 0 °C and a solution of 
TBSCl (5.35 g, 35.5 mmol) in toluene (12 mL).  The reaction was sealed and allowed to 
warm to room temperature overnight.  The reaction mixture was quenched with sat. 
NH4Cl (20 mL).  The layers were allowed to separate and the aqueous layer was 
extracted with dichloromethane (3 x 30 mL). The combined organics were dried over 
Na2SO4, filtered, and concentrated by rotary evaporation. The crude material was purified 
on SiO2 (1% to 2% EtOAc in hexanes, stained with CAM) to afford the title compound as 
a white solid (2.70 g, 43% yield). 
 
1H NMR (600 MHz, CDCl3): δ -0.14 (3H, s), -0.14 (3H, s), 0.79 (9H, s), 0.84 (6H, s), 
0.96 (6H, s), 1.13 (3H, s), 1.46 (3H, s), 1.50 (3H, s), 1.70 – 1.76 (1H, m), 1.99 – 2.05 
(1H, m), 2.09 – 2.17 (2H, m), 2.21 (3H, s), 2.82 (1H, d, J = 7.63 Hz), 3.08 (2H, s), 4.84 
(1H, d, J = 14.7 Hz), 5.00 (1H, d, J = 14.1 Hz), 6.39 (1H, s), 6.40 (1H, s); 13C NMR (150 
MHz, CDCl3): -5.8, -5.8, 18.4, 21.5, 23.0, 24.5, 24.6, 24.8, 25.8, 26.0, 26.2, 35.3, 49.4, 
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50.8, 60.3, 68.7, 82.6, 98.0, 114.8, 115.7, 120.4, 136.6, 141.2, 150.7; IR (neat): 3344.9 
(m), 2953.2 (w), 2855.8 (w), 1618.9 (m), 1582.1 (m), 1375.9 (m), 1315.4 (m), 1250.8 
(w), 1135.3 (m), 1079.1 (m), 1061.3 (m), 833.7 (s), 775.0 (s), 668.1 (m) cm-1; HRMS-
(DART-TOF) for C30H52BO5Si [M+H]: calculated: 531.36771, found: 531.36760. 
 
tert-butyldimethyl((1-methyl-3-(prop-1-en-2-yl)-2-(2,2,7-
trimethyl-4H-benzo[d][1,3]dioxin-5-yl)cyclopentyl)-
methoxy)silane. (4.163) To an oven-dried 2-dram vial with 
magnetic stir bar was added Et2O (21 mL) and 2-
bromopropene (675 µL, 7.63 mmol).  Cool to -78 ºC and add tBuLi (11.8 mL, 1.30 M) 
dropwise.  Allow the reaction to stir at -78 ºC for two hours.  Allow the reaction to warm 
to room temperature and stir for 15 minutes.  Once again, cool the flask to -78 ºC and add 
a solution of tert-butyldimethyl((1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)-2-(2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-5-yl)cyclopentyl)methoxy)silane (2.70 g, 
5.09 mmol) in Et2O (24 mL) dropwise.  Allow the reaction to stir at -78 ºC for 45 minutes 
and 15 minutes at 0 ºC.  At 0 ºC, add a solution of I2 (1.94 g, 7.63 mmol) and MeOH (41 
mL) and stir for 15 minutes.  Add NaOMe (824 mg, 15.26 mmol) in MeOH (17 mL) 
dropwise and allow the reaction mixture to warm to room temperature and continue to 
stir for three hours.  Concentrate the reaction mixture by rotary evaporation.  Take up the 
crude mixture in Et2O and wash organic layer with 5% Na2S2O3, 5% NaOH, 5% NaOH 
(with 10% H2O2), 5% Na2S2O3, and brine, sequentially.  The combined organics were 
dried over MgSO4, filtered, and concentrated by rotary evaporation. The crude material 
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was purified on SiO2 (1% to 2% EtOAc in hexanes, stained with CAM) to afford the title 
compound as a yellow oil (2.10 g, 93% yield). 
 
1H NMR (600 MHz, CDCl3): δ -0.15 (3H, s), -0.14 (3H, s), 0.80 (9H, s), 1.25 (3H, s), 
1.39 (3H, s), 1.43 (3H, s), 1.51 (3H, s), 1.48 – 1.55 (1H, m), 1.71 – 1.77 (1H, m), 1.98 – 
2.04 (1H, m), 2.13 – 2.19 (1H, m), 2.20 (3H, s), 2.79 (1H, d, J = 7.6 Hz), 3.03 (1H, d, J = 
10.0 Hz), 3.08 (1H, d, J = 9.4 Hz), 3.20 (1H, q, J = 9.4 Hz), 4.64 (1H, s), 4.69 (1H, s), 
4.75 (1H, d, J = 14.7 Hz), 5.01 (1H, d, J = 14.7 Hz), 6.29 (1H, s), 6.44 (1H, s); 13C NMR 
(150 MHz, CDCl3): -5.8, -5.8, 18.4, 21.6, 22.8, 23.0, 26.0, 26.1, 26.7, 27.1, 34.2, 49.5, 
49.8, 50.1, 60.4, 69.1, 98.0, 110.1, 115.1, 115.5, 122.0, 136.1, 137.0, 145.7, 150.7; IR 
(neat): 2952.9 (m), 2928.6 (m), 2855.6 (m), 1581.8 (m), 1462.4 (m), 1370.3 (m), 1318.5 
(m), 1203.8 (m), 1133.6 (m), 1085.0 (m), 833.9 (s), 775.2 (s) cm-1; HRMS-(DART-TOF) 
for C27H45O3Si [M+H]: calculated: 445.31380, found: 445.31174. 
 
 (3-isopropyl-1-methyl-2-(2,2,7-trimethyl-4H-benzo[d]-
[1,3]-dioxin-5-yl)cyclopentyl)methanol. (4.164) To an 
oven-dried round-bottomed flask with magnetic stir bar was 
added tert-butyldimethyl((1-methyl-3-(prop-1-en-2-yl)-2-
(2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-5-yl)cyclopentyl)methoxy)silane (1.12 g, 2.52 
mmol), PtO2 (30 mg) and EtOAc (133 mL).  Evacuate and refill the flask with H2 (10x).  
The reaction was stirred at room temperature for 3 hours under a H2 atmosphere.  The 
reaction mixture was put through a plug of celite and washed with EtOAc.  The combined 
organics were concentrated by rotary evaporation.  The crude silyl ether and THF (32) 
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was added to an oven-dried round-bottomed flask with magnetic stir bar.  Add TBAF (7.6 
mL, 1M) was added dropwise to the reaction mixture at room temperature and stirred 
overnight.  The reaction mixture was quenched with water.  The layers were allowed to 
separate and the aqueous layer was extracted with EtOAc (3 x 50 mL). The combined 
organics were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The 
crude material was purified on SiO2 (1% to 5% EtOAc in hexanes, stained with CAM) to 
afford the title compound as a colorless oil (593 mg, 71% yield). 
 
1H NMR (600 MHz, CDCl3): δ 0.59 (3H, d, J = 6.5 Hz), 0.88 (3H, d, J = 7.1 Hz), 1.01 
(1H, t, J = 5.28 Hz), 1.23 (3H, s), 1.39 – 1.47 (2H, m), 1.48 (3H, s), 1.51 (3H, s), 1.67 – 
1.79 (2H, m), 2.11 – 2.22 (2H, m), 2.27 (3H, s), 2.62 (1H, d, J = 6.5 Hz), 3.08 (1H, dd, J 
= 10.6 Hz, 5.9 Hz), 3.12 (1H, dd, J = 10.6 Hz, 3.53 Hz), 4.80 (1H, d, J = 14.7 Hz), 5.03 
(1H, d, J = 14.7 Hz), 6.41 (1H, s), 6.51 (1H, s); 13C NMR (150 MHz, CDCl3): 21.7, 22.2, 
24.3, 24.9, 26.5, 29.5, 29.9, 33.7, 49.6, 49.8, 51.3, 60.7, 69.3, 98.3, 115.3, 115.8, 122.0, 
136.6, 137.6, 151.2; IR (neat): 3467.8 (w), 2952.7 (m), 2868.0 (m), 1617.3 (w), 1579.7 
(m), 1453.2 (m), 1382.6 (m), 1313.9 (m), 1281.6 (m), 1159.8 (s), 1026.5 (s), 864.3 (s), 
737.7 (s) cm-1; HRMS-(DART-TOF) for C21H31O2 [M+H-H2O]: calculated: 315.23240, 
found: 315.23312. 
 
3-isopropyl-1-methyl-2-(2,2,7-trimethyl-4-oxo-4H-benzo[d]-
[1,3]dioxin-5-yl)cyclopentane-1-carboxylic acid. (4.166) To a 
round-bottomed flask with magnetic stir bar was added (3-
isopropyl-1-methyl-2-(2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-
O
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5-yl)cyclopentyl)methanol (61.6 mg, 185 µmol), MeCN (1.54 mL) and EtOAc (1.54  
mL).  The reaction mixture was cooled to 0 ºC.  A solution of NaIO4 (0.28 g, 1.30 mmol) 
and RuCl3 (4.2 mg, 18.5 µmol) in H2O (2.5 mL) was added dropwise to the reaction at 0 
ºC over 1 hour.  The reaction was allowed to stir at 0 ºC for 2 hours and at room 
temperature for 12 hours. The reaction was quench with 6M HCl (0.4 mL) and diluted 
with water (4 mL). The aqueous layer was extracted with EtOAc (5 x 5 mL). The 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude material was purified on SiO2 (10% to 30% EtOAc in hexanes, 
stained with CAM) to afford the title compound as a clear oil (27 mg, 41% yield). 
 
1H NMR (600 MHz, CDCl3): δ 0.62 (3H, d, J = 6.5 Hz), 0.84 (3H, d, J = 6.5 Hz), 1.15 – 
1.20 (1H, m), 1.54 (3H, s), 1.62 (3H, s), 1.69 (3H, s), 1.70 – 1.78 (2H, m), 2.09 – 2.14 
(1H, m), 2.21 – 2.27 (1H, m), 2.32 (3H, s), 2.65 – 2.71 (1H, m), 4.66 (1H, d, J = 7.0 Hz), 
6.63 (1H, s), 6.68 (1H, s), 9.56 (1H, br s); 13C NMR (150 MHz, CDCl3): 21.7, 21.9, 22.3, 
24.9, 25.8, 28.3, 29.0, 29.9, 33.5, 49.3, 51.3, 57.1, 105.0, 111.7, 116.2, 125.6, 145.3, 
146.1, 156.8, 162.3, 179.3; IR (neat): 2956.3 (w), 2871.2 (w), 1730.1 (s), 1696.6 (s), 
1616.2 (m), 1571.3 (m), 1265.3 (s), 1210.5 (m), 1157.0 (m), 1045.1 (m), 735.8 (s) cm-1; 
HRMS-(DART-TOF) for C21H29O5 [M+H]: calculated: 361.2015, found: 361.2014. 
 
debromohamigeran E. To a round-bottomed flask with 
magnetic stir bar was added 3-isopropyl-1-methyl-2-(2,2,7-
trimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl)cyclopentane-1-
carboxylic acid (23.0 mg, 63.8 µmol), DMSO (4 mL) and 48% 
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aqueous KOH (0.95 mL). The reaction flask was heated to 60 ºC and stirred for 1 hour.  
The reaction is cool to room temperature and 2M HCl (aq.) is added dropwise until a pH 
of 2 is reached.  The aqueous layer was extracted with EtOAc (8 x 2 mL). The combined 
organics were dried over Na2SO4, filtered, and concentrated by rotary evaporation.  The 
residue is heated at 35 ºC under hi-vac until the DMSO is distilled away from the 
product. 1H NMR showed product contaminated with DMSO.  The determined yield of 
the reaction accounts for the DMSO present. (18.9 mg, 93% yield). 
 
1H NMR (600 MHz, CDCl3): δ 0.59 (3H, d, J = 6.46 Hz), 0.81 (3H, d, 6.46 Hz), 1.03-
1.08 (1H, m), 1.55 (3H, s), 1.72-1.78 (1H, m), 1.82-1.87 (1H, m), 2.11-2.24 (2H, m), 2.29 
(3H, s), 2.63-2.71 (1H, m), 3.66 (1H, d, J = 6.45 Hz), 6.47 (1H, s), 6.67 (1H, s); IR (neat): 
3414.7 (w), 2956.5 (w), 2925.5 (w), 2870.4 (w), 1612.6 (m), 1263.1 (m), 1218.3 (m), 
1192.4 (m), 1010.4 (m), 949.7 (m), 876.3 (m), 735.9 (s) cm-1; HRMS-(DART-TOF) for 
C18H25O5 [M+H]: calculated: 321.1702, found: 321.1716. 
 
The purification of debromohamigeran E proved to be difficult and full characterization 
could not be performed.  Instead, similar to isolation studies 49 , the crude 
debromohamigeran E was subjected to alkylation conditions to form 
triethyldebromohamigeran E. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!49!Wellington, K. D; Cambie, R. C.; Rutledge, P. S.; Bergquist, P. R. J. Nat. Prod. 2000, 
63, 79 – 85.!
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triethyldebromohamigeran E. To an oven-dried vial with 
magnetic stir bar was added debromohamigeran E (10 mg, 31.2 
µmol) and acetone (5 mL). To the vial was added potassium 
carbonate (1.00 g) and MeI (1.00 mL). The vial was sealed and 
heated to 55 ºC overnight. Cool the flask to room temperature and filter the reaction 
mixture through a plug of SiO2 and wash with EtOAc.  The collected organic fraction 
was concentrated with rotatory evaporation.  The crude material was purified on SiO2 
(5% to 10% EtOAc in hexanes, stained with CAM) to afford the title compound as a clear 
oil (8.1 mg, 64% yield). All spectral data are in accord with the literature.49 
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Triethyldebromohamigeran0E:0Comparison0of01H0and013C0NMR0
Shifts0
1H0NMR0(ppm)0 Reported01H0
NMR0(ppm)0
13C0NMR0
(ppm)0
Reported013C0
NMR0(ppm)00.77! 0.77! 13.5! 13.5!0.81! 0.81! 14.3! 14.3!0.85! 0.85! 14.7! 14.7!1.32! 1.32! 22.1! 22.1!1.34! 1.33! 22.1! 22.1!1.37! 1.36! 22.2! 22.2!1.40! 1.40! 28.3! 28.3!1.56! 1.58! 29.2! 29.2!1.81! 1.81! 29.8! 29.8!2.04! 2.05! 34.1! 34.1!2.10! 2.10! 51.8! 51.8!2.29! 2.29! 54.7! 54.7!2.73! 2.73! 56.3! 56.3!3.15! 3.14! 60.0! 60.0!3.62! 3.62! 60.6! 60.6!3.75! 3.75! 64.2! 64.2!3.97! 3.97! 110.9! 110.9!3.98! 3.98! 121.9! 121.9!4.33! 4.34! 123.6! 123.6!4.38! 4.37! 138.9! 138.9!6.49! 6.49! 139.1! 139.1!6.53! 6.53! 155.7! 155.6!! ! 168.5! 168.6!! ! 175.8! 175.8!
 
4.14.8 Spectral Data 
For all published spectral data see the following link: 
http://pubs.acs.org/doi/suppl/10.1021/jacs.5b05477 
See below for examples of 1H and 13C spectra: 
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